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Abstract 
Outbreaks and sporadic cases of viral Infectious Intestinal Disease (IID) are a major 
public health issue resulting in significant morbidity and sometimes mortality each year.  The 
economic costs associated are substantial. 
Laboratory diagnosis of viral IID is important as the many infectious and non-
infectious causes cannot be reliably differentiated using clinical or epidemiological 
characteristics alone. An accurate diagnosis can aid patient management, infection control 
procedures and reduce health care costs by preventing unnecessary treatments, testing for 
alternative causes and hospital stay. It also aids public health surveillance. 
At the start of the research described in this thesis the West of Scotland Specialist 
Virology Centre (WOSSVC) used Electron Microscopy (EM) as the frontline test for 
outbreaks and sporadic cases of IID. However, although rapid on a small number of samples, 
this technique has been shown to be insensitive, laborious and is not suited to testing large 
numbers of samples.  
The research presented in this thesis sought to examine whether molecular diagnostic 
techniques such as conventional gel-based or real-time Polymerase Chain Reaction (PCR) 
assays could be a viable replacement for EM as the frontline test(s) for viral IID in a routine 
laboratory service of this type, and whether their implementation could bring benefits to the 
laboratory service in terms of improved rapidity, sensitivity and throughput. The aim was to 
adapt published PCR methods for use in routine diagnostic work rather than for research 
purposes, an approach that distinguishes this research from previous work in this area.  
In order to achieve this aim, the appropriate PCR techniques were first selected from 
the literature, based on a combination of clinical and laboratory requirements, and were 
adapted for use in the laboratory service. A series of laboratory experiments was then carried 
out in order to compare the sensitivity of the adapted methods to existing techniques such as 
EM and antigen detection assays (EIAs) and to other methods that emerged during the period 
of study including alternative PCR assays. Where found to be suitable, the selected PCR tests 
were implemented in the routine diagnostic service for viral IID. The effects of these changes 
on the laboratory service were then examined.  
The results show that since the introduction of molecular tests at WOSSVC for the  
detection of viral pathogens in cases of gastroenteritis the number of samples tested has risen 
steadily, as have the detection rates for each of the main viral causes of IID. Furthermore, this 
has been achieved at the same time as a substantial reduction in sample turn-around-times. 
Such improvements will have a positive impact in several areas of public health relating to 
viral IID and are discussed fully, including patient management, infection control and national 
surveillance.  
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 Introduction 
1.1. Introduction 
The thesis expounded in this research is that the implementation of the 
molecular method Polymerase Chain Reaction (PCR) for the diagnosis of the viral 
causes of outbreaks and sporadic cases of gastroenteritis can bring significant benefits 
to a routine laboratory service in terms of increased sample throughput, increased 
detection rates and rapidity of results. 
Outbreaks and sporadic cases of Infectious Intestinal Disease (IID) are a major 
public health issue, resulting in significant morbidity and sometimes mortality each 
year. Outbreaks affect more than one person, whilst sporadic cases are individual 
cases that cannot be confirmed as belonging to an outbreak. The associated economic 
costs are substantial. A recent study estimated that IID costs the United Kingdom 
greater than £743 million each year (Roberts et al, 2003). This total was based on 
health-care costs alone, including the cost of hospitalisation, GP consultation, 
treatments and laboratory investigations.  It did not include the cost to business in 
terms of lost workdays, the costs due to missed education or leisure time or the costs 
relating to public health interventions. Furthermore, the costs of outbreaks occurring 
in closed settings such as hospitals, residential homes and the food and leisure 
industry were not included. Few studies incorporate these factors, all of which are 
likely to increase the overall economic burden of IID significantly. 
Laboratory diagnosis of IID is important, as its agents cannot be reliably 
differentiated using just clinical or epidemiological characteristics alone. Accurate 
diagnosis can aid patient management, infection control procedures and reduce health 
care costs by preventing unnecessary treatments, testing for alternative causes and 
hospital stay. Accurate diagnosis also aids public health surveillance. In the UK a 
number of NHS laboratories provide routine diagnostic services for IID. In general 
these laboratories offer testing for bacteria, parasites and viruses. The exact nature of 
the types of tests offered and the pathogens tested for tend to differ between 
laboratories. Specialist centres are also available that offer a more comprehensive 
testing service for some pathogen types.  
Viral pathogens have been shown to be responsible for a significant proportion 
of the IID burden, particularly in sporadic cases in children and outbreaks in all age 
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groups. From a clinical standpoint, the ideal diagnostic test for viral IID in a routine 
diagnostic setting is one that gives an accurate diagnosis in a timeframe rapid enough 
to be useful to clinicians and public health officials. Ideally the test should also be 
high throughput (i.e. able to process a large number of samples simultaneously) as this 
will contribute to the overall test rapidity and is also more likely to mean that the test 
is robust when faced with the fluctuations in sample submissions seen with seasonal 
infections such as viral IID. From a laboratory standpoint the test should also be cost 
effective and easy to use. 
Many methods exist for the diagnosis of viral causes of IID, which differ in 
sensitivity, rapidity, ease of use and throughput. Electron Microscopy (EM), for 
example, is a commonly used method in many diagnostic virology laboratories, 
mainly for historical reasons. However, although rapid on a small number of samples, 
it is limited in terms of sensitivity, is laborious and is not suited to testing large 
numbers of samples. Antigen detection methods such as enzyme immunoassays (EIA) 
and Immunochromatography (ICG) offer similar sensitivity to EM but with the 
potential for improved rapidity, ease of use and throughput. These methods however, 
are not available for all the main viral causes of IID.  
In recent years, the molecular method Polymerase Chain Reaction (PCR) has 
been increasingly used in research on the main causes of viral IID. PCR assays are not 
currently offered by commercial companies but can often be more sensitive than 
either EM or antigen detection methods. Research studies utilising conventional gel-
based PCR have determined that viral pathogens are the main causes of IID in 
children and contribute significantly to IID in adults and immunocompromised 
patients. Furthermore, use of this method has established that norovirus is the 
principle cause of outbreaks of IID. However, early versions of this assay were 
technically challenging to implement as they consisted of numerous steps, which in 
turn reduces the test rapidity, robustness and throughput. Furthermore, such assays 
require a strict laboratory set-up and as a result are expensive to implement. Thus, 
although it is now possible to reduce the number of steps involved in conventional 
PCR, the assay is rarely used as a frontline diagnostic test for IID in routine laboratory 
services and is still mainly used as a research tool. 
Real-time PCR has the potential to overcome many of the pitfalls associated 
with the early PCR methods. Using real-time PCR, all or the majority of the numerous 
steps associated with PCR can be carried out in a single step. Reducing the number of 
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separate steps results in improved rapidity, ease of use and favours high throughput 
and automation. The costs of implementation, equipment and reagents have also 
reduced significantly in recent years as an increasing number of companies compete 
to sell to an increasing number of users. As a result, real-time PCR has characteristics 
that make it more likely to be of value in a routine diagnostic laboratory. 
The West of Scotland Specialist Virology Centre (WOSSVC) is one such 
diagnostic laboratory. The WOSSVC is based at Gartnavel General Hospital in 
Glasgow and it is one of only two specialist virology centres in Scotland. It provides a 
virology service for the whole of Glasgow. In addition, over 40% of its workload is 
from health boards outside Glasgow. The users include hospital-based users, users in 
primary care and general practice and private industry. Each year over 200 000, 
predominantly viral, investigations are performed.  
At the start of the research described in this thesis the WOSSVC used EM as 
the frontline test for outbreaks and sporadic cases of IID. Outbreak testing was carried 
out on samples from all age groups whilst for sporadic cases testing focused on 
samples from children less than 10 years of age and immunocompromised 
individuals.  
The research presented in this thesis sought to examine whether conventional 
gel-based or real-time PCR tests could be a viable replacement for EM as the frontline 
test for viral IID in a routine laboratory service of this type, and whether their 
implementation could bring benefits to the laboratory service in terms of improved 
rapidity, sensitivity and throughput. The aim was to adapt published PCR methods for 
use in routine diagnostic work rather than for research purposes, an approach that 
distinguishes this research from previous work in this area.  
First, the laboratory methods to be used for each step of the molecular service 
were selected from published scientific data based on the combination of clinical and 
laboratory requirements described earlier and knowledge of the equipment available 
in the laboratory. Following this the chosen PCR assays were adapted for use in the 
routine setting and evaluated against existing assays such as EM and commercial 
antigen detection methods. Since this is an evolving field of research, the assays were 
also compared to tests that emerged during the period of study including new EIA 
methods and alternative conventional and real-time PCR methods. Studies aimed at 
amending each assay, in order to reduce the turn-around-times and cost of each 
without affecting their sensitivity were also carried out. Based on this research several 
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changes to the routine service were implemented. The outcomes of these changes on 
the laboratory service in terms of sample throughput, detection rate and turn-around-
times were then examined retrospectively.  
This work will have wide applicability, as it will influence other diagnostic 
laboratories in Scotland and in other countries. It will also influence disease 
surveillance and patient management and form the basis for new services in future. 
1.2. Thesis Outline 
The structure of the thesis is as follows. 
Chapter 2 provides a background to the research carried out in this thesis. It 
begins with an overview of the burden of IID in developing and developed countries 
and discusses the economic costs of IID. This is followed by a discussion of the five 
main viral causes of IID: adenovirus, astrovirus, norovirus, rotavirus and sapovirus. 
Aspects of these pathogens discussed include their virology, classification, elicited 
immune response, epidemiology, the clinical illness in which they result, methods of 
preventing this illness, infection control and treatment. The contribution of viral 
pathogens to the overall burden of IID in sporadic cases of IID in adults and children, 
outbreaks and asymptomatic individuals is then outlined, which provides the rationale 
for decisions taken later in the work concerning the patient groups tested. 
The next section begins by outlining the importance of laboratory diagnosis in 
cases of IID and then discusses the ideal characteristics of a diagnostic test. Following 
this is a review of the available diagnostic assays such as EM, antigen detection, and 
conventional and real-time PCR. The chapter concludes with a description of the 
diagnostic service used at the WOSSVC for viral IID at the start of the research and 
outlines the aim of replacing this EM-based service with a PCR-based service in two 
parts: a norovirus RT-PCR as the frontline test for outbreaks of IID and PCR tests for 
both norovirus and the other viruses as the frontline test for sporadic IID in children 
less than 10 years of age and immunocompromised patients. 
Chapter 3 discusses the PCR and associated methods that were selected for 
evaluation as the proposed replacements for the EM-based service, including the 
sample preparation methods stool extraction and nucleic acid extraction. This is 
followed by a detailed review of the published PCR methods for adenovirus, 
astrovirus, norovirus, rotavirus and sapovirus. This chapter then concludes by 
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outlining which of these PCR tests were adapted for routine use in the proposed 
molecular service and explains the factors that influenced their choice including 
published evaluation data, the clinical and laboratory characteristics of an ideal test 
and the equipment available in the laboratory at the time of development.  
Chapter 4 begins with an explanation of how the new PCR assays were then 
assessed. The assessments are split into two parts: those that focussed on the 
development of a molecular service for outbreaks of IID; and those carried out with 
the development of a molecular service for sporadic cases of IID in mind. Each 
section contains a progressive series of controlled experiments comparing the adapted 
PCR methods (described in Chapter 3) to existing diagnostic methods such as 
Electron Microscopy (EM) and antigen detection methods, and to newer methods that 
emerged as the project progressed.  
The outbreak section begins by comparing the selected norovirus real-time 
PCR method to EM for testing samples from outbreaks of IID. This PCR method is 
then compared to two EIA methods and then two alternative PCR methods for 
norovirus: a conventional gel-based method recommended by a European 
collaboration in 2003, and a real-time PCR method using dual-labelled probes 
(published in 2003). The results of each comparison are discussed and the resultant 
changes to the WOSSVC diagnostic service are described.  
The section on the development of a routine sporadic service begins with an 
experiment attempting to multiplex gel-based methods for the remaining four viral 
pathogens into a smaller number of assays. The resultant assays are then compared to 
antigen detection methods for rotavirus and astrovirus before being compared to four 
different dual-labelled probe-based PCR methods. The results of each comparison and 
the resultant changes to the diagnostic service are then discussed. This section 
concludes with the description of a number of experiments aimed at reducing the turn-
around-times and cost of the resulting service without affecting the sensitivity of the 
assays.  
Chapter 5 contains an analysis of the effects of these test developments on the 
WOSSVC diagnostic service. The chapter begins by summarising the changes made 
to the service between 1999-2006 as a result of the research described above. Various 
measures are then used to examine the outcomes of the service developments, 
including the number of samples submitted for testing (examined by total, by health 
board of origin and by age group), the number of detections made, the number of 
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outbreaks classified as either positive or negative, and the turn-around-times of the 
results. These data are examined for both the outbreak and sporadic service and are 
cross referenced with the service changes to determine whether these resulted in 
improvements in sample throughput, test sensitivity and rapidity of results. 
Contributing to this analysis are the results of a questionnaire, which asked 
laboratories in Scotland to outline their testing protocols for outbreaks and sporadic 
cases of IID. This questionnaire examined how other laboratories use the WOSSVC 
service and examined whether the developments described have resulted in changes to 
their own services. 
Finally, a thorough discussion of all the research findings is presented in 
Chapter 6. Included in this are the likely outcomes of the service developments on 
non-laboratory aspects such as patient management, infection control and national 
surveillance. A discussion of the potential role of the molecular methods in new 
services for the prevention and investigation of outbreaks based on testing non-patient 
samples such as environmental samples is also included.  
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Background To The Research 
2.1. Overview 
This chapter outlines the importance of Infectious Intestinal Disease (IID) in 
public health. Its burden in terms of morbidity and mortality worldwide is discussed 
followed by an in-depth review of the economic cost of IID in developed countries. 
The main viral causes of IID are then reviewed with particular focus on each 
pathogen’s virology, classification, elicited immune response, epidemiology, the 
clinical illness in which they result, methods of preventing this illness, infection 
control and treatment. The contribution viral pathogens make to overall IID in 
children, adults and outbreaks is also discussed. The next section begins by describing 
the characteristics of an ideal diagnostic test for viral IID before outlining the different 
methods available. Electron Microscopy (EM), antigen detection assays, and 
Polymerase Chain Reaction (PCR) methods such as conventional gel-based and real-
time PCR are all described. The advantages and disadvantages of each test type are 
described, together with data on their relative performance. The chapter concludes 
with a description of the West of Scotland Specialist Virology Centre (WOSSVC) 
diagnostic service for viral IID at the start of the research followed by a description of 
the thesis aims for the improvement of this service using molecular methods. 
2.2. Importance Of Infectious Intestinal Disease (IID)  
2.2.1. Mortality And Morbidity Of IID Worldwide 
Infectious Intestinal Disease (IID) results in a substantial burden of morbidity 
and mortality worldwide. It is responsible for approximately 4 billion cases of 
diarrhoea and 3 to 4 million deaths each year (Farthing, 2000; World Health 
Organisation 1996; World Health Organisation 1994).  
In both the developing and the developed world the majority of illness and 
death is borne by infants and children, with the risk increasing as the weaning stage 
ends (Kosek, Bern and Guerrant, 2003). Children in developing countries experience 
most of the total annual burden of IID (Parashar et al, 2003). In economically 
deprived areas such as the Indian subcontinent, Africa and Latin America children can 
experience up to 10 episodes of IID per year. Repeated cases in children leads to 
malnutrition, which can result in impaired growth and development, and death. Most 
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deaths are a result of excessive fluid and electrolyte loss leading to severe dehydration 
and acidosis (Farthing, 1998) although deaths can easily be avoided by the prompt 
administration of fluid and electrolytes. The economic burden of treating IID in 
developing countries often takes up a substantial proportion of the nation’s health-care 
budget.  
The elderly are also at increased risk of severe IID. This is thought to be a 
result of decreasing immune and gastric acid protection. Others at risk of severe IID 
include the immunocompromised (e.g. HIV positive individuals, solid organ 
transplant and bone marrow transplant recipients), individuals with congenital 
abnormalities and travellers (Faruque et al, 2004; Mattila et al, 1992). 
2.2.2. Morbidity And Mortality Of IID In The Developed World 
In developed nations sporadic cases and outbreaks of IID result in significant 
morbidity and sometimes mortality. Sporadic cases are those that cannot be identified 
as belonging to a particular outbreak. In the US an estimated 79 million cases of 
sporadic IID occur each year resulting in approximately 325,000 hospitalisations and 
around 5000 deaths (Frenzen, 2003; Mead et al, 1999). The mortality rate is 
significant when compared to the mortality rates of other infection related deaths in 
the US. For example, cervical cancer, rheumatic fever and hepatitis B virus result in 
approximately 4400, 4800 and 4400 deaths per year respectively (American Cancer 
Society, 2001; American Heart Association, 2001; Kane, 1995). Studies carried out in 
other developed countries have also highlighted a substantial burden of sporadic IID. 
For example, each year Australia experiences an estimated 15 million cases of 
sporadic IID resulting in more than 1 million GP visits and more than 1 million 
missed workdays (Hellard et al, 2003). In the Netherlands an estimated 4.5 million 
episodes of sporadic IID occur each year (Wit MAS et al, 2001). As a result of these, 
more than 80,000 patients require hospitalisation and approximately 300,000 
workdays are missed. A study of sporadic IID in England estimated there to be 
approximately 9.4 million cases each year resulting in 1.5 million GP visitations 
(Wheeler et al, 1999). A telephone study in Ireland concluded that an estimated 3.2 
million cases of IID occurred in 2003 (Acute Gastroenteritis in Ireland, North and 
South - A Telephone Study, 2003). 
Outbreaks of IID (where multiple individuals are affected) are also an 
increasingly recognised problem in developed countries (Meakins et al, 2003; 
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Fankhauser et al, 2002; Lopman et al, 2003). An assessment of outbreaks reported to 
the Heath Protection Agency (HPA) from 1991-2000 showed that there were  more 
than 5000 outbreaks in England and Wales during this time. This total is likely to be a 
huge underestimate of the total number of outbreaks as many are not detected or 
reported each year. Over 50% of the outbreaks that were reported occurred in 
hospitals and residential care homes. Due to the general poor health of many of the 
patients present in hospitals and care homes the risk of significant morbidity and death 
in these settings as a result of IID is increased (Goller et al, 2004). Outbreaks in the 
food and leisure industry are also common with large outbreaks reported in holiday 
camps, hotels, restaurants and cruise ships (Koopmans and Duizer, 2003; Lawrence, 
2004).  
Few studies to date have examined the short and long term sequalae in patients 
with clinically diagnosed IID. Cumberland et al followed up a large cohort of patients 
with sporadic IID and found that a significant proportion had symptoms that persisted 
for longer than previously described (Cumberland et al, 2003). For example, over 
25% of patients had persistent diarrhoea 3 weeks after onset, approximately 12% had 
persistent vomiting and around 33% of adults and children had continued abdominal 
pain. As a result patients were more likely to request a repeat consultation with their 
GP within 3 months of the initial episode. This was especially true in children (those 
aged under 5 years) and the elderly (aged over 60 years). There was also an increased 
rate of hospitalisation and subsequent diagnosis of irritable bowel syndrome in 
patients who had suffered IID. Other studies have also shown an increased risk of 
irritable bowel syndrome after IID (Parry et al, 2003). Helms and colleagues followed 
a cohort of 48,547 patients in Denmark with diagnosed IID (Helms et al, 2002). 
Patients with IID were shown to have an increased risk of mortality both in the short 
and long term. The increased risk was mainly as a result of complications such as 
invasive illness (septicaemia, endocarditis, vasculitis, septic arthritis, etc), intestinal 
perforation, abscesses, and complications of surgery. These complications occurred 
weeks or months after the initial IID episode. 
2.2.3. The Economic Cost Of IID In Developed Countries 
The substantial morbidity caused by IID in developed countries has a 
significant economic impact. Many studies have attempted to measure the overall 
economic burden of sporadic IID. Most have based their estimates on the cost of 
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medical treatment (hospitalisation, Accident & Emergency visitation, GP/physician 
visitations and prescriptions/treatments), missed workdays (due to illness or having to 
care for a relative), laboratory investigations, and transport (of the affected individual 
to the GP/hospital). Garthright et al estimated the cost of sporadic IID in the US to be 
greater than $23 billion per year (Garthright, Archer and Kvenberg, 1988). Similar 
high totals have been estimated in Australia (more than $1000 million Australian 
dollars per annum), Canada ($1.1 billion US dollars per annum), the Netherlands (345 
million euros per year) and England (£743 million) (Hellart et al, 2003; Van den 
Brandhof et al, 2004; Roberts et al, 2003; Todd, 1989). No study has yet measured the 
cost of sporadic IID in Scotland but it is likely to be substantial.  
Most of the published studies described above are likely to be underestimates 
as many do not include the costs to business, the costs of missed education (e.g. at 
school/university), lost leisure time (e.g. interrupted evenings, weekends and 
holidays), and public health interventions (the costs of which are likely to be 
substantial). Furthermore these studies do not include costs relating to post IID 
complications such as repeat GP consultation or hospital admission (described above).  
The cost of outbreaks of IID moreover, has not been included in many of the 
aforementioned studies. Outbreaks of IID in hospitals are a substantial burden and can 
often affect multiple wards, resulting in ward closure, cancelled operations and even 
hospital closure. Few studies have attempted to measure these costs. A recent study by 
Lopman et al estimated the cost of health-care associated outbreaks of norovirus by 
monitoring 3 hospital sites in Avon, England during 2002 (Lopman et al, 2004). In 
total, outbreaks of IID caused by norovirus were found to have cost more than £115 
million-12.5% of the total Health care Associated Infection (HAI) budget or 1% of the 
total NHS expenditure on in-patient service.  
Zingg et al estimated the cost of a single nosocomial outbreak of norovirus 
(Zingg et al, 2005). The costs were estimated based on various factors including 
nursing care, staff sick leave, laboratory testing and the infection control team costs. 
In total, this single outbreak was estimated to cost the US health care system over 
$40,000. A recent study in England estimated the cost of a single norovirus outbreak 
to be greater than £280,000 (Cooke, Goddard and Golland, 2002). 
The cost of outbreaks of IID to the food and leisure industry is also likely to be 
substantial. Large outbreaks result in mass cancellations, emergency treatment, 
refunds and compensation proceedings. Any accompanying bad publicity is likely to 
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affect future bookings. However, no studies have so far attempted to measure these 
costs. 
2.3. Viral Causes Of IID 
There are at least 5 viral causes of IID: rotavirus, norovirus, sapovirus, 
astrovirus and adenovirus. Below is a detailed review of each of the pathogens 
virology, their classification, their elicited immune response, their epidemiology, the 
clinical illness they cause and various methods aimed at preventing, controlling and 
treating these infections due to these causes. This review will show that each of these 
pathogens is genetically complex with genomes that contain areas of significant 
variability between the many types and subtypes. This is important when considering 
the design of molecular assays, which is a major part of the next chapter. The complex 
immune responses elicited are highlighted to show that repeat infections can occur 
with each virus and that infections can occur in all age groups. Their numerous 
sources and transmission routes are also described in order to highlight how difficult 
these pathogens are to control and prevent. Together, these factors ensure that these 
viral pathogens contribute significantly to sporadic illness and outbreaks in all age 
groups. 
2.3.1. Rotavirus 
Rotaviruses were first discovered as a cause of human illness in 1973 by 
Bishop and colleagues using electron microscopy (EM) to examine duodenal biopsy 
specimens from children with gastroenteritis (Bishop et al, 1973). Rotaviruses are 
members of the Reoviridae family. They are icosahedral, non-enveloped viruses of 
70-75nm in diameter. The rotavirus capsid is composed of 3 concentric protein layers 
that enclose the viral genome. Viewed under the EM rotavirus particles have a 
characteristic “wheel-like” appearance (Figure 1) from which their name is derived 
(the latin for wheel is “rota”).  
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Figure 1: Rotavirus as viewed under electron microscopy (Copyright 1994 Veterinary 
Sciences Division) 
 
2.3.1.1. Genome Organisation and Function  
Rotaviruses possess a genome made up of 11 segments of double stranded 
RNA of approximately 18,850 base pairs in length. Each segment codes for 1 protein 
except segment 11, which codes for 2. Of the 12 proteins, 6 are structural (VP1-4, 6 
and 7) and 6 are non-structural (NSP1-6) (Figure 2). At present the role of a number 
of these proteins are unclear.  
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Figure 2: The genome segments and encoded proteins of rotavirus.   
 
Structural Proteins 
VP1 is coded for by gene segment 1. It is a minor component of the central 
core making up 2% of total virion mass. Comparisons of different rotaviruses have 
shown VP1 to be highly conserved both at amino acid and protein levels. It is the 
largest polypeptide and shares consensus sequences with several well-characterised 
RNA dependent RNA polymerases (Valenzuela et al, 1991). 
VP2 is encoded by gene segment 2 and alongside VP1 and VP3, makes up the 
inner core of the rotavirus. It is the most abundant protein of the inner core and it 
encloses the VP1, VP3 and genome (Jayaram et al, 2004). It is highly conserved and 
of the 3 proteins that make up the inner core it is the only one that has nucleic acid 
binding activity. VP2 interacts with VP6 in order to transport metabolites in and 
nascent RNA out during transcription (Prasad et al, 1988). VP2 is also thought to 
have a role in the assembly of the rotavirus particles and is necessary for replicase and 
transcription activity (Mansell and Patton, 1990). 
VP3 is encoded by gene segment 3. It is a minor component of the central 
core. It has sequence homology to other viral polymerases and is thought to have 
guanyltransferase and methyl transferase activity (Chen et al, 1999; Liu et al, 1992). 
The VP4 protein is 775 amino acids long and is the product of gene sequence 
4. Cyro-electron microscopy studies have shown that for every 780 copies of VP7 
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present in the outer layer, there are 120 copes of VP4 (Jayaram et al, 2004). It appears 
as spikes on the capsid surface and is implicated in cell entry, attachment, 
haemagluttination, neutralisation and virulence (Ciarlet and Estes, 2001). The VP4 
region contains several variable regions that define the P serotype (Gorziglia et al, 
1990). 
The VP6 protein is encoded by gene segment 6. It is the major constituent of 
the intermediate layer which contains 260 trimers of VP6 arranged as hexamers on a 
T=13 icosahedral lattice (Mathieu et al, 2001; Jayaram et al, 2004). It is sandwiched 
between the outer T=13 later (VP4/7) and the inner T=1 (VP2) layer. The VP6 is 
essential for transcription of the genome. It also has a structural and immunological 
role and is responsible for the wheel-like appearance of the rotavirus (Greenberg et al, 
1983; Kohli et al, 1987). Although VP6 is more conserved than either VP7 or VP4, 
this region contains variable regions that are used to determine the group (A-G) and 
subgroup antigens (Sg1, Sg2, non Sg 1 or 2, and Sg1+2).  
VP7 is encoded by gene segment 9 and is the only structural glycoprotein. It 
forms the outer layer of the viral capsid and comprises 30% of total virion mass 
(Jayaram et al, 2004). Cryo-electron microscopy reconstructions have identified that 
the outer layer comprises of 780 copies of VP7 which are located at the local and 
strict fold axis at T=13 (Prasad et al, 1990; Jayaram et al, 2004). The VP7 may 
modulate the VP4 function during cell attachment and entry and may also interact 
with cell surface molecules after VP4 attachment (Beisner et al, 1998; Mendez et al, 
1996; Mendez et al, 1999). Comparative studies of various rotaviruses have identified 
at least 6 (A-F) or 9 discrete regions within the VP7 (VR1-9) that show significant 
amino acid divergence (Gouveau et al, 1990; Green et al, 1987). These areas are the 
target of type-specific and cross-reactive neutralisation antibodies and are used to 
determine the rotavirus serotype (G type). Genotypic classification based on the VP7 
region has been shown to match serotype (Goveau et al, 1990).  
Non-Structural Proteins 
NSP1 is coded for by gene segment 5. At present its role is unknown but it is 
thought to have a role in modulating the inate immune response by degrading IFN-3 
(Barrow and Patton, 2005). Sequence analysis shows that this region contains 
extensive sequence variation, although there is a 88 amino acid region present that is 
conserved amongst all rotaviruses (Xu et al, 1994).  
 19 
NSP2 is encoded by gene segment 8.  As with NSP1 its role is currently 
unclear although it is proposed to have a role in RNA replication and packaging 
(Gombold et al, 1985). Studies have also showed it to have nucleoside triphosphate 
activity. Sequence comparisons of mammalian rotaviruses have shown a high level of 
amino acid conservation of over 83% (Patton et al, 1993). The last 75 nucleotides at 
the 5’ end and 23 nucleotides of the 3’ end are nearly identical among rotaviruses. 
NSP3 is coded for by gene segment 7. It has shown to be an RNA binding 
protein and therefore it has been proposed that it may have a role in re-initialisation of 
translation protein synthesis (Boyle and Holmes, 1986). Others have suggested that it 
may have a role in viral replication in the gut and then subsequent spread to other 
tissues (Mossol and Ramig, 2002). Sequence analysis of the NSP3 shows that more 
that 75% is conserved amongst mammalian rotaviruses (Rao et al, 1995). However, 
using this method, rotaviruses can be split into 3 evolutionary groups: SaII, Wa and 
S2. Of particular interest are the eighty nucleotides in the 3UTR region, which are 
highly conserved (Pang et al, 2004).  
The NSP4 is coded for by gene segment 10. It is the most studied NSP. 
Studies have shown it to interact with both VP6 and VP4 and it has been suggested 
that it may be involved in outer capsid assembly (Lynn et al, 2005).  Several studies 
have suggested that NSP4 is also a viral enterotoxin (Parr et al, 2006; Ball et al, 
2005). The proposed mechanism of action is via the activation of a signal transduction 
pathway resulting in altered intestinal epithelial transport, membrane destabilisation 
and altered calcium levels in the endoplasmic reticulum (Tian et al, 1995; Ball et al, 
1996; Horie et al, 1999). Studies using fusion proteins, containing 86-175 aminoacids 
of the murine NSP4 (expressed in E-coli), were found to cause severe diarrhoea when 
given to CD1 mice. Furthermore, sequence differences in the NSP4 have been 
observed between symptomatic and asymptomatic rotavirus infections (Kirkwood et 
al, 1996; Ward et al, 1997). However, others have failed to confirm either of these 
findings (Angel et al, 1998). Sequence analysis of the NSP4 shows there to be 2 hyper 
variable regions allowing rotaviruses to cluster into 2-5 groups (Cunliffe et al, 1997; 
Kirkwood et al, 1999). There are two main groups for human rotaviruses (A and B). 
These correlate with the VP6 subgroups-VP6 Sg1 matches with NSP4 A and VP6 Sg2 
matches with NSP4 B (Iturriza-Gomara et al, 2003). 
NSP5 is encoded by gene segment 11. It is the only segment with more than 
one Open Reading Frame (ORF) (Mitchell and Both, 1988). These are overlapping. 
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The ORF1 is 198 amino acids in length and the ORF2 is 92 amino acids. ORF2 codes 
for NSP6. At present their roles are unclear. Transient expression of this protein in 
uninfected cells has provided evidence for its participation in the formation of 
“viroplasms”, which are thought to be key structures for the replication of rotavirus 
(Lopez et al, 2005).  
2.3.1.2. Classification  
Serological cross reactivity of the inner capsid protein VP6 has determined 
there to be 7 groups of rotavirus (A-G) (Greenberg et al, 1983; Kapikian et al, 1981). 
Groups A-C are human and animal pathogens whereas the remainder are pathogens of 
animals only (Estes, 2001). Group A rotaviruses can be further divided into four 
subgroups (subgroup 1, subgroup 2, subgroup 1+2, subgroup non 1 and non 2) based 
on reactivities with two VP6 specific monoclonal antibodies. Subgroup 1 includes 
mostly animal and some human rotaviruses. Subgroup 2 includes mostly human 
rotaviruses, whereas subgroup 1+2 and subgroup non 1 and non 2 are mostly animal 
pathogens and are rarely associated with infection in humans. 
Strains of rotavirus are classified by the analysis of VP4 and VP7 surface 
proteins using a similar method to the one that is used to classify influenza. Using this 
method rotaviruses are attributed G types (based on the VP7 Glycoprotein) and P 
types (based on the VP4 Protease sensitive protein). So far, at least 14 G types and 20 
P types have been recognised (Rao, Gowda, and Reddy, 2000). This enormous 
antigenic and genetic diversity is the result of a number of mechanisms. The principle 
method of generating rotavirus diversity is thought to be re-assortment (known as 
antigenic shift) (Iturriza-Gomara et al, 2001). VP4 and VP7 are coded for on different 
RNA segments. Dual infection of a host by different rotavirus strains can lead to re-
assortment and the subsequent emergence of new G and P type combinations. Dual 
rotavirus infections are common. A recent study in the UK found that 2% of rotavirus 
infections were of mixed type (Iturriza-Gomara et al, 2000). Rates of mixed infection 
in other countries are thought to be higher (Ahmed et al, 1991; Unicomb et al, 1999; 
Jain et al, 2001). Although intra-group re-assortment has been described on a number 
of occasions it has yet to be documented for different rotavirus groups. One 
hypothesis is that rotavirus groups differ in their genome end terminal RNAs and this 
may prevent inter group re-assortment. 
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Other methods of generating rotavirus diversity are thought to include the 
accumulation of point mutations (known as antigenic drift) and recombination 
(Blackhall et al, 1996; Desselberger, 1996; Ramig, 1997).   
The introduction of animal rotaviruses or animal/human strain re-assortments 
has also been raised as possible contributors to rotavirus diversity (Cook et al, 2004; 
van der Heide et al, 2005; Palombo, 2002).  Studies have demonstrated that animal 
rotaviruses can cause symptomatic infection in humans (Desselburger et al, 2001; 
Theil, 1990; Kojima et al 1996; El-Attar et al, 2001). For example, Nakagomi and 
Nakagomi found a feline G3 rotavirus infection in a child with a pet cat (Nakagomi 
and Nakagomi, 1989). Molecular studies on human rotavirus type G9 have shown it to 
share genetic similarities to porcine strains thus raising the possibility that it may have 
been recently introduced from pigs (Iturriza-Gomera et al, 2000; Hoshino et al, 2005; 
Teodoroff et al, 2005). The clinical and epidemiological characteristics of G9 
infection compliment this view as it tends to occur in older age groups and cause more 
severe infection when compared to common rotavirus strains (Widdowson et al, 2000; 
Cubitt, Steele and Iturriza, 2000; Iturriza-Gomara, Kang and Gray, 2004). 
Furthermore this type had not been detected in the UK prior to 1995. Dual rotavirus 
infection with animal and human types has also been demonstrated (Nakaomi et al, 
1994; Holmes et al, 1999).  
2.3.1.3. Immune Response 
After primary infection, the immune response to rotavirus is mainly humoral. 
This response is thought to be homotypic although there is partial protection against 
other serotypes (Gorrell and Bishop, 1999). This has been confirmed by volunteer 
transmission and vaccination studies that have shown that natural infection or 
vaccination protects from severe disease in subsequent infections (Davidson, Hogg 
and Kirubakaran, 1983; Bishop et al, 1983; Hjelt et al, 1985; Bhan et al, 1993; Ward 
and Bernstein, 1994). However, although partial protection is elicited after primary 
infection subsequent infections occur throughout life. Valazquez and colleagues 
examined 200 Mexican infants over a 5-year period (Velazquez et al, 1996). By 2 
years of age approximately 96% of infants had had a primary rotavirus infection. Over 
the same period approximately 70% had a second rotavirus infection and by 5 years of 
age over 10% had suffered greater than 5 episodes of rotavirus. Cases of rotavirus in 
adults are being increasingly recognised, again highlighting partial protection 
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(Gonzalez-Losa et al, 2001; Wenman et al, 1979; Echeverria et al, 1983; Cubitt and 
Holzel, 1980; Holzen et al, 1980; Dupuis et al, 1995; Linhares et al, 1981). Some 
studies have shown that protection correlates with the formation serum IgA antibodies 
targeting VP4 and VP7 antigens and the VP6 capsid antigen (Ward, Bernstein and 
Shukla, 1989; Hjelt et al, 1987). Other studies have highlighted the importance of 
IgG, IgA and IgG or neutralising antibody (Clemens et al, 1992; O’Ryan et al, 1994; 
Velazquex et al, 2000). Cytotoxic T Lymphocytes (CTL) responses have been 
detected but their exact role has yet to be determined (Chiba et al, 1986; Chiba et al, 
1993). 
2.3.1.4. Epidemiology 
Group A rotavirus has a worldwide distribution and is the predominant cause 
of childhood gastroenteritis in the developed and developing world. In temperate 
regions rotavirus infections occur predominantly during the winter months (Cook et al 
1990). However, a recent study highlighted that the seasonality of rotavirus infections 
in Japan has shifted from winter to early spring (Suzuki et al, 2005). The reason for 
this is unclear. The seasonality is less defined in tropical areas with infections 
occurring all year round (Iturriza-Gomarra et al, 2000; Kapikian et al, 1976).  
Sources of rotavirus infection include individuals with asymptomatic 
infection. A recent case control study by de Wit et al detected rotavirus in 0.6% of 
control samples (de Wit et al, 2001). More recent studies using increasingly sensitive 
tests have detected higher rates (Amar et al, 2007). Individuals with long term 
shedding (4-57 days) and severe illness (as they have been shown to have a higher 
viral load in faecal samples (Richardson et al, 1998; Kang et al, 2004)) are another 
source of illness. Recent evidence also suggests interspecies transmission of rotavirus 
as numerous animal and human strains have been shown to share genetic and 
antigenic features (see section 2.3.1.2).  
Group A rotavirus has a low infectious dose (Goldman, 1992; Bishop, 1996). 
As a result transmission is person to person and occurs mainly via the faecal oral route 
(Al Frayh et al, 1987; Dennehy, 2000; Vipond, 2001). Evidence also points towards 
spread via the respiratory route (Price et al, 1986; Goldwater, Chrystie and Banatvala, 
1979). Studies using aluminium surfaces have shown rotavirus to remain stable for up 
to 60 days, suggesting transmission via contaminated fomites (Sattar et al, 1986; 
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Koopmans and Duizer, 2004; Abad, Pinto and Bosch, 1994). Other forms of 
transmission include contaminated food and water.  
Most rotavirus infection occurs in infants greater than 3 months of age 
(Sharma et al, 2002). Infants under 3 months can have symptomatic infection but 
most seem to be protected from severe infection, probably as a result of maternal 
antibody (Crawley et al, 1993).  
Adults are also at risk of rotavirus infection. However, although adults may 
obtain infection from the sources described above, the greatest risk is from rotavirus-
infected children (Zissis et al, 1976; Wenman et al, 1979; Grimwood et al, 1983; 
Anderson and Weber, 2004). Wenman et al showed child to parent transmission to be 
a common event, with 36 of 102 adults who had children with rotavirus infection also 
found to be positive for the virus. Infection has also regularly been documented in 
medical staff that are in frequent contact with rotavirus-infected infants (Samadi, Huq 
and Ahmed, 1983; Hjelt et al, 1985). As a result the seasonality of adult infection 
probably reflects that of children (Nakajima et al, 2001). However, Cox and Medley 
tested routine serum samples from hospitalised adults and detected IgM to rotavirus 
throughout the year thus suggesting a sporadic distribution similar to that in tropical 
areas (Cox and Medley, 2003).  
Other adults at risk of rotavirus infection include travellers (Keswick et al, 
1982; Vollet et al, 1979; Bolivar et al, 1979). A recent study of travellers returning 
from Jamaica with diarrhoea found that rotavirus infection was second only to 
Enterotoxigenic E-coli (Steffen et al, 1999).  
Outbreaks of rotavirus have been documented but are rare (MMWR, 2000; 
Halvorsrud and Orstavik, 1980; Abbas and Denton, 1987; Friedman et al, 1988; 
Foster et al, 1980). Closed settings such as hospitals, care homes, and day care centres 
are at particular risk.  
Evidence from molecular epidemiological studies has shown that different G 
types co-circulate at any location at any given time. A study of UK strains detected 
between 1995-1999 found a total of 15 different strains circulating during this period. 
Over 95% were of types G1-4  (Iturriza-Gomara et al, 2001).  This epidemiological 
pattern has also been seen in other countries. Santos and Hishino examined 45,571 
strains from 124 studies (1989-2004) carried out in 52 countries from 5 continents 
(Santos and Hishino, 2005). They found that types G1-4 (in conjunction with either 
P6 or P8 types) accounted for 88% of all circulating types. The newly emerged G9 
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was the fourth most important rotavirus type (4.1%). Different types were 
predominant in different geographical areas. For example, G1/P8 type accounted for 
more than 70% of strains in North America, Europe and Australia. However, this type 
accounted for only 30% of strains in South America and Asia. Another emerging G 
type (G5) has recently become common in South America. 
Group B rotaviruses show a different epidemiology to that of group A 
rotaviruses (Sen et al, 2001; Kelkar and Zade, 2004). Group B rotaviruses were first 
discovered as a cause of human illness in 1982 when large outbreaks of severe cholera 
like-illness were described in adults in China (Yang et al, 2002). Since then several 
outbreaks have been reported in China and more recently in India and Bangladesh 
(Barman et al, 2004; Ahmed et al, 2004; Sanekata et al, 2003; Kobayashi et al, 2001). 
Group C rotaviruses cause illness similar to that of group A rotaviruses and 
can affect children and adults (Kuzuya et al, 2003; Nilsson et al, 2000; Gabbay et al, 
1999; Souza et al, 1998; Teixeira et al, 1998; Otsu, 1998).  Studies in numerous 
countries have shown high sero-positive rates suggesting that infection is common 
(James et al, 1997; Nilsson et al, 2000; Steele and James, 1999; Jiang et al, 1995; 
Iturriza-Gomara et al, 2004). Targeted studies using sensitive molecular tests have 
detected group C rotavirus in approximately 1-10% of all cases of infantile 
gastroenteritis (Sanchex-Fauquier et al, 2003; Yan et al, 2004; Phan et al, 2004; 
Schnagl et al, 2004; Castello et al, 2002; Cunliffe et al, 2001). These studies have also 
highlighted that primary group C rotavirus infections may occur in children older than 
those that suffer group A rotaviruses. 
2.3.1.5. Clinical Illness 
Infantile rotavirus infection has an incubation period of approximately 1-2 
days followed by a sudden onset of watery diarrhoea lasting between 4-7 days. 
Diarrhoea is often accompanied by vomiting (Sharma et al, 2002; Bishop, 1996). The 
severity of the illness varies (Ruuska and Vesikari, 1990). For example, asymptomatic 
infection by so called “nursery strains” have been described (Crawley et al, 1993). 
More serious infections have also been described sometimes leading to neurological 
abnormalities resulting from electrolyte imbalances (Hung et al, 2003; Jones and 
Blikslager, 2002; Lin et al, 1996).  A recent study by Blutt et al detected virus and 
antigen in the serum of both animals and children raising the possibility that rotavirus 
may also escape from the gastrointestinal tract and cause disease elsewhere in the 
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body (Blutt et al, 2003; Blutt et al, 2007). Studies have demonstrated rotavirus in the 
Central Nervous System (CNS) of patients with neurological illness such as meningo-
encephalitis but whether this is a cause, bystander or contaminant is unclear (Lynch et 
al, 2003; Lynch et al, 2001; Pager et al, 2000). Rotavirus has also been demonstrated 
in the kidney, liver and lung (Nuovo et al, 2002; Gilger et al, 1992). Other reported 
complications of rotavirus infection include necrotising enterocolitis (Rotbart and 
Levin, 1983), infantile acute hemorrhagic edema, and possible intussusception (Bines 
et al, 2004; Robeinson et al, 2004; Nelson et al, 2002; Rennels et al, 1998; Mulcahy 
et al, 1982; Konno et al, 1978; Sharma et al, 2004; Boccia et al, 2001; Di lernia, 
Lombardi and Lo Scocco, 2004). 
In immunocompromised children, chronic and severe rotavirus infections have 
frequently been documented (Saulsbury, Winkelstein and Yolken, 1980; Troussard et 
al, 1993; van Kraaij et al, 2000). In 1980 for example, 2 children with primary 
immune deficiencies developed chronic diarrhoea that improved after the 
administration of human breast milk containing high titres of rotavirus antibody 
(Gilger et al, 1999). Gilger et al also described 4 children with various immune 
deficiencies who were suffering from chronic diarrhoea and were found to have 
rotavirus present in the liver and kidney.  
The clinical illness seen in adults has mainly been determined through 
volunteer studies (Hardy, 1987; Jewkes et al, 1981; Kapikian et al, 1983; Ward et al, 
1990; Ward et al, 1986). The incubation period seems to be longer than in children (2-
6 days) and symptoms of diarrhoea, fever, headache, malaise, nausea and cramping 
last 1-4 days. Case reports have indicated a similar incubation period and symptoms 
to those ascertained through volunteer studies, although reports from elderly patients 
have shown more prolonged symptoms and shedding.  
Rotavirus infection has also been described in adult solid organ transplant 
patients, Bone Marrow Transplant (BMT) patients, patients with cancer and adults 
who are infected with HIV. Bolivar et al investigated 90 adult patients with solid 
tumours or leukaemia (Bolivar et al, 1983). Two patients developed rotavirus 
infection with subsequent graft versus host disease. Yolken et al examined 78 adult 
BMT patients and found evidence of rotavirus infection in 9 (Yolken et al, 1982). 
Most of those affected suffered abdominal cramps and diarrhoea. Six developed 
respiratory illness (as proven by chest infiltrates on a chest radiograph) of whom five 
subsequently died.  
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Other reports of rotavirus pneumonitis have included a patient undergoing 
steroid treatment for multiple sclerosis (Thomas, Pollok and Gazzard, 1999). 
Stelzmueller and colleagues described rotavirus cases in 3 adult solid organ transplant 
patients. All developed enteritis and one developed toxic megacolon with ulcerative 
colitis (Stelzmueller et al, 2005). In each case the rotavirus infection was associated 
with secondary infections and prolonged hospitalisation.  
Albrecht et al followed 66 HIV positive patients from 1987-1991. Thirteen 
were found to be positive for rotavirus. These patients had evidence of chronic 
diarrhoea for up to 8 weeks duration (Albrecht et al, 1993). Other studies have also 
described chronic diarrhoea and shedding in HIV positive individuals (Liste et al, 
2000). 
2.3.1.6. Treatment  
Treatment of infantile rotavirus is unnecessary in most cases. However, when 
needed, treatment relies upon oral, intramuscular or intravenous re-hydration 
(Sachdev, 1996; Mahalanabis et al, 1995). The use of probiotics has also been 
examined with some studies showing reduced duration of diarrhoea (Szajewska and 
Mrukowicz, 2001). As mentioned above, breast milk containing anti-rotavirus 
antibodies has also been used (Saulsbury, Winkelstein and Yolken, 1980; Schoub et 
al, 1978).  Recent studies using nitrazoxanide, a thiolzolide anti-infective agent, have 
shown it to reduce the duration of symptoms in paediatric patients (Rossignol and 
Gohary, 2006; Rossignol et al, 2006). 
Treatment in adults is similar to that advocated for children. Oral rehydration 
and (if needed) pain relief utilising codeine, loperamide and diphenoxylate have been 
used. The use of oral human immunoglobulin has also been found to be of benefit. For 
example, Guarino et al noted a reduction in diarrhoea duration (76 hours vs 131 
hours) following this treatment. Such formulations have also been used in the 
immunocompromised (Guarino et al, 2002; Guarino et al, 1997; Guarino, 1996; 
Guarino et al, 1996; Guarino et al, 1994; Guarino et al, 1991). 
2.3.1.7. Control And Prevention  
Controlling rotavirus infections is difficult due to its low infectious dose, 
environmental stability and possible respiratory spread (Taylor and Greenough, 1989; 
Le Baron et al, 1990). Most measures are based on universal precautions (frequent 
 27 
hand washing is important for example) and are similar to those outlined for norovirus 
infection (Rao, 1995; Sattar et al, 1994).   
Rotavirus vaccines, however, have shown promise in prevention. The first 
such vaccine was a bovine strain tested in Finnish children in the 1980s (Vesikari et 
al, 1983). This vaccine was found to be safe and resulted in protection against repeat 
challenge, and partial cross-protection from other rotavirus types. However, 
development was halted after further clinical trials in Rwanda and Gambia showed 
reduced effectiveness (Georges-Courbot et al, 1991; Hanlon et al, 1987). Similar 
inconsistent results were found with other animal mono-valent vaccines (Bernstein et 
al, 1995; Snodgrass et al, 1984). 
Multi-valent vaccines containing animal strains and mono-re-assortments of 
human outer capsid strains G1-4 were tested in the early 1990s (Kapikian et al, 1996). 
In one trial 1278 children aged between 5-25 weeks were given three doses (at 2, 4, 
and 6 months) of a multi-valent vaccine. The vaccine resulted in 50% protection from 
rotavirus infection. In those infected with rotavirus there was a 60-92% reduction in 
severe gastroenteritis and 100% protection from severe dehydration (Bernstien et al, 
1995; Rennels et al, 1996; Santosham et al, 1997; Joesuu et al, 1997). Rotashield™, 
as the vaccine was called, was approved by the FDA in the US in 1998. However, 
after the administration of more than 1.5 million doses in the first 10 months, an 
excess of intersussception in vaccinated children was detected by the vaccine adverse 
event monitoring system (MMWR, 1999; Murphy et al, 2001). The risk of 
intersussception in vaccinated children was estimated to be 1 in 2500 and may have 
resulted in upwards of 1600 cases. This risk was deemed to be too great in a country 
where the actual risk of mortality due to rotavirus was 1 in 100,000. The vaccine was 
immediately removed from the childhood vaccination schedule. However, recent re-
appraisal of the data by scientists at the US National Institute of Health found no 
evidence of an overall increased risk of intersussception (Roberts, 2004). Since then 
other vaccines have been developed. A mono-valent (G1) vaccine has recently been 
licensed in Mexico (Perez-Schael et al, 2002). Another monovalent and a multi-valent 
(G1-4 and P1) vaccine has recently been trialled with promising results (Glass and 
Parashar, 2006). A hexa-valent vaccine (for types G1-4, 8 and 9) is also being trialled 
(Roberts, 2004; Bonn, 2004). 
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2.3.2. The Caliciviruses: Norovirus And Sapovirus 
Norovirus and sapovirus are two of the four genera in the Caliciviridae family 
(Green et al, 2000; Thiel and Konig, 1999). The remaining two genera are vesivirus 
and lagovirus, which are animal viruses. Norovirus was first discovered in 1968 in the 
faecal samples of students and teachers from a school outbreak of gastroenteritis in 
Norwalk, Ohio, US (Kapikian et al, 1972). Sapovirus was detected in 1976 by 
Madeley and Cosgrove and later during a sequence of outbreaks at a home for infants 
in Sapporo, Japan (Madeley and Cosgrove, 1976; Chiba et al, 1977). Caliciviruses are 
non-enveloped with a diameter of 27-35nm. Under electron microscopy the surface of 
the viral particles have “cup-like” depressions (Figure 3 and Figure 4) from which 
these viruses get their name (“Calici” is latin for goblet/cup). Caliciviruses are 
positive sense, single stranded RNA viruses with a genome of approximately 7.7kb in 
length. 
Figure 3: Norovirus as viewed under electron microscopy. 
Figure provided by David Brown, Health Protection Agency, Colindale. 
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Figure 4: Sapovirus as viewed under electron microscopy.                                               
Figure provided by David Brown, Health Protection Agency, Colindale. 
 
2.3.2.1. Genome Organisation And Function 
Norovirus Genome Structure 
Most understanding of the norovirus genome organisation and function has 
come from expression studies with cDNA clones and recombinant expression systems 
(Hardy, 2005). These studies have shown that noroviruses are genome protein linked 
at the 5’ end and polyadenylated at the 3’ end (Jiang et al, 1993; Lambden et al, 
1993). Noroviruses have 3 ORF. ORF1 codes for the non-structural proteins (p48, 
NTPase, p22, VPg, 3C like protease and the RdRp). ORF2 codes for the major capsid 
protein VP1 whereas ORF3 codes for the minor structural protein VP2 (Figure 5). 
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Figure 5: The genomic structure of the caliciviruses.                                                        
Figure taken from: Atmar and Estes, 2001. 
 
 
 
Norovirus Non-Structural Proteins 
The ORF1 is more conserved than either the ORF2 or ORF3. However, 
significant variation can still be found. The non-structural protein p48 is located at the 
N terminal protein of the ORF1 and varies in both length and sequence between 
different norovirus genogroups (Hardy, 2005). Its role is currently unknown but it is 
thought to play a role in the regulation of cell proliferation. The p41 NTPase is similar 
in sequence to the 2C in picornaviruses. Experiments suggest it is an NTPase without 
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helicase activity with similar activity to the polio 2C (Pfister and Wimmer, 2001). 
Sequence analysis of different noroviruses suggests that nucleotide homology can be 
as low as 36% in this region (Atmar and Estes, 2001; Katayama et al, 2002). The p22 
protein is also of unknown function.  It holds a similar position to that of the 3A in the 
poliovirus genome. As a result it has been suggested that it may have a role in 
membrane localisation of replication complexes (Belliot et al, 2003). Sequence 
analysis of this region has highlighted areas of significant variation with similarities 
of approximately 50% (Katayama et al, 2002).  VPg is a protein of 15kDa in length 
and is found covalently linked to genomic and subgenomic mRNA (Burroughs and 
Brown, 1978). Experiments using caliciviruses devoid of VPg have found them to be 
non-infectious and FCV devoid of VPg has reduced viral protein synthesis 
(Daughenbaugh et al, 2003). Therefore it has been suggested that VPg is involved in 
ribosome recruitment to viral RNA. 3Clpro is similar in sequence to the picornavirus 
3C and is thought to be the viral protease. The RNA dependent RNA polymerase has 
similar structural and catalytic elements to the RdRp of other RNA viruses (Ng et al, 
2002; Ng et al, 2004). Sequence analysis of the VPg, 3Clpro and the RNA polymerase 
show that these regions are reasonably conserved amongst norovirus genogroups with 
similarities of approximately 70% (Katayama et al, 2002). 
Norovirus Structural Proteins 
The structural proteins VP1 and VP2 make up the norovirus capsid. X-ray 
crystallography has shown the capsid to be composed of 90 dimers of VP1 with a 
small number of VP2 copies (Prasad et al, 1994). These are together in a T=3 
icosahedral virion (Prasad et al, 1996; Prasad et al, 1999).  
Studies of VP1 have shown that it folds into 2 domains linked together by a 
flexible hinge region: S (shell) and P (protrusion). S is essential for the icosahedral 
virion whereas the P domain forms the arch-like structures extending from the shell. 
The P domain has 2 sub-domains (P1 and P2). P1 and P2 correspond to the leg and 
the top of the arch-like capsomere and contain substantial variation structurally. This 
is of two types: the orientation with respect to the S domain and the size of the P2 
region. On an amino acid and nucleotide level, P1 is moderately conserved. However, 
sequence analysis of the P2 region shows it to be highly variable (Chen et al, 2004). 
Changes in the amino acid sequence are likely to result in structural variations in the 
size and shape of the determinants of cell binding, antigenicity and host specificity 
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(Chen et al, 2004). This region is also thought to determine the ABO histo 
susceptibility discussed below (see section 2.3.2.3)(Tan et al, 2003). The P2 region is 
under immune pressure and thus accumulation of amino acid changes occurs rapidly. 
For example, analysis of the P2 region in an immunocompromised patient with 
chronic norovirus infection detected up to 32 amino acid changes in one year (Nilsson 
et al, 2003).  
The VP2 is a protein of 208-268 amino acids. in length with a molecular 
weight of 22-29kDa. The nucleotide sequence of the VP2 region varies significantly 
between strains (Seah et al, 1999; Katayama et al, 2002). It is a basic protein, which 
suggests it may bind RNA and be involved in RNA packaging. 
Sapovirus Genome Structure 
Sapoviruses have two or three open reading frames depending on genotype 
(Figure 5). Of the five genotypes currently recognised. GI and GIV and GV are 
predicted to have a third ORF (Schuffenecker et al, 2001).  
The 2C-like NTPase (NTPase), VPg, 3C-like protease, RNA-dependent RNA 
polymerase, and capsid protein (VP1) are encoded in the ORF1 polyprotein, which is 
afterwards cleaved into the nonstructural and structural proteins (Oka et al, 2005). 
The roles and genetic variability of each of the non-structural proteins are likely to be 
similar to those of the norovirus genome discussed above. The ORF2 codes for minor 
structural proteins of unknown function (Vinje et al, 2000).  
Like norovirus, the capsid region of the sapovirus contains most of the 
nucleotide variation. Analysis of the amino acid sequence of the sapovirus genome 
shows that the capsid region can be separated into 3-4 regions (Okada et al, 2006). 
Two of these regions contain significant variation: the N terminal variable and the 
central variable region contain significant variation. The other two regions, known as 
the N terminal region and the C terminal region show more conservation between 
genogroups and strains. Chen et al suggested that the CVR region is homologous to 
the P2 region of the noroviruses in that it is located on the viral surface and may 
confer strain/antigen specificity (Chen et al, 2004). 
2.3.2.2. Classification 
Historically, noroviruses have been classified using cross-challenge studies in 
volunteers and cross-reactivity by Immune EM. However, this method has poor 
accuracy and reproducibility. Serotyping with neutralisation is not possible as there is 
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no cell culture system available (Duizer et al, 2004). As a result, nucleotide 
sequencing has played a major role in norovirus characterisation. Four regions have 
been used for classification (Ando et al, 2000; Vinje et al, 2004): region A (the 
RdRp), region B (the 3’ end of the ORF1), region C (short stretch near to the 5’ end of 
ORF2) and region D (located at the 3’ end of the ORF2). Nucleotide sequencing has 
tentatively suggested that there are 5 assigned genogroups, each containing a number 
of clusters and strains (Fankhauser et al, 2002). Zheng et al aligned the capsid protein 
sequences of 164 noroviruses and found genogroups, clusters and strains to differ by 
41-61%, 15-45% and 0-14% respectively (Zheng et al, 2006). Using sequencing, 
genogroup 1 and 2 were found to contain the largest number of norovirus clusters. 
There are at least 8 in genogroup 1 and 17 in genogroup 2. The genogroups 1, 2 and 4 
are known to cause human infections. Genogroups 3 and 5 contain animal 
noroviruses.  
Classification of sapoviruses is also an evolving process and because of the 
issues highlighted with norovirus above has thus far relied upon nucleotide 
sequencing methods. Various classification schemes have been proposed. Vinje et al 
proposed 3 genogroups based on the sequence analysis of the capsid region (Vinje et 
al, 2000). However, more recent studies have suggested that there are 5 or 6 
genogroups, each containing clusters and strains. For example, Gallimore et al 
examined the sapovirus capid sequence and described 5 genogroups.  Genogroups 
were found to differ by 49-55%, clusters by 19-25% and strains by 1-5%. The 
sapoviruses known to cause human infections were shown to be members of 
genogroups 1, 2, 4 and 5, whereas animal strains fell into group 3 (Gallimore et al, 
2006). Okada et al, analysed the capsid region of 15 sapoviruses. In their study these 
divided into 6 genogroups, 2 of which represented animal sapoviruses (Okada et al, 
2006). Based on the capsid region the animal strains were shown to differ from the 
human strains by 40-44%. 
The large amount of diversity observed in norovirus and sapovirus strains is a 
result of the accumulation of point mutations due to error prone RNA replication and 
recombination events (Matson and Szucs, 2003; Nilsson et al, 2003; Dingle, 2004). 
Nilsson et al examined sequential samples taken from an immunocompromised 
patient with chronic norovirus infection and identified a section in the capsid region 
(called the P2 domain) where mutations frequently accumulated, eventually leading to 
the formation of new phenotype (under immune pressure). Jiang et al identified the 
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first norovirus recombinant in 1999 and since this discovery several more have been 
reported (Jiang et al, 1999; Katayama et al, 2002; Lochridge and Hardy, 2003; Vinje 
et al, 2000). Evidence from these reports suggests that recombination occurs at the 
junction between ORF1 and ORF2. Other potential recombination sites include the P2 
region (Rohayem et al, 2005).  
Recently a sapovirus recombinant has also been described (Katayama et al, 
2004). As with norovirus, the recombination event is thought to have occurred at the 
RdRp-Capsid junction. Recombination seems to be restricted to intragroup strains 
since intergroup and intergenus recombination has yet to be described (Katayama et 
al, 2004). 
2.3.2.3. Immune Response 
The immune response to norovirus is not yet fully understood (Matsui and 
Greenberg, 2000). Early transmission studies showed that the majority of adults are 
susceptible to norovirus infection suggesting that childhood norovirus infection fails 
to elicit long-term protection (Parrino et al, 1977; Wyatt et al, 1974). Parrino et al 
examined the formation of short and long-term immunity by challenging 12 
volunteers with norovirus. Of these, 6 became ill. The 6 volunteers who became ill 
were then re-challenged with the same virus 27-42 months later. All became ill thus 
demonstrating an absence of long-term immunity. However, the same 6 patients were 
then re-challenged 6-14 weeks later and this time all failed to become ill suggesting 
the formation of short-term immunity. 
Long-term immunity has been described in a number of studies and may be a 
result of repeated exposure (Ewald et al, 2000; Black et al, 1982; Ryder et al, 1985). 
For example, in 1998 a foodborne outbreak of norovirus occurred in a group of 
tourists who were staying with an aboriginal community (Matsui and Greenberg, 
2000). Although the aborigines ate the same meal as the tourists none became ill. 
Similar reports have been published in Bangladesh and Panama (Ryder et al, 1985). 
The relationship between the different norovirus strains is also complicated by 
some evidence of cross-protection (Wyatt et al, 1974). Wyatt et al examined the 
immune relationship between the norovirus strains Norwalk, Hawaii and Montgomery 
County virus. Volunteers were challenged first with one of the three noroviruses. The 
results showed that those who became ill were then re-challenged with the same virus 
or another. Those initially challenged with Norwalk virus became ill when challenged 
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with Hawaii virus. However if re-challenged with Montgomery County virus some 
cross protection was observed. Other studies have found similar results (Madore et al, 
1990; Noel et al, 1997). 
A confusing relationship exists between the presence of pre-existing antibody 
to norovirus and susceptibility. Sero-prevalence studies have shown that antibody 
production to norovirus is lowest in the 0-5 years age group and increases with age, 
which is consistent with the theory that antibody production aids resistance, since 
children are more susceptible to norovirus than adults (Jing et al, 2000). However, 
antibody is also often found to be significantly higher in susceptible adults than those 
able to resist infection.  
Recent evidence has pointed towards genetic factors as determinants of 
norovirus susceptibility (Hutson, Atmar and Estes, 2004; Rockx et al, 2005; Hutson et 
al, 2002). Studies utilising Virus Like Particles (VLPs), which are structurally and 
antigenically similar to norovirus, have shown that noroviruses will only attach to and 
infect host cells in the gut if they express specific, genetically determined 
carbohydrates (Lindesmith et al, 2003; Hutson et al, 2003; White et al, 1996). These 
carbohydrates are thought to include H, Lewis and histo-blood group antigens 
(Harrington et al, 2002; Harrington et al, 2004; Marionneau et al, 2002; Huang et al, 
2003; Green et al, 1988). These carbohydrates have a wide tissue distribution and are 
thought to be present on saliva, red blood cells, and gastro duodenal epithelial cells. 
Evidence from serological and volunteer studies supports this theory. For example, it 
has been found that convalescent sera and human breast milk block VLPs from 
binding to the aforementioned carbohydrates (Jiang et al, 2004). Individuals unable to 
produce H antigen do not become infected when challenged with norovirus 
(Lindesmith et al, 2003; Hutson et al, 2002; Harrington et al, 2002; Meyer et al, 
2004). Rockx et al found that individuals with type B histo-blood group antigen are 
protected against norovirus G1 strains but not G2 strains thus highlighting that 
different noroviruses may bind preferentially to different carbohydrates (Rockx et al, 
2005; Huang et al, 2005). This may explain the worldwide predominance of G2.4 
norovirus types (see section 2.3.2.4). Unlike some norovirus types, these viruses have 
been shown to be able to bind to a broad range of carbohydrate targets. As a result 
they have a large susceptible target population. These findings may also explain the 
confusing relationship between pre-existing antibody and risk of infection as 
described above. Pre-existing antibodies to a particular norovirus may be an 
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indication that the individual is particularly susceptible to that virus and has suffered 
repeated infections in the past. 
These genetic characteristics have also been shown to be important pre-
determinates of other gastrointestinal infections. For example, B histo-blood group 
antigen was shown to be less common in patients with haemolytic uraemic syndrome 
after an E-coli 0157 outbreak in Sakai, Japan (Hutson, Atmar and Estes, 2004).  
The immune response to sapovirus is less well defined. Studies in adults have 
shown a low incidence of infection thus suggesting that primary infection in 
childhood results in long-term immunity (Chiba et al, 2000). 
2.3.2.4. Epidemiology 
Since long-term immunity to norovirus is rare, humans of all ages are 
susceptible to repeat infections throughout life. As a result norovirus is frequently 
implicated in sporadic cases of IID and is now thought to be the predominant cause of 
outbreaks of IID, especially in closed settings such as hospitals, residential homes, 
hotels, schools and cruise ships etc (Matson, 2005; Thornton et al, 2005; Isakbaeva et 
al, 2005).  
Sapovirus is predominantly a pathogen of children with infections limited to 
mainly the very young (de Wit, Koopmans and van Duynhoven, 2003). As a result its 
burden is likely to be less than that of the other viral causes of IID. Outbreaks due to 
sapovirus have been documented but are rare (Johansson et al, 2005). 
Limited data exist on the epidemiology of sapoviruses. As a result the 
remainder of this section mainly focuses on the epidemiology of norovirus infections. 
Sporadic cases and outbreaks show winter predominance although cases and 
outbreaks can occur all year round (Zahorsky, 1929; Adler and Zickl, 1969; Mounts et 
al, 2000; Lopman et al, 2003; Hale et al, 2000). Norovirus has a low infectious dose 
with fewer than 10 viral copies capable of causing illness in a human adult volunteer 
(Levett et al, 1996; Moe et al, 1999). The vast majority of norovirus cases are a result 
of faecal-oral spread but there is also evidence of airborne spread (via droplets 
produced during vomiting) and spread by contaminated fomites (Widdowson et al, 
2005; Fretz et al, 2005; Caul, 1994).  Environmental studies using surrogate virus 
feline calicivirus (FeCv) have estimated that (at 20oC) the virus may remain infectious 
on surfaces for between 21-30 days  (Sattar, 2004; Barker, Vipond and Bloomfield, 
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2004; Steinmann, 2004; Doultree et al, 1999; Hota, 2004; Gehrke, Steinmann and 
Goroncy-Bermes, 2004) 
Potential sources of infection include those with asymptomatic infection 
(Duizer et al, 2004; Marshall et al, 2001; Vinje et al, 1997; de Wit et al, 2001). 
Asymptomatic infections have been detected have been measured in a few studies. 
For example, in the Netherlands asymptomatic norovirus infections have been 
detected in between 1-5% of the general population but have been detected in up to 
19% of individuals in outbreak settings. Asymptomatic sapovirus infections have also 
been detected in young children (range 1-13%). Other sources include those with 
symptomatic infection who have prolonged viral shedding after their symptoms have 
resolved. There is evidence of norovirus shedding up to 7 weeks or more after 
resolution of symptoms in immunocompetent individuals (Ball et al, 2005; Rockx et 
al, 2002; Cliver, 1997). Longer durations of shedding have also been observed in 
immunocompromised patients (Nilsson et al, 2003). There is also evidence of pre-
symptomatic shedding (Lo et al, 1994).  
The remainder of cases are likely to be a result of contaminated food or water 
(Hirakata et al, 2005; Paez Jimenez et al, 2004; Parshionikar et al, 2003; Boccia et al, 
2002). Data suggests that most foodborne infections are caused by norovirus. A recent 
study in the US estimated that 67% of all foodborne infections were due to norovirus 
(Mead, 1999). Food can become contaminated in numerous ways. Infected food 
handlers are a common source (Lo Sv et al, 1994; White et al, 1986; Gaulin et al, 
1999). At-risk foods include those with prolonged hands-on preparation such as salads 
and sandwiches (Holtby et al, 2001; Kilgore et al, 1996).  
A number of large outbreaks have been linked to the consumption of bivalve 
shellfish such as oysters, which have been shown to filter sewage from sea water and 
concentrate virus in their flesh (Chalmers and McMillan, 1995; Ang, 1998; Stafford et 
al, 1997; Kohn et al, 1995)  
Several outbreaks have been linked to the consumption of sewage-
contaminated drinking water (van den Berg et al, 2005; Kukkula et al, 1999; Brown et 
al, 2001; Lodder et al, 1999; Hafliger, Hubner and Luthy, 2000). Such water has also 
been used in the preparation and storage of particular foods.  
Noroviruses have been shown to be resistant to freezing and have been 
implicated in a number of outbreaks relating to frozen foods. Noroviruses have also 
been detected in bottled mineral water, although the significance of these findings has 
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been questioned (Sanchez, Joosten and Meyer, 2005; Beuret et al, 2002; Beuret, 
Kohler and Luthi, 2000; Lomothe et al, 2003).  
Several studies have suggested a possible animal source, since noroviruses 
have been detected in cattle and other animals (Van der Poel et al, 2003; Van der Poel 
et al, 2000; Smiley, 2002; Smiley et al, 2003). These strains have yet to be associated 
with human illness. A recent study by Widdowson et al found significant levels of 
antibodies to bovine norovirus strains in vets and others in frequent contact with 
cattle. These data suggest that infection with these animal strains is possible and may 
contribute to the diversity of noroviruses (Widdowson et al, 2005).  
Recent studies have suggested that norovirus may also be an important travel 
associated infection. Chapin et al found norovirus in 65% of travellers returning to the 
US from Mexico and Guatemala with travel-associated diarrhoea (Chapin et al, 2005).  
Molecular epidemiological studies have shown that a number of norovirus 
strains and serotypes circulate at any one time, with one type predominant worldwide 
(Gallimore et al, 2004; Hale et al, 2000; Kageyama et al, 2004). Since 1996 type G2.4 
strains have dominated worldwide (Lopman et al, 2004; Noel et al, 1999). 
Occasionally a new strain may supersede previous strains to become predominant. 
This was the case in 2002 when a new G2.4 variant emerged worldwide (Lopman et 
al, 2004). This emergence was accompanied by several alterations in the 
epidemiology of norovirus infection.  For example, although there still appeared to be 
a peak of activity over the winter months particularly in closed settings, there was also 
an increase in outbreak reports during the summer months (Lopman et al, 2003). This 
new variant norovirus contained a mutation at position 4820 (from AACTTG to 
AATCTG). It is unclear, however, how this change led to such an increase in activity. 
It has been suggested that this variant is more stable in the environment or more 
virulent. However, some researchers have suggested that the sudden increase in 
norovirus infection may instead be the result of a large, as yet, unidentified 
introduction of this new variant.  
A similar increase in activity was observed in 2005 and again in 2006 (CDR 
weekly, 2005; HPS weekly report, 2005; Bull et al, 2006; Gallimore et al, 2007). 
These have also been associated with the emergence of a new norovirus G2.4 
norovirus variant. Recent data also suggests that sapovirus may act in a similar 
fashion (Gallimore et al, 2006). Gallimore and colleagues sequenced the sapoviruses 
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detected in the UK between 1989 and 2004 and found a change in the predominant 
strain in 2004 (from G1.1 to G2.1). 
2.3.2.5. Clinical Illness 
Classically, the clinical symptoms of norovirus and sapovirus were derived 
from transmission studies (Dolin et al, 1971; Gotz et al, 2001; Kaplan et al, 1982; 
Graham et al, 1994). These studies reported that after an incubation period of 24-48 
hours the illness is of sudden onset with nausea, headache, cramps, vomiting and 
diarrhoea. Symptoms resolve after 24-48 hours. The studies also showed that children 
with norovirus infection are more likely to have episodes of vomiting whereas adults 
have a predominance of diarrhoea. However more recent work has suggested that 
these findings may be inaccurate (Rockx et al, 2002). A recent community cohort 
study in the Netherlands found that vomiting was less common in children under 1 
year of age than in older patients. This study also showed that the symptoms of 
norovirus and sapovirus lasted longer than previously thought (5 days and 6 days 
respectively).  
Clinically, most infections caused by norovirus and sapovirus are thought to 
be mild. However, it is increasingly recognised that norovirus is responsible for a 
significant proportion of childhood hospitalisation due to IID (see 2.3.6). Studies of 
norovirus hospital outbreaks have shown that infection lasts longer in this setting, and 
can often be severe, with an increased risk of mortality-probably as a result of 
underlying illness (Lopman et al, 2004; Meakins et al, 2003, Mattner et al, 2006).  
Unusual presentations of norovirus have been observed in some individuals, 
usually as a result of physical stress or immunocompromise. For example, an outbreak 
of norovirus at a military field hospital in Afghanistan resulted in neck stiffness, 
confusion and photophobia, and in one case disseminated intravascular coagulation 
(MMWR, 2002). These symptoms were probably a result of electrolyte imbalance 
similar to that seen in severe rotavirus infections. Studies of norovirus infection in the 
elderly have also highlighted the occurrence of post infection complications (Goller et 
al, 2004; Oliver et al, 1985). For example, in one elderly care home outbreak a 
“residual malaise” was present in 42% of those affected 1-4 weeks after onset.  
Other studies have highlighted the presence of anorexia, lethargy and vertigo 
in the weeks after symptoms. In some elderly patients these non-specific symptoms 
and even the original acute symptoms can recur (Goller et al, 2004). 
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Chronic diarrhoea and shedding have been observed in both solid organ 
transplant patients and bone marrow transplant patients (Kaufman et al, 2003; 
Gallimore et al, 2004). In some cases shedding for up to 2 years has been observed 
(Nilsson et al, 2003). The importance of caliciviruses in HIV positive individuals is 
uncertain. A recent study by Rodriguez-Guillen et al suggested that caliciviruses are 
not implicated in HIV associated diarrhoea in adults. However, caliciviruses were 
found to be more frequent in HIV positive children (Rodriguez-Guillen et al, 2005). 
2.3.2.6. Control   
Controlling an outbreak of norovirus is difficult due to its low infectious dose 
and numerous modes of transmission.  
Most of the current guidelines concern norovirus outbreaks in the hospital 
setting (Chadwick et al, 2000)1. Controlling an outbreak on a ward or other closed 
setting requires rapid implementation of infection control procedures. Lopman et al 
estimated that control procedures must be implemented within 3 days of an outbreak 
onset if they are to be successful. However, detecting an outbreak at such an early 
stage is difficult due to the high frequency of non-infectious gastrointestinal disease 
such as incontinence and anti-microbial associated diarrhoea (Lopman et al, 2003).  
Recommended control procedures include the wearing of gloves and aprons 
when in contact with infected patients or contaminated areas (see Table 1 and Table 
2). Hand washing is advocated at all times. Studies using FeCv have shown ethanol 
based hand rubs with a 70-95% concentration of ethanol to be best (Kampf, Grotheer 
and Steinmann, 2005). However, other studies have questioned this finding and 
suggested that these protocols need to be compared to standard hand washing 
procedures before such conclusions can be drawn (Duizer and Koopmans, 2006). 
Guidelines suggest that affected staff should be excluded for 48-72 hours after 
suffering their last symptoms (this should also be applied to infected food handlers). 
Wards should also be closed to further admissions. Staff and patients from the 
affected areas should be prevented from entering other unaffected areas. There is also 
evidence that patient cohorting is effective in containing affected patients and 
contaminated areas.  
                                                 
1
 http://www.hps.scot.nhs.uk/enviro/guidelinedetail.aspx?id=18578 
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Cleaning norovirus from the environment is essential but difficult, and re-
infections have been documented following the re-introduction of individuals into 
previously contaminated areas. Since there is no culture method for measuring the 
viability of norovirus or sapovirus many cleaning and disinfection studies have 
utilised animal caliciviruses known to be related to norovirus in an attempt to 
establish efficient methods. Studies using FeCv have shown conflicting results 
(Duizer et al, 2004; Sattar, 2004; Barker, Vipond and Bloomfield, 2004; Steinmann, 
2004; Doultree et al, 1999; Hota, 2004; Gehrke, Steinmann and Goroncy-Bermes, 
2004). For example, Steinmann demonstrated that ethanol was effective in cleansing 
FeCV from the environment whereas Duizer et al found that ethanol was not 
effective. Doultree et al showed that glutaraldehyde, iodine and hypochlorite at 
1000ppm were effective. Other studies have suggested the use of sodium bicarbonate 
(Malik and Goyal, 2006). For soft furnishing a steam clean of at least 70oC is thought 
to be effective (Doultree et al, 1999). 
Although these procedures have proved successful in containing some ward 
outbreaks, spread to other wards is a common occurrence. The reasons for this are 
unclear. It has been suggested that large multi-ward outbreaks are a result of a 
breakdown in the infection control procedures, which can often be difficult to achieve 
in practice (Christie, 2002; Cowden, 2002). For example, closing wards is difficult 
when faced with acute bed shortages due to other winter pressures. The failure to 
close a ward may prevent extensive cleaning, which is needed to remove virus from 
the environment. Restricting staff and patient movement is also difficult. Many staff 
may be asked to work in a number of wards and patients will be frequently moved 
between different wards. The duration of exclusion (48-72 hours) may also be too 
short, as many studies have indicated that virus can be excreted for longer periods. 
This raises the possibility that a staff member may return to work before viral 
shedding has ceased and spread further infection. Furthermore, agency nursing staff 
may not be entitled to sick pay and will therefore be tempted to return to work before 
their illness has resolved. However, it may also be possible that large multi-ward/area 
outbreaks may be a result of the multiple introductions of different noroviruses.  
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Table 1: Recommended infection control guidelines within wards (Chadwick et al, 
2000).     
 
Table 2: Recommended infection control guidelines between wards (Chadwick et al, 
2000).     
 
2.3.2.7. Prevention  
At present there is no vaccine for norovirus or sapovirus infection. Since the 
immune response to norovirus infection is not yet understood, developing a vaccine 
may prove difficult. Most of the vaccine studies pre-date the discovery of the genetic 
determinants of norovirus immunity (as discussed earlier). Most have utilised VLPs. 
VLPs are morphologically and antigenically similar to noroviruses, are stable, 
immunogenic, can be produced in large amounts, and can be stored in lyphophilised 
form (Estes et al, 2000). Initial studies in mice have shown them to be highly 
immunogenic after oral administration and to result in serum and mucosal immunity 
(Guerrero, Ball and Estes, 1997). Phase 1 trials in humans have shown them to be safe 
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but the immune response elicited was significantly less than that observed after 
natural infection (Ball et al, 1999). Further trials are to be carried out (Tacket, 2005). 
2.3.3. Astrovirus 
Astrovirus was first discovered in 1975 by Appleton and Higgens in 
hospitalised children with gastroenteritis (Appleton and Higgens, 1975). Astroviruses 
are members of the Astroviridae family. Under electron microscopy the astrovirus 
capsids are 28-30nm in diameter and have a characteristic 5-6 pointed star appearance 
(Figure 6).  
2.3.3.1. Genome Organisation and Function 
Astroviruses are positive sense, ssRNA viruses with a genome of 
approximately 6.8 kb in length (Figure 7). The genomic organisation is as follows: a 
5NCR region followed by three ORF (1a, 1b and 2), a 80 nucleotide NCR and a poly 
A tail of 30 nucleotides (Belliot et al, 1997; Jiang et al, 1993; Lewis et al, 1994).  
The ORF1a is 2700 nucleotides in length whereas ORF1b is 1550 nucleotides 
in length. ORF1a and 1b code for the non-structural proteins such as the protease and 
the RNA dependent RNA polymerase. ORF1a also encodes other motifs including 
transmembrane helices, a nuclear localisation signal and immunogenic epitopes. 
ORF1a length can also vary amongst strains although the significance of this is at 
present uncertain.  
The ORF2 codes for the viral capsid. The viral capsid precursor is 86-90kDa 
in size and after protease processing forms 2-5 major proteins (Herring et al, 1981; 
Monroe et al, 1991; Belliot et al, 1997; Wang et al, 2001). ORF2 is less conserved 
than ORF1a and 1b and varies significantly between astrovirus types (Wang et al, 
2001).  Analysis of the ORF2 regions has detected 4 main areas: the N region, the 
central upper, central lower regions and C region. The N and C regions were shown to 
be relatively conserved between different astroviruses. The two regions between 
these, the central upper and central lower, are the regions that show the most 
variation. The central upper region can vary in sequence length between serotypes. It 
is not thought to be present on the virion surface. The central lower region contains 
several stem loops. These genes are thought to contain the regions that determine 
immune response, cell attachment and entry. As a result these regions differ between 
serotypes. 
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 The 3’ NCR is highly conserved between the 8 astrovirus types and it is 
thought it may play a role in the initiation of RNA synthesis (Monceyron et al, 1997). 
In addition, it has been postulated that it may also play a role in RNA stability, 
translation initiation and intracellular localisation. 
2.3.3.2. Classification 
Astroviruses are serotyped using neutralisation antibodies. Various methods 
exist including immunoflourscence, neutralisation assays or IEM. Sequence analysis 
of a 348bp region of the ORF2 has been shown to correlate with serotype. 
Overall there are 8 recognised types of astrovirus (Monroe, Holmes and 
Belliot, 2001). Types 1-7 were distinguished by 1995 whereas type 8 was recognised 
more recently (Taylor et al, 2001). Types 1-7 cluster into 2 groups. Group A contains 
types 1-5 whereas group B contains types 6 and 7. Type 8 can cluster with either 
group depending on the area sequenced (Taylor et al, 2001; Walter et al, 2001; 
Belliot, Laveran and Monroe, 1997). This has led some researchers to speculate that 
type 8 is a recombinant virus. The area most studies suggest as the potential 
recombination site is the ORF1b/ORF2 junction. 
2.3.3.3. Immune Response 
At present the immune response to astrovirus is not well understood. The fact 
that cases are mainly restricted to the young or elderly suggests that primary infection 
results in long-term protection, which then wanes in old age (Glass et al, 1996). 
Koopmans et al showed that immunity was homotypic (Koopmans et al, 1998). 
Infections in adolescence and adulthood are therefore likely to be caused by rarer 
types of the virus. 
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Figure 6: Astrovirus as viewed under the electron microscope.                                                                                                                                  
Figure taken from: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/05000000.htm 
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Figure 7: The genomic structure of astrovirus (Walter and Mitchell, 2003). 
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2.3.3.4. Epidemiology 
Astroviruses have a worldwide distribution (Walter and Mitchell, 2003) and 
are found in humans, lambs, calves, deer, piglets, mice, dogs and ducks. Human 
infections are mainly seen in infants and the elderly (Noel et al, 1996). Reports of the 
age of initial infection vary in different studies. A hospital study in France showed 
acquisition to be in those aged less than 7 months (Marie-Cardine et al, 2002). 
However, a community-based study in France and a hospital study in Spain showed 
the age of acquisition to be between 2-4 years (Chikhi-Brachet et al, 2002; Guix et al, 
2002). Interestingly the age of acquisition may vary according to type, with astrovirus 
types 1-3 acquired in children under 3 years whereas types 4 and 8 occur at an older 
age (Guix et al, 2002). This is no doubt related to the predominance of the various 
types (see below). 
The seasonality of astrovirus varies in different regions (Walter and Mitchell, 
2003). In Egypt, Brazil and Eastern USA a spring/summer peak of activity has been 
reported. However, in Korea, Argentina and Western USA a winter predominance 
occurring alongside rotavirus infections has been observed (Giordano et al, 2001; 
Kang et al, 2002; Rodriguez-Baez et al, 2002).  
Astroviruses have been shown to cause endemic illness and outbreaks in 
closed settings such as hospitals, schools and care settings (Cubitt et al, 1999; 
Mitchell et al, 1995; Oishi et al, 1994). Transmission is mainly fecal-oral but may 
also involve contaminated fomites (Abad et al, 2001). Other sources include 
contaminated food (including oysters and mussels) and sewage-contaminated water 
(Pinto et al, 2001; Le Guyader et al, 2000; Taylor et al, 2001). 
Numerous studies have shown that, like other viral causes of IID, multiple 
serotypes co-circulate at any one time (Lee and Kurtz, 1994; Mustafa, Palombo and 
Bishop, 2000; Palombo and Bishop, 1996). Overall, type 1 astrovirus is the most 
common. Types 2-4 are of medium frequency whereas types 5-7 are rare. Type 8 has 
had an increasing incidence in some countries including Egypt, Spain, France and 
Australia. This raises the possibility that type 8 is an emerging genotype.  
2.3.3.5. Clinical Illness And Treatment 
The clinical illness caused by astrovirus is similar to rotavirus but is milder 
(Dennehy et al, 2001; Pang and Vesikari, 1999; Guerrero et al, 1998; Kurtz et al, 
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1979). Studies show that after an incubation period of 1-4 days there is a sudden onset 
of watery diarrhoea. Illness is mainly seen in infants over 6 months of age.  
Immunocompetent individuals can shed virus for up to 2 weeks post resolution 
of symptoms. Some studies have suggested that persistence may be linked to infection 
with certain astrovirus types. Cabellero et al found higher levels of persistence and 
viral shedding in faecal samples showing infection with astrovirus type 3 (Caballero 
et al, 2003). 
Severe infections have been observed especially in the immunocompromised, 
those with malnutrition and those co-infected with another viral enteric pathogen 
(Walter and Mitchell, 2000; Grohmann et al, 1993; Roman et al, 2003). There have 
been several reports of prolonged and recurrent illness in immunocompromised 
individuals.  
However, the illness caused by astrovirus is usually mild and self-limiting and 
therefore no specific therapy is needed. For severe infection replacement of fluids and 
electrolytes may be necessary. 
2.3.3.6. Control And Prevention 
Control of astrovirus infection relies upon the application of universal 
hygienic and disinfection practices especially in hospitals and other closed settings. 
Food handlers are advised to follow guidelines excluding them from work until 
several days after symptoms subside (Table 1 and Table 2). At present there is no 
vaccine available for the prevention of astrovirus. 
2.3.4. Adenovirus  
Adenoviruses are non-enveloped icosahedral viruses of 70-80nm in diameter 
(Figure 8). Adenoviruses were first isolated in 1953 from tissue cultures of human 
adenoidal tissue (Cocchi, 1960). They belong to Adenoviridae family, genus 
Mastadenovirus. Adenoviruses have an icosahedral capsid with icosahedral 
symmetry. The protein capsid is made up of 252 capsomers: 240 hexons and 12 
pentons. Each penton has a protruding fiber.   
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Figure 8: Adenovirus as viewed under the electron microscope.                              
Figure taken from: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/em_adeno.gif 
 
 
2.3.4.1. Genome Organisation and Function 
Adenoviruses are dsDNA viruses with a genome of approximately 335kb in 
length (Brown et al, 1996; Horwitz, 1996).  The genome contains several inverted 
terminal repeats that vary in length between different adenoviruses (Wold and 
Gooding, 1991). As a result the adenovirus genome differs between genera and 
species. All adenoviruses produce early (E1-4), intermediate and late RNA (1-5) 
transcripts and virus-associated RNA gene transcripts. 
The Early RNA Transcripts 
The E1 is a transcription unit with 2 regions, E1A and 1B (Shenk and Flint, 
1991; Shenk, 2001). The E1A is a transcription activator of virus (of other early and 
late proteins) and some cellular promoters, whereas E1B contributes to evading the 
immune response by blocking host mRNA transport to the cytoplasm and inhibiting 
p52-mediated apoptosis (Wold and Gooding, 1991). High levels of sequence identity 
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in the E1/A region have been observed between members of the same subgroup. For 
example, Avvakumov et al, found four region which were relatively conserved 
between adenoviruses (similarity scores of between 50-60%) (Avvakumov et al, 
2002). However, between these regions significant sequence variation is observed 
(similarity scores of <30%). 
The E2 transcript codes for the viral proteins that are directly involved in 
adenovirus replication. It contains 2 regions (E2A and 2B), which code for a number 
of proteins. These include E2A-DBP (a single stranded DNA binding protein), E2B-
pTP (a terminal precursor protein functioning as a protein primer for initiation of viral 
DNA replication) and E2B-ad pol (DNA polymerase).  
The E3 transcript has at least 8 recognised ORFs, which vary according to 
adenovirus serotype. The E3 transcripts are mainly used to counteract host antiviral 
defences. Modes of action include the inhibition of CTL responses and TNF alpha 
mediated cell lysis.  
The E4 transcript has numerous ORF that, like that of E3, vary according to 
adenovirus serotype. For example adenovirus type 5 has six recognised ORFs whereas 
adenovirus 11 has five. The E4 transcript is thought to encode for proteins that 
regulate viral and cellular gene expression at the transcriptional and post 
transcriptional level. 
The Intermediate Region 
The adenovirus intermediate region produces 2 proteins: pIX and pIVa2. The 
pIX is a structural component of the virus and is a transcriptional activator of the 
major late promoter (Lutz et al, 1997; van Oostrum and Burnett, 1985). The pIVa2 is 
also a transcriptional activator of the major late promoter, but is also thought to be 
involved in genome packaging. 
Late Proteins. 
The late proteins are organised into one primary transcript unit that is 
processed using different poly A sites to produce distinct mRNAs. These are 
recognised as late proteins L1-5. 
The L1 late protein facilitates capsid assembly and enables genome 
encapsidation via interaction with pIVa2 (Shenk, 2001). 
The L2 late protein contains 3 ORFs coding for the Penton, pVII and pV. The 
penton, alongside the fiber, plays an important role in host cell binding and 
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penetration. pVII is the major component of the adenovirus core whereas pV acts as 
the bridge between the core and the penton base. It should be noted that pV contains a 
second ORF of unknown function (Shenk, 2001). 
The L3 late protein contains 3 ORFs, which code for the pVI, pII (hexon) and 
L3-23 (Shenk, 2001). The pVI is a capsid component that is associated with the 
hexon. It possibly acts as a bridge between capsid and core components. The pII 
(hexon) trimerises with itself to form the major capsid. It contains at least 7 hyper 
variable regions but there are regions outside these areas that are conserved between 
adenovirus serotypes (Crawford-Miksza and Schnurr, 1996). These areas are thought 
to determine the adenovirus serotype. The L3-23K is the adenovirus protease. It 
cleaves viral precursor proteins during viral maturation. 
The L4 has 4 ORFs (Andrade et al, 2001). Three proteins have thus far been 
identified. The L4-100K is a non-structural protein that is required for hexon 
assembly, late protein synthesis and inhibition of granzyme B mediated lysis. The L4-
33k is a protein of unknown function. The pVIII is associated with hexons and is 
possibly a link between hexon capsomere and core capsids. 
The L5 late protein is a single ORF. It codes for the adenovirus fibre. Analysis 
of the nucleotide sequence shows that the fibre contains areas of significant variation. 
It forms a structure consisting of a tail, shaft and knob. The knob determines the 
adenovirus tissue tropism via cell surface receptors. 
2.3.4.2. Classification 
Adenovirus serotypes are classified according to the ability to induce specific 
neutralising antibodies. The serotype specific antigens are located on the virion 
surface (possibly via the hyper variable regions on the hexon region). The results of 
analysis of the HVR regions of the hexon region match their serotypic classification. 
The adenovirus genera (A-F) are determined by numerous factors including the 
haemagluttination of rat and monkey cells or the oncogenicity in hamsters. 
2.3.4.3. Epidemiology 
Adenovirus IID is mainly endemic but outbreaks have also been reported in 
closed settings (Richmond et al, 1979; Retter et al, 1979; Yolken et al, 1982; Murphy, 
1981; Albert, 1986). Adenovirus IID has no specific seasonal pattern and spread is 
mainly via the fecal-oral route. Most infections occur in childhood and studies have 
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shown that by 3 years of age 30-100% of children are seropositive for adenovirus 
(type 40 and 41).  
2.3.4.4. Clinical Illness And Treatment 
Clinical illness due to adenovirus is similar to that of other viral causes of 
illness (Bhan et al, 1988; Whitelaw, Davies and Parry, 1977; Richmond et al, 1979; 
Vesikari et al, 1981; Johansson et al, 1980; Blaskovic, Freitag and McLaughlin, 
1982). Symptoms include watery, non-bloody faecal samples and vomiting. The 
duration of symptoms (3-11 days) is possibly longer than that produced by other viral 
causes of IID (Dowling and Wynne, 1981) and it is thought that type 41 causes a 
longer illness than type 40. In general, adenovirus IID results in shedding for between 
1-14 days.  
Although fatal cases have been described, the illness is usually mild and 
treatment is not needed (Whitelaw, Davies and Parry, 1977). Disseminated adenovirus 
type 40 or 41 infection has rarely been described in immunocompromised patients, 
although a recent case report by Slatter et al described a paediatric BMT patient who 
died of disseminated adenovirus 41 infection (Slatter et al, 2005). 
2.3.4.5. Control And Prevention 
Control of infection relies upon universal precautions and strict 
decontamination procedures as described for norovirus (Table 1 and Table 2).  No 
vaccine is available for adenoviruses that cause IID.  
2.3.5. Other Possible Viral Causes Of IID 
There are many other possible causes of viral IID mentioned in the literature. 
In most cases a causative role has yet to be proven.  
It has been suggested, for example, that the enteroviruses (members of the 
Picornaviridae family) are a rare cause of gastroenteritis in humans. Echoviruses (4, 
11, 14, 18, 19 and 22) and coxsackie A1 have been implicated in outbreaks of 
diarrhoea in immunocompetent and immunocompromised humans (Townsend et al, 
1982; Patel et al, 1985; Melnick, 1996). Another member of the Picornaviridae 
family, aichivirus, has been associated with both sporadic and outbreaks of IID in 
Japan and south East Asia (Yamashita et al, 1993; Yamashita et al, 1995). However, a 
role for this virus in IID in other countries has yet to be determined. 
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Reoviruses (members of the Reoviridae family) have regularly been found in 
faecal samples and most children have antibodies to all 3 serotypes (Tyler and Fields, 
1996). However, although a role in childhood IID has been suggested, firm evidence 
has yet to be established (Giordano et al, 2005). 
Toroviruses and coronaviruses are members of the virus family 
Coronaviridae. Toroviruses have been established as a cause of IID in cattle and 
horses, and recent studies have suggested a role in sporadic IID in children 
(Koopmans et al, 1997; Waters et al, 2000). Coronaviruses are recognised as causes 
of the common cold in humans. Like toroviruses, they have been shown to be a cause 
of IID in animals. Coronavirus particles have been found in the faecal samples of 
cases of IID but have also been found in healthy volunteers (Holmes, 2001). 
Like the coronaviridae family, parvovirus is associated with IID in animals. In 
addition, parvovirus-like particles have frequently been found by EM in faecal 
samples. However, a causative role has yet to be established. Picobirnaviruses are 
members of the Birnaviridae family and have been found to be significantly 
associated with IID in Aids patients (Grohmann et al, 1993). They have also been 
found to be associated with IID in various animals (Leong et al, 2000). 
2.3.6. The Contribution of Viral Pathogens To The Burden Of IID 
The significant morbidity and economic burden of IID in the developed world 
has already been outlined (section 2.2). But what proportion of the total number of 
cases is due to viruses?  
The contribution of each of the five main viral pathogens to overall IID in 
children, adults and outbreaks has only recently been ascertained using sensitive 
detection techniques such as PCR (see section 2.4.3.3) and is discussed in the 
following section.   
2.3.6.1. Burden Of Viral IID In Children 
Recent studies using sensitive techniques have established that viral pathogens 
are the major cause of sporadic IID in children, both those requiring hospitalisation 
and those presenting to GPs. For example, Simpson et al detected viral pathogens in 
60.3% of children hospitalised for IID in Addenbrookes hospital, England (Simpson 
et al, 2003). de Wit et al detected viral pathogens in over 44% of community managed 
cases of IID in children presenting to GPs in the Netherlands (de Wit et al, 2001). 
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Pang et al investigated 832 samples from community cases of IID in children (aged 
under 2 years) in Finland and found a viral pathogen in approximately 60% of cases 
(Pang et al, 2000). Similar detection rates (48-75%) have been shown in other 
countries (Phan et al, 2005; Bon et al, 1999; Bereciartu, Bok and Gomez, 2002; Qiao 
et al, 1999; Oh, Gaedicke and Schreier, 2003). 
Rotavirus is the predominant cause of childhood IID in both the community 
and hospital setting (Brandt et al, 1983; McIver et al, 2001; Fruhwith et al, 2001). For 
example, Barnes et al examined 4,637 samples from children admitted to hospital 
with IID between 1980-93 and found rotavirus in 39.6% of cases (Barnes et al, 1998). 
Bon et al examined 414 children who consulted their GP for IID in France between 
1995-99 (Bon et al, 1999). Overall, 61% of all cases were attributed to rotavirus. 
Similar findings have been found in numerous other studies (Giordano et al, 2001; 
Fischer, 2001; Donelli et al, 1993; Sethi, Khuffash and al-Nakib, 1989; Waters et al, 
2000; Boga et al, 2004; Oh, Gaedicke and Schreier, 2003; Subekti et al, 2002; Qiao et 
al, 1999; de Wit et al, 2001; Pang et al, 2000; Froggatt et al, 2004; Chikhi-Brachet et 
al, 2002).  
An increasing number of studies have shown that norovirus is second only to 
rotavirus as a cause of community or hospital managed IID in children. For example, 
Oh et al examined the burden of norovirus in children hospitalised in Germany (Oh, 
Gaedicke and Schreier, 2003). Between February 2001 and January 2002, 20.7% of 
cases were attributed to norovirus. Chikhi-Brachet and colleagues examined 161 
patients with community managed IID in France in 1998-99. Norovirus was detected 
in 19% of cases (Chikhi-Brachet et al, 2002). Similar findings (7.6-29.9%) have been 
reported in numerous other studies (Kirkwood and Bishop, 2001; Simpson et al, 2003; 
McIver et al, 2001; Subekti et al, 2002; Qiao et al, 1999; Phan et al, 2004; Bereciartu, 
Bok and Gomez, 2002; Sakai et al, 2001; Boga et al, 2004; Rodriguez-Baez et al, 
2002; Phan et al, 2005; Buesa et al, 2002; de Wit et al, 2001; Bonn et al, 1999; Farkas 
et al, 2000; Pang et al, 2000; Froggatt et al, 2004; Chikhi-Brachet et al, 2002; 
Simpson et al, 2003; Fretz et al, 2005). 
The burden of adenovirus in children with community and hospital managed 
IID is less than that of rotavirus and norovirus. Studies have demonstrated detection 
rates between 2-7.9% of children hospitalised with IID or managed in the community 
(Wood et al, 1988; Barnes et al, 1998; Giordano et al, 2001; Donelli et al, 1993; 
Sethi, Khuffash and al-Nakib, 1989; Simpson et al, 2003; Bereciartu, Bok and 
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Gomez, 2002; Waters et al, 2000; de Wit et al, 2001; Pang et al, 2000; Froggatt et al, 
2004; Chikhi-Brachet et al, 2002; Simpson et al, 2003; Basu et al, 2003).  
The burden of astrovirus in hospital or community managed IID is similar to 
the proportion attributable to adenovirus with detection rates ranging between 0-
16.2% (Phan et al, 2004; Qiao et al, 1999; McIver et al, 2001; Liu et al, 2004; 
Dennehy et al, 2001; de Wit et al, 2001; Bonn et al, 1999; Pang et al, 2000; Froggatt 
et al, 2004; Chikhi-Brachet et al, 2002; Simpson et al, 2003; De Grazia et al, 2004; 
Espul et al, 2004).  
Sapovirus is predominantly a pathogen of very young children. As a result, 
sapovirus is the least common of the viral causes of IID. Studies have demonstrated 
detection rates of 0-9.2% (Froggatt et al, 2004; Phan et al, 2005; Pang et al, 2000; 
Pang, 2001; Farkas et al, 2000; Simpson et al, 2003). In general, studies reporting 
higher rates of sapovirus infections have usually investigated only younger study 
populations (those under 2 years).  
2.3.6.2. Burden Of Viral IID In Adults 
Viral pathogens contribute significantly to IID in adults. de Wit et al examined 
the incidence and cause of IID in two studies; one of patients attending GPs between 
1996-99 and the second a general population-based cohort study in the Netherlands 
(de Wit et al, 2001 (i); de Wit et al, 2001 (ii)). The GP study (which examined 34 
sites) covered all age groups and took place between 1996-99. Faecal samples were 
taken from 857 patients and tested for viral and other microbiological pathogens. 
Overall, 37.5% of cases of IID tested positive for at least one pathogen (15.4% of 
cases were positive for a virus, 16.5% were positive for bacteria, and 8.3% were 
positive for parasites). The burden of viral pathogens was greatest in the 0-4 years age 
group (44.7%). It was less in the older age groups (15.4% in the 5-14 years age group, 
14.1% in those aged 15-29 years, 7.3% in 30-59 year olds, and 7.8% in those aged 
over 60 years). In comparison the bacterial pathogens, in particular Campylobacter 
spp, were restricted mainly to the older age groups (2.6% in the 0-4 age group, 15.6% 
in the 5-14 age group, 14.7% in those aged 15-29 years, 10.5% in 30-59 year olds and 
7.8% in patients aged over 60 years). From this study it can be seen that although 
viruses are not the most common cause of IID in adults presenting to GPs the disease 
burden is still substantial. In the population-based cohort viruses were detected in 
33.5% of community managed cases of IID (bacteria were detected in 2.4% of cases 
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and parasites 6.8%). Viral pathogens were found to be responsible for most cases of 
IID in all age groups with the majority of viral diagnoses attributable to norovirus.  
The norovirus burden was thus higher in the community setting, possibly because it 
results in milder infections that do not necessarily require GP or hospital attention. 
2.3.6.3. Burden Of Viral IID In Outbreaks 
It has recently been established that the majority of IID outbreaks are caused 
by norovirus. Fankhauser et al examined 284 outbreaks submitted to the Centre for 
Disease Control (CDC) from 1992-2000 (Fankhauser et al, 2002). Of these, 93% were 
found to be caused by norovirus. Similar findings have been reported elsewhere 
(Chatterjee et al, 2004; Inouye et al, 2000; van Duynhoven et al, 2005). For example, 
Lopman et al reviewed the causes of outbreaks reported in a number of European 
studies occurring between 1995-2000 (Lopman et al, 2003). Noroviruses were shown 
to cause most cases of outbreaks in England and Wales (96%), Germany (100%), 
Sweden (97%), the Netherlands (84%), Slovenia (43%) and Spain (57%). The other 
viruses discussed are also known to cause outbreaks of IID, however outbreaks of this 
type are much less common than those caused by norovirus. 
2.4. Laboratory Methods For The Diagnosis Of Viral Causes Of IID 
Laboratory diagnosis of viral IID is important, as the aetiological causes of IID 
(bacteria, parasites or viruses) cannot be differentiated based on clinical or 
epidemiological data alone. There are many tests available for the detection of viral 
causes of IID. Some are predominantly used in the research setting whereas others are 
commonly used in routine diagnostic services.  
The requirements of a diagnostic test are quite different to an assay that is to 
be used in the research setting. Both settings require tests that have high sensitivity 
and specificity, however in the diagnostic setting speed, throughput and ease of use 
are also essential. Ideally, for a diagnostic test to be clinically useful it should be 
sensitive, specific, rapid and high throughput. A test with these characteristics will 
bring several advantages. First, the high sensitivity and specificity will increase the 
likelihood of the clinician receiving an accurate etiological diagnosis. Providing an 
etiological cause rather than a “syndromic” diagnosis allows clinicians and public 
health officials to make informed management decisions regarding patient care based 
on knowledge of the prognosis, length of infectiousness and possible transmission 
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routes. A rapid diagnosis may also prevent unnecessary tests for other potential causes 
or empirical treatment. Although not generally recommended for treating IID, a recent 
study in Ireland found that approximately 7.5% of patients who consulted a GP for 
symptoms of IID received antibiotics, which represented 15% of all treatments 
prescribed (Acute Gastroenteritis in Ireland, North and South-A Telephone Study, 
2003). A rapid and accurate diagnosis may also help reduce unnecessary or prolonged 
hospitalisations whilst other tests are carried out. Taken together, all these factors will 
also help reduce health care costs. Rapidity is particularly important in the outbreak 
setting as it may influence decisions on infection control measures such as patient 
isolation or cohort nursing. A high throughput test will contribute to rapidity and will 
increase the robustness of the assay when faced with seasonal peaks in sample 
submissions and sudden increases resulting from the emergence of a new virus type. 
From the laboratory standpoint, an ideal test should not be expensive to implement 
and maintain. In addition, it should also be easy to use and robust since the tests may 
be operated by less specialised staff. 
Accurate and rapid diagnosis will also inform public health surveillance 
systems. Rapidity ensures surveillance data is timely whereas the ability to provide an 
accurate result allows the morbidity, mortality and economic cost of particular 
infections to be measured and prevention measures to be planned or evaluated.  
Since the initial discovery of viral causes of IID by EM in 1972 several 
techniques for the detection of viral causes of IID have been developed. These include 
the direct detection techniques culture and EM, antigen detection assays and the 
nucleic acid detection technologies such as PAGE, hybridisation and PCR. The 
advantages and disadvantages of each of are described in the following sections 
2.4.1. Direct Detection Of Viral IID. 
2.4.1.1. Culture Methods 
One of the shared characteristics of the different viral causes of IID is their 
fastidious nature. There have been few reports of the successful use of culture systems 
to grow these viruses. Those that have been successful have often used specialist cell 
lines that are not commonly used in laboratories. For example, a permissive cell line 
for rotavirus is the monkey kidney epithelial cell line MA104 (Brydon et al, 1977; 
Purdham et al, 1975; Babiuk et al, 1977; Urasawa, Urasawa and Taniguchi, 1981). 
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Group B rotavirus has also been successfully cultured and is distinguished from group 
A rotavirus by forming multinucleated syncitia. Norovirus and sapovirus have proved 
impossible, thus far, to culture in either cell lines or organ cultures. Duizer et al 
attempted to culture norovirus in 24 different cell lines with and without various 
supplements (Duizer et al, 2004). No successful growth was reported. Wobus et al 
successfully cultured a murine norovirus in dendritic and macrophage cell lines 
(Wobus et al, 2005). However, whether or not this cell line can be used in human 
norovirus strains remains to be seen. Astrovirus has been frequently isolated using the 
cell line Ca-Co-2 (Grimm et al, 2004; Brinker et al, 2000; Pinto, Diez and Bosch, 
1994). Rohayem et al compared Ca-Co-2 to Reverse Transcriptase Polymerase Chain 
Reaction (RT-PCR) for the diagnosis of astrovirus. In 287 samples Ca-Co-2 detected 
8 as positive whereas 19 were detected by RT-PCR. Other cell lines that can be used 
for astrovirus include MA104 and T84. Adenovirus types 40 and 41 have been 
successfully cultured in the cell line Graham 293 (Szucs and Uj, 1998).  
In general most of the methods described above are prolonged and laborious 
and not suited for high throughput work. As a result viral culture is rarely used for 
diagnosis, as other methods are more sensitive, rapid and are easier to use. However, a 
culture system is still desirable in order to carry out viability studies to assess 
detergents and future antivirals. 
2.4.1.2. Electron Microscopy 
EM was instrumental in the discovery of the viral causes of IID and as a result 
has been the diagnostic gold standard for many years. It is an open technique allowing 
the detection of a number of pathogens if present in the sample (Biel and Madeley, 
2001). This characteristic is also useful in the search for new pathogens (Curry, 2003). 
Of all the viral causes of IID rotavirus is probably the most easily identified using this 
method as the virus can be excreted in large quantities for prolonged periods (over 
1010 viral particles/ml has been described). Furthermore, rotavirus can be readily 
identified by its “wheel like” appearance under EM. However, other viral pathogens 
are more difficult to detect using EM. The “star like” appearance of astrovirus is often 
only present in around 10% of the viral particles. The “cup like” depressions of 
norovirus are often indistinct although they tend to be more distinct in sapovirus. As a 
result astrovirus and norovirus pathogens can often be mistaken for each other.  
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The overall detection limit of EM is approximately 106 viral particles/ml of 
faecal sample. However, viruses causing IID are often shed at levels below this 
detection limit, especially a few days after the onset of symptoms. As a result EM is 
reliant on collecting samples early on in the illness, when viral shedding is at its 
greatest. Furthermore, if samples are not refrigerated before examination the viral 
particles can break down reducing the sensitivity of the assay still further 
(McCaughey et al, 2000).  
Samples that contain no virus or levels of virus below the detection limit can 
take time to examine, since the whole sample has to be scanned in detail to check for 
the presence of the virus, thus prolonging turn-around-times and lowering throughput. 
The use of Immune Electron Microscopy (IEM) can increase the sensitivity, 
specificity and rapidity of EM. IEM utilises convalescent serum or immune serum and 
mixes this with faecal sample. The viral particles, if present, should then form large 
antibody-antigen complexes, which are easier to detect by EM. The adaptation of this 
method to include a grid coated in antibody (called Solid Phase IEM or SPIEM) is 
also useful (Kjeldsberg, 1994; Wood et al, 1989; Svensson, Grandien and Pettersson, 
1983; Svensson and von Bonsdorff, 1982). Both methods have also been used to 
serotype viral pathogens and measure immune responses.  
Overall, however, EM is laborious since each sample requires detailed manual 
examination, which predisposes it to low throughput. It is also insensitive in 
comparison to other techniques (Buesa et al, 1996; Pang et al, 1999; Simpson et al, 
2003). It requires highly trained personnel and expensive equipment. Automated 
systems have been described which reduce the need for specialised personnel 
(Utagawa et al, 2002), however these are often very expensive. The large initial cost 
of EM (in terms of both equipment and building costs) and continued maintenance 
costs has resulted in EM being restricted to specialised virology testing centres.  
2.4.2. Antigen Detection Methods 
Since the 1980s an increasing number of in-house and commercial antigen 
detection methods have been described for the detection of viral IID. These methods 
have many advantages over EM. They are easy to use, high throughput and have a 
rapid turn-around-time (less than 4 hours from sample arrival to result). They are also 
less expensive than EM as they do not need specialised equipment or large laboratory 
space.  As a result these assays tend to be used by a wider range of laboratories for the 
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detection of viral causes of IID. Commercial assays have proved particularly useful, 
as the reagents are already provided, they have good standardisation, Quality Control 
(QC) and technical support. These assays are available in numerous formats including 
Enzyme ImmunoAssay (EIA), Latex Agglutinations assays (LA), and 
ImmunoChromatoGraphy methods (ICG). 
Most of the commercial antigen detection assays available are for the detection 
of rotavirus and adenovirus. Methods are also available for the simultaneous detection 
of both viruses (Giordano et al, 2005; Rabenau et al, 1998).  
For rotavirus, most assays utilise monoclonal or polyclonal based assays that 
target the conserved VP6 antigen (Anand et al, 2001; Eing et al, 2001; Kelkar et al, 
2004). Monoclonal-based EIA assays (developed in the 1990s) are more sensitive 
than polyclonal based assays, whilst both tend to be more sensitive than LA methods 
(Dennehy, Gauntlett and Tente, 1988; Thomas et al, 1988; Altindis et al, 2004). 
However LA is more rapid than EIA (Thomas et al, 1994; Kohno et al, 2000). ICGs 
are now regarded to be as sensitive as EIA and as rapid as LA for rotavirus diagnosis 
(Wilhelmi et al, 2001; Bon et al, 2005).  
All of the above antigen detection methods are considered at least as sensitive 
for rotavirus, if not more so, than EM. Detection limits tend to be between 104-107 
viral particles/ml. However, their reduced specificity can result in false positive 
results. This is especially true during non-peak times of the year (Moore, Steele and 
Alexander, 2000; Banyai et al, 2003; Sanekata et al, 1990). Other problems include 
their reduced sensitivity in adult patients and in others who shed low levels of 
rotavirus (Anderson and Weber, 2004). They are also, at present, unable to detect non 
group A rotavirus strains (James et al, 1998). 
There are a number of commercial antigen detection methods available for 
adenovirus including EIA, LA and ICG (Moore, Steele and Alexander, 2000; Banyai 
et al, 2003; Sanekata et al, 1990). Most of the assays target the hexon antigen and are 
either in monoclonal or polyclonal format (Vizzi et al, 1996; Wood et al, 1989; Wood 
et al, 1989; Nishio et al, 1990). Monoclonal-based EIAs tend to be superior to LA and 
ICG. In comparison to EM, the assays show comparable or slightly greater sensitivity. 
As with rotavirus however, antigen based methods for adenovirus detection have 
reduced specificity and can result in false positive reactions (Moore, Steele and 
Alexander, 2000; Banyai et al, 2003; Sanekata et al, 1990).  
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The development of an antigen detection assay for noroviruses has been 
hampered by their variability and complicated immune reactions (described earlier). 
Early antigen detection methods were in-house and targeted viral capsid proteins 
using hyper immune sera from mice, guinea pigs and rabbits, targeting viral capsid 
proteins. These assays often failed to detect all of the different types of norovirus and 
thus were restricted to research laboratories only (Nakata, Estes and Chiba, 1988). 
Some in-house assays were specifically devised to detect the predominant strains, 
allowing other methods to be used on a smaller subset of samples (Vipond et al, 2000; 
Matson et al, 1989). The ability to express norovirus capsid proteins in a 
baculoexpression system allowed the generation of VLPs. VLPs have been used to 
immunise animals, producing both monoclonal and polyclonal antibodies. This led to 
the discovery of genotype and genogroup specific antibodies, which in turn led to the 
development of a small number of commercial EIAs for the detection of norovirus. 
Studies have shown these assays to be more sensitive than EM. Richards et al 
compared a commercial polyclonal EIA (IDEIA, Dako Cytomation) with EM on a 
panel of outbreak specimens (Richards et al, 2003). Overall the sensitivity of the EIA 
was greater than that of EM (55.5% vs 23.9%). It was concluded that this EIA would 
prove useful in laboratories without access to EM or molecular methods such as PCR. 
However, this assay was later withdrawn and replaced with a monoclonal-based EIA. 
Burton-Macleod et al compared the monoclonal EIA (IDEIA, Dako Cytomation, Ely, 
UK) to another commercial EIA called the Denka EIA (Seiken Co. LTD, Tokyo, 
Japan) on 103 samples containing G1 and G2 norovirus, and representatives of other 
enteric viral pathogens (Burton-Macleod et al, 2004). Although the Denka kit was 
more sensitive than the Dako assay (70% vs 30%) the specificity was significantly 
reduced (69% vs 100%). The Denka assay also detected sapovirus. However, neither 
EIA was recommended for routine diagnosis. Recent assessments of other commercial 
EIAs for norovirus have also proved disappointing (Dimitradis and Marshall, 2006).  
There are relatively few antigen detection methods available for the detection 
of astrovirus. A number of in-house EIAs have been described in the literature with 
varying levels of sensitivity (Herrmann et al, 1990; Komoriya et al, 2003; Kohno et 
al, 2000). Recently commercial assays have become available. Putzker et al compared 
a commercial EIA assay (IDEIA, Dako Diagnostika, Hamburg, Germany) with EM 
on 213 faecal samples  (Putzker et al, 2000). Overall the EIA was able to detect all of 
the sample positives as EM from all 8 astrovirus groups. A recent study by Liu et al 
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compared the same commercial EIA with RT-PCR (using primers mon 269 and 270). 
They found that the EIA had comparable sensitivity to the RT-PCR assay (Liu et al, 
2005).  
At present there is no commercial assay available for the detection of 
sapovirus. Several in-house assays have been described. Most use polyclonal 
antibodies but these have tended to be insensitive (Hansman et al, 2005; Hansman et 
al, 2006). The use of VLPs for sapovirus may in future lead to the development of 
commercial assays for its detection. 
Overall, antigen detection methods are a useful laboratory diagnostic method. 
Studies have shown them to be at least as sensitive as EM with the advantage that 
they are rapid, easy to use, and high throughput. They are also inexpensive to 
implement in a laboratory, as they require little extra equipment or specialised 
training. However, despite these advantages, question marks remain over their 
specificity, especially for norovirus detection. They also have stringent requirements 
concerning the time from sample collection to testing taking place, which must be 
between 3-7 days depending on the pathogen under test. Furthermore, no commercial 
assay is currently available for sapovirus.  
2.4.3. Nucleic Acid Detection Assays  
2.4.3.1. Poly-Acrylomide Gel Electrophoresis (PAGE) 
An inexpensive and effective alternative to either EM or antigen detection 
methods for the diagnosis of rotavirus is polyacrylomide gel electrophoresis (PAGE). 
To carry out this technique the segmented dsRNA is extracted directly from faecal 
samples, electrophoretically separated on polyacrylomide gels and then detected by 
silver staining (Steele et al, 1993; Johnson and McCrae, 1988). The sensitivity is as 
good as EIA and can be improved using nucleic acid extraction techniques. This 
method detects all rotavirus types and allows group A rotavirus to be differentiated 
from other rotaviruses as it has a distinctive banding pattern to that of group B and C. 
However, the steps described above mean that this method is laborious and therefore 
not routinely used in laboratories. 
2.4.3.2. Hybridisation 
A number of hybridisation assays have been described that use complementary 
labelled probes such as radio labelled dioxygenin (Willcocks et al, 1991; Moe et al, 
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1991). Some of these assays have been shown to be as sensitive and specific as EIAs 
for rotavirus (Ali et al, 1993; Flores et al, 1983). However, hybridisation assays for 
variable RNA viruses such as norovirus and sapovirus have shown reduced 
sensitivity, mainly because of the difficulty in targeting conserved areas. As a result 
these assays quickly became redundant, as laboratories preferred the increased 
sensitivity of other molecular techniques such as PCR (described in the following 
section). 
2.4.3.3. Polymerase Chain Reaction (PCR) Assay 
PCR (shown in Figure 9) is a very sensitive technique allowing the detection 
of minute quantities of virus (Mullis and Faloona, 1987; Holland et al, 1991). PCR 
utilises a pair (or more) of synthetic oligonucleotides called primers, which are 
specific to a conserved region (of defined length) of the genome of the virus to be 
detected. These primers are then added to a mixture containing dNTPs (nucleotides), 
various buffers, and an enzyme called Taq DNA polymerase. To this mixture the 
nucleic acid from a clinical sample is added. This PCR mixture then undergoes a 
cycle of temperature changes consisting of: a denaturation step that causes the DNA 
strands to separate; an annealing step during which the primers bind to the target 
sequence; and an extension step where the Taq DNA polymerase uses the primers as a 
substrate to create a complimentary strand, by adding dNTPs to the primers. At the 
end of one PCR cycle the number of starting target sequences doubles. After 30-50 
cycles millions of copies of the original template can be made.  
Although principally a DNA detection technique the detection of RNA can be 
achieved by the addition of a Reverse Transcriptase (RT) step, which converts RNA 
to cDNA that can then be used in PCR reactions.  
Successful PCR relies upon numerous factors. Efficient nucleic acid extraction 
is needed to purify the nucleic acid from the clinical sample and remove substances 
that may inhibit the PCR (Rasool, Monroe and Glass, 2002). There are many different 
methods available for this (Hale, Green and Brown, 1996; Kok et al, 2000; Santos and 
Gouvea, 1994). Many are in a commercial kit format thus improving the reliability 
and ease of use of the extraction process. Many of these kits also work using an 
automated robot format allowing multiple samples to be extracted reliably and within 
a short time period, which is useful in a high throughput (i.e. diagnostic) laboratory 
and helps improve the rapidity of PCR.  
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Another important factor for successful PCR is the choice of primers. Primers 
should be designed to detect and amplify conserved regions of the target virus. 
Targeting variable regions may prevent primers from binding and can result in false 
negative PCR results. 
Figure 9: The Polymerase Chain Reaction assay. 
 
The use of multiple primers (known as multiplex PCR) allows the detection of 
multiple pathogens within a single PCR reaction (O’Neil et al, 2002). Multiplexing a 
number of PCR methods into a single tube can improve test rapidity by allowing a 
number of tests to be carried out in one step and can also reduce tests costs by using 
less reagent.  
Carrying out a nested PCR can increase the sensitivity of a PCR test. Nested 
PCR consists of a second PCR reaction that uses the PCR product as a template and 
primers that target an area within the first PCR target region. However, although this 
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increases the sensitivity of the PCR, it also raises the risk of false positive results due 
to contamination. 
Currently, two forms of PCR assay exist - conventional methods and the more 
recent real-time PCR techniques. Both are based on the above chemical reaction and 
differ only in how the result is analysed. In conventional PCR, which was the first 
kind to be developed, the product from the PCR reaction is detected by adding a 
volume of the PCR mixture to an agarose gel once the reaction is complete. After 
electrophoresis the gel is examined under ultraviolet light. If the target was present in 
the original sample a band of defined length (corresponding to the target sequence) is 
observed. Other methods of confirmation include micro-titre plate hybridisation and 
southern hybridisation (van der Vliet, Hermans and Klatser, 1993; Keller et al, 1990). 
This form of PCR therefore provides end point analysis, which means that the result is 
only available at the end of the test.  
Real-time PCR, in contrast, allows visualisation of the PCR process as it 
occurs. This technique first began to appear in the late 1990s. Instead of a band on a 
gel a positive reaction is shown by an increase in flourescence above background 
levels. The PCR cycle point at which the sample becomes positive is called the cycle 
threshold (Ct). The Ct is directly related to the starting target copy number. The lower 
the Ct (i.e. the nearer it is to zero) the greater the starting target copy number (Figure 
10), which means that real-time PCR is a semi-quantitative assay and with the use of 
known standards can be made fully quantitative (Kang et al, 2004). 
There are a number of chemistries available for real-time PCR including dual-
labelled probes (formally known as TaqMan™ probes), molecular beacons, Minor 
Groove Binding probes (MGB), fluorescent-labelled primers and DNA chelating dyes 
(Figures 11-14). The advantages and disadvantages of these chemistries are discussed 
in Table 3. Most published assays use dual-labelled probes or molecular beacons. This 
is probably due to the fact that the addition of a probe or beacon improves specificity, 
since this and the primers have to bind to the PCR to provide a positive result. 
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Figure 10: Real-time PCR fluorescent curve. 
 
The figure shows a representative amplification plot (fluorescence signal versus cycle number) for real time PCR. In the initial cycles of 
PCR, there is little change in fluorescence signal (This is the baseline for the amplification plot). An increase in fluorescence above the 
baseline indicates the detection of accumulated PCR product. The parameter Ct (threshold cycle) is defined as the cycle number at which 
the fluorescence passes the fixed threshold. So the higher the initial amount of the target in the sample, the sooner accumulated product 
is detected in the PCR process as a significant increase in fluorescence, and the lower the Ct value.  
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Figure 11: Dual-Labelled Probes. 
 
 
 
 
Dual-labelled probes (also known as Taqman™ probes) are oligonucleotides that contain a fluorescent dye on the 5' base, and a 
quenching dye located on the 3' base. When excited the fluorescent dye transfers energy to the nearby quenching dye molecule rather 
than fluorescing, resulting in a nonfluorescent probe. Dual labelled probes are designed to hybridise to an internal region of a PCR 
product. During PCR, when the polymerase replicates a template on which the probe is bound, the 5' exonuclease activity of the 
polymerase cleaves the probe. This separates the fluorescent and quenching dyes, allowing detection of the signal from the reporter dye. 
Fluorescence increases in each cycle, proportional to the rate of probe cleavage (http://probes.invitrogen.com). 
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Figure 12: Molecular Beacons. 
 
 
Here the primer binding site is within the loop. Molecular beacons contain fluorescent and quenching dyes and are designed to adopt a 
hairpin structure while free in solution, bringing the fluorescent dye and quencher into close proximity. When a molecular beacon 
hybridises to a target, the fluorescent dye and quencher are separated and the fluorescent dye emits light upon irradiation. Unlike dual 
labelled probes, molecular beacons are designed to remain intact during the amplification reaction. (http://probes.invitrogen.com) 
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Figure 13: Scorpion primers. 
 
 
Schematic representation of real-time PCR with Scorpion primers. In the hairpin loop structure, the quencher (black circle) forms a 
nonfluorescent complex with the fluorophore (green circle). Upon extension of the amplicon, the Scorpion probe hybridises to the newly 
formed complementary sequence, separating the fluorophore from the quencher and restoring the fluorescence 
(http://probes.invitrogen.com). 
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Figure 14: Uniprimers. 
 
 
 
Schematic representation of real-time PCR with UniPrimers. In the first round of amplification, the reverse primer, containing a special 
sequence tag, primes synthesis along the template. In the second round, the forward primer primes synthesis that extends through the 
special sequence tag, forming a complementary sequence to the tag. In the third round, the UniPrimer hybridizes to this complementary 
sequence via the special sequence tag. The hairpin structure of the UniPrimer ensures that the quencher (black circle) suppresses the 
fluorescence of the fluorophore (green circle). Finally, in the fourth round, synthesis extends through the hairpin loop, relieving the 
quenching of the fluorophore (http://probes.invitrogen.com). 
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Table 3: Comparisons of the various technologies available for real-time PCR. 
Chemistry Advantages Disadvantages 
Molecular beacons Specific 
Sensitive 
Susceptible to probe mis-match 
Expensive 
Low fluorescence 
Less available 
Dual-labelled probes Specific 
Many publications available 
Increased fluorescence 
Less susceptible to probe mis-match 
Many manufacturers 
False negative results can still 
occur 
Minor groove binders Specific 
Increased fluorescence produced 
Can be used in small conserved areas 
Susceptible to probe mis-match 
Few suppliers 
Expensive 
Labelled primers 
(e.g. sunrise, 
scorpion, and lux) 
Cheap (no probe needed) 
As sensitive as probe-based technology 
Less homology needed (no probe region) 
Primer-dimer formation 
Strict design criteria 
Chelating dyes Cheap 
Used on large regions 
Primer-dimer formation 
Less specific than other methods 
 
Since both conventional and real-time PCR methods detect nucleic acid rather 
than viral particles or antigen, these tests involve less stringent requirements than 
either EM or EIA concerning the time taken between sample collection and testing. 
Both methods have also been shown to offer significantly improved sensitivity in 
comparison to other diagnostic methods (for a full review of each of the PCR methods 
available see Chapter 3), although more data is available on the performance of 
conventional PCR due to the relatively recent nature of real-time technology. For 
example, for rotavirus detection, Buesa et al carried out a comparison of conventional 
RT-PCR, PAGE and EM on 200 samples. The PCR assay detected 66 positive 
samples, whereas PAGE and EM detected 59 and 56 positive samples respectively 
(Buesa et al, 1996). Similar results were found by Pang et al, who compared a 
different gel-based RT-PCR with a commercial EIA (Rotaclone) on a total of 2398 
infants. In Pang et al’s study, 256 cases of rotavirus-associated gastroenteritis were 
detected by EIA whereas with RT-PCR, 84 (33%) more cases of rotavirus 
gastroenteritis were diagnosed (Pang et al, 1999). Similarly, Simpson et al compared 
a real-time RT-PCR assay with EM on 305 samples collected from children under five 
years of age with acute gastroenteritis (Simpson et al, 2003). The RT-PCR method 
detected 86 rotavirus-positive samples, compared to 70 using EM (an increase in 
detection rate of 22.9%). Similar increases in detection have been observed when 
comparing PCR to EM for adenovirus. For example, Simpson et al detected 40 
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adenovirus-positive samples using real-time PCR compared to 12 detected by EM (an 
increase of 233%). 
Similar, if not greater, increases in detection rate have been observed when 
using PCR for the detection of norovirus, astrovirus and sapovirus. Early studies using 
EM and EIA often failed to detect these viruses. For example, Waters and colleagues 
used EM and EIA to examine 1386 samples from children admitted to hospital in 
Canada with IID. Although the detection rate for rotavirus and adenovirus was in line 
with other studies, the detection rates for norovirus, astrovirus and sapovirus were 
found to be 2%, less than 1% and less than 1% respectively (Waters et al, 2000). An 
Italian study examining 417 children hospitalised with IID found, using EM, 
astrovirus in less than 1% of cases. No cases of norovirus or sapovirus were reported 
(Donelli et al, 1993). The use of PCR has significantly increased the detection rate of 
these pathogens. For example, Frogatt et al examined 3,172 samples from children 
(aged under 7 years) in Bristol, UK (Froggatt et al, 2004). Using EM, 0.9% of cases 
tested positive for norovirus. The use of EIA and a gel-based RT-PCR increased the 
detection rate to 4.2% and 10.3% respectively. In the study carried out by Simpson et 
al norovirus was detected using real-time RT-PCR in 46 samples compared to 6 using 
EM. This study also showed an increase of astrovirus positives (7 vs 3) and 
sapoviruses (8 vs 1) using the real-time PCR assay.  
This increased sensitivity of PCR in comparison to other techniques has in 
recent years helped establish that viral pathogens are the major cause of sporadic IID 
in children both requiring hospitalisation and presenting to GPs, and that these 
pathogens also contribute significantly to sporadic IID in adults  (Simpson et al, 2003; 
de Wit et al, 2001 (i); de Wit et al, 2001 (ii)) 
The greatest impact, however, has been in the diagnosis and investigation of 
outbreaks of IID. Before the application of RT-PCR in the late 1990s the aetiology of 
most outbreaks of IID was undetermined. This was highlighted by Bean and Griffin 
who examined 7500 outbreaks of IID reported to the CDC between 1973-87 (Bean 
and Griffin, 1990). Of these, only 38% had a diagnosed aetiological cause (1.8% were 
attributed to viruses). In contrast, the utilisation of PCR methods has now established 
that the majority of IID outbreaks are caused by norovirus. Fanklauser et al examined 
284 outbreaks submitted to the CDC from 1992-2000 using a conventional gel-based 
PCR (Fankhauser et al, 2002). Of these, 93% were found to be caused by norovirus. 
Similar findings have been reported elsewhere based on the use of PCR techniques 
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(Chatterjee et al, 2004; Inouye et al, 2000; van Duynhoven et al, 2005). For example, 
Lopman et al reviewed the causes of outbreaks reported in a number of European 
studies occurring between 1995-2000 (Lopman et al, 2003). Noroviruses were shown 
to cause most cases of outbreaks in England and Wales (96%), Germany (100%), 
Sweden (97%), the Netherlands (84%), Slovenia (43%) and Spain (57%). The other 
four viruses discussed are also known to cause outbreaks of IID, however outbreaks 
of this type are much less common than those caused by norovirus. 
There is some concern that PCR techniques may in fact be over-sensitive, 
detecting low levels of virus that may be due either to prolonged shedding after the 
resolution of symptoms or to asymptomatic infection in patients with illness due to 
other causes. 
Prolonged viral shedding after the resolution of symptoms has been detected in 
a number of cases (Richardson et al, 1998; Ball et al, 2005; Rockx et al, 2002; Cliver, 
1997). Moreover, the fact that in such cases the more sensitive PCR techniques have 
detected virus for the longest periods suggests that it is shed at low levels. Richardson 
et al, for example, followed up 37 children with acute rotavirus infection. Using EIA 
rotavirus was detected up to 21 days (with a mean of 7 days) after infection whereas 
RT-PCR detected rotavirus up to 57 days post-infection. Here, the mean was 10 days 
(Richardson et al, 1998). The extended duration of shedding could not be linked to 
disease severity or age. Norovirus shedding, also, has been detected up to 7 weeks or 
more post-infection (Ball et al, 2005; Rockx et al, 2002) whereas sapovirus and 
astrovirus have been detected up to 2 weeks post-infection using RT-PCR (Rockx et 
al, 2002; Cliver, 1997). However, the percentage of infections that result in prolonged 
shedding has yet to be established and may be in the minority (Rockx et al, 2002; de 
Wit et al, 2001).  
True asymptomatic infections have also been observed in a small number of 
studies and are likely to be the result of a complicated relationship between various 
viral and host factors (Graham et al, 1994). For example, Graham et al inoculated 50 
volunteers with norovirus and of these 32% showed seroconversion and viral 
shedding in the absence of clinical symptoms. Recent studies have attempted to 
demonstrate that a link exists between the severity of the illness and the level of virus 
shed, with the suggestion that less severe or asymptomatic infections result in low 
levels of shedding. Kang et al, for example, used a real-time PCR to quantitate 
rotavirus shedding and compared it to Vesikari severity scores in 66 children 
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presenting to hospital with IID (Kang et al, 2004). Those with mild to asymptomatic 
infection were found to have very low viral loads (i.e. Ct values close to 40 cycles) 
compared to those with more severe infection. Similarly, Pang et al compared RT-
PCR to EIA on children with IID (Pang et al, 1999). The RT-PCR detected more 
cases of rotavirus in comparison to the EIA, but these were more often from those 
with mild/asymptomatic infection. These findings have not been restricted to 
rotavirus. Richards et al used real-time PCR to quantitate norovirus shedding in 
volunteers with symptomatic and asymptomatic infection (Richards et al, 2004). Two 
of the 3 volunteers with asymptomatic infection (note a very small sample size) were 
found to have a low level of viral shedding. Gallimore et al tested asymptomatic staff 
and patients after an outbreak of norovirus in a hospital ward (Gallimore et al, 2004). 
In total, 87 asymptomatic staff were tested and of these 26% were positive for 
norovirus. Since these were detected by a nested method but not by a less sensitive 
single round PCR it was suggested that the virus in the asymptomatic cases was being 
shed at low levels.  
However, others studies have failed to find a link between viral shedding and 
disease severity. In the study mentioned above by Richards et al one of the 
asymptomatic patients was found to have a high viral load in the stool. Conversely, 
low levels were also detected in a number of symptomatic volunteers with more 
severe infection. Zhang et al also used real-time PCR to correlate astrovirus viral load 
and severity in 54 patients presenting at hospital with gastroenteritis (Zhang et al, 
2006). Here, no link between viral load and severity was observed. Consequently, the 
link between low level viral shedding and asymptomatic infection has yet to be 
confirmed.  
Furthermore, the rate of asymptomatic infection in different patient groups and 
the population at large has also yet to be determined. Much of what is known about 
the rate of asymptomatic IID infections has come from a small number of case-control 
studies. Some of these studies have suggested that asymptomatic shedding is very 
common, whereas other studies have found it to be rare or have failed to detect such 
cases at all. Many of these differences are likely to be a result of the tests used, the 
cohort examined and the country the study was carried out in. For example, Tompkins 
et al examined the detection rate of various pathogens in cases of IID and controls in 
both a general population and a GP cohort (Tompkins et al, 1999). This study used 
EM and EIA to test for viral pathogens. Detection rates were found to be low (1.1%-
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1.2%) in both control groups, with rotavirus and norovirus most common in both 
populations. Recently, the same samples were re-tested using more sensitive PCR 
methods for norovirus, rotavirus and sapovirus (Amar et al, 2007). The detection rate 
for norovirus, rotavirus and sapovirus in the control groups increased significantly 
from the previous study to means of 16% (range 5-31%), 14% (range 4-29%) and 2% 
(range 0-13%) respectively. Examining the detection rate by age group showed that 
the highest values were detected in the young. It is important to note, however, that 
children under 5 yrs of age may have been over-represented in the study resulting in 
an inflated mean detection rate. Moreover, information on whether the control cases 
had had a recent gastrointestinal illness was not known, which is a serious flaw as the 
detections may not have been due to true asymptomatic cases but examples of 
prolonged shedding following infection. Other case control studies have used 
molecular methods for the detection of viral pathogens. For example, de Wit et al 
used RT-PCR to test for norovirus and sapovirus and EIA methods to test for 
adenovirus, astrovirus and rotavirus. They detected viruses in approximately 9.1% of 
controls taking part in a community cohort study (de Wit et al, 2001). Of this total, 
norovirus was detected in 5.2% of the control samples. Again, however, this value 
may have been an over-estimate as children were over-represented in the study 
(Marshall et al, 2004). However, similar rates for norovirus asymptomatic infection 
have been found in studies in Japan and Mexico (Garcia et al, 2006; Akihara et al, 
2005). High levels of asymptomatic infection have also been found in the outbreak 
setting (Vinje et al, 1997) and in countries with low socioeconomic conditions (Garcia 
et al, 2006). On the other hand other studies have failed to detect norovirus at all in 
asymptomatic control groups (Marshall et al, 2004). Marshall et al tested samples 
from 399 asymptomatic individuals with a nested RT-PCR and failed to detect a 
single norovirus case. Meanwhile, few studies have applied molecular techniques to 
investigate the detection rate of adenovirus and astrovirus in asymptomatic patients.  
In summary, therefore, the concern that PCR techniques may be over-
sensitive, detecting asymptomatic cases of IID or cases following resolution of the 
symptoms, is based on several assumptions that have yet to be fully proven. Although 
there is evidence that prolonged shedding post-infection does take place, the 
proportion of infections that this applies to has yet to be established and may be in the 
minority. Meanwhile, data on whether asymptomatic infection is associated with viral 
shedding (at low levels) is more contradictory, as is the evidence on the rate of such 
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infections in patient groups and the population at large. While it is possible, therefore, 
that the use of PCR may result in some cases of unnecessary detection of IID these are 
likely to be in the minority.  
Whilst similar levels of sensitivity are achievable using both types of PCR, in 
practical terms there are some differences between them that mean real-time 
techniques are more likely to be of use in a routine diagnostic setting. Despite 
conventional gel-based PCR having been available for some time, its use is still 
mainly restricted to specialist testing centres and research facilities. This is a result of 
many factors. Firstly, in order to reduce the risk of contamination the laboratory needs 
to be set up with a particular structure or flow through to prevent amplified product 
being reintroduced into subsequent PCR reactions. Conventional PCR is also 
technically demanding and requires specially trained staff in order to develop, 
implement and “trouble shoot” assays. The need for a post-amplification step such as 
agarose gel electrophoresis reduces the likelihood of automation and thus the potential 
for high throughput. As a result, although sensitive, the assay is not rapid or capable 
of processing a large number of samples at one time. The combination of these factors 
means that little use of conventional PCR is made in non-specialist and routine 
diagnosis laboratories. Despite this adaptations can be used to improve conventional 
PCR and increase its usefulness in the routine setting. For example, multiplexing 
more than one PCR test into a single test can reduce test costs and improve rapidity.    
Real-time PCR offers the potential to overcome many of the problems 
encountered with traditional gel-based PCR (Mackay, Arden and Nitsche, 2002; 
Lomeli et al, 1989; Heid et al, 1996; Pfaffl, 2001). In contrast to traditional gel-based 
PCR, for example, real-time PCR is a closed technique, which means all of the PCR 
steps take place in one tube (reverse transcriptase, PCR and detection). This 
characteristic is likely to improve reproducibility and robustness, and reduces the risk 
of contamination thus favouring automation and high throughput. As a result, real-
time PCR has the potential to be more rapid. The closed system also reduces the need 
for a strict laboratory set-up and as a result reduces implementation costs. The cost of 
reagents and equipment are also starting to reduce, as companies compete to provide 
to an increasing numbers of users. As a result, of all the methods discussed in this 
section, this thesis takes the view that it is real-time PCR that is most near to the ideal 
test outlined in the introduction. 
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2.5. The WOSSVC Diagnostic Service For Viral IID. 
The West of Scotland Specialist Virology Centre (WOSSVC) is based at 
Gartnavel General Hospital (GGH) in Glasgow. It is one of only two specialist 
virology centres in Scotland and provides a virology service for the whole of 
Glasgow. In addition, a significant proportion of its workload (over 40%) is from 
health boards outside Glasgow. The users include hospital-based users, users in 
primary care and general practice and private industry. Each year over 200,000 
investigations are performed. Since the late 1990s, as part of an ongoing programme 
of innovative service development the number of in-house molecular tests has 
increased significantly and these are now used in routine services for detecting viral 
and bacterial pathogens in Cerebrospinal Fluid (CSF) samples, respiratory samples, 
blood, urine, vesicle fluids and genial swabs.  
At the start of the research documented in this thesis, although the process of 
implementing molecular methods had begun in other areas, the WOSSVC diagnostic 
service for viral gastroenteritis was based solely upon electron microscopy. The 
laboratory offered this service for samples from outbreaks of IID, and samples from 
sporadic cases of IID in children less than 10 years of age and immunocompromised 
patients. However, as made clear in previous sections, EM is laborious and not suited 
to testing large numbers of samples. Furthermore recent research has clearly 
highlighted the insensitivity of EM in comparison to emerging techniques, particularly 
PCR. In the interests of continuing to improve the diagnostic service offered 
therefore, a need was identified to replace EM in the laboratory with an improved test 
for the detection of viral IID. Based on the literature PCR was identified as the most 
suitable candidate. However, although highly sensitive and able to test a number of 
samples at any one time, PCR has been found to be technically demanding to 
implement, maintain and troubleshoot. To date these factors have resulted in its use 
being largely restricted to a research setting. However, the view taken in this thesis is 
that such tests have the potential to be adapted for use in the routine setting, 
particularly real-time versions of this technique.  
Consequently, the overall aim of this work was to improve the routine 
diagnostic service for IID offered at the WOSSVC, by replacing EM as the frontline 
test with PCR methods adapted from the literature. This was broken down into several 
smaller objectives. The initial objective was to select and adapt appropriate PCR 
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techniques from the literature. The second was to compare these techniques to 
possible alternatives such as EIA and EM through a series of laboratory experiments 
to ensure their suitability. The final aim was to implement the new techniques in the 
routine service and examine their impact on the quality of the service offered. 
2.6. Summary 
This chapter has provided the background to the research presented in this 
thesis and through this the motivation for its existence. The chapter began with an 
overview of the public health importance of IID in developing and developed 
countries. Particular focus was then given to the cost of IID in developed countries in 
order to show that IID is a significant cause of morbidity in such countries and 
although mortality is low, the economic cost is substantial.  
This section was followed by a description of the five main viral causes of IID. 
For each pathogen a number of characteristics were described including: their 
virology, classification, elicited immune response, epidemiology, the clinical illness in 
which they result, methods of preventing this illness, infection control and treatment. 
This section was designed to show that these genetically complex pathogens are a 
cause of world wide sporadic illness and outbreaks in all age groups, and can cause 
severe and chronic illness in numerous patient groups. The multiple types and 
subtypes and the complex immune responses were highlighted to show that repeat 
infections can occur with each virus. The virology of each virus was also described in 
order to highlight the variable nature of some parts of the viral genomes. This is 
important when considering the design of molecular assays to test for these pathogens, 
which is a major part of the next chapter. Their numerous sources and transmission 
routes were also described in order to highlight how difficult these pathogens are to 
control and prevent.  
Following this, a review of the different laboratory methods available for the 
detection of viral IID was presented. This began with a description of the 
characteristics of an ideal diagnostic test in order to highlight that a routine diagnostic 
test has different requirements to an assay that is to be used as a research tool. The 
advantages and disadvantages of each diagnostic method were then described in this 
context. This section outlined the increased sensitivity offered by PCR techniques, 
which have helped to establish that viral pathogens are the most common cause of IID 
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in children and outbreaks of IID and contribute significantly to such illness in adults. 
As such, services for their diagnosis are particularly important. It was then highlighted 
that conventional and in particular real-time PCR methods have the potential to be 
adapted for use in the routine diagnostic laboratory and the aims of the research were 
described.  
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Selection And Development Of The PCR 
Protocols For Investigation 
3.1. Overview  
This chapter describes in detail the selection and development of the PCR tests 
to be investigated as a potential replacement for the existing EM-based diagnostic 
service for viral gastroenteritis. The chapter begins by describing key decisions taken 
with regard to the structure of the proposed new service, based on a review of the 
literature (described in Chapter 2). These include the decision to split the service in 
two, with samples from outbreaks treated separately to those from sporadic cases of 
IID, and the decision on which pathogens to test for in each case. This is followed by 
a summary of the steps involved in a generic PCR assay. For each key stage (i.e. the 
sample preparation followed by the PCR method itself) the available protocols are 
then reviewed, and the factors affecting the eventual choices made for each of the 
outbreak and sporadic services are discussed. The methods selected in each case are 
described in detail, together with any adaptations necessary for use in the routine 
laboratory setting. The chapter ends with a full technical description of the sample 
preparation and PCR methods assessed in the research described in Chapter 4. 
3.2. Introduction 
It was established in Chapter 2 that norovirus is the principle cause of 
outbreaks of gastroenteritis, whilst for sporadic cases of IID there are five main viral 
causes: adenovirus, astrovirus, norovirus, rotavirus and sapovirus. Based on this 
information, the decision was taken to divide the new diagnostic service into two 
parts: a separate service for samples from outbreaks of IID and one for those from 
sporadic cases, with the distinction between the two types made via the clinical details 
provided on the specimen request form. This division of the service allows the tests in 
each case to be tailored to best match the known characteristics of the two types of 
viral IID. For the outbreak service, for example, the decision was taken to adopt a 
norovirus assay as the frontline test for sample investigation, based on an increasing 
number of reports showing norovirus to be the principle cause of outbreaks of IID 
(see Chapter 2). For the sporadic service, the decision was taken to employ this same 
norovirus assay together with PCR tests for adenovirus, astrovirus, rotavirus and 
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sapovirus to investigate sporadic cases of gastroenteritis in children under 10 years of 
age and immunocompromised patients (the patient groups already tested using the 
EM-based service). As shown in Chapter 2, these viral pathogens contribute 
significantly to IID in children and can cause severe and chronic infection in 
immunocompromised individuals of all age groups. In the case of the outbreak 
service, moreover, it was decided that samples which tested negative for norovirus 
should be examined further using the tests for the other non-norovirus pathogens. 
Testing for other possible causes of IID was rejected (in both services) since this 
would mean additional cost when the clinical significance of many of these pathogens 
is unclear.  
A PCR test for viral IID is made up of numerous individual stages including 
the sample preparation steps (stool extraction followed by nucleic acid extraction), 
and the PCR-related steps such as reverse transcription (if the target is RNA), the PCR 
step itself (or two PCR steps if using a nested protocol) and, if using a conventional 
PCR method, agarose gel analysis for the interpretation of results. Numerous methods 
are available for each of these steps that each differ in their sensitivity, specificity, 
ease of use, cost and rapidity. Furthermore, some of these steps can be bought from 
commercial companies whereas others must be carried out using in-house methods. 
As a result each method must be chosen carefully in order to develop a PCR test that 
is both effective and applicable for use in the routine diagnostic setting.  
This chapter motivates the choice of laboratory protocols for use in the 
proposed new molecular service for IID and describes each of the methods in detail. It 
begins by describing the methods chosen for stool and nucleic acid extraction. A 
review of the published PCR methods for the detection of the five main viral 
pathogens is then given. This discusses the advantages and disadvantages of each 
method and outlines relevant evaluation data. The factors that affected which of these 
assays were selected for further investigation in this research are then described, 
together with details of the eventual methods chosen and the adaptation of these to the 
routine setting.  
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3.3. Laboratory Methods 
3.3.1. Sample Preparation Methods 
Sample preparation in the form of stool extraction followed by nucleic acid 
extraction is a core part of all PCR based tests carried out on stool. Stool extraction is 
carried out in order to remove any sample debris that may inhibit nucleic acid 
extraction and other laboratory equipment. The nucleic acid extraction method is 
carried out in order to remove PCR inhibitors and, in some cases, to concentrate 
nucleic acid (Atmar and Estes, 2001). Concentrating the nucleic acid in a sample aids 
the sensitivity of the PCR test, as more nucleic acid can be added to a PCR reaction. A 
number of methods are available for each of the stool and nucleic acid extraction 
steps, the choice of which is independent of the PCR method chosen. 
3.3.1.1. Stool Extraction Protocol 
Faecal extraction consists of three main steps. First the stool is added to some 
form of liquid medium to make a 10-20% solution, which is then centrifuged in order 
to pellet cell debris. The supernatant is then removed and can be used for nucleic acid 
extraction. Various solutions and centrifugation speeds have been described in the 
literature (Schaffer et al, 1985; Logan et al, 2006; Lennette, Balows, Hausler and 
Sahdow, 1985 (Fourth Edition)). Solutions described include distilled water, 
phosphate buffered saline (PBS), viral transport medium (VTM), Hanks medium and 
specially designed medium from commercial companies, although no studies exist 
that focus on comparing the utility of these methods. The method implemented in this 
research uses PBS to make the 10-20% solution, which is then centrifuged at 3,000 
rpm for 30 minutes. Examples of its use can be found in the literature (Lennette et al, 
1985) and its effectiveness was already established in the laboratory as part of the 
existing EM protocol. Details of the exact implementation are outlined in section 3.4. 
3.3.1.2. Nucleic Acid Extraction Method 
Nucleic acid extraction is necessary to purify and concentrate nucleic acid 
(DNA and RNA) from stool samples and to remove any factors that may inhibit PCR. 
There are numerous in-house and commercial methods available for nucleic acid 
extraction.  
An in-house method commonly used for the extraction of nucleic acid from 
stool samples is the “Boom” method (Boom et al, 1990). This method uses guanidium 
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thiocyanate to lyse the stool samples. Acid phenol-chloroform-isoamyl alcohol is then 
used to extract nucleic acid from the lysed faecal samples and the nucleic acid is then 
purified by silica binding. This protocol has been shown to successfully extract 
ssRNA, dsRNA and DNA from stool samples (Rasool et al, 2002). Other published 
in-house methods used for the extraction of nucleic acids from stool samples include 
(Atmar and Estes, 2001); exclusion chromatography (using spin columns containing 
sephadex G200); heat release (heating stool samples for 5 minutes at 95-99oC); and 
antibody capture (virus-specific antibodies, bound to a 96-well plate, bind virus from 
clinical samples and viral RNA and/or DNA is released from the capsid after washing 
and heating). These methods differ in their ability to purify nucleic acids and are 
variously suited to particular sample types, viruses and nucleic acid types.  
In general, in-house extraction procedures are inexpensive and are therefore 
suited to use in the research setting. Their primary aim is to remove inhibitors from 
the sample and then efficiently extract nucleic acid. Of less importance are their ease 
of use and the number of samples that can be extracted at any one time. As a result, 
these methods tend not to be high throughput, can be difficult to standardise and 
require prolonged hands-on time, which increases the risk of error and contamination. 
These factors combined mean that such methods were not considered for use in the 
research described in this thesis. 
Numerous commercial companies offer methods for nucleic acid extraction 
(Fiebelkorn et al, 2002; Loens et al, 2007; Jongerius et al, 2000; Chiu et al, 2006).  
Most of these are based on either silica-gel-membrane or magnetic-particle extraction 
technology. Purification using silica-gel–membrane technology uses the “Boom” 
method described above and numerous kits are available that can extract RNA or 
DNA, or can perform total nucleic acid extraction from numerous sample types. 
Magnetic particle systems can also be used to extract both RNA and DNA. Samples 
are first lysed and then the target RNA or DNA (or both) is bound to the magnetic 
particles. The nucleic acid is then washed before elution.  
Although more expensive than in-house techniques, commercial methods are 
easy to use, standardised, and as a result offer improved Quality Control (QC). All of 
the necessary components are delivered in a single kit, including reagents that have 
been pre-optimised for the process. In comparison to in-house methods such systems 
can result in fewer errors, are more consistent, and reduce the risk of contamination. 
They are often available in a manual format that is suited to processing small numbers 
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of samples. However, a number of companies also offer automated extraction 
platforms that allow rapid, reliable and high throughput extraction (between 8-96 
samples in 1-4 hrs). As a result these are ideal for use in the routine diagnostic setting 
and were considered suitable for use in this research. 
 At the time of the research the Qiagen Biorobot 9604 with the Qiagen Blood 
kit was already in use for the nucleic acid extraction of samples for other molecular 
tests at the laboratory. Since this system was also found to meet the requirements of 
the proposed new service for viral IID it was also used in this research. Implementing 
an alternative additional system was not considered as this could be expensive and 
may not be of use for the other molecular assays that test for alternative sample or 
virus types. The Qiagen system utilises silica-gel-membrane extraction technology 
(based on the Boom method) and can process up to 96 samples and controls in 
approximately 2hrs. Following initial set-up the process is fully automated, which aids 
ease of use. This kit has been shown to offer sensitive extraction of both RNA and 
DNA from numerous sample types including faecal samples, blood, urine, vesicle 
fluid, genital swabs, respiratory samples (throat swabs, nasopharyngeal aspirates etc), 
CSF, tissue and blood spots (Qiagen, 2001). Moreover, PCR methods that use this 
extraction system have been shown to be sensitive via numerous External Quality 
Control (EQC) schemes including those provided by Quality Control for Molecular 
Diagnostics (QCMD), the National External Quality Assurance Scheme (NEQAS) 
and the United Kingdom Clinical Virology Network (UKCVN).  
As an indication of the Qiagen platform’s ability to sensitively extract RNA 
and DNA the results of three EQC panels tested at the WOSSVC are presented here 
(Table 4, Table 5 and Table 6). Results are shown for PCR tests on CSF, RSV, 
Human metapneumovirus (hMpV) and HSV positive samples (since no EQA panel is 
currently available for viral causes of IID). Although the panels are concerned with 
the PCR systems as a whole, the sensitivity of such systems is dependent on effective 
nucleic acid extraction and in each case was found to be high. This, together with its 
ability to extract both DNA and RNA from stool samples, and its high throughput, 
rapidity and ease of use made this automated extraction system highly suitable for the 
proposed molecular diagnostic service for viral gastroenteritis. Details of the exact 
extraction protocol are outlined in section 3.4. 
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Table 4: Results of a NEQAS EQA panel for molecular detection in CSF (2004). 
Sample 
Number 
Expected 
Result 
WOSSVC 
Result 
% Of NEQAS Participants With Correct Result 
(N=123) 
1 Enterovirus Enterovirus  98% 
2 HSV-1 HSV-1 100% 
3 HSV-2 HSV-2 97% 
4 VZV VZV 98% 
5 HSV-1 HSV-1 90% 
6 Negative Negative 100% 
 
Table 5: Results of a QCMD EQA panel for molecular detection in respiratory samples 
(2005). 
Sample 
Number 
Target 
Concentration  
(Genome Equi/Ml) 
Expected 
Result 
WOSSVC 
Result 
% Of QCMD 
Participants  
With Correct Result 
(N=16) 
1 10E-3 RSV RSV 87% 
2 10E-5 RSV RSV 69% 
3 10E-6 RSV RSV 56% 
4 - Negative Negative 100% 
5 10E-3 hMPV hMPV 93% 
6 10E-4 hMPV hMPV 86% 
7 10E-2 hMPV hMPV 93% 
 
Table 6: Results of a QCMD EQA panel for HSV-1 and 2 samples (2004). 
Sample 
Number 
Target Concentration 
(Genome Equi/Ml) 
Expected 
Results 
WOSSVC 
Results 
% Of QCMD Participants 
With Correct Result 
(N=143) 
1 - Negative Negative 95% 
2 7.5x106 HSV-2 HSV-2 98% 
3 2x103 HSV-1 HSV-1 62% 
4 2x103 HSV-1 HSV-1 64% 
5 2x107 HSV-1 HSV-1 97% 
6 - Negative Negative 95% 
7 1.2x106 VZV VZV 93% 
8 2.5x103 HSV-2 HSV-2 92% 
9 7.5x102 HSV-2 HSV-2 77% 
10 2x104 HSV-1 HSV-1 93% 
11 7.5x103 HSV-2 HSV-2 93% 
12 6.7x103 HSV-1 HSV-1 83% 
3.3.2. PCR Methods 
There are numerous PCR methods available in the literature that can be used 
for the detection of adenovirus, astrovirus, norovirus, rotavirus and sapovirus. The 
majority of these are conventional single round and nested gel-based PCR methods, 
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although the number of real-time PCR methods using SYBR green or dual-labelled 
probe-based technology has increased in recent years. The following section provides 
a review of the published PCR protocols for each viral pathogen that were considered 
for use in the new outbreak and sporadic service. For each pathogen the areas of the 
genome targeted by the PCR assays are outlined, alongside data on the variability of 
each target region. In addition, the findings from relevant studies comparing the PCR 
methods to other diagnostic methods (molecular and non-molecular) are given. 
Following the review, the methods chosen to be adapted for use in each of the 
proposed services are described, alongside the reasons for each choice and details of 
any adaptations necessary for use in the routine diagnostic laboratory setting.  
3.3.2.1. PCR Methods Considered For The Outbreak Service 
RT-PCR Assays For The Detection Of Norovirus 
There have been numerous RT-PCR assays published for norovirus detection 
and a number of targets have been described. Early versions were gel-based and 
tended to target the RNA dependent RNA polymerase (RdRp) part of the genome, as 
this region was initially thought to be the most functionally conserved region between 
noroviruses (Kojima et al, 2002). PCR assays that target this region have remained 
popular. However, significant variation can still be found in this region, which can 
hamper the detection of a number of norovirus strains and genotypes (Katayama et al, 
2002). On the other hand, the advantage of this variability is that the RT-PCR product 
from this region can further analysed in order to identify types and subtypes. 
In some of the earliest work in this area, Ando et al developed two broadly 
reactive RT-PCR assays that targeted the RdRp region, were shown to be specific and 
could detect and differentiate between norovirus strains from genogroup 1 and 2 
(Ando et al, 1995). Green et al developed a RT-PCR that used primers Ni and E3 to 
amplify a 113bp region of the norovirus RdRp (Green et al, 1995). This RT-PCR was 
compared to EM on 132 samples from outbreaks and sporadic cases of gastroenteritis 
that had occurred in the UK between 1992-1994. Of the 101 samples that tested 
positive for norovirus using EM, the PCR detected 93 as positive. Of the 31 samples 
that tested negative for norovirus using EM, the PCR detected 5 as positive. Based on 
the results of this study the authors judged that this PCR method offered a sensitive 
alternative to EM. The assay was also shown to be specific by cross testing with other 
pathogens including sapovirus. In the years following it became commonly used by 
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testing centres throughout Europe and was used as the frontline test by the Health 
Protection Agency (HPA) in London (Vinje et al, 2003).  
Numerous other methods that target the RdRp region have been published for 
the detection of norovirus in clinical samples, shellfish, water and other environmental 
material (Green et al, 1995; Ando et al, 1995; Green et al, 1995; Guyader et al, 1996; 
Hafliger et al, 1997; Lees et al, 1995; Wyn Jones et al, 2000; Myrmel et al, 1999; 
Green et al, 1998). Nested and hemi-nested PCR formats have also been described, 
sometimes offering up to 1000 times more sensitivity than single round PCR assays 
(Green et al, 1998; Hafliger et al, 1997).  
However, despite the large number of tests available that target the RdRp 
region, few studies have been published that directly compare these methods. In 2003, 
Vinje et al carried out an assessment of a number of conventional RT-PCR methods 
that targeted this region. The aim was to determine which were commonly used in 
European laboratories, and if possible, determine which of them offered the best 
sensitivity. This study showed that the most commonly used methods were single 
round RT-PCR assays that utilised either the primers Ni and E3, JV12 and JV13, or 
mon 431-434, together with a nested assay that used the primers 32 and 33 for the first 
round RT-PCR, and primers 35 and 36 for the second nested step. Each assay was 
tested using a panel of 82 samples that tested positive for norovirus using EM and 
contained representatives from genogroups 1, 2 and 4. The end point detection limit of 
each test was determined using a number of dilution series,of multiple norovirus 
genotypes. Overall, no one assay was found to be significantly superior to another. 
Looking at the data in more detail showed that the RT-PCR test that used primers Ni 
and E3 detected approximately 85% of the G1 types examined and 58% of the G2 
types. The assay that used JV12 and JV13 detected 100% of the G1 types examined 
and 75% of the G2 types. The nested method utilising the primer sets 32-33 and 35-36 
detected 85% of the G1 types examined and 85% of the G2 types, whereas the single 
round RT-PCR method using the primers mon 431-434 detected 85% of the G1 types 
examined and 69% of the G2 types. When these assays were compared on dilution 
series a wide variation in their end point detection limits was found.  This study 
highlights that even tests targeting the same region can vary significantly in their 
sensitivity. Of the methods compared, the authors concluded that the primers JV12 
and JV13 offered more universal detection and as a result recommended these primers 
to laboratories that had yet to implement RT-PCR. Subsequently, these primers have 
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also been used successfully in a nested format (Medici et al, 2005) and have been 
used in a multiplex format in tests for  adenovirus and astrovirus (Rohayem et al, 
2004). 
A number of Nucleic Acid Sequence-Based Amplification (NASBA) assays 
have also been described that target the RdRp region. Comparisons with established 
RT-PCR methods have shown that these have comparable sensitivity (Moore et al, 
2004; Houde et al, 2004; Rutjes et al, 2006; Greene et al, 2003; Patterson et al, 2006). 
This technology can also be used to quantitate the amount of virus in a stool sample 
via the amplification of known standards. 
Real-time PCR is a relatively new technique and therefore few methods of this 
type have been described that target the RdRp region. Pang et al described a SYBR 
green method which, for G2 detection only, targeted the RdRp area (the G1 assay 
targeted the capsid region)(Pang et al, 2004). Compared to conventional RT-PCR 
using the primers JV12 and JV13, the real-time PCR was found to be more sensitive 
for G2 types. However, specificity was reduced as cross-reactions were observed 
between the G1 and G2 assay reducing its value as a typing assay. In another study 
Simpson et al used the primers JV12 and JV13 in a SYBR green format. Their 
method was shown to be significantly more sensitive than EM (Simpson et al, 2004). 
Richards et al also used previously published primers (mon 431-434) in a SYBR 
green real-time format (Richards et al, 2004). Here, although the assay was not 
directly compared to any others it was shown to be sensitive.  
As an alternative approach, a number of norovirus RT-PCR assays have been 
published that target the capsid area. Yamazaki et al, for example, described an assay 
that targeted the capsid region (Yamazaki et al, 1996). This assay was compared to 
EM and was shown to be more sensitive. Vinje et al described a broadly reactive RT-
PCR that targeted the capsid VP1 region. This was used for both diagnosis and 
epidemiological study but was not compared to an alternative method (Vinje et al, 
2004). However, compared to the RdRp region, the capsid contains significantly more 
variation as it includes the highly variable regions that determine antigenic 
determinants, cell attachment and entry (Katayama et al, 2002). These areas come 
under immune pressure, which in turn promotes the emergence of new norovirus 
phenotypes (Nilsson et al, 2003). The variable nature of the capsid region thus 
increases the risk of false negative reactions due to nucleotide changes in the primer 
regions. Careful design is needed to ensure detection of a wide range of types and 
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continued test monitoring is needed to maintain test sensitivity. The variable nature of 
the capsid region has also hampered the development of real-time probe-based RT-
PCR methods, as these methods require a greater area of nucleotide conservation than 
conventional PCR methods. Some examples do exist, however. Pang et al described a 
real-time RT-PCR method that targeted the capsid region in order to detect G1 
noroviruses (Pang et al, 2004). However, although it could detect all of the G1 types 
tested, the detection limit was found to be approximately 3 logs less sensitive than 
conventional RT-PCR using primers JV12 and JV13. As described above, cross 
reactions between G1 and G2 types were also seen.  
In 2002, Katayama et al published a similarity study of 18 norovirus 
sequences that showed for the first time that the most conserved region of the 
norovirus genome is the ORF1-ORF2 junction (Katayama et al, 2002). As a result, 
most of the recently published tests have targeted this region rather than the RdRp or 
capsid region, with the aim of detecting a wide range of norovirus types and subtypes. 
This finding, moreover, has significantly aided the development of real-time PCR 
methods since these require greater regions of conservation to allow probe as well as 
primer binding. 
One of the first assays to be published that targeted the ORF1-ORF2 junction 
was described by Kojima et al (Kojima et al, 2002). This assay was a gel-based 
multiplex assay that utilised two primer sets for the detection and differentiation of 
genogroup 1 and genogroup 2 noroviruses. It was compared to two other RT-PCR 
methods that targeted the RdRp and the capsid regions respectively, using 35 samples 
that tested positive for norovirus using EM. The new assay developed by Kojima et al 
was shown to be specific and detected all 35 samples as positive whereas the other 
assays detected 28 and 27 as positive. The new test was also shown to detect a wide 
range of norovirus strains, and the PCR product could be used for epidemiological 
studies using sequence analysis. 
Kageyama et al described the first real-time RT-PCR assay to target this 
region (Kageyama et al, 2003). Aligning the sequence data provided by Katayama’s 
original study with a further 70 partial ORF1-ORF2 sequences led to the development 
of two probe-based real-time RT-PCR methods for the separate detection of norovirus 
types G1 and G2. The assays were compared to two conventional RT-PCR methods, 
one targeting the capsid region and one the RdRp. Of the 81 samples that tested 
positive for norovirus using EM, the real-time PCR methods together detected 80 
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whereas the two conventional RT-PCR methods detected 62 and 67, respectively. In 
addition, the real-time RT-PCR method was shown to be specific and detected a 
further 20 positive samples in a panel of 28 samples that had tested negative using 
EM. 
Houde et al compared this real-time PCR assay to both a NASBA test and a 
conventional RT-PCR that used the primers described by Ando et al (Ando et al, 
1995; Houde et al, 2006). All of the assays detected the same number of norovirus- 
positive clinical samples from a panel of G2 types. However, the real-time RT-PCR 
method was found to be more sensitive by at least 1-2 logs than either of the others 
when the endpoint detection limits of each assay were assessed. Jolkihumar et al 
further improved the sensitivity of this real-time RT-PCR method by up to 100 fold 
by removing the degeneracies from the forward G2 primer (Jolkihumar et al, 2005). A 
new probe-based G1 RT-PCR was also developed that targeted the ORF1-ORF2 
junction and which was shown to more sensitive than the G1 real-time assay 
developed by Kageyama and described above. Other studies have also published real-
time RT-PCR methods (including dual-labelled probe-based and ones based on MGB 
chemistries) that target the ORF1-ORF2 region (Pang et al, 2004; Schmid et al, 2004; 
Hoehne et al, 2006). In each case the assays were compared to conventional RT-PCR 
methods and were found to be more sensitive. 
3.3.2.2. Selection And Development Of The PCR Methods For Use In The 
Proposed Outbreak Service 
As described in Chapter 2, norovirus is highly variable “genomically” and, 
although one strain tends to dominate at any one time, there exists a wide range of 
types and subtypes (Katayama et al, 2002; Fankhauser et al, 2002; Green et al, 1995; 
Koopmans, 2000; Gallimore et al, 2004; Hale et al, 2000; Kageyama et al, 2004). 
Moreover, individuals with norovirus infection have been shown to shed virus at 
levels below the detection limits of current tests, such as EM, soon after disease onset 
(Waters et al, 2000; Donelli et al, 1993).  
In terms of a diagnostic test, therefore, the priority is to select one that can 
detect a wide range of norovirus types and that has a low limit of detection. It is 
important, moreover, that the sensitivity remains stable over long periods of use with 
a minimum level of monitoring, which means that tests that target the most conserved 
area of the genome are preferred. Although, as shown, it is possible to develop 
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sensitive tests for norovirus that target other areas, the variable nature of these regions 
increases the risk of sensitivity drift over time and/or sudden loss of sensitivity due to 
the emergence of a new virus type or subtype. 
The first norovirus RT-PCR for use in the outbreak service was developed 
during 2000. At this time the RdRp region was widely believed to be most 
functionally conserved area amongst noroviruses. As a result tests that targeted this 
region were considered most appropriate for use in the proposed diagnostic service, 
since assays that targeted the ORF-1 and ORF-2 junction had yet to be published. 
Various single round, nested and hemi-nested RT-PCR methods have been 
published that target the RdRp region. Many of these have been shown to be specific 
and more sensitive than EM (Froggatt et al, 2004; Simpson et al, 2003; Ando et al, 
1995; Green et al, 1995 (i); Green et al, 1995 (ii)). However, although nested and 
hemi-nested RT-PCRs have been shown in some cases to offer high sensitivity the 
trade off is that the additional steps involved reduces test rapidity and ease of use 
(Green et al, 1998; Hafliger et al, 1997). The larger number of steps also results in 
more potential for error. Consequently, for the purposes of this work, single round 
RT-PCR assays were preferred as these are made up of fewer steps and as a result are 
likely to be more rapid and easier to use. Numerous single round RT-PCR were 
published at the time this research began and some had already been shown to offer 
improved sensitivity in comparison to EM (Ando et al, 1995; Green et al, 1995; 
Green et al, 1995). Of these, the RT-PCR described by Green et al was chosen to be 
adapted for the detection of norovirus in outbreak samples (Green et al, 1995). This is 
a conventional single round RT-PCR assay that had been shown to be specific and 
able to detect a broad range of norovirus types, and had been compared to EM on 
outbreak samples and found to be sensitive. A major contributing factor that led to the 
selection of this assay over the other candidates outlined above was that a gel-based 
version of the assay was used as the frontline test by the HPA in England (Vinje et al, 
2003). During its use there it had been shown to be able to detect the predominant 
strains circulating in England and it was hypothesised that similar types may be 
encountered in Scotland.  
Once this assay was selected the aim was to adapt this conventional gel-based 
RT-PCR into a real-time format, in order to increase its potential for rapid turn-
around-times and, by association, high throughput. At the time no real-time RT-PCR 
assays for the detection of norovirus had been published (highlighting the novelty of 
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this work). Rapidity is particularly important in a norovirus test that is to be used in 
the outbreak setting as rapid results may inform decisions on the infection control 
procedures to be used.  
In order to convert the chosen assay into a real-time format SYBR green 
technology was employed, which was the predominant real-time technology available 
at the time. This is an established means of converting conventional PCR tests into a 
real-time PCR format. SYBR green is a DNA chelating dye that is incorporated into 
DNA, fluoresces under ultra violet excitation and is measured at the end of each PCR 
cycle. This negates the need for post amplification analysis (such as gel-based 
analysis) and can therefore reduce turn-around-times, improve ease of use and reduce 
the risk of contamination. However, SYBR green is non-specific and will bind to any 
DNA being produced during the PCR reaction including non-specific products and 
primer-dimers. With careful primer design and reagent optimisation such pitfalls can 
be limited but, to increase specificity, it is good practice to confirm positive results 
using melt curve analysis. The PCR product melting point is directly related to its 
sequence composition, length and concentration (Mackie et al, 2002). A small PCR 
product, for example, tends to result in a melting point that is consistently within a 
narrow temperature range, thus aiding interpretation of the results. As such, the PCR 
product produced by the chosen assay developed by Green et al (which was 113 bp in 
length) was highly suited to this technique. 
The real-time version of the assay was implemented on the Lightcycler™ RT-
PCR platform, which was one of only two PCR platforms available in the laboratory 
at the time of this initial development phase, the other being a conventional PCR 
block (the ABI 9700). The Lightcycler™ platform was a leading edge commercial 
platform at the time, as evidenced by its widespread use in the published real-time 
PCR assays (Schalasta et al, 2000; Ohyashiki et al, 2000; Kamihari et al, 2000; Espy 
et al, 2000; Kessler et al, 2000), although the number and choice of real-time 
platforms available has since increased. 
The Lightcycler™ platform allows the testing of 32 reactions per run, 
compared to a typical 48-96 in conventional PCR platforms. It is designed for small 
PCR reaction volumes (<10ul), which are placed in glass capillaries that can be 
rapidly heated and cooled. As a result, the PCR parameters are much shorter than in 
conventional PCR methods. Using this system, 40 cycles of PCR can be carried out in 
less than 40 minutes (whereas conventional PCR parameters take between 3-5 hours). 
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It therefore has the potential for both high throughput and rapid testing, making it 
highly suitable for the proposed norovirus outbreak service. 
Other adaptations of the assay described by Green et al included the 
replacement of the stated RT step with a previously published in-house method (Ellis 
et al, 1997). This method utilises random hexamers and is therefore a universal RT-
step, converting all RNA in the extracted sample to cDNA. This means that the cDNA 
produced is not specific to a particular test and may be used for all PCR assays. This 
has significant value in a routine diagnostic setting since, for example, samples of 
different types can be processed together and samples that are to be tested for multiple 
pathogens do not have to be repeatedly processed for each individual test (increasing 
the efficiency and reducing costs in both cases). Another advantage of this approach is 
that it reduces the potential for error since the RT step is standardised in the laboratory 
for all RT-PCR assays, which in turn aids quality control.  
For the PCR step itself, the primers (Ni and E3) were used as described in 
Green et al. Reagents that were optimised for use on the Lightcycler™ platform were 
employed in the form of a commercial mastermix. The SYBR green was added to this 
mastermix before use, as was Taq start antibody, which helps prevent non-specific 
Taq polymerase activity. Details of the exact protocol used in implementing the assay 
are provided in section 3.4.  
From 2003, several other real-time PCR platforms were obtained by the 
laboratory, including the Rotorgene (Corbitt research™), Icycler (Biorad™) and ABI 
7500 (Applied Biosystems™). Each of these systems supports a number of different 
real-time PCR chemistries including SYBR green, dual-labelled probes, MGB, 
molecular beacons and labelled primers. Compared to the Lightcycler™ platform 
these offer improved throughput as they can process 72-96 samples in approximately 
1-2 hours.  
At the same time, it had recently been shown that the most conserved region of 
norovirus was in fact the ORF1-ORF2 junction, rather than the RdRp region 
(Katayama et al, 2002) and assays that target this region had begun to appear (Kojima 
et al, 2002; Kageyama et al, 2003). One was a real-time RT-PCR method (Kageyama 
et al, 2003) and had been shown to detect both G1 and G2 noroviruses, which 
together are responsible for the majority of human cases of norovirus IID. The real-
time RT-PCR assay used dual-labelled probe-based technology and was shown to be 
more sensitive than two conventional RT-PCR assays. Dual-labelled probes (also 
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known as Taqman™ probes) are oligonucleotides that contain a fluorescent dye on the 
5' base, and a quenching dye located on the 3' base. They are designed to hybridise to 
an internal region of a PCR product. During PCR, when the polymerase replicates a 
template on which the probe is bound, the 5' exonuclease activity of the polymerase 
cleaves the probe. This separates the fluorescent and quenching dyes, allowing 
detection of the signal from the reporter dye. Fluorescence increases in each cycle, 
proportional to the rate of probe cleavage. Compared to SYBR green based assays, the 
advantage of this technique is that the incorporation of a probe means it can be more 
specific, and therefore a melt curve step is not required. From a diagnostic standpoint, 
the removal of the need for a melt curve step reduces the duration of the test and 
further reduces the potential for human error.  
The assay described by Kageyama et al was therefore chosen for investigation 
as a further possible development of the routine norovirus outbreak service in 2003. 
The primers, probes and PCR parameters (i.e. the concentration and annealing 
temperatures) were used as described. However, the published method used two 
separate dual-labelled probe-based real-time assays to detect G1 and G2 noroviruses, 
whereas here the two assays were multiplexed with the aim of reducing turn-around-
times and test costs. The multiplexed test was implemented on the ABI 7500 platform 
as this offered the maximum capacity of 96 sample reactions. Reagents that were 
optimised for use on the platform were employed in the form of a commercial 
mastermix. With this kit the RT step, PCR and detection all take place in a single 
tube. This was a further improvement on the previous test, reducing the number of 
steps involved. Details of the exact protocol used in implementing the assay are 
provided in section 3.4. 
3.3.2.3. PCR Methods Considered For The Sporadic Service 
PCR Assays For The Detection Of Adenovirus 
Numerous adenovirus PCR tests are available in the literature. The vast 
majority target the hexon region of the adenovirus genome. The hexon is a product of 
L3 and is the major component of the adenovirus capsid. Although there are also 7 
hyper variable regions that determine the subgenera and serotypes, it also contains 
regions that are conserved throughout most adenovius serotypes (Crawford-Miksza 
and Schnurr, 1996). The combination of conserved and variable regions means that, 
with careful PCR design, the hexon region can be used both for diagnosis and can be 
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used for epidemiological purposes. Conventional single round and nested PCR assays 
have been described that target this region (Allard et al, 1990; Morris et al, 1996; 
Echavarria et al, 1999; Na et al, 2002; Lee et al, 2005; Formiga-Cruz et al, 2005). 
Furthermore, the conserved regions have also proven to be useful targets for dual-
labelled probe-based real-time PCR methods (Heim et al, 2003; Claas et al, 2005).  
Allard et al provided an example of a single round PCR method that, using a 
low annealing temperature, could detect all known adenovirus serotypes (Allard et al, 
1990). This assay was shown to be more sensitive than a latex agglutination method 
and a group F specific PCR. However, later studies found this assay to be insensitive 
for the detection of group B adenoviruses and serotype 11 (Morris et al, 1996). 
A number of other single round PCR methods exist that target the hexon 
region and detect all adenovirus serotypes (Echavarria et al, 1999; Na et al, 2002; Lee 
et al, 2005). For example, Hierholzer et al developed a single round PCR that detected 
all adenovirus serotypes by targeting a 162bp region of the P2 domain within the 3’ 
region of the hexon (Hierholzer et al, 1993). Freymuth et al compared this assay to 
immunoflourescence on 277 nasopharyngeal aspirates (NPA) samples and showed a 
significant increase in detection of adenovirus (in 30 samples vs 4) (Freymuth et al, 
1997). Cooper et al described a single round PCR method that targeted a 140bp region 
of the hexon region using primers ADJC1 and ADJC2 (Cooper et al, 1999). This PCR 
was compared to tissue culture on 59 eye swabs. The PCR detected adenovirus in 51 
eye swabs whereas using culture it was detected in 40. A later study multiplexed this 
assay with in-house PCR methods for HSV and Chlamydia trachomatis (Elnifro et al, 
2000 (i)). Compared to tissue culture the PCR detected adenovirus in 48 of 49 eye 
swabs whereas tissue culture detected 26 samples as positive. In a subsequent study 
this assay was also shown to provide typing information after restriction enzyme 
digestion (Elnifro et al, 2000 (ii)).  
Single round multiplex PCR assays have also been described that allow 
detection of all adenovirus serotypes. Pring-Akerblom et al provided an example of 
such an assay where each adenovirus subgroup could be determined by its PCR 
product size (Pring-Akerblom et al, 1999). A number of PCR methods have also been 
published that are in a nested format (Takeuchi et al, 1999; Avellon et al, 2001; 
Inagara et al, 1996) or detect a particular serotype, serotypes or subgroup (Cooper et 
al, 1996; Houng et al, 2002; Fujimoto et al, 2000; Echavarria et al, 1999). The nested 
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assays were found to offer high sensitivity and have been used to detect adenovirus in 
water sources (Lee et al, 2005; Formiga-Cruz et al, 2005). 
In recent years a number of dual-labelled probe-based real-time PCR methods 
have also been described that target the hexon region. A number of these have been 
designed to target only a particular sub-genera or serotype of adenovirus. For 
example, Logan et al described a dual-labelled probe-based assay that detected group 
F adenoviruses (Logan et al, 2006; Jiang et al, 2005). Other such assays include one 
for the detection of group C adenoviruses (Garnell et al, 2002), one for type 4 
adenovirus (Houng et al, 2002) and one for all non group F adenoviruses (Faux et al, 
2004). Others have been described that detect all adenovirus serotypes via the hexon 
region. Ebner et al decribed a 2 reaction adenovirus real-time PCR that utilised 5 
probes and 8 primers and was designed to detect and differentiate between adenovirus 
subgenera A, C, F and B, D, E (Ebner et al, 2005). However, it should be noted that 
the group F adenoviruses were detected by both assays. Heim et al also developed a 
real-time dual-labelled probe-based PCR assay that targeted the hexon region and was 
able to detect all adenovirus serotypes (Heim et al, 2003). This, unlike the assay 
published by Ebner, utilised a single set of primers and one probe. The new assay was 
compared to the nested PCR described by Allard et al (Allard et al, 1992) and was 
shown to be more sensitive. Claas et al, meanwhile, described a MGB assay that 
targeted the hexon region and could detect all adenovirus serotypes (Claas et al, 
2005). 
Although the hexon region is targeted in most of the PCR assays for the 
detection of adenovirus, alternative targets have also been used. The E1 region is one 
example. As described in Chapter 2, the E1a/b region of adenoviruses is a 
transcription unit that encodes two proteins which play a major role in the adenovirus 
infection cycle (Shenk and Flint, 1991; Shenk, 2001). However, although moderately 
high levels of E1 sequence identity have been observed between members of the same 
subgroup, with similarity scores of approximately 50-60%, significant variation has 
been found between adenoviruses from different subgroups with similarity scores of 
less than 30% (Avvakumov et al, 2002). As a result it can be difficult to design assays 
that detect all adenovirus subgroups and serotypes based on targeting this region. 
Allard et al described a group F specific PCR that targeted this region (Allard et al, 
1990). The PCR products for the group F PCR were 2187 bp and 838 bp for 
adenovirus 40 and 41 respectively. This assay was compared to a universal PCR that 
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targeted the hexon region of the adenovirus genome (308 bp) and to a latex 
agglutination assay on 60 stool samples taken from children with gastroenteritis. 
Although both PCR assays were found to be more sensitive than the latex 
agglutination assay, the group F specific assay also detected a number of non group F 
adenovirus types indicating low specificity. This assay was also found to be 10 times 
less sensitive than the PCR assay that targeted the hexon region. In 1992, the group F 
PCR assay was adapted to a two-step nested assay, which resulted in an improvement 
in sensitivity that made it comparable to the PCR assay which targeted the hexon 
region (Allard et al, 1992). Roussell et al also developed a group F specific PCR that 
targeted the E1b region. This assay successfully detected adenovirus type 41 in 
samples that had previously tested positive using EM. However, it was not compared 
in detail to any other diagnostic method (Rousell et al, 1993). 
A few published assays have targeted the adenovirus pIX gene. The pIX gene 
is encoded by the adenovirus intermediate region. The pIX gene is the minor 
structural component of the capsid and serves to cement the hexon in place (Akalu et 
al, 1998). Members of different adenovirus genera show wide variation in the 
sequence of the pIX region, especially in the C terminal part. As a result careful 
design of the PCR parameters (e.g. primers, annealing temperatures etc) is warranted 
if all adenovirus serotypes are to be detected. Akalu et al developed a PCR test that 
targeted this region. However, assessment showed that the PCR failed to detect 
adenoviruses from groups A, D and E. 
Finally, there are some examples of PCR assays that target the fiber gene. The 
adenovirus fiber is coded for by the late protein L5. The fiber is present on the capsid 
surface and determines tissue tropism (Stone et al, 2003). The fiber has a role in 
haemagluttination and the formation of neutralisation antibody. As a result 
considerable fiber sequence variation can be found between serotypes. Consequently, 
it has proven difficult to design primers that detect all adenovirus serotypes, with the 
published assays described using separate PCR tests to detect each adenovirus type 
(Xu et al, 2000) or detecting groups B and C only (Adhikary et al, 2001; Bruzzone et 
al, 2000). 
RT-PCR Assays For The Detection Of Astrovirus 
There are numerous astrovirus RT-PCR assays published in the literature. 
Single round and nested conventional RT-PCR assays and real-time RT-PCR assays 
 99 
exist for the detection of astrovirus (Cubitt et al, 1999, Akhter et al, 1995; Major et al, 
1992; Jonassen et al, 1993; Jonassen et al, 1995; Noel et al, 1995; Zhang et al, 2006; 
Le Cann et al, 2004; Royeula et al, 2006). In general, these assays target either the 3’ 
terminus NCR region or the capsid region.  
Sequence alignments of all known astrovirus serotypes (1-8) have shown the 
88 bp 3’ end of the astrovirus genome to be highly conserved (Monceyron et al, 1997; 
Belliot et al, 1997; Wang et al, 2002). This makes it a highly effective target for 
diagnostic PCR assays but less useful for epidemiological study. Numerous diagnostic 
RT-PCR methods have been developed that target this small but conserved region 
(Cubitt et al, 1999, Akhter et al, 1995; Major et al, 1992). Jonassen et al, for example, 
developed an RT-PCR assay targeting this region, which produced a PCR product of 
77 bp (Jonassen et al, 1993; Jonassen et al, 1995). This assay was assessed on 38 
samples that tested positive for astrovirus using EM and was shown to detect all but 2 
of the panel. However, it was also shown to be non specific. Cubitt et al used a similar 
RT-PCR method to investigate an outbreak of astrovirus in a BMT ward. Compared 
to EM and EIA, the RT-PCR was shown to be more sensitive, detecting positive cases 
earlier than the other methods and showing that those infected were shedding virus for 
longer periods.  
In recent years, the 3’NCR region has also proved to be a good target for real-
time PCR (Zhang et al, 2006; Le Cann et al, 2004; Royeula et al, 2006). Le Cann et al 
described a dual-labelled probe-based assay that was used to detect astrovirus in 
sewage. Although not assessed on clinical samples or samples of known subtypes it 
was shown theoretically to detect all 8 serotypes. Zhang et al, meanwhile, used a 
SYBR green based assay to quantify the level of astrovirus in several patient groups 
in order to examine whether there was a correlation between viral load and disease 
severity (no relationship could be found). Royeula et al also developed a real-time 
PCR based on using SYBR green that was shown to be more sensitive than both an 
EIA and a conventional PCR. 
An alternative PCR target for the detection of astrovirus is the capsid region of 
the genome. However, as with other RNA viruses the capsid region contains areas of 
high variability (Belliot et al, 1997; Wang et al, 2001). Wang et al described 4 sub-
regions in the capsid, each with differing levels of variability. The terminal N and the 
C regions were relatively conserved (56-86%) between astrovirus serotypes making 
them suitable targets for diagnostic purposes, whereas the two regions in-between 
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contained significant levels of variation. These in-between areas are thought to 
contain the regions that determine antigenicity and cell attachment and entry and are 
therefore useful for epidemiological study. Researchers have taken advantage of these 
characteristics to design RT-PCR assays that can detect all astrovirus serotypes, and 
can also provide a PCR product that can be sequenced for epidemiological study (Yan 
et al, 2003; Royahem et al, 2004). Noel et al described two RT-PCR methods that 
targeted the capsid region, one using primers mon 244-245 and one using mon 269-
270 (Noel et al, 1995). Both offered universal detection, and typing of the product by 
sequence analysis. Of the two sets of primers, mon 269-270 was found to result in the 
most sensitive test. These primers have been used in numerous other studies since 
(Mustafa et al, 1998; McIver et al, 2000; Simpson et al, 2004; Medina et al, 2000). 
McIver et al compared this RT-PCR to EM on clinical samples and found it to detect 
astrovirus in the same number of cases as EM. Medina et al showed that it was more 
sensitive then EIA on 251 samples from children with acute gastroenteritis, detecting 
an extra 12 positive samples. These primers have also been used to target the capsid 
region in a SYBR green format and the resulting assay was shown to be more 
sensitive than EM (Simpson et al, 2004). As of yet, however, no probe-based real-
time PCR assay has been published that targets this region. This is likely to be due to 
the variable nature of the region. 
RT-PCR Assays For The Detection Of Rotavirus 
Most of the published RT-PCR assays for the detection of rotavirus target the 
following parts of the genome: the VP7, VP4, NSP3, VP6 and NSP2 regions. 
One of the first RT-PCR assays described for the detection of rotavirus 
targeted the VP7 gene (Gouvea et al, 1990). The product VP7 is the major constituent 
of the rotavirus outer capsid and is the target of type-specific antibodies (Jayaram et 
al, 2004). The advantage of targeting this region with PCR is that it contains at least 6 
discrete regions that determine the rotavirus subgenera. Therefore, with careful primer 
design, it can be used for the simultaneous detection and subtyping of rotavirus from 
clinical samples. However, careful monitoring is needed to maintain the sensitivity of 
such an assay to ensure that changes in the primer binding sites which result in 
reduced sensitivity do not occur.  
In the assay described by Gouvea et al the primers Beg9 and End9 were used 
as a first round PCR to detect the 5’ and 3’ end of gene segment 9, giving a RT-PCR 
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product of 1062 bp. Following this, a nested step was used that employed primers 
specific for the main rotavirus G types. 
Several studies have since utilised this nested method for diagnosis and 
epidemiology (Pang et al, 1999; Ushijima et al, 1994). Pang et al, for example, found 
it to offer increased diagnostic sensitivity when compared to an EIA test on samples 
from children with IID (Pang et al, 1999). Ushijima et al used this method to show the 
presence of rotavirus in various clinical specimens (such as CSF, serum and throat 
swabs) in patients with acute rotavirus infection.  
Other methods that target the VP7 region have also been described. Xu et al 
described a single round RT-PCR that amplified the full length of gene segment 9. 
This assay was found to be significantly more sensitive than a hybridisation assay and 
a standard electropherotype method when compared on stool samples (Xu et al, 
1990). 
The rotavirus VP4 protein has also been used as a target for PCR. This is a 
viral haemaglutinin and plays a major role in cell attachment, entry and penetration 
(Estes, 2001; Gorziglia et al, 1990). It is a product of gene segment 4 and contains the 
variable regions that are used to determine the rotavirus P type. Like the VP7 region, 
with careful primer design, assays that target this region can be used for both 
diagnosis and epidemiological study. Numerous methods have been described that 
target this region for the detection of rotavirus. Gentsch et al described a nested assay 
that could be used to detect and type rotaviruses (Gentsch et al, 1992). Masendycz et 
al also described a nested RT-PCR that could be used for the same purpose 
(Masendycz et al, 1997). This was compared to an EIA method and a cDNA 
hybridisation probe on 102 clinical samples. Overall, the nested RT-PCR assay was 
found to be the most sensitive, with the hybridisation probe second followed by the 
EIA. Rasool et al adapted the assay described by Gentsch et al to a single round RT-
PCR that was shown to detect all human rotaviruses (Gentsch et al, 1992; Rasool et 
al, 2002). Following this, Min et al described a SYBR green based real-time RT-PCR 
method that utilised the primers reported by Rasool et al for the same purpose, 
although here again this was not compared to any other method (Min et al, 2006). 
An alternative genome target for the detection of rotavirus is the VP6 region. 
The VP6 is the major constituent of the intermediate layer of the rotavirus. It has an 
important structural and immunological role (Greenberg et al, 1983; Pothier et al, 
1987). Sequence analysis has shown that the VP6 is relatively conserved between 
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human rotaviruses. As a result it is a potentially good target for the detection of a wide 
range of rotaviruses, although in practice few assays of this type have been developed 
to date. Kang et al described a real-time SYBR green based assay that targeted a 379 
bp region of VP6 (Kang et al, 2004). This quantitative assay was not compared to any 
other diagnostic methods but was used to investigate the relationship between the 
severity of the rotavirus illness and the amount of rotavirus detected in the stool (they 
found that low viral loads were often found in less severe and asymptomatic 
infections). 
Other areas of the rotavirus genome have also been considered for PCR 
targeting including the NSP2 and the NSP3 regions. The role of NSP2 is currently 
unclear although it has been suggested to have a role in RNA replication and 
packaging (Gombold et al, 1985). Sequence analysis has shown that the first 75 
nucleotides of the 5’ end and the last 28 nucleotides of the 3’ end are conserved in all 
rotaviruses (Patton et al, 1993). Xu et al described a one step RT-PCR that targeted 
the 3’ and 5’ end of the NSP2. The assay detected all group A rotaviruses (Xu et al, 
1990). It was compared to PAGE and a hybridisation assay and was shown to be 
significantly more sensitive than either method (between 5000-100,000 times). The 
large PCR product also contained restriction enzyme sites, which favours cloning and 
sequencing. 
Little is also known about the role of NSP3, although some have suggested a 
role in protein synthesis or viral replication (Poncet et al, 1996). The NSP3 protein is 
coded for by rotavirus gene segment 7. It contains areas of sequence variability that 
can be used to divide rotaviruses into 3 evolutionary groups (SaII, Wa and S2). 
However, there is also a region of approximately 80 nucleotides in the 3 UTR that is 
highly conserved in all rotavirus strains (Rao et al, 1995). Pang et al described a 
probe-based real-time RT-PCR assay that targeted this highly conserved area (Pang et 
al, 2004). This assay was compared to both EM and the nested RT-PCR that targets 
the VP7 (Goveau et al, 1990) on 623 samples from children with gastroenteritis. The 
assays were also compared on a dilution series of a sample that tested positive for 
rotavirus using EM. Overall, the real-time RT-PCR detected 123 samples as positive, 
whereas the conventional nested RT-PCR detected 113 and EM detected 79. On the 
dilution series the real-time RT-PCR was shown to have a detection limit that was 2 
logs greater than the nested assay. 
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RT- PCR Assays For The Detection Of Sapovirus 
In comparison to the number of PCR methods published for the other viral 
causes of IID there are considerably fewer available for the detection of sapovirus. 
Amongst those published, most target the RdRp or capsid regions or the polymerase-
capsid junction. 
Early examples in particular targeted the RdRp region, since early studies had 
shown that this area was more conserved than the capsid region (Berke et al, 1997; 
Liu et al, 1995; Matson et al, 1995). One of the first RT-PCR assays described for the 
detection of sapoviruses was described by Jiang et al (Jiang et al, 1999). This RT-
PCR detected both norovirus and sapovirus using the primers p289-290. Sapovirus 
was distinguished from norovirus based on the PCR product size (the norovirus PCR 
product was 312 bp whereas sapovirus was 331 bp). Later studies highlighted that 
these primers also detected rotavirus via a cross reaction with gene segment 1 (Lindert 
et al, 2004). Robinson et al also published a single round RT-PCR assay that targeted 
this region. It was used to examine the epidemiology of sapoviruses in South West 
England but was not compared to any other method (Robinson et al, 2002). Vinje et al 
compared a single round assay that targeted the RdRp (using primers JV33 and SR80) 
with two other RT-PCR assays that also targeted the RdRp (Ando et al, 1995; Noel et 
al, 1997). The assay was designed using a sequence alignment of the known sapovirus 
sequences, which represented the three recognised genogroups (Vinje et al, 2000). 
The three assays were then compared using 31 stool samples that had tested positive 
for sapovirus using EM. The assay using the primers JV33-SR80 detected 
considerably more samples as positive than the other assays. Since then these primers 
have also been used in a real-time SYBR green based assay by Simpson et al 
(Simpson et al, 2004). This method was shown to be more sensitive than EM on 
samples from children with IID, both hospitalised and managed in the community. 
However, it should be noted that significant variation can still be found within the 
RdRp (Oka et al, 2006). As a result designing an assay that can detect all sapovirus 
types and subtypes remains difficult and requires careful primer design. 
The capsid has been targeted by a small number of sapovirus RT-PCR assays 
(Okada et al, 2006; Okada et al, 2002; Vinje et al, 2000). Like noroviruses, the capsid 
region of the sapovirus contains some areas of high genetic variability, which are 
likely to be the determinants of antigenicity, cell attachment and entry. Thus, although 
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the capsid region can be used for diagnosis, the variable nature of the capsid region 
tends to make it more suitable for epidemiological studies (Gallimore et al, 2006). For 
example, Okada et al described a nested RT-PCR multiplex assay that targeted the 
capsid and gave genotype data without the need for sequencing (Okada et al, 2002). 
In recent years, RT-PCR assays have been described that target the RdRp-
Capsid junction. This work is based on growing awareness that this is the most 
conserved region of the sapovirus genome, rather than the RdRp region. This was 
highlighted by the similarity study carried out by Oka et al described earlier in 
Chapter 2 (Oka et al, 2006). Okada et al developed a nested RT-PCR that could be 
used to detect and type all sapovirus genogroups (Okada et al, 2006). This assay 
consisted of universal primers and primer sets for each sapovirus genogroup but was 
not compared to any other assay. A small number of dual-labelled probe-based RT-
PCR assays have also been developed which also target this region. Oka et al carried 
out a similarity study of a number of sapovirus types from all genogroups to develop a 
real-time probe-based RT-PCR able to detect all 5 sapovirus genogroups using 4 
primers and 2 MGB probes (Oka et al, 2006). This assay was compared to another 
real-time RT-PCR assay developed by Chen et al (Chen et al, 2006), which also 
targeted the RdRp-Capsid junction. Both assays were shown to offer similar 
sensitivity (an improvement over conventional RT-PCR), with the exception that the 
assay described by Chen et al was unable to detect the newly discovered genogroup 
G5. 
3.3.2.4. Selection And Adaptation Of The PCR Assays For Use In The 
Proposed Service For Sporadic Cases Of IID 
As with the norovirus outbreak service described above, the research relating 
to the sporadic service took place in two stages. The first development phase took 
place between 2000 and 2002.  
As outlined earlier, at this time there were two PCR platforms available in the 
laboratory; the LightcyclerTM, which is real-time; and the ABI 9700, which is a 
conventional PCR block. However, based on the fact that norovirus had been found to 
be the cause of most outbreaks of IID, together with the high level of disruption 
caused by outbreaks of gastroenteritis in closed settings such as hospitals, the decision 
was taken to prioritise use of the LightcyclerTM for the proposed norovirus outbreak 
service. This meant that, initially, the development of new tests for the sporadic 
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service focused on conventional PCR methods that could be implemented on the ABI 
9700. This platform allows the processing of 96 samples and controls per run. On it, 
the PCR step of an assay takes approximately 3-5hrs to run, depending on the exact 
nature of the reaction. Post amplification analysis is then required to complete the test, 
which is carried out within the laboratory using agarose gel analysis (an established 
means of observing PCR results). 
As with the outbreak service, the selection of sensitive assays able to detect all 
or the majority of the known subtypes of each pathogen was again a priority, as was 
the use of single round assays in order to minimise the number of steps involved. 
Here, moreover, in order to further reduce the number of steps in the overall testing 
process (and thus the associated costs) the ambition was to develop a multiplex assay 
that could test for all four pathogens simultaneously. Since an RT step is, in theory, 
only required to test for three out of the four pathogens (not adenovirus, which is a 
DNA virus) this would mean applying an unnecessary RT step in the case of 
adenovirus, as it is not possible to add both cDNA and DNA to a multiplex PCR 
simultaneously. However, there are several examples in the literature of tests that 
employ this approach (Yan et al, 2004; O’Neill et al, 2002), which is possible since 
DNA may still be present in the reverse transcribed template. Moreover, in 
comparison to four separate tests a multiplex assay was felt to have significant 
benefits in terms of the lower material and staffing costs, and reduced turn-around-
times (the latter was also important in providing an improvement on the existing EM 
service). It did, however, mean that in order to aid result interpretation it was 
important to choose assays for each pathogen with different PCR product lengths.  
With these factors in mind the first adenovirus PCR selected for investigation 
was the single round PCR described by Cooper et al (Cooper et al, 1999; Elnifro et al, 
2000; Elnifro et al, 2000 (ii)). This PCR assay targeted the adenovirus hexon region 
and was selected since it was shown in more than one study to be both sensitive and 
able to detect all adenovirus serotypes. Also, its PCR product was small (140bp) 
which favoured multiplexing with one or more of the other non-norovirus assays. 
For astrovirus, the RT-PCR described by Noel et al using primers mon 269-
270 (Noel et al, 1995) was chosen. This assay targeted the capsid region of the 
astrovirus genome, detected all known astrovirus serotypes, and was chosen because it 
had been tested in several research studies and shown to be more sensitive than both 
EM and EIA without the need for a nested step (Mustafa et al, 1998; McIver et al, 
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2000; Simpson et al, 2004; Medina et al, 2000). In addition, the size of the PCR 
product was favourable to multiplexing as it was different to that of the assay chosen 
for adenovirus (449bp vs 140bp). This was crucial since although the 3’NCR region 
of astrovirus is generally held to be less variable than the capsid region the RT-PCR 
product of assays that target the 3’NCR are similar in length to that of the adenovirus 
PCR (<100bp). 
The RT-PCR assessed for rotavirus was a single round version of the assay 
that used the primers con2 and con3 to target the VP4 region of the rotavirus genome 
(Gentsch et al, 1992; Rasool et al, 2002). This was chosen because it was a single 
round assay and was shown to detect all rotavirus types. Many of the other assays 
available were nested RT-PCR assays that may have offered increased sensitivity but 
involved a greater number of steps. Of the assays that were single round RT-PCR 
assays, moreover, a further benefit of this one was that the PCR product was smaller 
than many of the other published assays (220 bp), which makes the PCR reaction 
more efficient. The PCR product length was also different to that of the tests chosen 
for the other pathogens.  
The initial test selected for sapovirus was the assay described by Vinje et al 
(Vinje et al, 2000). This assay targeted the RdRp region of the sapovirus genome, 
which was thought to be the most conserved region at the time of the initial 
developments. The assay was chosen since it was a single round RT-PCR and had 
been shown to be sensitive and capable of detecting all of the recognised genogroups 
of sapovirus at the time. The size of the predicted RT-PCR product was 349 bp, which 
was different to that of the other PCR assays. 
For each of the selected assays the primers were used as described in the 
original paper, which also specified the annealing temperature used. This was 
different in each case. However, for a multiplex assay a single temperature is 
required. It was therefore decided to employ the median temperature of all four tests 
in the first iteration of the new multiplex assay. A reverse transcriptase step was also 
applied as part of the sample preparation in all cases to samples for all four pathogens, 
despite the fact that adenovirus is a DNA virus. In theory a reverse transcriptase step 
was required in tests for only three of the four pathogens (i.e. all except adenovirus). 
The step was carried out using the laboratory-standard method described earlier for 
norovirus detection. Details of the exact protocols used in implementing the assay are 
provided in section 3.4.  
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In 2003, when the other real-time platforms became available in the laboratory 
the possibility of implementing real-time PCR for all tests in the sporadic service was 
introduced, although in fact the developments did not take place until 2004 (for 
reasons described in Chapter 4). Here the decision was taken to move straight to dual-
labelled probed-based technology, rather than SYBR green based assays, in line with 
the ongoing developments in tests for the outbreak service and for the reasons 
described earlier. Due to the relatively recent nature of this technology, however, the 
choice of available assays was limited. 
For adenovirus, the real-time dual-labelled probe-based assay described by 
Heim et al was examined (Heim et al, 2003). This targeted the hexon region of the 
virus and was chosen since it could detect all adenovirus serotypes and used just one 
set of primers and probes. Other published assays used multiple primers and probes, 
which would increase test costs and complexity with little potential gain in sensitivity. 
For astrovirus the real-time RT-PCR chosen was that published by Le Cann et al (Le 
Cann et al, 2004). This assay targeted the 3’NCR region of the genome and had been 
shown theoretically to detect all astrovirus serotypes. It was also the only dual-
labelled probe-based assay published for astrovirus at this point. For rotavirus 
detection the dual-labelled probe-based assay published by Pang et al was examined 
(Pang et al, 2004). This targeted the NSP3 region and was again the only assay of this 
type published at the time. It had been shown to detect all rotavirus types and in tests 
was more sensitive than a nested RT-PCR (Gouvea et al, 1990) and EM.  
At the time of development, no dual-labelled probe-based real-time PCR assay 
was available for the detection of sapovirus in the literature (the first assay was 
published in 2006). As a result an in-house assay was developed. Analysis of 
available sapovirus sequences detailed in the BLAST (Basic Local Alignment Search 
Tool) database identified small conserved regions of the capsid and RdRp areas (300-
500 bp). Attempts using the software package Beacon Designer (Premier Biosoft) to 
design a dual-labelled probe-based assay that targeted the submitted sequence from 
the RdRp were unsuccessful, as no test could be designed to meet the recommended 
guidelines (Qiagen, 2004). However, a suitable test that targeted the capsid region was 
created. 
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The real-time PCR amplicon was then tested for secondary structure, and for 
specificity. Secondary structure prediction was carried out using Michael Zukers’ m-
fold server2. The predicted secondary structure for the sapovirus amplicon is shown in 
Figure 11. The software predicted that there was little secondary structure of note (as 
measured by the low dG), which suggests it would have little effect on test sensitivity. 
The amplicon was then resubmitted to BLAST to determine which sapovirus 
genotypes and types it would theoretically be able to detect. This process showed that 
the assay was only complimentary to sapovirus G1 types (Table 7). However, no 
cross-reactions to other viruses or organisms were predicted suggesting the test would 
be specific. Data from the HPA and other studies suggested that sapovirus G1 types 
were the most predominant strains pre-2004 (Okada et al, 2002; Gallimore et al, 
2006). Thus, although this test would be unlikely to detect non G1 types, it was 
decided to assess it in comparison to the gel-based RT-PCR described above with the 
intention of replacing it either when a new assay was published or improved software 
design programs were available in the laboratory to allow the development of a more 
sensitive assay capable of detecting more types.  
Where assays were selected from the literature the primers, probes and 
annealing temperatures were used exactly as described. The in-house sapovirus real-
time PCR test used standard dual-labelled probe-based PCR conditions. All RNA 
real-time PCR assays utilised a commercial one step real-time RT-PCR kit from 
Invitrogen. This kit, also used in the norovirus dual-labelled probe-based RT-PCR 
allows the RT step, PCR and detection all to take place in a single tube, removing the 
need for a separate RT step. This again increases the efficiency of the process and 
reduces the potential for error. Such kits, however, only became economically viable 
around this time. The adenovirus assay utilises a commercial DNA mastermix 
(Invitrogen). Details of the exact protocol are described in section 3.4.  
                                                 
2
 (http://www.bioinfo.rpi.edu/~zukerm/rna/) 
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Figure 11: Predicted structure of the sapovirus real-time PCR amplicon. 
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Table 7: Alignment of primers and probe in real-time PCR developed for sapovirus. 
Prototype Strain Genogroup Forward Primer Probe Reverse Primer 
Real-time assay  GCTGTTSCYACTGGTGCA CCAATCSAATGTCCCTGAGGCAATACGSAA TGCTTGGAARGACAGGATGCC 
Leeds/00/UK 
(DQ158098) 
1.4 GCTGTTGCCACTGGTGCA CCAATCCAATGTCCCTGAGGCAATACGCAA TGCTTGGAACGACAGGATGCC 
Sapporo/82/JP 
(U65427) 
1.1 GCTGTTGCCACTGGTGCA CCAATCCAATGTCCCTGAGGCAATACGCAA TGCTTGGAATGACAGGATGCC 
Stockholm/97/SE 
(AF104182) 
1.3 GCTGTCGCTACTGGGTCA CCAATCAAATGTCCCTGATGCAATACGCAA TGCTTGGAACGATAGAATGCC 
Houston/90/US 
(U95644) 
1.2 GCTGTTGCTACTGGTTCC CCAATCAAATGTCCCTGAAGCGGTACCAGA TGCTTGGAATGACAGAATGCC 
Mex340/90 
(AF435812) 
2.2 GCTATGGCGACAGGAGCA CACGAGCAACGTACCAAATTGCATCCGGGA ACCCTGGACTACACGGCAAGC 
Lyon598/97/FR 
(AJ271056) 
2.1 GCAATGGCCACAGGGGCA AACCAGCAATGTGCCCAACTGCATCCGGGA ACCATGGACCACCCGGCAAGC 
Bristol/98/UK 
(AJ249939) 
2.1 GCAATGGCCACAGGGGCA GACCAGCAATGTGCCCAACTGCATCCGGGA ACCATGGACCACCCGGCAAGC 
*Primers could not find a match for representatives of sapovirus genogroups G3 (AF182760), G4 (AF435814) and G5 (AY289803). 
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3.4. Technical Description Of Laboratory Methods 
3.4.1. Sample Preparation Methods 
3.4.1.1. Faecal Extraction 
Faecal samples were processed by making a 10% solution in Phosphate 
Buffered Saline (PBS). Samples were then centrifuged at 3,000 rpm for 30 minutes. 
Sample supernatants were then transferred to labelled specimen tubes before nucleic 
acid extraction.  
3.4.1.2. Nucleic Acid Extraction  
The nucleic acid extraction procedure was carried out on the Qiagen 96 DNA 
blood biorobot 9604 (Qiagen, Crawley, West Sussex, UK). Briefly, 40ul of protease 
(140mg/ml), 220ul of specimen and 240ul of buffer AL (Guanidium chloride) was 
added to each well and incubated at 56°C for 10 minutes. 250 µl of ethanol (96-100%) 
was then added to each well. 670ul of the sample lysate was then added to the vacuum 
manifold and 310ul of buffer AW1 (Wash Buffer) was added. AW1 was removed by 
vacuuming for 7 minutes. 1100ul of AW2 (Wash Buffer) were then added to each 
specimen and removed by vacuuming for 2 minutes. This step was then repeated. The 
extraction plate was then placed on the S block and centrifuged for 10 min at 6,000 
rpm to dry the membrane. 200ul Buffer AE (10mM Tris-Cl; 0.5mM EDTA; ph9) was 
then added to each well incubation at room temperature for 1 minute. The extraction 
plate was then placed upon a collection tube plate and centrifuged at 6,000 rpm for 3 
min to elute the nucleic acid.  
3.4.2. PCR Methods 
3.4.2.1. Reverse Transcriptase Step (Gel-Based RT-PCR) 
Where the PCR assay involved an RNA target, after nucleic acid extraction the 
following reverse transcription step was employed for all conventional and SYBR 
green based real-time PCR (Ellis et al, 1997). Briefly, 22.2ul of RNA was added to a 
reaction mixture (17.8ul) containing 20mM Tris (pH 8.4), 50mM KCI (Invitrogen, 
Paisley, UK), 7.5mM MgCL2 (Invitrogen, Paisley, UK), 1.5mM dNTPs (Roche, 
Lewes, UK), 20ng of pd(N)6, 1.6U RNA guard (Amersham Pharmacia Biotech, US) 
and 200U of Malony murine leukaemia virus reverse transcriptase (Invitrogen, 
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Paisley, UK). The RT step was carried out under the following cycling conditions: 10 
minutes at 25oC, 45 minutes at 37oC, 5 mins at 99oC. Samples were then centrifuged 
to ensure that the sample was thoroughly mixed. 
3.4.2.2. PCR Methods For The Outbreak Service  
Real-Time SYBR Green Based Assay  
In the first PCR method investigated in 2000 amplification was performed in a 
10ul mixture, containing 5ul of 5mM Mg2+ universal LightCycler™ mastermix 
(BioGene, Cambs, United Kingdom), 5pM of each primer Ni and E3 (Table 8), 
Sybergreen and 2.5ul of cDNA template. The PCR parameters were used as in the 
original publication (Green et al, 1995). First a pre-amplification step of 94oC for 45 
seconds was carried out. This was followed by 40 cycles of: 94oC for 1 sec, 43oC for 5 
seconds and 74oC for 1 sec. The amplification product was then melted by raising the 
temperature from 70 to 94oC.  
Dual-Labelled Probe-Based Real-Time PCR For Norovirus 
In the new assay developed for norovirus in 2003, amplification of norovirus 
was carried out in a 50ul reaction volume using the Invitrogen superscript III one step 
q-RT-PCR system (Invitrogen, Paisley, UK) containing 10ul of extracted nucleic acid, 
0.05uM of each probe PROBE RING 1a, PROBE RING 1b and PROBE RING 2, and 
0.5uM of each primer COG1F, COG 1R, COG 2F, COG 2R (Table 9). Reverse 
transcription was performed for 30 min at 50oC. Using an ABI 7500 SDS platform, 
platinum taq polymerase was activated at 95oC for 2 min followed by 40 cycles of: 
95oC for 30 seconds and 56oC for 60 seconds.  
3.4.2.3. PCR Methods For The Sporadic Service (Adenovirus, Astrovirus, 
Rotavirus And Sapovirus) 
The following section details the implementation of the gel-based multiplex 
assay developed and assessed in 2000, and the real-time assays subsequently 
investigated in 2004. Note that in the case of the real-time assays for astrovirus, 
rotavirus and sapovirus the PCR conditions (i.e. cycling times etc.) were the same in 
each case, with the result that these tests could all be run on the same plate.  
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Gel-Based Multiplex Assay For Adenovirus, Astrovirus, Rotavirus And 
Sapovirus 
In the test assessed in 2000 10ul of cDNA was added to a 50ul reaction 
containing 10xPCR buffer (100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM 
of each dNTP, and 0.2mM of each primer (Table 8). A mixture of 2U of Taq DNA 
polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, Paolo Alto, USA), 
and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo Alto, USA) 
was incubated at room temperature for 10 minutes before being added to the final 
reaction mixture. PCR conditions were as follows: 94oC for 3 mins; 40 cycles of 94oC 
for 30 seconds, 47oC for 40 seconds, 72oC for 30 seconds; with a final extension step 
of 72oC for 7 min. Products were then subjected to agarose gel electrophoresis. 
Positive bands were expected at 140bp for adenovirus, 220bp for rotavirus, 449bp for 
astrovirus and 320bp for sapovirus. 
Dual-Labelled Probe-Based Real-Time PCR For Adenovirus 
Amplification of adenovirus was carried out in a 50ul reaction volume using 
Invitrogen platinum Taq DNA (Invitrogen, Paisley, UK) containing 10ul of extracted 
sample, 0.05uM of ADENO probe and 0.5uM of each primer ADENO 1 and ADENO 
2 (Table 9). Using an ABI 7500 SDS platform, platinum taq polymerase was activated 
at 95oC for 2 min, followed by 40 cycles of: 95oC for 30 seconds and 60oC for 60 
seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Astrovirus 
Amplification of astrovirus was carried out in a 50ul reaction volume using the 
Invitrogen superscript III one step q-RT-PCR system (Invitrogen, Paisley, UK) 
containing 10ul of extracted nucleic acid, 0.05uM of ASTRO probe, and 0.5uM of 
each primer ASTRO 1 and ASTRO 2 (Table 9). Reverse transcription was performed 
for 30 min at 50oC. Using an ABI 7500 SDS platform, platinum taq DNA polymerase 
was activated at 95oC for 2 min, followed by 40 cycles of: 95oC for 30 seconds and 
60oC for 60 seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Rotavirus 
Amplification of rotavirus was carried out in a 50ul reaction volume using the 
Invitrogen superscript III one step q-RT-PCR system (Invitrogen, Paisley, UK) 
containing 10ul of extracted nucleic acid, 0.05uM of ROTA probe, and 0.5uM of each 
primer ROTA 1 and ROTA 2 ( 
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Table 4). Reverse transcription was performed for 30 min at 50oC. Using an 
ABI 7500 SDS platform, platinum taq polymerase was activated at 95oC for 2 min, 
followed by 40 cycles of: 95oC for 30 seconds and 60oC for 60 seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Sapovirus 
Amplification of sapovirus was carried out in a 50ul reaction volume using the 
Invitrogen superscript III one step q-RT-PCR system (Invitrogen, Paisley, UK) 
containing 10ul of extracted nucleic acid, 0.05uM of probe SAPO probe, and 0.5uM 
of each primer SAPO 1 and SAPO 2 (Table 9). Reverse transcription was performed 
for 30 min at 50oC. Using an ABI 7500 SDS platform, platinum taq polymerase was 
activated at 95oC for 2 min, followed by 40 cycles of: 95oC for 30 seconds and 60oC 
for 60 seconds. 
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Table 8: Oligonucleotide primers for PCR tests in the outbreak and sporadic service (2000-2003). 
Virus Service Primers Sequence Amplicon 
size 
Nucleotide 
position 
Norovirus (SYBR 
green assay) 
Outbreak and sporadic service Ni 
 
E3 
GAA TTC CAT CGC CCA CTG GCT 
 
ATC TCA TCA TCA CCA TA 
 
113bp 4495-4608 
bpa 
Rotavirus Con1 
Con2 
TTGCCACCAATTCAAAATAC 
ATTTCGGACCATTTATAACC 
220bp 676-896 
bpb 
Astrovirus Mon269 
Mon270 
TCAGATGCATTGTCATTGGT 
CAACTCAGGAAACAGGGTGT 
449bp 212-676 
bpc 
Adenovirus ADRJC1 
ADRJC2 
GACATGACTTTCGAGGTCGATCCCATGGA 
CCGGCTGAGAAGGGTGTGCGCAGGTA 
140bp 2840-2980 
bpd 
Sapovirus 
Sporadic service and outbreak samples that test negative 
for norovirus 
Jv66 
Sr80 
GTGTANATCCARTCATCACC 
TGGGCATTCTACACAAAACCC 
320bp XX 
 a Based on alignment with AB220921 (Norovirus Hu/ Chiba/complete genome) 
 b Based on alignement with AB222786 (Human rotavirus VP4 complete sequence) 
 c Based on alignement with AB000288 (Human astrovirus serotype 1 capsid gene) 
 d Based on alignment with X51783 (adenovirus type 41 hexon region) 
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Table 9: Oligonucleotide primers and probes for real-time PCR tests in the outbreak and sporadic service (2004-2006). 
Virus Service Primers Probe Nucleotide 
position 
Norovirus Outbreak 
and 
sporadic 
service 
COG1F- CGYTGGATGCGNTTYCATGA 
COG1R- CTTAGACGCCATCATCATTYAC 
COG2F- 
CARGARBCNATGTTYAGRTGGATGAG 
COG2R- TCGACGCCATCTTCATTCACA 
PROBE RING 1A- VIC-AGATYGCGATCYCCTGTCCA-
BHQ-1 
PROBE RING 1B- CY5-AGATCGCGGTCTCCTGTCCA-
BHQ-1 
PROBE RING 2- FAM-TGGGAGGGCGATCGCAATCT-
BHQ-1 
For G1  
(5291-5375)a 
 
For G2  
(5003-5100)b 
Rotavirus ROTA 1-ACCATCTACACATGACCCTC 
ROTA 2-GGTCACATAACGCCCC 
ROTA PROBE FAM-
ATGAGCACAATAGTTAAAAGCTAACACTGTCAA-BHQ-1 
 
987-1083c 
Astrovirus ASTRO 1-CCGAGTAGGATCGAGGGT 
ASTRO 2-
GCTTCTGATTAAATCAATTTTAA 
ASTRO PROBE FAM-
CTTTTCTGTCTCTGTTTAGATTATTTTAATCACC-BHQ-1 
236-312d 
Adenovirus ADF-GCCACGGTGGGGTTTCTAAACTT 
ADR-GCCCCAGTGGTCTTACATGCACATC 
ADPRO-FAM TGCACCAGACCCGGGCTCAGGACTCCGA-
BHQ1 
17363-17495e 
Sapovirus 
Sporadic/ 
service and 
outbreak 
samples 
that test 
negative for 
norovirus 
SAPO 1-GCTGTTSCYACTGGTGCA 
SAPO 2-GGCATCCTGTCRTTCCAAGCA 
SAPO PROBE FAM-
CCAATCSAATGTCCCTGAGGCAATACGSAA-BHQ-1 
139-233f 
a
 Based on the alignment of M87661 
b
 Based on the alignment ofAF145896 
c
 Based on the alignment of DQ490535.1 
d
 Based on the alignment of AJ620757.1 
e
 Based on the alignment of DQ923122.2 
f Based on the alignment of AB327277.1 
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Assessment Of The PCR Protocols And 
Subsequent Development  
4.1. Overview 
This chapter outlines a series of studies relating to the evaluation of the PCR 
protocols described in the previous chapter. The chapter is made up of three parts: the 
first outlines the experimental assessment of the test developed for norovirus in 
outbreaks of IID; the second outlines the evaluation of the selected tests for 
adenovirus, astrovirus, rotavirus and sapovirus for the investigation of sporadic IID; 
and the third part describes the results of a number of adaptations to the tests 
eventually implemented, which aimed to reduce the turn-around-time and cost of each 
of these tests without affecting their sensitivity. Evaluation in each case consists of an 
experimental comparison of the sensitivity of the PCR with that of alternative 
techniques (such as EM and EIA) available at the time of the research. The chapter 
concludes by summarising the results of the experiments and their implications for the 
laboratory diagnostic service. 
4.2. Introduction 
Chapter 3 outlined the PCR methods that were chosen and adapted for 
investigation as the potential replacements for EM in the laboratory diagnostic service 
for IID. This chapter describes a series of experiments relating to their assessment 
and, where found suitable, their subsequent evolution once implemented into the 
routine diagnostic service.  
In the first part of the chapter the experimental evaluation of the tests 
developed for norovirus in outbreaks of IID is described. Initially for this service, the 
norovirus RT-PCR method described by Green et al (Green et al, 1995) was chosen 
and adapted to a SYBR green based real-time PCR method, which was implemented 
on the LightcyclerTM platform. The first experiment in this series thus compares this 
Lightcycler™ RT-PCR to the existing EM test on a panel of untested stool samples 
taken from outbreaks and sporadic cases of gastroenteritis.  
The Lightcycler™ RT-PCR is subsequently compared to a number of other 
methods that emerged during the period of study (2000-2006) including a 
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conventional gel-based RT-PCR, two commercial EIAs and an alternative dual-
labelled probe-based real-time RT-PCR.  
The conventional RT-PCR method was recommended in 2003 by a European 
collaboration that compared a number of commonly used RT-PCR methods, including 
the original method described by Green et al (Vinje et al, 2003). Of the many methods 
assessed, the conventional RT-PCR assay using primers JV12 and JV13 was found to 
be most sensitive and was recommended to laboratories yet to set up a PCR service 
for norovirus. This assay and the Lightcycler™ RT-PCR are compared using dilution 
series of typed norovirus-positive samples and a panel of untested stool samples taken 
from outbreaks and sporadic cases of IID.  
The EIA methods were compared to the Lightcycler™ RT-PCR based on the 
manufacturer’s claim that these are a sensitive, high throughput, rapid and easy to use 
alternative to EM and RT-PCR. The methods are compared using panels of untested 
samples from both outbreaks and sporadic cases of IID.  
The final study outlined in this section is a comparison of the Lightcycler™ 
RT-PCR with the dual-labelled probe-based real-time RT-PCR (Kageyama et al, 
2003) selected and adapted (as described in Chapter 3) once the appropriate 
technology became available in the laboratory. These methods are compared on 
panels of outbreak and sporadic samples, and dilution series of norovirus-positive 
samples.  
The second part of this chapter outlines the data relating to the evaluation of 
the PCR methods for sporadic cases of IID. The initial aim was to replace EM with a 
multiplex gel-based PCR for adenovirus, astrovirus, rotavirus and sapovirus alongside 
the norovirus assay developed for the outbreak service. The initial experiment outlines 
the results of the attempts made to adapt the four conventional gel-based PCR assays 
chosen in Chapter 3 into a multiplex RT-PCR assay. The sensitivity of the multiplex 
RT-PCR assay with respect to each pathogen is compared to the individual PCR 
assays on both dilution series of samples and panels of samples known to be positive 
for one of the four pathogens.  
Based on the results of this experiment adaptations to the multiplex assay are 
described. The resultant assays are compared to antigen detection methods for 
astrovirus and rotavirus using a panel of clinical samples from sporadic cases of IID 
in children. Such methods have been shown to have sensitivity comparable or better 
than EM and are commonly used in routine microbiology laboratories (Anand et al, 
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2001; Eing et al, 2001; Kelkar et al, 2004; Giordano et al, 2005; Rabenau et al, 1998; 
Cubitt et al, 1999).  
Finally, the gel-based PCR assays developed are compared to the dual-labelled 
probe-based real-time PCR methods chosen and adapted as described in Chapter 3, 
using panels of untested clinical samples from sporadic cases of IID and a number of 
dilution series of typed positive samples.  
Based on these series of experiments the eventual tests implemented for the 
outbreak and sporadic services are described. The third part of this chapter then 
outlines experiments carried out in an attempt to reduce the turn-around-times and 
cost of these tests without affecting their sensitivity. The first examines the effect of 
reducing the length of the PCR cycling times on test sensitivity and rapidity. 
Following this is a study examining whether real-time PCR tests for DNA pathogens 
can be carried out using the parameters employed for RNA pathogens without a loss 
in test sensitivity (and hence can be carried out simultaneously). Further studies 
include an examination of whether pooled positive controls (i.e. a single control 
containing all 5 viral causes of IID) can be used in order to reduce the cost of PCR 
testing by allowing more clinical samples to be processed at any one time. The use of 
primer and probe pools (vials containing aliquoted volumes of both optimised primer 
and probe) is also examined to determine whether these can provide easier and more 
rapid test set up. The final experiment examines whether reducing the PCR reaction 
volumes affects the sensitivity of the PCR assays.  
4.3. Assessment Of The PCR Protocols For Use In The Proposed 
Outbreak Service  
4.3.1. Real-Time Lightcycler™ RT-PCR (SYBR Green) Vs EM 
The aim of this first experiment was to compare the novel Lightcycler™ 
SYBR green real-time assay for norovirus described in Chapter 3 to the existing EM 
method employed in the laboratory. The specificity of the Lightcycler™ RT-PCR 
assay was first assessed using a panel made up of recognised enteric and other 
pathogens. It was then compared to EM using a panel of untested samples from 
outbreaks and sporadic cases of IID. As with all the experiments in this series the 
panel consisted of all samples submitted to the laboratory during a fixed period of 
time in order to provide a realistic cross-section of samples with which to test the two 
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methods. Samples from sporadic cases of IID were included since the test developed 
for the outbreak service was also to be used to test for norovirus in the proposed 
sporadic service. 
4.3.1.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel consisted of a total of 12 stool samples and 7 nucleic 
acid extracts containing variously: bacterial and parasitical causes of IID; non-
norovirus viral pathogens known to cause IID; and other pathogens that can be 
detected in stool that are unrelated to IID. The bacterial and parasitical stool samples 
included: Salmonella enteridis, Campylobacter jejuni, Giardia lambdia, E-coli 0157 
and Cryptosporidium parvum. These samples were provided by Monklands District 
General Hospital. The stool samples containing non-norovirus causes of IID included: 
astrovirus types 1 and 3; sapovirus (Sapporo/82/JP); rotavirus types G1 and G2; and 
adenovirus types 41 and 40. Nucleic acid extracts of other pathogens unrelated to IID 
included: enterovirus; CMV; HSV-1 and 2; EBV; Nessieria gonnorhoeae and 
Chlamydia trachomatis. With the exception of the sapovirus sample, provided by Dr 
Koopmans (Bilthoven, Netherlands), the remaining samples were clinical samples 
stored as part of the WOSSVC collection. All samples were extracted using the 
nucleic acid extraction protocol described in Chapter 3. 
Clinical Samples 
The comparison of the Lightcycler™ RT-PCR with EM was carried out using 
samples from 9 suspected outbreaks of viral gastroenteritis (consisting of a total of 85 
samples) together with a further 90 samples from sporadic cases of IID. As in all the 
experiments, and the laboratory diagnostic service itself, the information used to 
determine whether a sample was from an outbreak or sporadic case of IID was 
derived from the specimen request forms. The samples used in this experiment were 
all those submitted to the laboratory diagnostic service between October and 
December 2000. As with all other clinical samples employed in this research, details 
of the date of illness onset and its duration are not known since the clinician did not 
provide these. The conditions of transport were also not recorded. This, in fact, is true 
for the majority of samples submitted to the laboratory. Thus, although these factors 
affect the performance of the tests examined, the samples employed in the research 
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are representative of those expected in the ‘live’ service. Negative PCR controls (in 
the form of VTM) were included in each run to control for test contamination.  
Laboratory Methods 
The Lightcycler™ RT-PCR assay was implemented as described in Chapter 3, 
incorporating stool extraction (section 3.4.1.1), nucleic acid extraction (section 
3.4.1.2) and the RT and PCR steps (sections 3.4.2.1 and 3.4.2.2). As part of the 
assessment process samples that tested positive for norovirus were then re-processed 
starting from stool extraction and the interpretation of the results confirmed by 
running the PCR product on an agarose gel.  
The existing EM protocol employed uses the same stool extraction technique. 
Following this 2-5ml of the supernatant is spun at 100,000 rpm for 30 minutes. The 
supernatant is then removed and the pellet air dried for at least 10 minutes before 
being re-suspended. A drop of the virus suspension is then mixed with a drop of 
negative stain in a 50mm sterile Petri dish and placed on the ‘matt’ surface of an EM 
specimen grid. Grids are then examined at an instrument magnification of 60K. Each 
grid is examined for a period of at least 15 minutes.  
4.3.1.2. Results 
 The LightCycler™ RT-PCR did not detect any of the specificity panel 
as positive, suggesting it was specific. Meanwhile the results for the clinical samples 
showed that, overall, 29 tested positive for norovirus using the EM technique 
compared to 47 using the LightCycler™ RT-PCR (Table 10). 
 Table 10: Comparison of LightCycler™ RT-PCR and EM. 
Sample Type Number of Samples EM Positive LightCycler™ Positive 
Outbreak 1 5 3 5 
Outbreak 2 5 0 0 
Outbreak 3 6 4 4 
Outbreak 4 6 0 0 
Outbreak 5 6 1 3 
Outbreak 6 7 0 0 
Outbreak 7 5 0 1 
Outbreak 8 41 3 6 
Outbreak 9 4 2 3 
Total Outbreak  85 13 22 
Sporadic  90 16 25 
Total samples 175 29 47 
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The table shows that the Lightcycler™ RT-PCR consistently detected 
norovirus in more samples than the EM test, in samples from both suspected 
outbreaks of norovirus (from various sources) and sporadic cases of IID. 
Examining the results in more detail, all samples that tested positive for 
norovirus using EM also tested positive using the Lightcycler™ RT-PCR. Moreover, 
all negative controls tested negative using the LightCycler™ RT-PCR. Examination 
of the melting curves of the samples that tested positive using the LightCycler™ RT-
PCR showed melting point temperatures of between 81-83oC (see Figure 12 for an 
example) for all but two samples, which were outwith this range (80.3oC and 80.4oC). 
In order to corroborate the results, all Lightcycler™ RT-PCR positive results were re-
investigated, by repeating the test from extraction and running the PCR products on a 
gel. A band of 113bp in length was observed for all 47 samples, confirming the 
original results.  
Figure 12: Example of Lightcycler™ RT-PCR SYBR green melt curves (norovirus-
positive results). 
 
At the WOSSVC, an outbreak is confirmed as being caused by a particular 
pathogen if at least two of the submitted samples from a particular location are found 
to be positive for that pathogen. On the other hand, for an outbreak to be classified as 
negative at least six samples from the same outbreak have to be submitted and found 
to be negative for the pathogen in question.  In either case, more than one sample is 
required before a classification is made in order to reduce the risk of false diagnoses.  
Based on these criteria four of the nine outbreaks investigated were confirmed 
using EM compared to five using the Lightcycler™ RT-PCR assay (Table 10). Both 
tests in addition detected a single norovirus positive in samples from one other 
outbreak, which meant the outbreak could not definitely be attributed to norovirus.  
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4.3.1.3. Study Conclusions 
The results of this study showed that the Lightcycler™ RT-PCR assay was 
specific and more sensitive than the existing EM protocol, detecting more outbreaks 
and individual cases of norovirus (Miller, Gunson and Carman, 2002). The increased 
sensitivity of the Lightcycler™ RT-PCR in comparison to EM confirmed the findings 
of earlier work (Buesa et al, 1996) and was subsequently substantiated further 
(Rabenau et al, 2003; Simpson et al, 2003). However, a possible disadvantage found 
was the varied melting temperature observed for the positive samples in this study 
(80-83oC). This highlights a potential difficulty in defining a strict melting 
temperature range for result interpretation, as norovirus RdRp variation may result in 
a PCR product with a melting temperature outwith the accepted range and thus a false 
negative result. Since this research was carried out other studies using SYBR green 
based RT-PCR assays have also highlighted melting temperature variation as a 
problem and have related this to norovirus type (Richards et al, 2004). Here, however, 
all samples with a melting temperature range of 80-83oC were confirmed when re-
tested using agarose gel analysis to interpret the results, indicating this is an 
acceptable range to employ. Thus, the increased sensitivity of the Lightcycler™ RT-
PCR assay combined with its increased sample capacity meant the decision was taken 
to implement it as the frontline test for outbreak samples in January 2001. EM was 
retained for testing all samples from sporadic cases of IID and as the secondary test 
for outbreak samples that tested negative for norovirus using the new PCR assay. 
4.3.2. Real-Time Lightcycler™ RT-PCR (SYBR Green) Vs A 
Recommended Conventional Gel-Based RT-PCR  
Following implementation of the Lightcycler™ assay as part of the new 
laboratory diagnostic service the primers it employs, Ni and E3, were independently 
assessed as part of a European collaboration study designed to identify which of the 
commonly used RT-PCR methods offered the most sensitive and wide ranging 
detection of norovirus types (Vinje et al, 2003). This study found that the primers Ni 
and E3 were unable to detect some G1 and G2 types, and that of all the RT-PCR 
assays examined, the most sensitive assay used the primers JV12 and JV13. As a 
result these were recommended to other laboratories interested in setting up a RT-
PCR assay for norovirus (Vinje et al, 2003).  
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In order to investigate these findings, the Lightcycler™ RT-PCR assay was 
compared to the recommended gel-based RT-PCR. First, the specificity of the gel-
based RT-PCR was assessed using the same panel employed earlier in assessing the 
Lightcycler™ RT-PCR. Subsequently, the two assays were compared using a dilution 
series of a G1 and G2 norovirus sample. Finally, the two PCR methods were 
compared using clinical samples from both the sporadic and outbreak setting.  
4.3.2.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel described in section 4.3.1.1 for the assessment of the 
Lightcycler™ assay was also employed in this experiment. 
Clinical Samples 
The gel-based RT-PCR was compared to the LightCycler™ RT-PCR method 
using 81 faecal samples collected from 46 sporadic cases and 7 outbreaks (containing 
a total of 35 samples) of suspected viral gastroenteritis. All samples were submitted to 
the WOSSVC during January to February 2002. Negative PCR controls (in the form 
of VTM) were included in each PCR run to control for test contamination. Both RT-
PCR methods were also compared using a 10 fold dilution series of a G1 (White 
Rose) sample and a G2 (Lordsdale/93/UK X86557) norovirus-positive sample. The 
G1 sample was provided by Dr Marion Koopmans whereas the G2 sample was from 
the WOSSVC collection. 
4.3.2.2. Laboratory Methods 
The Lightcycler™ assay was used as previously described (section 4.3.1.1). 
The gel-based RT-PCR employed the same stool, nucleic acid extraction and RT 
methods (sections 3.4.1.1, 3.4.1.2 and 3.4.2.1). Following this, 10ul of cDNA was 
added to a 50ul reaction containing 10xPCR buffer (100mM tris-HCI, 15mM MgCl2, 
500mM KCL), 0.2mM of each dNTP, 0.2mM of primers JV12Y and JV13I 
(Koopmans et al, 2003). A mixture of 2U of Taq DNA polymerase, 0.028uM TaqStart 
antibody (Clontech Laboratories, Paolo Alto, USA) and 4xTaqStart antibody dilution 
buffer (Clontech Laboratories, Paolo Alto, USA) was incubated at room temperature 
for 10 minutes before being added to the final reaction mixture. PCR was carried out 
under the following conditions: 94oC for 3 mins, followed by 40 cycles of the 
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following: 94oC for 1 min, 37oC for 1 min, 74oC for 1 min. This is followed by a final 
extension step of 72oC for 7 mins. Products were then subjected to agarose gel 
electrophoresis. Positive bands were expected at 324bp. 
4.3.2.3. Results 
The gel-based RT-PCR was shown to be specific as it did not detect any of the 
specificity panel as positive. Results from testing the sample panel showed that, in 
total, the gel-based RT-PCR detected more norovirus-positive samples than the 
LightCycler™ RT-PCR (28 vs 19), as shown in Table 11.  
6 of the 7 of the suspected outbreaks were diagnosed as being caused by 
norovirus using both methods. One outbreak contained 1 positive sample that was 
detected by both methods. Based on the criteria outlined above this outbreak could not 
be confirmed as being caused by norovirus. No additional outbreaks were diagnosed 
using the gel-based RT-PCR assay although the overall sample percentage positive 
rate was greater using the gel-based RT-PCR method (approximately 69% vs 49%). 
All negative controls tested negative using both assays. 
Table 11: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR. 
Sample Type Number of Samples Lightcycler™ Positive Gel-based Positive 
Outbreak 1 13 4 6 
Outbreak 2 3 2 3 
Outbreak 3 3 1 1 
Outbreak 4 4 3 3 
Outbreak 5 4 2 3 
Outbreak 6 5 2 4 
Outbreak 7 3 2 3 
Total Outbreaks 35 16 23 
Sporadic  46 3 5 
Total 81 19 28 
 
The increased sensitivity of the conventional gel-based RT-PCR was 
confirmed using the dilution series. Using a G2 norovirus sample the conventional 
RT-PCR was shown to be more sensitive than the Lightcycler™ RT-PCR assay with a 
detection limit of 10-4 compared to 10-3 (Table 12). However, similar end point 
detection limits were observed when testing the dilution series of the G1 (White rose) 
positive sample (Table 13). 
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Table 12: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR 
on a dilution series of a norovirus-positive sample (Lordsdale/93/UK (X86557). 
Dilution of G2 Sample LightCycler™ Result Gel-based Result 
10-1 + +  
10-2 + + 
10-3 + + 
10-4 - + 
10-5 - - 
 
Table 13: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR 
on a dilution series of a norovirus-positive sample (G1 - White Rose). 
Dilution of G1 Sample LightCycler™ Result Gel-based Result 
10-1 + +  
10-2 + +  
10-3 + +  
10-4 - - 
 
4.3.2.4. Study Conclusions 
This study demonstrated that of the two methods examined the gel-based RT-
PCR method recommended by Vinje et al (Vinje et al, 2003) offered more sensitive 
diagnosis of individual cases of norovirus in outbreaks and sporadic cases of viral 
gastroenteritis (Gunson, Miller and Carman, 2003(i)). The increased sensitivity of the 
gel-based RT-PCR was confirmed using the dilution series of a G2 positive sample, 
but not using a G1 dilution panel. However, the real-time LightCycler™ RT-PCR 
assay did confirm an equal number of outbreaks and had the advantage of providing 
fewer and shorter steps. For example, the Lightcycler™ RT-PCR includes the 
following steps: stool extraction, nucleic acid extraction, a reverse transcriptase step 
and then PCR (a total of 4 steps). The gel-based RT-PCR consists of all of these plus 
a gel-based analysis step, which can take approximately 1-3 hours depending on the 
number of samples under scrutiny. Moreover, the PCR step in the LightcyclerTM test 
is considerably shorter (approximately 45 mins versus 2-4 hours in the gel-based 
assay). As discussed earlier the fewer the steps in a test the less potential for human 
error and the faster the process. This together with the fact that it did not miss any 
outbreaks meant that the LightCycler™ RT-PCR remained the assay of choice for the 
investigation of outbreaks of IID at the WOSSVC. 
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4.3.3. Real-Time Lightcycler™ RT-PCR Vs First And Second 
Generation Commercial EIA Methods 
During the period of study a number of commercial EIA tests became 
available for the diagnosis of norovirus. The manufacturers of these assays claim they 
are a rapid, high throughput and sensitive alternative for laboratories with no access to 
EM or RT-PCR techniques. However, few data exist comparing these antigen 
detection methods to RT-PCR methods. In this study, first and second-generation EIA 
assays were compared with the LightCycler™ RT-PCR on samples from outbreaks 
and sporadic cases of IID. The first generation EIA (IDEIA, DAKO Cytomation, 
Cambridgeshire, UK) uses polyclonal antibodies to detect and differentiate between 
G1 and G2 norovirus strains. In 2003, it was replaced by a second generation EIA. 
This second generation EIA (IDEIA NLV, Dako Ltd, Ely, Cambridgeshire, UK) uses 
a cocktail of genotype-specific monoclonal antibodies to detect and differentiate 
between the antigens of G1 and G2 norovirus strains.  
4.3.3.1. Methods 
Sample Panels 
Comparison Of First Generation EIA With Lightcycler™ RT-PCR 
The two assays were compared using 35 faecal samples from 7 outbreaks of 
gastroenteritis and 46 from sporadic cases of gastroenteritis sent to the WOSSVC 
during October to November 2002. Each sample was tested within 3 days of 
collection from the patient in line with the EIA manufacturer’s requirements. Samples 
for which the two tests produced different results were re-tested using the gel-based 
RT-PCR assessed in the previous experiment in order to corroborate the results. The 
specificity of both assays was assessed using 7 VTM vials.  
Comparison Of Second Generation EIA With Lightcycler™ RT-PCR 
The two assays were compared using 42 faecal samples from 6 suspected 
outbreaks of gastroenteritis and 28 from sporadic cases of gastroenteritis sent to the 
WOSSVC during March to April 2003 (Gunson, Miller and Carman, 2003 (ii)). Each 
sample was tested within 3 days of collection from the patient in line with the EIA 
manufacturer’s requirements.  Samples for which the two tests produced different 
results were re-tested using the gel-based RT-PCR assessed in the previous 
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experiment in order to corroborate the results. The specificity of both assays was 
assessed using 7 VTM vials.  
4.3.3.2. Laboratory Methods 
The Lightcycler™ RT-PCR and gel-based RT-PCR were used as described in 
the previous sections. 
First Generation Commercial EIA For Norovirus   
The reagents were reconstituted according to the manufacturer’s instructions 
(DAKO Cytomation, Cambridgeshire, UK). Briefly, approximately 0.1g of faecal 
specimens was added to 1ml of sample diluent and mixed thoroughly. For the 
genogroup 1 assay, the appropriate number of microtitre wells for samples and 
controls was selected from the kit. 100ul of G1 cut off control was added to the 
appropriate well. 100ul of the negative control was added to two wells. 100ul of the 
samples to be tested were added to the appropriate wells. 100ul of G1 conjugate was 
then added to each well and the plate was incubated at 20-30oC for 120 minutes. The 
wells were then washed 5 times using working strength wash buffer. 100ul of 
substrate was then added to the wells. This was then incubated at 20-30oC for 30 
minutes. 100ul of stopping solution was then added to the well. The colour change 
was then measured photometrically at 450nm with 600nm reference. According to the 
manufacturer, negative controls must have a mean absorbance value of under 0.15 
A450 units. Positive controls must have a cut off value of more than 0.18 A450 units. 
Samples with A450 units above the positive control threshold are considered positive. 
Any sample with an A450 value of within 0.010 of the cut off control should be 
considered equivocal and retested, or interpreted alongside clinical and 
epidemiological data.  
For the genogroup 2 assay the appropriate number of microtitre wells was 
removed from the kit. 100ul of G2 cut off control was added to the appropriate well. 
100ul of the negative control was added to two wells. 100ul of the samples to be 
tested were added to the appropriate wells. 100ul of G2 conjugate was then added to 
each well and the plate was incubated at 20-30oC for 120 minutes. The wells were 
then washed 5 times using working strength wash buffer. 100ul of substrate was then 
added to the wells. This was then incubated at 20-30oC for 30 minutes. 100ul of 
stopping solution was then added to the well. The colour change was then measured 
photometrically at 450nm with 600nm reference. Negative controls must have an A450 
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value of less than 0.15. Positive controls must have a cut off value of more than 0.18 
A450 units. Samples with A450 units above the positive control threshold are considered 
positive. Any sample with an A450 value of within 0.010 of the cut off control should 
be considered equivocal and retested, or interpreted together with clinical and 
epidemiological data.  
Second Generation Commercial EIA For Norovirus  
The EIA for norovirus was carried out as per the manufacturer’s instructions 
(DAKO Cytomation, Cambridgeshire, UK). Briefly, approximately 0.1g of faecal 
specimens was added to 1ml of sample diluent and mixed thoroughly. For the 
genogroup 1 assay, the appropriate number of microtitre wells was selected from the 
kit. 100ul of G1 cut off control was added to the appropriate well. 100ul of the 
negative control was added to two wells. 100ul of the samples to be tested were added 
to the appropriate wells. 100ul of G1 conjugate was then added to each well and the 
plate was incubated at 20-30oC for 120 minutes. The wells were then washed 5 times 
using working strength wash buffer. 100ul of substrate was then added to the wells. 
This was then incubated at 20-30oC for 30 minutes. 100ul of stopping solution was 
then added to the well. The colour change was then measured photometrically at 
450nm with 600nm reference. Negative controls must have a mean A450 value of less 
than 0.15. Positive controls must have a cut off value of over 0.18 A450 units. Samples 
with A450 units above the positive control threshold are considered positive. Any 
sample with an A450 value of within 0.010 of the cut off control should be considered 
equivocal and retested, or interpreted alongside clinical and epidemiological data.  
For the genogroup 2 assay the appropriate number of microtitre wells were 
selected. 100ul of G2 cut off control was added to the appropriate well. 100ul of the 
negative control was added to two wells. 100ul of the samples to be tested were added 
to the appropriate wells. 100ul of G2 conjugate was then added to each well and the 
plate was incubated at 20-30oC for 120 minutes. The wells were then washed 5 times 
using working strength wash buffer. 100ul of substrate was then added to the wells. 
This was then incubated at 20-30oC for 30 minutes. 100ul of stopping solution was 
then added to the well. The colour change was then measured photometrically at 
450nm with 600nm reference. Negative controls must have an A450 value of under 
0.15. Positive controls must have a cut off value of more than 0.18 A450 units. 
Samples with A450 units above the positive control are considered positive. Any 
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sample with an A450 value of within 0.010 of the cut off control should be considered 
equivocal, and retested or interpreted together with clinical and epidemiological data.  
4.3.3.3. Results 
Comparison Of First Generation EIA With Lightcycler™ RT-PCR 
In total, the Lightcycler™ assay detected norovirus in more samples than the 
EIA (18 versus 6), as shown in Table 14. All of the Lightcycler™ positives were 
confirmed using the gel-based RT-PCR, compared to 5 of the 7 EIA positives. A total 
of 4 norovirus-positives were detected by both assays  
Table 14: Comparison of LightCycler™ PCR and first generation EIA. 
Sample Type Number of Samples LightCycler™ Positive EIA Positive 
Outbreak 1 13 4 2 
Outbreak 2 3 2 0 
Outbreak 3 3 1 1 
Outbreak 4 4 3 0 
Outbreak 5 4 1 0 
Outbreak 6 5 2 0 
Outbreak 7 3 2 1 
Total Outbreak 35 15 4 
Sporadic 46 3 2 
Total 88 18 6 
 
The EIA detected norovirus-positive samples in 3 of the 7 suspected 
outbreaks. However, in 2 of these outbreaks only 1 sample tested positive. As 
discussed earlier, the WOSSVC criteria state that a norovirus outbreak must contain at 
least 2 positive samples in order to be confirmed as positive, as the presence of 1 
positive sample could be due to a sporadic case of norovirus. Using this criterion here, 
only 1 outbreak could be confirmed as being caused by norovirus. The LightCycler™ 
RT-PCR, in comparison, confirmed norovirus as the cause in 5 outbreaks.  
Amongst the sporadic cases of IID the LightCycler™ RT-PCR detected 
norovirus in 3 samples. All 3 results were confirmed using the gel-based RT-PCR. In 
contrast, the EIA test detected norovirus in 2 sporadic samples, neither of which could 
be confirmed using the gel-based RT-PCR. In terms of specificity the EIA detected 
one of the VTM samples as positive. Testing with the gel-based RT-PCR, however, 
confirmed that the VTM sample was norovirus-negative. Meanwhile all negative 
controls tested negative using the Lightcycler™ assay.  
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Comparison Of Second Generation EIA With Lightcycler™ RT-PCR 
In total, the LightCycler™ RT-PCR detected norovirus in more samples than 
the EIA (26 versus 9), as shown in Table 15. All of the Lightcycler™ positive results 
were confirmed using the gel-based RT-PCR. A total of 8 samples tested positive for 
norovirus using both assays. The EIA detected norovirus in 2 samples that tested 
negative using the LightCycler™ RT-PCR assay. However, neither of these positive 
results could be confirmed using the second RT-PCR. One sample was classified as 
equivocal using EIA but tested positive for norovirus suing the Lightcycler™ RT-
PCR. 
In total 6 suspected outbreaks of viral gastroenteritis were investigated. Using 
the WOSSVC criteria, the EIA technique diagnosed norovirus as the cause of 1 of the 
6 outbreaks (outbreak 6), whereas the LightCycler™ RT-PCR established norovirus 
as the cause in all outbreaks. 
Amongst the sporadic cases of IID the LightCycler™ RT-PCR detected 
norovirus in 5 samples. All 5 results were confirmed using the gel-based RT-PCR. In 
contrast, the EIA test detected norovirus in 3 sporadic samples, only one of which 
could be confirmed using the gel-based RT-PCR. In terms of specificity all negative 
controls tested negative using the Lightcycler™ assay and the EIA.  
Table 15: Comparison of Lightcycler™ PCR and EIA  
Sample Type Number of Samples  Lightcycler™ Positive EIA Positive 
Outbreak 1 5 2 0 
Outbreak 2 6 4 1 
Outbreak 3 8 4 1 
Outbreak 4 11 3 0 
Outbreak 5 6 4 1 
Outbreak 6 6 4 3 
Total Outbreak 42 21 6 
Sporadic 28 5 3 
Total 70 26 9 
4.3.3.4. Study Conclusions 
These results show that both the first and second generation EIA were 
inadequate for norovirus detection. The LightCycler™ RT-PCR detected norovirus in 
more samples and confirmed more norovirus outbreaks than either EIA. In both 
comparisons all of the extra cases of norovirus detected by the LightCycler™ RT-
PCR were confirmed using the alternative (more sensitive) gel-based RT-PCR. In 
contrast both EIAs produced positive results that could not be confirmed using the 
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gel-based RT-PCR. It is possible that these samples tested negative using the gel-
based method due to primer mismatches or inhibition. However, given that these 
samples also tested negative using the Lightcycler™ assay, the EIA results may also 
have been false positives and therefore the specificity of these assays should be 
questioned. The fact that in the first study a VTM negative control tested positive for 
norovirus using the EIA points toward this conclusion.  
As these EIA tests are relatively new, there are few comparisons with PCR 
available in the literature. Richards et al compared the first generation (polyclonal 
based) EIA with a RT-PCR assay on patient samples taken from outbreaks of IID 
(Richards et al, 2003). Overall they found the EIA to be less sensitive and specific 
than the RT-PCR method. These results confirmed those of the above study. 
However, Richards et al concluded their report by stating that EIA is a suitable 
alternative to EM as an initial screening tool before testing all samples found to 
negative using PCR or EM. This, however, is likely to result in longer turn-around-
times since a significant proportion of samples are likely to test negative using EIA 
and thus require a second phase of testing. Moreover, the lower specificity of the EIA 
found in this research may result in the false diagnosis of norovirus outbreaks leading 
to unnecessary implementation of costly infection control procedures. It is worth 
noting that the first generation EIA was withdrawn from the market in 2003.  
A recent study by Burton-MacLeod further substantiated the results of the 
above study examining the second generation (monoclonal based) EIA. In the 
reported study the EIA was assessed on a panel of known types of norovirus and other 
causes of viral IID (Burton-MacLeod et al, 2004). They found the EIA could not 
detect all G2 strains and had an overall sensitivity of 39% (albeit with a specificity of 
100%). They concluded that the Dako assay could not be used as a frontline test for 
norovirus. Other recent studies have also found the Dako assay to have lower 
sensitivity and specificity than RT-PCR tests (Wilhelmi et al, 2007; Castriciano et al, 
2007; Dimitriadis, Bruggink and Marshall, 2006; Dimitriadis and Marshall, 2005). 
For example, Wilhemli et al assessed the EIA using 117 samples that tested positive 
for norovirus using RT-PCR. They found the EIA to have a sensitivity of 76.9% and a 
specificity of 85%. Similar results were obtained by Castriciano et al and Dimitraidis 
et al. 
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Based on the findings of this research the EIA method was not implemented in 
the WOSSVC and the LightcyclerTM RT-PCR remained the frontline assay for 
outbreaks of norovirus. 
4.3.4. Real-Time Lightcycler™ RT-PCR Vs Dual-Labelled Probe-
Based Real-Time PCR 
As discussed earlier, in 2003 the WOSSVC obtained a number of real time 
PCR platforms that could support other real time chemistries including dual-labelled 
probes. Compared to the Lightcycler™ platform, these platforms offer greater 
throughput (72-96 vs 32 per run) and potentially, therefore, more rapid turn-around-
times. Dual-labelled probe-based real-time PCR methods may also offer improved 
specificity in comparison to a SYBR green based approach due to the incorporation of 
an additional probe complimentary to the target sequence. As a result such assays do 
not require a melting curve step, which aids rapidity and offers easier result 
interpretation not reliant on melting temperature. 
The aim of this experiment, therefore, was to compare the Lightcycler™ RT-
PCR to the dual-labelled probe-based RT-PCR selected and adapted as described in 
Chapter 3. First the specificity of the new assay was tested using the panel employed 
earlier in assessing the Lightcycler™ assay. The sensitivity of the two real-time 
assays was then compared using clinical samples from outbreaks and sporadic cases 
of IID and dilution series of both a G1 and G2 positive sample.  
Resource constraits meant that corroboratory testing using an alternative 
method was not carried out at the time. However, all samples for which the two tests 
produced different results were re-tested using an alternative nested RT-PCR in 2007 
(Gallimore et al, 2007). The assay described by Gallimore et al was selected since it 
targets parts of both the RdRp and the ORF-2 regions. This extra testing was carried 
out in order to confirm the initial results obtained in 2004 and to ensure that the 
correct service decisions were made regarding the routine diagnostic service.  
4.3.4.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel described in section 4.3.1.1 for this original assessment 
of the assay was again employed in this experiment.  
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Clinical Samples 
The dual-labelled probe-based real-time RT-PCR and the LightCycler™ RT-
PCR were compared using 217 faecal samples collected from 6 suspected outbreaks 
of IID (n=64 samples), and 153 community managed cases of acute gastroenteritis. 
All samples were submitted to the WOSSVC during October to December 2003. 
Finally, each method was compared using a dilution series of a known G1 
(Birmingham (AJ277612)) sample and a known G2 (Lordsdale/93/UK (X86557)) 
sample. The G1 sample was provided by Dr M Koopmans whereas the G2 sample 
was part of the WOSSVC sample collection. 
Laboratory Methods 
The LightCycler™ RT-PCR assay was implemented as described earlier. The 
dual-labelled probe-based assay was implemented as described in section 3.4.2.2 of 
Chapter 3. 
Nested RT-PCR For Norovirus 
 Extracted RNA (12.5ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) using primers G2FBN and G2SKR (25 pmoles/reaction) 
under the following conditions. The RT step was carried at 50oC for 30 minutes 
followed by the first round PCR step at 95oC for 15 minutes. This was followed by 35 
cycles of: 95oC for 40 seconds; 45oC for 40 seconds and 72oC for 1 min. 2ul of first 
round product was then transferred to a 48 ul second round reaction (Qiagen) 
containing primers G2FBN2 and G2SKR (50 pmoles/ reaction) and subjected to 40 
cycles of: 94oC for 40 seconds; 45oC for 25 seconds and 72oC for 1 minute 30 
seconds. This was followed by a hold step 72oC for 10 min. Products were visualised 
using agarose gel electrophoresis. A PCR product of 357bp was expected if norovirus 
was successfully amplified from the sample. 
4.3.4.2. Results 
The dual-labelled probe-based RT-PCR was shown to be specific since it did 
not detect any of the specificity panel as positive. When compared on the sample 
panel the new real-time assay detected norovirus in more samples than the 
LightCycler™ RT-PCR in total (41 vs 13) as shown in Table 16. All extra positives 
detected by the dual-labelled probe-based assay were confirmed as containing 
norovirus by re-testing with the nested RT-PCR.  
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Using the standard WOSSVC criteria, the probe-based method diagnosed 
norovirus to be the cause of 4 outbreaks (outbreaks 1, 3, 4 and 5). In comparison, the 
LightCycler™ RT-PCR diagnosed norovirus as the cause of only one outbreak 
(outbreak 3). In both tests a single positive sample was detected in one other 
suspected outbreak (in outbreak 2 using the dual-labelled probe-based assay and 
outbreak 4 using the LightCycler™ RT-PCR), neither of which could be confirmed as 
being caused by norovirus due to the lack of multiple positive samples. All of the 
samples from one outbreak tested negative for norovirus using both methods 
(outbreak 6).  
Table 16: Comparison of dual-labelled probe-based PCR and LightCycler™ RT-PCR.  
Sample  
Type 
Number of Samples Dual-labelled Probe-based  
Positives 
Lightcycler™  
Positives 
Outbreak 1 21 3 0 
Outbreak 2 5 1 0 
Outbreak 3 7 7 6 
Outbreak 4 5 2 1 
Outbreak 5 13 13 0 
Outbreak 6 13 0 0 
Total Outbreak 64 26 7 
Sporadic 153 15 6 
Total 217 41 13 
 
Amongst the sporadic cases, the dual-labelled probe-based assay detected 
norovirus in more samples (15 vs 6).  
Finally, the greater sensitivity of the dual-labelled probe-based RT-PCR was 
confirmed using the dilution panels of a G1 and G2 positive sample (made up of 10 
fold dilutions). The results are shown in Table 17 and Table 18. The dual-labelled 
probe-based assay was found to have a lower detection limit for both norovirus type 
G1 (10-5 vs 10-2) and G2 (10-6 vs 10-4).  
Table 17: Comparison of dual-labelled probe-based RT-PCR and LightCycler™ RT-PCR 
on a dilution series of a norovirus positive sample (G1-Birmingham AJ277612). 
Dilution of G1 Sample LightCycler™ Result Dual-labelled Probe-based Result (Ct) 
10-1 + + (23.2) 
10-2 + + (27.0) 
10-3 - + (30.2) 
10-4 - + (33.4) 
10-5 - + (36.2) 
10-6 - - 
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Table 18: Comparison of dual-labelled probe-based RT-PCR and LightCycler™ RT-PCR 
on a dilution series of a norovirus positive sample (G1-Lordsdale/93/UK X86557). 
Dilution of G2 Sample LightCycler™ Result Dual-labelled Probe-based Result (Ct) 
10-1 + + (20.1) 
10-2 + + (23.4) 
10-3 + + (27.1) 
10-4 + + (30.2) 
10-5 - + (33.6) 
10-6 - + (37.0) 
10-7 - - 
4.3.4.3. Study Conclusions 
Overall, the results showed that the adapted version of the dual-labelled probe-
based test described by Kageyama et al was specific and consistently more sensitive 
than the Lightcycler™ assay (Gunson and Carman, 2005). This was confirmed by 
repeat testing of the discrepant results using an alternative PCR assay in 2007. The 
dual-labelled probe-based PCR also had the potential for increased throughput since it 
could test more samples per run than achievable on the Lightcycler™ method. As 
mentioned above the Lightcycler™ assay consisted of four steps (stool extraction, 
nucleic acid extraction, RT, and PCR) whereas the dual-labelled probe-based assay 
consists of just three steps (the RT and PCR steps are combined). Based on these 
results it was used to replace the Lightcycler™ assay as the frontline test for norovirus 
in outbreaks of IID in January 2004. 
4.4. Assessment Of The PCR Protocols For Use In The Proposed 
Sporadic Service 
4.4.1. Gel-based Multiplex RT-PCR For Adenovirus, Astrovirus, 
Rotavirus And Sapovirus Vs Individual PCR Assays For Each  
The aim of the first experiment in this series was to compare the sensitivity of 
the novel multiplex assay described in Chapter 3 with that of the individual assays 
from which it was developed, to ensure the multiplex RT-PCR was at least as 
sensitive. Of particular interest were the results for adenovirus, to determine if the 
addition of an RT step affected the sensitivity of the test.  The final multiplex was 
then assessed for specificity using a panel of samples containing recognised 
gastrointestinal pathogens. 
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4.4.1.1. Methods 
Sample Panels 
Clinical Samples 
Both methods were initially compared using 10-fold dilution series of four 
different samples, each known (via testing by EM) to be positive for one of the four 
viral pathogens of interest. Testing with a dilution series is an important first step in 
the assessment of multiplex assays prior to the assessment using clinical samples, in 
order to determine if there are any cross-reactions between the primers that reduce test 
sensitivity. The clinical panel in this case consisted of 74 samples from sporadic cases 
of IID containing 20 that tested positive for adenovirus (using the EIA method 
Adenoscreen (Microgen) at the Royal Hospital for Sick Children (RHSC) in Glasgow, 
10 samples that tested positive for astrovirus using EM at the WOSSVC, 20 rotavirus-
positive samples tested using an EIA method (Microgen), at the RHSC and 24 
sapovirus-positive samples containing representatives of both G1 and G2 sapoviruses 
(provided by Dr M Koopmans, Bilthoven, Netherlands).  
Specificity Panel 
The specificity panel described in section 4.3.1.1 was also employed in this 
experiment, with the addition of 7 norovirus types for cross-testing purposes. The 7 
norovirus types consisted of 5 G1 types (Birmingham AJ277612), White Rose, Malta, 
Musgrove and Mikkelo) and 2 G2 types (Lordsdale/93/UK X86557 and Leeds/90/UK 
AJ277603) and were sourced from Dr M Koopmans, Bilthoven, Netherlands and the 
G2 types were part of the WOSSVC sample collection. 
4.4.1.2. Laboratory Methods 
All samples were processed using the faecal extraction and nucleic acid 
extraction protocols outlined in Chapter 3 (section 3.4.1.1 and 3.4.1.2). Where 
employed, the reverse transcriptase step was the standard laboratory method described 
in Chapter 3 (section 3.4.2.1). The multiplex RT-PCR for adenovirus, astrovirus, 
rotavirus and sapovirus is also described in Chapter 3 (section 3.4.2.3). 
Individual PCR For Adenovirus 
10ul of cDNA was added to a 50ul reaction containing 10xPCR buffer 
(100mM tris-HCI, 15mM MgCl2, and 500mM KCL), 0.2mM of each dNTP and 
0.2mM of primers ADJC1 and ADJC2 for adenovirus (Cooper et al, 1999). A mixture 
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of 2U of Taq DNA polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, 
Paolo Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, 
Paolo Alto, USA) was incubated at room temperature for 10 minutes before being 
added to the final reaction mixture. The PCR conditions were 94oC for 3 mins, 
followed by 40 cycles of: 94oC for 30 secs, 47oC for 40 secs, 72oC for 30 secs; with a 
final extension step of 72oC for 7 mins. Products were then subjected to agarose gel 
electrophoresis. Positive bands were expected at 140bp for adenovirus. 
Individual RT-PCR For Astrovirus 
10ul of cDNA was added to a 50ul reaction containing 10xPCR buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP and 0.2mM 
of primers mon269 and mon270 for astrovirus (Noel et al, 1995). A mixture of 2U of 
Taq DNA polymerase, 0.028uM of TaqStart antibody (Clontech Laboratories, Paolo 
Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo 
Alto, USA) was incubated at room temperature for 10 minutes before being added to 
the final reaction mixture. PCR conditions were 94oC for 3 mins, 40 cycles of: 94oC 
for 1min, 50oC for 1 mins, 72oC for 1 min; with a final extension step of 72oC for 7 
mins. Products were then subjected to agarose gel electrophoresis. Positive bands 
were expected at 449bp for adenovirus. 
Individual RT-PCR For Rotavirus 
10ul of cDNA was added to a 50ul reaction containing 10xPCR buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of 
each primer con1 and con2 (Gentsch et al, 1992; Rasool et al, 2002). A mixture of 2U 
of Taq DNA polymerase, 0.028uM TaqStart antibody™ (Clontech Laboratories, 
Paolo Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, 
Paolo Alto, USA) was incubated at room temperature for 10 minutes before being 
added to the final reaction mixture. PCR conditions were 94oC for 5 mins, 40 cycles 
of: 94oC for 30 secs, 42oC for 1 minute, 72oC for 1 minute 30 secs; with a final step of 
72oC for 7 mins. Products were then subjected to agarose gel electrophoresis. Positive 
bands were expected at 220bp for rotavirus. 
Individual RT-PCR For Sapovirus 
10ul of cDNA was added to a 50ul reaction containing 10xPCR buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of 
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primers JV66 and SR80 for sapovirus (Vinje et al, 2000). A mixture of 2U of Taq 
DNA polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, Paolo Alto, 
USA), and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo Alto, 
USA) was incubated at room temperature for 10 minutes before being added to the 
final reaction mixture. PCR conditions were 94oC for 3 mins, 40 cycles of: 94oC for 1 
min, 37oC for 1 min 30 secs, 74oC for 1 minute; with a final extension step of 72oC 
for 7 min. Products were then subjected to agarose gel electrophoresis. Positive bands 
were expected at 349bp for sapovirus. 
4.4.1.3. Results  
Results for the dilution series (Table 19) showed significant reductions in the 
end point detection limits for astrovirus, rotavirus and sapovirus the multiplex version 
of the assay. In fact, the multiplex assay failed to detect rotavirus at any of the 
concentrations tested. 
Assuming that these decreases in sensitivity were due to cross-reactions 
between the primers for each pathogen, each set of primers was removed in turn from 
the multiplex assay in order to investigate the source(s) of the problem. All other 
constituents and parameters in the multiplex assay remained the same. 
Removing the adenovirus PCR assay from the multiplex RT-PCR assay did 
not improve the end point detection limit of the astrovirus, rotavirus or sapovirus RT-
PCR tests (Table 20). Similarly, removing the astrovirus RT-PCR and did not 
improve the rotavirus and sapovirus RT-PCR (Table 21). However, removing the 
rotavirus RT-PCR resulted in the remaining multiplex RT-PCR assay producing 
similar levels of sensitivity to the corresponding individual PCR assays (Table 22).  
Table 19: Comparison of multiplex PCR for adenovirus, astrovirus, rotavirus and 
sapovirus with singleton assays on dilution series. 
Adenovirus Astrovirus Rotavirus Sapovirus Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10-1 + + + + - + + + 
10-2 + + - + - + + + 
10-3 + + - - - + - + 
10-4 + + - - - - - - 
10-5 - - - - - - - - 
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Table 20: Comparison of multiplex PCR for astrovirus, rotavirus and sapovirus with 
singleton assays on dilution series. 
Astrovirus Rotavirus Sapovirus Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10-1 + + - + + + 
10-2 - + - + + + 
10-3 - - - + - + 
10-4 - - - - - - 
10-5 - - - - - - 
 
Table 21: Comparison of multiplex PCR for adenovirus, rotavirus and sapovirus with 
singleton assays on dilution series. 
Adenovirus Rotavirus Sapovirus Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10-1 + + - + + + 
10-2 + + - + + + 
10-3 + + - + - + 
10-4 + + - - - - 
10-5 - - - - - - 
 
Table 22: Comparison of multiplex PCR for adenovirus, astrovirus and sapovirus with 
singleton assays on dilution series. 
Adenovirus Astrovirus Sapovirus Dilution 
Multi 
Result 
Single  
Result 
Multi  
Result  
Single  
Result  
Multi  
Result  
Single  
Result  
10-1 + + + + + + 
10-2 + + + + + + 
10-3 + + - - + + 
10-4 + + - - - - 
10-5 - - - - - - 
 
When tested using the 74 clinical samples, moreover, this version of the 
multiplex assay detected all cases of adenovirus, astrovirus and sapovirus in the panel. 
In addition, it did not detect any samples in the specificity panel as positive and hence 
was shown to be specific. 
In all versions of the multiplex assay the inclusion of an RT step was shown to 
have no effect on the sensitivity of the adenovirus detection. The data also showed 
that changing the original annealing temperature as part of the multiplexing process 
had little effect on the individual assays’ sensitivity.  
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4.4.1.4. Study Conclusions 
The results from this experiment showed that it was not possible to multiplex 
all four assays without seriously affecting their sensitivity. Instead, the four chosen 
PCR assays were reduced to two tests: a single RT-PCR assay for rotavirus and a 
novel multiplex assay for the detection of adenovirus, astrovirus and sapovirus. 
Although not as efficient as a single four-way test, this still represents a saving in the 
cost and rapidity of testing in comparison to four separate tests since fewer steps will 
be carried out, less reagents will be used and less technician time is required. 
However, on balance it was felt that the benefits of a dual PCR test solution were not 
enough to warrant the replacement of the EM service for sporadic IID at this stage. 
4.4.2. Developed Gel-Based PCR Methods Vs EIA Methods  
As described earlier, EIA methods are popular assays in laboratories without 
access to EM or PCR. Studies have shown these to be similar in sensitivity to EM 
(Giordano et al, 2005; Rabenau et al, 1998; Putzker et al, 2000) although few studies 
exist comparing them to PCR methods. The advantage of such methods is that they 
are considered simple to implement, easy to use and are rapid and high throughput. 
The aim of this second study, therefore, was to measure the sensitivity of 
commercial EIA methods in comparison to the RT-PCR assay for rotavirus and the 
multiplex RT-PCR for adenovirus, astrovirus and sapovirus developed in the previous 
experiment. Should the EIA methods prove as sensitive as the PCR assays, or more 
so, this and the relative ease of their implementation in comparison to a dual PCR 
solution would mean these were potential candidates as the replacement for EM in the 
sporadic service.  
The multiplex RT-PCR assay was compared to an EIA for astrovirus, whilst 
the rotavirus RT-PCR was compared to both an ICG and an EIA for the detection of 
rotavirus. EIA methods for the detection of adenovirus and sapovirus were not 
included in the comparison since an adenovirus EIA was not available in the 
laboratory during the period of study and a commercial sapovirus EIA had yet to be 
developed. Similarly, an ICG test for astrovirus was not available in the laboratory 
during this time. Both types of test were assessed using faecal samples taken from 
children with clinically diagnosed IID. 
Subsequently, in 2007, all samples for which the two tests produced different 
results were re-tested using the dual-labelled probe-based real-time RT-PCR assays 
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described in section 3.4.2.3 of Chapter 3 once these became available. These are 
useful methods for confirmation since they target alternative regions of the rotavirus 
and astrovirus genome (Pang et al, 2004; Le Cann et al, 2004) to the gel-based 
methods. This extra testing was carried out in order to confirm the initial results 
obtained in 2004 and to ensure that the correct service decisions were made regarding 
the routine diagnostic service.  
4.4.2.1. Methods 
Sample Panels 
Comparison Of Rotavirus RT-PCR With Commercial EIA And ICG 
The single gel-based RT-PCR assay was compared with a commercial ICG 
and EIA on 107 faecal samples collected from children under 5 years old with 
sporadic IID. All samples were from patients clinically diagnosed as having 
gastroenteritis (as shown on the specimen request forms) and were submitted to 
Monklands District General Hospital (MDGH), Lanarkshire between February and 
April 2002. All samples had initially been tested at MDGH using an ICG test for 
rotavirus (Rotascreen Dipstick, Microgen Bio Products). Samples were then 
immediately sent to the WOSSVC and tested using both the RT-PCR and a 
commonly used EIA (Rotascreen II EIA, Microgen Bio Products). All samples were 
tested within 7 days of collection from the patient in line with the EIA manufacturer’s 
requirements. Negative (VTM) PCR controls were included in each PCR run.  
Comparison Of Multiplex RT-PCR With Commercial EIA For Astrovirus 
In total, 48 faecal samples were used to compare the EIA with the multiplex 
RT-PCR for astrovirus, adenovirus and sapovirus. All samples had originally been 
sent to Monklands District General Hospital (MDGH), Lanarkshire in February to 
April 2002, from children under 5 years old with clinically diagnosed community 
managed gastroenteritis. All samples had tested negative for rotavirus (using ICG) 
and for other microbiological pathogens at the MDGH. They had also tested negative 
at the WOSSVC for adenovirus, rotavirus and sapovirus using the singleton gel-based 
RT-PCR assays described earlier and norovirus using the Lightcycler™ RT-PCR test. 
All samples were tested within 7 days of collection from the patient in line with the 
EIA manufacturer’s requirements. Negative (VTM) PCR controls were included in 
each PCR run to control for test contamination.  
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4.4.2.2. Laboratory Methods 
All samples to be tested using both the rotavirus RT-PCR and the multiplex 
RT-PCR were processed using the faecal extraction and nucleic acid extraction 
protocols outlined previously in Chapter 3 (Section 3.4.1.1 and 3.3.1.2). The rotavirus 
RT-PCR is described previously (section 4.4.1.1) and the multiplex developed in the 
previous experiment is described below. The real-time PCR methods for rotavirus and 
astrovirus are also described in Chapter 3 (section 3.4.2.3). 
Multiplex RT-PCR For Adenovirus, Astrovirus And Sapovirus 
10ul of cDNA was added to a 50ul reaction containing 10xPCR buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of 
each set of primers for each of the different pathogens. A mixture of 2U of Taq DNA 
polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, Palo Alto, USA), 
and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Palo Alto, USA) was 
incubated at room temperature for 10 minutes before being added to the final reaction 
mixture. PCR conditions were 94oC for 3 mins, 40 cycles of: 94oC for 30 secs, 47oC 
for 40 secs, 72oC for 30 secs; with a final extension step of 72oC for 7 min. Products 
were then subjected to agarose gel electrophoresis. Positive bands were expected at 
140bp for adenovirus, 449bp for astrovirus and 349bp for sapovirus. 
Commercial EIA Assay for Rotavirus (Microgen) 
The commercial antigen detection assay used for rotavirus was the Rotascreen 
II EIA test supplied by Microgen Bio-Products, Camberley, Surrey, UK. Before 
carrying out the EIA test all reagents were made up as per the manufacturer’s 
instructions. The commercial EIA was then carried out according to its 
manufacturer’s instructions (Microgen Bio-Products, Camberley, Surrey, UK). 
Briefly, approximately 0.1g of faecal specimens was added to 1ml of sample diluent 
and mixed thoroughly. The appropriate number of microtitre wells for samples and 
controls was selected from the kit. 50ul of positive control was then added to the 
appropriate positive control well. 50ul of negative control was added to the 
appropriate negative control well. 50ul of the sample/s were then added to the 
appropriate wells. 50ul of conjugate was then added to each well. The plate was then 
incubated at room temperature for 30mins. The wells were then washed three times 
using the wash buffer. 100ul of substrate was then added to all wells before a second 
incubation step at room temperature for 20mins. 100ul of stop solution was then 
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added to each well. The wells were read at absorbance 450nm. According to the 
manufacturer’s instructions, the positive control must have an absorbance value of 
more than 0.6 A450 units. The negative control must have an absorbance value of less 
than 0.15A450 units. Samples are regarded as positive if the A450 value is greater than 
the A450 value of the negative control plus 0.1 absorbance units. It is recommended 
that faecal samples giving absorbance values within 10% of the cut off should be 
retested.  
Commercial EIA For Astrovirus 
The EIA used for astrovirus used an amplified IDEIA test (DAKO 
Cytomation, Cambridgeshire, UK) and was carried out in accordance with the 
manufacturer’s instructions. Approximately 0.1g of faecal specimens were added to 
1ml of sample diluent and mixed thoroughly. The appropriate number of microtitre 
wells was selected from the kit. 100ul of positive control was added to the appropriate 
positive control well. 100ul of negative control was added to the appropriate negative 
controlwell. 100ul of clinical sample was added to the appropriate well. 100ul of 
conjugate was then added to all wells. Wells were incubated at 25oC for 60 minutes 
and then washed five times using wash buffer. 100ul of substrate was then added to 
each well and incubated at 25oC for 10 minutes. 100ul of stopping solution was 
added. Wells were read photometrically at 450nm. According to manufacturers 
instructions the positive control must have an absorbance value of more than 0.5 
absorbance units. Negative controls should have absorbance values of less than 0.15 
absorbance units. Cut off values are calculated by adding 0.1 absorbance units to the 
negative control value. Positive samples must have absorbance units above the cut off 
value. A result within 0.1 absorbance units of the cut off value should be interpreted 
cautiously taking into account the clinical and epidemiological data.   
4.4.2.3. Results 
Comparison Of Rotavirus RT-PCR With EIA And ICG 
The RT-PCR assay detected rotavirus in 58 samples whereas the ICG detected 
it in 29 and the EIA in 28 (Table 23-Table 25). Rotavirus was detected in the same 17 
samples by both antigen detection methods. These, plus all other EIA and ICG 
positive results were confirmed using the RT-PCR. All negative controls tested 
negative using the RT-PCR assay and the EIA and ICG methods. In 2007, all of the 
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RT-PCR positive results were confirmed as positive using the dual-labelled probe-
based RT-PCR. 
Table 23: Comparison of RT-PCR and EIA for the detection of rotavirus. 
 RT-PCR 
EIA Positive Negative 
Positive 28 0 
Negative 30 49 
 
Table 24: Comparison of RT-PCR and ICG for the detection of rotavirus. 
 
RT-PCR 
ICG Positive Negative 
Positive 29 0 
Negative 29 49 
 
Table 25: Comparison of ICG and EIA for the detection of rotavirus. 
 
EIA 
ICG Positive Negative 
Positive 17 12 
Negative 11 67 
 
Comparison Of Multiplex RT-PCR With Commercial EIA For Astrovirus 
Using the multiplex RT-PCR, initial testing of the sample panel provided 
results with numerous non-specific bands that could not be read with confidence 
(Figure 13). At this stage it was not clear if this were due to human error or a more 
serious problem with the robustness of the multiplex RT-PCR. Repeat testing rectified 
the problem so that the results could be examined.  
Following repeat testing the multiplex RT-PCR detected astrovirus in 18 
samples compared to 8 that tested positive using the EIA (Table 26). Astrovirus was 
detected by both tests in 7 cases. The other sample that tested positive for astrovirus 
using the EIA tested negative using the multiplex RT-PCR. 29 samples tested 
negative for astrovirus using both assays. No other viral causes of IID were detected 
in these samples using the multiplex RT-PCR, confirming the findings of the 
singleton assays and the Lightcycler™ RT-PCR. All extra RT-PCR positive results 
were confirmed as positive using the dual-labelled probe-based RT-PCR. The sample 
that tested positive for astrovirus using the EIA assay but negative using the multiplex 
RT-PCR was also found to be negative using the dual-labelled probe-based assay. 
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Figure 13: Example Of Non-Specific Banding Patterns Observed With The Multiplex RT-
PCR. 
 
 
Table 26: Comparison of RT-PCR And EIA For The Detection Of Astrovirus. 
 RT-PCR 
EIA Positive Negative 
Positive 7 1 
Negative 11 29 
4.4.2.4. Study Conclusions 
The results showed that both the rotavirus and the multiplex RT-PCR methods 
were more sensitive than either of the antigen detection methods examined (Gunson et 
al, 2003(iii); Gunson et al, 2003(iv)). Both detected the relevant pathogen in more 
samples than the antigen detection methods (The improved sensitivity of these assays 
was confirmed by re-testing the extra positive samples using real-time PCR in 2007). 
These results are similar to those found for the assessment of the norovirus EIA 
methods in the previous section.  
The poorer sensitivity of the EIA methods meant these were rejected as 
replacements for the existing EM-based service for sporadic cases of IID. However, 
the numerous steps involved in a dual PCR solution together with concerns over the 
robustness of the multiplex RT-PCR (since repeat testing was required in this 
experiment to establish clear result bands) meant that, at this stage, the decision was 
also taken not to proceed with the implementation of the gel-based assays as the 
frontline tests for sporadic cases of IID. EM remained the test employed in routine 
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service until 2004, when dual-labelled probe-based technology was introduced. This 
is described in the following section. 
4.4.3. Developed Gel-Based PCR Methods Vs Dual-Labelled Probe-
Based Real-Time PCR Methods 
As mentioned earlier, in 2003 the WOSSVC implemented a number of PCR 
platforms that could support real-time chemistries such as dual-labelled probes.  
This introduced the possibility of implementing real-time PCR tests for 
adenovirus, astrovirus, rotavirus and sapovirus in the diagnostic service for sporadic 
cases of IID, a two test gel-based PCR solution having previously been rejected on the 
basis of involving too many steps. Commercial antigen detection methods had also 
been rejected due to their limited sensitivity.  
The aim of the third experiment in this series, therefore, was to assess the 
sensitivity of the real-time assays for adenovirus, astrovirus, rotavirus and sapovirus 
selected and developed as described in Chapter 3 in comparison to the two gel-based 
PCR tests. The assays were compared using a number of dilution series and a panel of 
322 stool samples taken from children with clinically diagnosed sporadic IID. The 
dual-labelled probe-based assays were also assessed using the sample specificity 
panel described earlier. 
In 2007, all samples for which the two test types of produced different results 
were re-tested using a number of gel-based PCR methods. These methods were 
chosen because they targeted alternative regions of the viral genome to that targeted 
by the real-time PCR methods. In addition some of these were nested protocols - a 
type of assay that, although rejected for routine use due to the numerous steps 
involved, has been shown to be sensitive. Although confirmatory testing had no effect 
on the service decisions made at the time, it provided reassurance that the correct 
decisions were taken. 
 All discrepant adenovirus results were tested using the assay described by Xu 
et al (Xu et al, 1990). This is a universal adenovirus test that targets an alternative part 
of the hexon region to the others under examination. For astrovirus discrepant results, 
a hemi nested RT-PCR was used that targets the capsid region (Gallimore et al, 2005). 
The assay uses the same primers (mon 269 and mon 270) as described by Noel et al in 
the first round and uses an adapted mon 269 as the internal primer in the second 
nested step. This assay had already been shown to be more sensitive than the single 
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round RT-PCR described by Noel et al. For rotavirus, all discrepant results were 
tested using the nested RT-PCR described by DiStefano et al (Distefano et al, 2005). 
This assay targets the VP7 region of the rotavirus genome. Finally for all sapovirus 
discrepant results, the universal nested RT-PCR described by Okada at al was used 
(Okada et al, 2006). This assay targeted both the RdRp and Capsid region.  
4.4.3.1. Methods 
Sample Panels 
Specificity Panel 
The same specificity panel as used in section 4.4.1.1 was used to assess the 
specificity of the dual-labelled probe-based real-time PCR methods.  
Dilution Series 
In order to establish end point detection limits of each test 8 separate dilution 
series were tested. The following pathogens were represented (each in a separate 
dilution series): rotavirus types G1 and G2; adenovirus types 40 and 41; astrovirus 
types 1 and 3 and sapovirus types G1 (Sapporo/82/JP U65427) and G2 (Bristol/98/UK 
AJ249939). 
Clinical Samples  
A total of 322 faecal specimens were collected from children (aged less than 5 
years) with clinically diagnosed gastroenteritis. All samples were submitted to 
Monklands General District Hospital (MDGH), Lanarkshire by GPs in the 
Lanarkshire area between December 2000 and March 2001. Samples were 
subsequently sent to the WOSSVC for PCR testing. The first phase of the study tested 
all samples using the developed gel-based RT-PCR for rotavirus, the LightcyclerTM 
RT-PCR for norovirus, and the gel-based multiplex RT-PCR assay for adenovirus, 
astrovirus, and sapovirus. Samples were then stored at –70oC. Subsequently (in 2004) 
all samples were tested using the dual-labelled probe-based real-time PCR for 
adenovirus, astrovirus, rotavirus and sapovirus described in Chapter 3. Following this 
second testing, samples were stored at –70oC before confirmatory testing in 2007. 
4.4.3.2. Laboratory Methods 
All samples to be tested using the gel-based and real-time PCR methods were 
processed using the faecal extraction and nucleic acid extraction procedures outlined 
previously. The gel-based RT-PCR technique for the detection of rotavirus and the 
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multiplex RT-PCR assay for astrovirus, adenovirus and sapovirus are described in the 
previous experiment. The dual-labelled probe-based methods for adenovirus, 
astrovirus, rotavirus and sapovirus are described in Chapter 3 (section 3.4.2.3).  
Confirmation PCR Methods 
PCR For Adenovirus 
Extracted DNA (25ul) was amplified using a 25ul volume of the Qiagen PCR 
master mix (Qiagen, Crawley, UK) using primers AD1 and AD2 (both at 50 
pmoles/µl per reaction). The plate was incubated in the Applied Biosystems PCR 
machine using the programme 94oC for 4 min, 40 cycles of: 94oC for 1 min, 54oC for 
45 sec and 72oC for 2 min; followed by a hold step of 72oC for 10 min. Products were 
visualised using agarose gel electrophoresis. For the hexon assay a PCR product of 
482bp was expected if adenovirus was successfully amplified from the sample.  
Nested RT-PCR For Astrovirus 
Extracted RNA (12.5ul) was amplified using a combined one step RT-PCR kit 
(Qiagen, Crawley, UK) using primers Mon 269 and Mon 270 (25 pmoles/ reaction). 
The plate was incubated in the Applied Biosystems PCR machine using the 
programme 50oC for 30 min, 95oC for 15 min and 35 cycles of: 95oC for 40 sec, 45oC 
for 40 sec and 72oC for 1 min. 2ul of first round product was transferred to a 48 ul 
second round reaction (Qiagen) containing primers mon269N (an adapted primer 
internal to mon 269) and mon270 (50 pmoles/reaction). This was then subjected to 40 
cycles of: 94oC for 40 sec, 45oC for 25 sec and 72oC for 1 min 30 sec. This was 
followed by a hold step 72oC for 10 min. Products were visualised using agarose gel 
electrophoresis. A PCR product of 424bp was expected if astrovirus was successfully 
amplified from the sample. 
Nested RT-PCR For Rotavirus 
Extracted RNA (12.5.ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) and the published forward and reverse primers (25 pmoles/ 
reaction). The plate was incubated in the Applied Biosystems PCR machine using the 
programme 50oC for 30 min, 95oC for 15 min and 35 cycles of: 95oC for 40 sec and 
45oC for 40 sec. This was followed by 72oC for 1 min. 2ul of first round product was 
then transferred to a 48 ul second round reaction (Qiagen) containing the published 
internal primers (50 pmoles/reaction) and subjected to 40 cycles of: 94oC for 40 sec, 
45oC for 25 sec and 72oC for 1 min 30 sec. This was followed by a hold step of 72oC 
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for 10 min. Products were visualised using agarose gel electrophoresis. A PCR 
product of 365bp was expected if rotavirus was successfully amplified from the 
sample. 
Nested RT-PCR For Sapovirus 
Extracted RNA (12.5.ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) using primers F13/14 and R13/14 (25 pmoles/reaction). 
The plate was incubated in the Applied Biosystems PCR machine using 50oC for 30 
min, 95oC for 15 min and 25 cycles of: 95oC for 40 sec, 45oC for 40 sec and 72oC for 
1 min. 2ul of first round product was then transferred to a 48 ul second round reaction 
(Qiagen) containing primers F22 and R2 (50 pmoles/reaction) and subjected to 40 
cycles of: 94oC for 40 sec, 45oC for 25 sec and 72oC for 1 min 30 sec. This was 
followed by a hold step of 72oC for 10 min. Products were visualised using agarose 
gel electrophoresis. A PCR product of 420bp was expected if sapovirus was 
successfully amplified from the sample. 
4.4.3.3. Results 
None of the real-time assays detected any of the specificity panel as positive 
indicating that they were specific. 
For each of the dilution series tested the real-time PCR methods were shown 
to have a lower limit of detection than the conventional gel-based (Table 27-Table 
30). For both rotavirus types the real-time RT-PCR assay was shown to be 
approximately 3 log more sensitive. The improvement was by a factor of 1-2 log for 
the real-time RT-PCR for astrovirus types 1 and 3, and for the adenovirus real-time 
PCR it was 1 log. The sapovirus real-time RT-PCR was more sensitive on the G1.1 
dilution series by approximately 2 log (Gunson, Collins and Carman, 2006(i)). 
However, it failed to detect any of the G2.1 dilutions. This was as anticipated based 
on the developmental data reported in Chapter 3, where sequence alignment showed 
the test was unlikely to detected G2 types. 
Results from testing the sample panel showed that the gel-based RT-PCR 
assays detected one or more pathogens in 209 (65.0%) of the 322 faecal samples 
investigated (Table 31). All of these positive results were also detected using the real-
time dual-labelled probe-based methods. In addition, a further 36 viral pathogens were 
detected using the real-time methods. In total therefore, the real-time PCR methods 
detected viral pathogens in 245 samples (76.1%). A viral pathogen could not be 
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detected in 77 faecal specimens using these methods. Greater numbers of positive 
detections were observed for all of the individual real-time PCR tests in comparison to 
the conventional gel-based PCR assays. The greatest increase in detections was 
observed for the rotavirus, adenovirus and astrovirus tests. A smaller number of extra 
positive detections was observed for the dual-labelled probe-based assay for 
sapovirus. In 2007, upon re-testing with the gel-based confirmatory assays, all the 
extra real-time PCR results were confirmed as positive. 
Table 27: Comparison of real-time PCR for adenovirus with multiplex RT-PCR assay on 
an adenovirus dilution series. 
Reat-Time PCR Result Multiplex RT-PCR Result Dilution 
Ad40 Ad41 Ad40 Ad41 
10-1 +  +  + + 
10-2 +  +  + + 
10-3 +  +  + + 
10-4 +  +  + + 
10-5 +  +  + - 
10-6 +  - - - 
10-7 - - - - 
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Table 28: Comparison of real-time RT-PCR for astrovirus with multiplex RT-PCR assay 
on an astrovirus dilution series. 
Reat-Time RT-PCR Result Multiplex RT-PCR Result Dilution 
Astrovirus  
Type 1 
Astrovirus  
Type 3 
Astrovirus  
Type 1 
Astrovirus  
Type 3 
10-1 +  +  + + 
10-2 +  +  + + 
10-3 +  +  + + 
10-4 + +  + - 
10-5 +  +  - - 
10-6 +  - - - 
10-7 +  - - - 
10-8 - - - - 
Table 29: Comparison of real-time RT-PCR for rotavirus with gel-based RT-PCR on a 
rotavirus dilution series. 
Reat-Time RT-PCR Result Gel-Based RT-PCR Result Dilution 
Rotavirus G1 Rotavirus G2 Rotavirus G1 Rotavirus G2 
10-1 +  +  + + 
10-2 +  +  + + 
10-3 +  +  + + 
10-4 +  +  - + 
10-5 +  +  - - 
10-6 +  +  - - 
10-7 - +  - - 
10-8 - - - - 
 
Table 30: Comparison of real-time RT-PCR for sapovirus with multiplex RT-PCR assay 
on a sapovirus dilution series. 
Reat-Time RT-PCR Result Multiplex RT-PCR Assay Result Dilution 
Sapovirus G1.1 Sapovirus G2.1 Sapovirus G1.1 Sapovirus G2.1 
10-1 +  - + + 
10-2 +  - + + 
10-3 +  - + - 
10-4 +  - - - 
10-5 +  - - - 
10-6 - - - - 
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Table 31: Comparison of real-time PCR and gel-based PCR detection rates for 
adenovirus, astrovirus, rotavirus and sapovirus. 
Aetiological IID (s) Gel-Based PCR Reat-Time PCR 
Rotavirus 
     81  (25.2%)     95  (30%) 
Astrovirus 
     70  (21.7%)     82  (25.5%) 
Adenovirus 
     30  (9.3%)     38  (11.8%) 
Sapovirus 
     11  (3.4%)     13  (4.0%) 
Rotavirus and astrovirus 
       8  (2.5%)       8  (2.5%) 
Adenovirus and astrovirus 
       2  (0.6%)       2  (0.6%) 
Adenovirus and rotavirus 
       5  (1.5%)       5  (1.5%) 
Sapovirus and rotavirus 
       1  (0.3%)       1  (0.3%) 
Astrovirus, adenovirus and rotavirus 
       1  (0.3%)       1  (0.3%) 
Total viral pathogens detected 
  209   (65.0%)   245  (76.1%) 
Total negative 
  113  (35.0%)     77  (23.9%) 
Total samples 322 322 
4.4.3.4. Study Conclusions 
The dual-labelled probe-based real-time PCR methods were shown to be 
specific and more sensitive than their conventional gel-based counterparts. The real-
time PCR methods detected more viral pathogens in more samples in the sample panel 
and had a lower end point detection limit in most of the series tested. The increased 
detection rate was confirmed by re-testing with gel-based methods in 2007. 
The only test where real-time PCR was not found to be an improvement was 
the dual-labelled probe-based RT-PCR for sapovirus, which failed to detect the G2.1 
type. This confirms the development data presented in Chapter 3, which showed that 
the primers and probe developed were specific to G1 sapoviruses only and would fail 
to detect sapoviruses from the other genogroups. However, despite this the real-time 
PCR assay detected more cases of sapovirus in the sample panel than the gel-based 
RT-PCR, which detects sapoviruses from several genogroups (G1-3). This suggests 
that G1 types were more common in this panel and that the new dual-labelled probe-
based assay was still useful.  
The 2-test gel-based solution incorporates more steps than using 4 separate 
dual-labelled probe-based methods. For example, to test one sample using both the 
rotavirus RT-PCR and the multiplex RT-PCR would require 7 separate steps 
(including universal steps for stool extraction, nucleic acid extraction and reverse 
transcriptase, together with the PCR steps and agarose-gel analysis steps for each 
assay). To test a single sample using all real-time PCR methods, on the other hand, 
would require 6 separate steps (including universal steps for stool extraction, nucleic 
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acid extraction, and four separate RT-PCR steps for each of the 4 assays). Moreover, 
in the gel-based methods the RT and PCR steps together can take 4-5 hours, compared 
to 1-1.5 hours using the real-time methods. The agarose gel analysis step in addition 
can take 2-3 hours, depending on the number of samples under scrutiny 
The improved sensitivity of the real-time PCR methods, coupled with the 
reduced duration and number of steps involved, resulted in these assays being 
implemented as the frontline tests for the detection of adenovirus, astrovirus, rotavirus 
and sapovirus sporadic cases of IID in November 2004 (and as the secondary tests for 
outbreaks of IID that were negative for norovirus). These methods replaced EM, 
which was retained solely for examining outbreaks classified as negative for all 5 
main viral pathogens using the real-time PCR methods.  
4.5. Experiments Aimed At Improving the Efficiency and Cost Of 
Reat-Time PCR In The Routine Diagnostic Setting 
Based on the research described, from 2004 dual-labelled probe-based real-
time PCR methods have been employed at the WOSSVC as the frontline tests for both 
sporadic cases and outbreaks of IID. In this third section, a number of experiments 
aimed at reducing the turn-around-time of these real-time PCR methods and 
increasing sample throughput are described. Some of these methods are also aimed at 
reducing the cost of carrying out a real-time PCR test. The experiments described 
examined the effect on test sensitivity of variously reducing the length of PCR 
parameters; carrying out DNA PCR under RT-PCR conditions; using pooled positive 
controls; using primer/probe pools and reducing the overall volume of PCR reagents. 
4.5.1. Reducing The PCR Cycling Times 
Most probe-based real-time PCR assays consist of the following steps: a Taq 
DNA polymerase activation step of 95oC for 2-15 minutes (depending on the exact 
Taq DNA polymerase used) and 40-50 cycles of the following steps: a denaturation 
step of 95oC for 15-30 seconds, and an annealing/extension step of 60oC for 60 
seconds. If the target is RNA then a reverse transcriptase step of 50oC for 30 minutes 
is required prior to these steps. Based on these parameters the overall turn-around-
time of most real-time PCR assays ranges from 2-2.5 hours (excluding extraction). 
Any technique that can be used to reduce this duration without affecting the 
sensitivity of the test represents a saving, both in terms of the result turn-around-times 
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and the economic cost of the test (since shorter duration means more efficient use of 
laboratory equipment, allowing more testing within the working day). The aim of this 
first experiment, therefore, was to examine whether the PCR cycling times in the 
implemented tests could be reduced without affecting their sensitivity.  
The dual-labelled probe-based real-time PCR methods for astrovirus, 
adenovirus, norovirus, rotavirus and sapovirus were compared using normal and 
reduced PCR cycling conditions. As a first approximation the cycling times were 
reduced by 50%. The reduced PCR parameters consisted of the following: the RT step 
(where in use) was reduced from 30 minutes to 15 minutes; the denaturation step from 
15 seconds to 8 seconds; and the annealing/extension step was altered from 60 
seconds to 30 seconds. The Taq DNA polymerase activation step was not changed as 
it was felt that this would result in sub-optimal Taq DNA polymerase activity and was 
most likely to reduce sensitivity. 
4.5.1.1. Methods 
The effect of employing different cycling time parameters was assessed using 
(10 fold) dilution panels of adenovirus, astrovirus, norovirus, rotavirus and sapovirus 
positive samples. The cycle thresholds of each dilution and the end point were 
recorded and compared. 
4.5.1.2. Results And Study Conclusions 
The results of this study (Table 32) showed that reducing the duration of the 
reverse transcription, the denaturing and annealing/extension steps by 50% reduced 
the reaction run time of the assay significantly without any concurrent loss in 
sensitivity. Overall the reaction run time was reduced to approximately 60 minutes 
from 100 minutes for DNA real-time PCR, and to 75 minutes from 120 minutes for 
RNA real-time PCR. As a result, the reduced PCR cycling time parameters were 
introduced into the routine service in January 2005. 
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Table 32: Comparison of real-time PCR sensitivity with normal and reduced PCR cycling parameters. 
Adenovirus Ct Value Astrovirus Ct Value Norovirus Ct Value Rotavirus Ct Value Sapovirus Ct Value 
Dilution 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters  
10-1 25.1 25.7 27.1 27.5 22.8 21.9 26.1 25.5 21.7 21.4 
10-2 30.6 29 30.8 30.4 26.3 25.9 28.8 27.5 25.1 24.9 
10-3 33.4 33.6 34.2 34.1 29.8 30.0 32.7 30.4 28.9 29.0 
10-4 - - - - 34.8 33.7 - - 32.8 33.0 
10-5 - - - - - - - - 36.2 37.2 
10-6 - - - - - - - - - - 
TRT 
(mins)  100 60 120 75 120 75 120 75 120 75 
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4.5.2. Simultaneous RNA and DNA Testing 
Where purchased from the same supplier, the kits for most DNA and RNA 
real-time PCR tests contain the same reagents (Taq DNA polymerase, buffers etc.), 
which has the advantage that the same temperature(s) can be used to activate the 
enzymes contained in them. Thus, where the PCR parameters are also the same across 
tests, multiple assays can be processed simultaneously on the same plate. This 
increases the efficiency of platform use and helps reduce sample turn-around-times.  
In the service for sporadic cases of IID, the RNA assays implemented for 
astrovirus, rotavirus and sapovirus employed the same kit and PCR parameters, and as 
a result were routinely processed on the same plate to ensure the platform was always 
used to its maximum capacity. (The norovirus RNA assay employed a different 
annealing temperature and as a result was always carried out separately.) 
The second experiment in this series sought to examine whether the real-time 
DNA assay for adenovirus could also be carried out on the same plate as these RNA 
assays. The adenovirus assay also employed the same reagents and PCR conditions as 
the tests for astrovirus, rotavirus and sapovirus - with the exception that there was no 
RT step. The RT step in this case involved an extra temperature hold of 15 minutes at 
50oC (reduced from 30 minutes following the results of the previous experiment). The 
aim of this experiment, therefore, was to examine whether the adenovirus assay could 
be implemented using these (RNA) conditions without affecting its sensitivity, and 
thus could be carried out at the same time as the RNA assays.  
4.5.2.1. Methods 
A dilution series of an adenovirus-positive control was tested using the 
adenovirus PCR under both DNA and RNA conditions (see section 3.4.2.3 in Chapter 
3). The endpoint Ct value was recorded and compared.  
4.5.2.2. Results And Study Conclusions 
The results of this study (Table 33) showed that the adenovirus assay did not 
suffer any loss in performance when executed using the RNA cycling conditions. As a 
result, from January 2005, where otherwise the platform would be operating at less 
than maximum capacity, the adenovirus test was run simultaneously with those for 
astrovirus, rotavirus and sapovirus under RNA conditions.  
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Table 33: Comparison of adenovirus real-time PCR under DNA and RNA testing 
conditions. 
Dilution Adenovirus PCR Ct  
(Under DNA Conditions) 
Adenovirus PCR Ct  
(Under RNA Conditions) 
10-1 19.8 20.0 
10-2 23.5 23.7 
10-3 26.5 26.7 
10-4 29.9 29.6 
10-5 33.0 33.3 
10-6 36.7 36.8 
4.6. Use Of Pooled Positive Controls 
Positive and negative controls are an essential part of any diagnostic service. A 
positive control i.e. a sample known to be positive for the pathogen of interest (and in 
the case of real-time PCR tests, with a known Ct value) is included in the process 
from sample preparation onwards. In a stable system the test result for this control 
should always be consistent, providing reassurance in each run that the test is working 
properly. This, in turn, increases the confidence in the negative results provided, 
indicating that they are not due to a loss in sensitivity of the assay. 
In the implemented IID service a positive control was included for each 
pathogen that samples could potentially be tested for (6 in total including G1 and G2 
for norovirus). This meant, however, that 6 of the 96 wells in each nucleic extraction 
run were required for positive controls alone. Positive controls were also required on 
the PCR reaction plate(s) for each pathogen tested for on that particular plate.  
The aim of this experiment, therefore, was to examine whether all positive 
controls could be pooled into one tube, thereby freeing up both extraction wells and 
PCR wells for actual clinical samples. Since extraction costs in particular are a 
substantial component of the overall test cost this would, if successful, help reduce the 
cost of the service as well as improving sample throughput and thus turn-around-
times. 
4.6.1.1. Methods 
To make up the pooled control, 6 samples containing variously adenovirus, 
astrovirus, norovirus (G1 and G2), rotavirus and sapovirus were diluted to give a Ct of 
between 28-31. From this, the dilution that would give a Ct value approximately 1 log 
above this value was made. The 6 controls were then added together and the volume 
made up with VTM to make a 1:10 dilution of this (returning the Ct to between 28-
 160 
31). Following this the pooled control was aliquoted into single use vials. In order to 
test its effectiveness, the pooled control was then repeatedly tested over a period of 
time using the relevant PCR assays (from sample preparation onwards) to check that 
the Ct value detected for each pathogen in the pooled control was stable over time. 
The control was tested on the day of manufacture, at week 4, week 8 and week 24, 
and when not in use was stored at –70oC. 
4.6.1.2. Results And Study Conclusions 
Experimental data showed that pooling all positive controls into a single pool 
resulted in a stable control that could reliably be used to monitor a PCR reaction 
(Table 34). As a result pooled controls were implemented in the IID service in 
January 2005.  
Table 34: Effect of using pooled positive controls on test sensitivity. 
 
Adenovirus  
Result   
(Ct) 
Astrovirus  
Result  
(Ct) 
Norovirus  
G1 Result 
(Ct) 
Norovirus  
G2 Result 
(Ct) 
Rotavirus  
Result 
(Ct) 
Sapovirus  
Result 
(Ct) 
Day of Manufacture 29.2 31.2 29.7 31.2 28.2 29.5 
Week 4 29.4 31.8 29.9 31.0 28.6 29.4 
Week 8 29.1 30.9 28.9 31.2 28.9 29.9 
Week 24 30.0 31.4 29.5 31.9 28.3 29.3 
4.7. Use of Primer/Probe Pools 
All PCR methods utilise a number of reagents, which have to be added 
together before use. Although the real-time PCR methods implemented in the IID 
service utilised commercial RNA and DNA kits that have most PCR reagents added 
together in a ready-to-use mix (including buffer, dNTPs, Mg2+ and, in the case of 
DNA mastermixes, Taq Polymerase), the primers, probe and sometimes water still 
had to added separately in addition to the sample and, where appropriate, the RT-PCR 
enzyme. However, the greater the number of pipetting steps there are in a test the 
more likely it is that an error may occur.  
The aim of this experiment, therefore, was to examine whether the necessary 
primers, probes and water for a given assay could be added together in large quantities 
in pre-prepared batches and then frozen, stored and defrosted as required without 
affecting the sensitivity of the test. Batch processing in this way has several potential 
advantages. First, preparing the mastermix, RT enzyme and primer/probe pools in 
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large quantities ensures that the concentrations of each are the same between runs (i.e. 
it facilitates reproducibility). It also reduces the number of steps required in each 
individual run of an assay, thereby reducing the potential for human error and 
speeding up the process. The proposed batches were of 2-3 aliquots, each containing 
enough volume for 24 PCR reactions, and stored at –20oC. 
4.7.1.1. Methods 
The use of primer/probe pools was tested using the dual-labelled probe-based 
assays for adenovirus (an example of a DNA test) and astrovirus (an example of an 
RNA test). First, for each, a positive control was tested using unpooled primers/probes 
(as in the implemented service) to establish a baseline Ct value for the control. 
Following this, batches of the appropriate Mastermix (and RT enzyme in the case of 
astrovirus) were prepared by aliquoting these separately into 24-reaction volumes. 
The relevant primers, probes and water were then also pooled into 24-reaction 
aliquots.  
To test the effect of pooling on test sensitivity the positive control was then re-
tested using the pooled primers/probes to check the Ct value detected was the same as 
in the original test. The primer/probe pools were then stored at –20oC and the process 
repeated at week 4, week 6 and week 8 to examine whether the performance of the 
primer/probe pools was affected by the storage and de-frosting process.  
4.7.1.2. Results And Study Conclusions 
Examination of the Ct values for the astrovirus and adenovirus controls 
showed no difference when tested at baseline, day of manufacture, 4, 6 and 8 weeks 
(Table 35). Use of primer/probe pools did not affect the sensitivity of either test and 
these were equally effective after storage and defrosting. Based on these results the 
use of primer/probe pools for all real-time PCR methods was implemented in January 
2005.  
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Table 35: Effect of using primer/probe pools on test sensitivity. 
 Adenovirus Result 
(Ct value) 
Astrovirus Result 
(Ct value) 
Before Pooling 28.6 31.5 
Day of Manufacture 28.7 31.2 
Week 4 29.0 32.2 
Week 6 27.9 31.5 
Week 8 28.4 30.8 
4.7.2. Reducing The PCR Reagent Volume  
Most published real-time PCR reactions are carried out in 50ul volumes. This 
was also the case in the original implementation of the real-time tests used in the new 
IID service. Reducing this volume could significantly reduce the cost of the test, since 
more tests could then be carried out per commercial kit. The aim of this study, 
therefore, was to examine whether reducing the PCR reaction volume would affect 
test sensitivity.  
4.7.2.1. Method 
The possibility of reducing reagent volumes was examined using the dual-
labelled probe-based assay for adenovirus (as an example of a DNA test) and 
norovirus types G1 and G2 (an example of an RNA test). For each a positive control 
was diluted 10 fold. Each dilution series was then tested in triplicate using PCR 
reaction volumes of 50ul, 25ul and 15ul. The endpoint detection limits of each test 
using the different volumes were then examined to look for any loss in sensitivity. 
4.7.2.2. Results And Study Conclusions 
The results of this experiment showed that reducing the PCR reaction volume 
had no significant effect on the endpoint detection limit of the real-time PCR methods 
examined (Table 36). As a result reaction volumes in the implemented tests were 
reduced from 50ul to 25ul in January 2005 and further to 15ul in January 2007 once it 
was confirmed in routine service that the initial reduction in volume had no 
detrimental effects.  
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Table 36: End point detection limits of tests for adenovirus and norovirus using 
different PCR volumes. 
Adenovirus Result (Ct) Norovirus G1 Result (Ct) Norovirus G2 Result (Ct) 
Dilution 
50ul 25ul 15ul 50ul 25ul 15ul 50ul 25ul 15ul 
10-1 19.2 18.8 19.3 22.1 21.8 22.1 26.2 26.5 25.8 
10-2 22.5 21.8 22.0 25.7 25.4 26.0 29.8 30.0 29.5 
10-3 26.0 25.8 25.9 29.0 29.1 29.4 33.0 34.2 33.5 
10-4 29.3 28.5 29.1 32.4 33.0 33.2 36.2 37.2 38.3 
10-5 33.0 32.9 33.3 36.4 37.2 36.8 - - - 
10-6 37.0 36.2 37.6 - - - - - - 
10-7 - - - - - - - - - 
4.8. Summary 
This chapter presented a series of studies that assessed the sensitivity of the 
PCR methods selected and described in Chapter 3 in relation to possible alternatives 
were adapted for routine diagnostic use. The experiments were split into three parts: 
those concerned with the development of the norovirus outbreak service, those 
relating to the sporadic service, and finally, experiments aimed at improving the 
efficiency of the tests implemented in both services.  
Results from the first experiment relating to the outbreak service showed that 
the SYBR green based Lightcycler™ RT-PCR developed as described in Chapter 3 
was more sensitive than EM for the detection of norovirus, in both samples from 
outbreaks and sporadic cases of IID (Miller, Gunson and Carman, 2002). This method 
was implemented as the frontline test for outbreak samples in January 2001. It was 
subsequently compared to two commercial EIA methods for norovirus and was found 
to be both more sensitive and specific than either (Gunson, Miller and Carman, 
2003(ii)). The Lightcycler™ method was also compared to a recommended gel-based 
RT-PCR that was held to be the most sensitive of the methods available at that time. 
However, although the Lightcycler™ RT-PCR assay was in fact shown to be less 
sensitive it did not miss any outbreaks and, moreover, involved fewer steps (Gunson, 
Miller and Carman, 2003(i)). As a result the decision was taken to retain it as the 
frontline test for norovirus in the outbreak service at this stage. The final experiment 
in this series, carried out in 2003 once the technology became available, showed that 
the new dual-labelled probe-based test for norovirus was also more sensitive than the 
Lightcycler™ RT-PCR, which in this case missed both individual cases and outbreaks 
of norovirus (Gunson and Carman, 2005). The dual-labelled probe-based RT-PCR 
also had the potential to offer better throughput and rapidity. As a result this assay 
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was implemented in 2004 and remains the frontline test for norovirus in the outbreak 
service at the time of writing.  
The initial experiments relating to the sporadic service focused on 
multiplexing the individual tests chosen in Chapter 3 for use in a single multiplex 
assay capable of testing for adenovirus, astrovirus, rotavirus and sapovirus. The result 
was two gel-based assays: a rotavirus RT-PCR and a multiplex RT-PCR for 
adenovirus, astrovirus and sapovirus. Rotavirus could not be included in the multiplex 
since this resulted in a loss in sensitivity in both rotavirus and astrovirus detection. In 
the second experiment the two assays developed were then compared to antigen 
detection methods for astrovirus and rotavirus, and shown to be more sensitive than 
either (Gunson, Collins and Carman, 2006(i)). However, the number and duration of 
the steps required to carry out the two gel-based assays, plus concerns over the 
appearance of non-specific products in the multiplex RT-PCR, meant that these were 
not implemented in the sporadic service at this stage. In the final experiment in this 
series, again carried out once the necessary technology was available, the two gel-
based RT-PCR methods were compared to individual dual-labelled probe-based real-
time PCR assays on dilution series and a panel of clinical samples. In each case the 
dual-labelled probe-based real-time PCR assay detected a lower dilution of pathogen, 
and detected more clinical samples as positive than the relevant gel-based RT-PCR 
assay. The dual-labelled probe-based RT-PCR approach also involved fewer steps and 
had the potential to offer better throughput and rapidity than the EM test still used in 
the routine service. As a result these assays were implemented alongside the norovirus 
RT-PCR in November 2004 in the service for sporadic cases of IID. 
Once dual-labelled probe-based PCR assays were implemented in both the 
outbreak and sporadic services a series of experiments aimed at improving the 
efficiency of these tests was carried out (Gunson, Collins and Carman, 2006(ii)). In 
the first experiment it was shown that reducing PCR cycling times had no effect on 
test sensitivity and improved rapidity. The second experiment showed that the DNA 
test for adenovirus could be carried out under the same conditions (i.e. on the same 
PCR plate) as any of the RNA tests for astrovirus, rotavirus or sapovirus without 
affecting its sensitivity (the norovirus assay involved a different annealing 
temperature to any of the other tests and as a result was always kept separate). Further 
studies then showed that pooled positive controls, primer/probe pools and reduced 
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reagent volumes could all be employed without affecting test performance. Use of 
these measures was therefore implemented in January 2005. 
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Chapter 5  
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Effects Of Introducing The PCR Protocols 
On The Laboratory Diagnostic Service 
5.1. Overview 
 This chapter examines the effects of implementing the PCR assays described 
in the previous chapter as the frontline tests for the investigation of outbreaks and 
sporadic cases of gastroenteritis on the laboratory diagnostic service offered by the 
WOSSVC.   
First, the test monitoring system introduced following implementation of the 
PCR assays is described. The impacts of the changes on the routine laboratory service 
is then examined through the analysis of the WOSSVC laboratory records from 1999-
2006, together with a Scotland-wide survey of laboratory testing protocols for cases of 
IID, which was first carried out in 2004 and updated in 2006. These data are examined 
to determine whether the implementation of the new assays provided any benefits to 
the routine laboratory service in terms of key measures of performance including 
sample throughput, test sensitivity and turn-around-times. Data on each of these 
aspects are presented at key stages during the period of change (1999-2006) and the 
implications for the routine laboratory service are discussed.  
5.2. Introduction 
As a result of the research described in Chapter 4, several changes were made 
to the WOSSVC routine laboratory service (these are summarised in Table 37). This 
chapter examines the effects of these changes on the laboratory service, including the 
need to implement a test monitoring system, and discusses whether or not the changes 
have led to benefits in terms of improved sample throughput, test sensitivity and turn-
around-times.  
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Table 37: Summary of testing protocols for outbreaks and sporadic cases of IID in the 
WOSSVC between 1999-2006. 
Year Outbreaks Of Gastroenteritis Sporadic Cases Of Gastroenteritis In 
Children <10 Years And 
Immunocompromised Patients 
Pre-2001 EM on all stool samples. 
2001-
2003 
LightcyclerTM real-time RT-PCR for 
norovirus introduced in January 2001. 
 
If test result negative, EM. 
EM on all stool samples. 
 
2004 Dual-labelled probe-based real-time RT-
PCR for norovirus introduced in January 
2004. 
 
If test result negative, EM. 
Dual-labelled probe-based real-time RT-PCR 
for rotavirus, astrovirus, adenovirus, norovirus 
and sapovirus introduced in November 2004. 
Once weekly batch testing used.   
2005 Primer/probe pools, reduced cycling times, 
pooled positive controls and reduced PCR 
reagent volumes introduced in January 2005.  
2006 
Primer/probe pools, reduced cycling 
conditions, pooled positive controls and 
reduced PCR reagent volumes 
introduced in January 2005. 
 
If negative, testing for rotavirus, 
astrovirus, adenovirus and sapovirus 
using dual-labelled probe-based real-
time RT-PCR. 
 
If test result negative for all of the above, 
EM. 
Frequency of testing increased to at least three 
times weekly from January 2006. 
5.3. PCR Test Monitoring 
Unlike commercial tests such as EIA, PCR assays developed in the laboratory 
do not have their own quality control systems. As a result, following routine 
implementation of such assays, it is important to monitor the tests carefully to detect 
any contamination, or sudden or long-term loss in sensitivity that could lead to false 
negative or positive results. 
The real-time PCR assays implemented in the new diagnostic service for viral 
causes of IID were monitored in a number of ways. Firstly, positive and negative 
controls were included in each PCR test. For each assay a single positive control was 
included to ensure that the entire testing protocol (including the extraction, reverse 
transcriptase and PCR steps) was optimally sensitive. Initially the positive control 
used in all the PCR assays described here was a sample that had tested positive for the 
pathogen in question using EM and had been diluted to the endpoint detection limit of 
the PCR test. For a run to be passed as valid the positive control had to be detected as 
positive. If the control was found to be negative then the run had to be repeated. 
Subsequently, from 2005, all dual-labelled probe-based real-time PCR assays utilised 
a single positive control containing all viral pathogens to be tested. For a run to be 
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passed as valid the Ct value of the positive control had to fall within a pre-determined 
range (plus or minus three standard deviations from the pre-determined mean, which 
was determined by testing the control at least 20 times). Again, if the control did not 
fall within the pre-determined range then the run was repeated. The Ct of the positive 
control was monitored using Westgard rules, which are designed to detect inter-test 
variation and test drift (Niesters, 2002; Gray et al, 1995; Gray, 1999). 
All PCR runs also included negative controls, which took the form of a viral 
transport medium for every eight extractions. Negative controls were included to 
detect test contamination, which can result in a false positive result. For a PCR run to 
be passed as valid all negative controls had to test negative using the PCR assays.  If 
any of the negative controls tested positive then all samples and controls had to be re-
extracted and the test repeated. 
The real-time PCR assays were also monitored to check for the emergence of 
variant viruses containing nucleotide base changes in the areas of the genome targeted 
by the primers or probes in the test, and which may result in a loss in test sensitivity. 
This is a particular problem in the case of norovirus, rotavirus and sapovirus where 
new variants have been shown to emerge in the past (Lopman et al, 2004; Gallimore 
et al, 2006). For norovirus, the number of negative outbreaks occurring over time was 
measured. An increase in the number of negative outbreaks would suggest that the test 
had become insensitive and may need to be re-designed or replaced by an alternative 
test. For the remaining pathogens, this kind of assessment is more difficult and relied 
upon awareness of the latest developments in the literature.  
5.4. Data Collection 
5.4.1. WOSSVC Laboratory Data (1999-2006) 
All WOSSVC laboratory data for viral gastroenteritis testing from 1999-2006 
was transferred from the routine laboratory record database (Telepath) and 
downloaded into an Excel™ spreadsheet for examination. The data collected for each 
sample included:  
o the patient name and date of birth;  
o the date the sample was received in the laboratory and the date the final 
result was reported (from which the turn-around time can be deduced);  
o the sample origin (e.g. GP, hospital, laboratory or health board);  
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o whether the sample was from a recognised outbreak or was a sporadic case 
of gastroenteritis (this was determined via the clinical details outlined on 
the specimen request form);  
o the test/s carried out and;  
o the final result/s.  
Based on these data, the data for outbreak samples and sporadic samples were 
analysed separately and summary statistics for each year were calculated, including:  
o the total number of samples tested;  
o the total number of positive detections made;  
o the total number of outbreaks confirmed as being caused by norovirus (or 
another pathogen) and the number of outbreaks classified as negative for 
all viral pathogens (outbreak samples only);  
o the turn-around-times for each test/sample (the time taken in days from 
when the sample was received in the laboratory and the date the final result 
was reported); 
o the distribution of Health Boards of origin and;  
o the age distribution of the patients tested.  
These data were then cross-referenced with the changes in the routine service, 
described above and summarised in Error! Reference source not found., in order to 
determine the effects of the changes on each of these aspects.  
The total number of samples tested each year is used as an indicator of the 
usefulness of the tests in place, since increased use suggests that clinicians find the 
test useful. The sample submission data was also compared with the turn-around-
times to examine whether changes in the numbers of samples submissions affected 
test rapidity. Ideally the assays should be able to process large or small numbers of 
samples with little effect on turn-around-times.  
The total number of positive detections achieved for each virus type is a 
measure of sensitivity, and was measured for both outbreak and sporadic samples 
each year. A sensitive test is more likely to provide an etiological diagnosis, which in 
turn will be useful in the clinical and public health setting as the result is more likely 
to influence patient management and infection control. Measuring the number of 
laboratory-confirmed positive and negative outbreaks was used as an additional 
method of assessing test sensitivity. At WOSSVC, an outbreak is confirmed as being 
caused by a particular pathogen if at least two of the submitted samples from a 
 171 
particular location are found to be positive for that pathogen using a laboratory 
method (Richards et al, 2003; Duizer et al, 2007). On the other hand, for an outbreak 
to be classified as negative at least six samples from the same outbreak have to be 
submitted and found to be negative for the pathogen in question.  In either case, more 
than one sample is required before a classification is made in order to reduce the risk 
of false diagnoses. Outbreak samples that do not meet either set of criteria e.g. 
because there are too few, remain unclassified.  Improvements in test sensitivity 
should result in increased positive outbreak classifications while ensuring that the 
number of outbreaks classified as negative remains low.  
The effect of each new test or test amendment on test rapidity was measured 
by measuring the turn-around-times for outbreak and sporadic samples. Ideally turn-
around-times should be as short as possible so that the results can usefully influence 
patient and outbreak management. Test rapidity is particularly important in the 
outbreak setting. 
The sample submission data broken down by health board was examined to 
determine whether the number of health boards using the WOSSVC service increased 
in response to service developments (again, an indication that users are finding the 
service useful).  
The age of the patients from which samples were submitted was also 
examined to determine whether submission patterns had changed in line with the new 
test developments. 
5.4.2. Survey Of Laboratory Methods And Reporting Protocols 
In March 2004, as part of a study examining the effect of laboratory protocols 
on national surveillance systems, a telephone survey was carried out in order to ask 
laboratories to outline their current testing and reporting protocols for viral 
gastroenteritis. In total, 22 laboratories were contacted representing all NHS boards in 
Scotland except Orkney, Shetland, the Western Isles, Fife and the Borders 
(laboratories from these health boards declined to take part). The questions that were 
asked are outlined in Table 38.  
The survey results were used in addition to the laboratory data to determine 
how Scottish microbiology laboratories used the WOSSVC diagnostic service for 
viral IID. This included whether or not any laboratories used the sporadic service 
offered by the WOSSVC on a routine basis and whether the WOSSVC outbreak 
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molecular service was used either as the frontline test for outbreaks of IID or as a 
confirmatory test. 
Information on the types of tests used by the laboratories for both sporadic 
cases and outbreaks of gastroenteritis was then updated in 2006 in order to determine 
whether changes in the WOSSVC diagnostic service had led to service developments 
in other laboratories. 
Table 38: Survey of laboratory testing protocols for sporadic cases and outbreaks of 
viral gastroenteritis.  
Questions 
Do you test for viral pathogens in sporadic cases of IID? 
What viral pathogens do you test for in sporadic cases? 
What age groups do you test in sporadic cases? 
What diagnostic tests do you use in sporadic cases? 
What viral pathogens do you test for in outbreaks of viral gastroenteritis? 
5.5. Results 
5.5.1. WOSSVC Laboratory Data 1999-2006 
5.5.1.1. Total Number Of Samples Tested  
Figure 14 shows the total number of samples tested annually for IID at 
WOSSVC in the period 1999-2006 (incorporating both sporadic and outbreak cases). 
Figure 15 shows the same data but with the figures broken down by the test type 
employed. 
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Figure 14: Total number of IID samples tested (1999-2006). 
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From Figure 14 it can be seen that from 2001 the total number of samples 
tested for IID at the WOSSVC increased, with a sharp peak observed in 2002. This 
increase in sample numbers is likely to be due to the emergence of a new norovirus 
variant (see Chapter 2). The increase continued to be seen year on year. Examining 
this data by sample source (outbreak or sporadic) shows that this increase was largely 
driven by increases in the number of outbreak samples submitted, which from 2001 
made up the majority of the IID samples submitted to the WOSSVC. Samples from 
sporadic cases of IID were similar in all years examined except 2006 where the 
number submitted more than doubled compared to previous years. This increase was 
also due to the emergence of a new norovirus variant (Gallimore et al, 2007). 
 174 
Figure 15: Total number of IID samples tested by test type (1999-2006).   
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Examining this same data by type of test carried out shows that the increase in 
submissions of outbreak samples coincided with the implementation of the 
LightcyclerTM real-time RT-PCR for norovirus as the frontline test for the 
investigation of samples of this type in 2001 (Figure 15). After its implementation the 
number of samples tested from outbreaks of gastroenteritis using the LightcyclerTM 
real-time PCR assay increased in each year. Moreover, the increase in the total 
number of samples tested continued after the implementation of the dual-labelled 
probe-based real-time RT-PCR in 2004.  
The number of sporadic samples tested by EM remained similar in all years of 
its use (1999-2003). The molecular service for sporadic samples was implemented in 
2004. After its implementation, initially the numbers tested were similar to that tested 
by EM. However, in 2006 the number of samples tested from sporadic cases rose to 
over a thousand (N=1147). This was the largest number of submissions in all years of 
the study. Implementation of the new test for sporadic cases of IID also resulted in a 
further drop-off in the number of samples tested using EM, since use of this test was 
now limited to the investigation of PCR negative outbreaks of gastroenteritis. 
 175 
5.5.1.2. Total Number Of Positive Detections  
Figure 16 shows the norovirus detection rate in samples from outbreaks during 
the period 1999-2006. EM was the test used from 1999-2000, the LightcyclerTM real-
time RT-PCR was employed from January 2001, and subsequently, the dual-labelled 
probe-based real-time PCR was introduced in late 2004. Figure 17 shows the total 
number of positive viral detections made from sporadic cases of IID between 1999-
2006. EM was the frontline test for sporadic cases between 1999 and late 2004 and 
dual-labelled probe-based real-time PCR assays replaced EM from November 2004 
onwards. For each figure the percentages shown were calculated relative to the 
number of samples tested using this method in each year.  
Figure 16: Detection rates for norovirus in outbreak samples (1999-2006). 
0
5
10
15
20
25
30
35
40
45
1999 2000 2001 2002 2003 2004 2005 2006
%
 
o
f t
o
ta
l s
am
pl
es
 
po
si
tiv
e
 
Figure 16 shows that using EM, norovirus was detected in between 10-12% of 
all outbreak samples submitted. The results obtained when the LightcyclerTM and 
dual-labelled probe-based real-time RT-PCR were introduced demonstrate a 
substantial improvement on this detection rate, with norovirus identified in between 
28% and 41% of the samples tested. A similar pattern of increased detection was 
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observed for sporadic cases of IID after the implementation of the molecular service 
for samples of this type (Figure 17).  
Figure 17: Detection rate achieved in sporadic samples. 
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Between 1999 and October 2004 for example, when EM was the frontline test 
for sporadic cases of IID, adenovirus was detected in less than 2% of all samples 
tested. When, however, the dual-labelled probe-based real-time PCR service was 
implemented in November 2004 the detection rate for adenovirus rose to 14-22%. 
Similarly, after the implementation of the molecular service the detection rate for 
norovirus in sporadic cases of gastroenteritis increased from 1-7.4% to 12-24%. 
Increases in the detection rate were also observed for astrovirus and sapovirus. 
Rotavirus was the only viral pathogen for which the implementation of PCR did not 
result in a significant improvement in the detection rate. For the years examined the 
detection rates achieved by EM ranged between 1-15% whereas those achieved by 
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dual-labelled probe-based real-time RT-PCR were 0-12%. Overall, however, the 
detection rate in the sporadic setting ranged between 48-52% in the years following 
implementation of the molecular tests. This is significantly higher than that achieved 
with EM, where the overall percentage positive rates varied from just 2-23%. 
5.5.1.3. Total Number Of Outbreaks Confirmed Caused By Norovirus  
Figure 18 shows the number of clinically diagnosed outbreaks of 
gastroenteritis that were confirmed as being caused by norovirus during the period 
1999-2006, together with the number that met the criteria for a norovirus-negative 
outbreak i.e. could not be attributed to norovirus using the tests employed.   
Figure 18: Total number of outbreaks confirmed positive and negative for norovirus. 
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It can be seen from Figure 18 that the number of outbreaks confirmed as being 
caused by norovirus increased considerably after the implementation of the 
LightcyclerTM real-time RT-PCR in 2001. In 1999 and 2000 the numbers of outbreaks 
confirmed by EM as being caused by norovirus were 15 and 16 respectively.  After 
the introduction of the LightcyclerTM real-time RT-PCR in 2001 the number of 
norovirus-positive outbreaks detected quickly increased to 83. Moreover, in each of 
the following five years the number of outbreaks in which norovirus was confirmed as 
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the cause followed an upward trend and exceeded the level detected previously by 
EM. Of note is 2002, in which an exceptionally high number of norovirus-positive 
outbreaks was detected (N=223).  This is likely to have been due to the emergence of 
a new norovirus variant, which in other countries was also associated with a large 
increase in cases and outbreaks of norovirus (Lopman et al, 2004). A large number of 
norovirus outbreaks was also detected in 2006. As shown earlier, this is also 
associated with the emergence of a new norovirus G2.4 variant (Gallimore et al, 
2007). 
Figure 18 also shows that the number of outbreaks that were confirmed 
negative for norovirus has also fallen steadily since the implementation of the 
LightcyclerTM real-time RT-PCR in 2001. In 1999 and 2000 the number of norovirus-
negative outbreaks was 20 and 23 (representing 60% and 55% of all classified 
outbreaks tested by EM).  In 2001 and 2002, the proportion of classified outbreaks 
that tested negative for norovirus using the LightcyclerTM real-time PCR fell to 21% 
and 27%, respectively. From 2003 and after the implementation of the dual-labelled 
probe-based real-time RT-PCR in 2004 the number of norovirus negative outbreaks 
fell to very low levels. In these years the total number of classified outbreaks that 
were confirmed negative for norovirus using PCR was between just 4 and 8 
(representing between 2-8% of all classified outbreaks tested).  
5.5.1.4. Turn-Around-Times  
Figure 19 and Figure 20 summarise the WOSSVC turn-around-times for 
outbreak and sporadic samples between 1999-2006.  
It is clear from these figures that the use of real-time RT-PCR has improved 
the turn-around-times of samples tested both in the outbreak and sporadic setting. For 
example, when EM was the frontline test for outbreaks of gastroenteritis in 1999 and 
2000, 50% of results were reported between 5 to 7 days after arriving in the 
laboratory, whilst 90% were reported between 11 to 13 days after submission (Figure 
19). The implementation of the LightcyclerTM real-time RT-PCR for norovirus from 
2001-2003 resulted in an considerable improvement in these turn-around-times, with 
50% of results available by day 5 after submission and 90% reported by day 8 in all 
years (Figure 20). The implementation of the dual-labelled probe-based real-time RT-
PCR in 2004 resulted in further improvements, with 50% of results reported just 3 
days after submission and 90% of sample results reported by day 6 during this year. A 
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further improvement in turn-around-times was then again observed in 2005 when 
primer/probe pools, reduced PCR cycling times, and pooled positive controls were 
implemented. In this year 50% of results were reported by day 2 and 90% by day 5. 
This improvement was maintained in 2006. 
Examining the turn-around-times for sporadic samples shows that between 
1999 and 2004, use of EM resulted in 50% of samples being processed by days 5 to 9, 
but 90% was not achieved until days 11 to 23. This is longer than that achieved using 
EM for outbreak samples and was despite the fact that, overall, fewer samples were 
tested using EM during this period. In 2004, after the implementation of the molecular 
service, 50% of results were processed by day 3, whilst 90% were reported by day 13. 
However, these figures were achieved on a very small number of samples (n=119). In 
2005, when larger numbers of samples were tested, 50% of results were available by 
day 9 and 90% by day 23. This was slower than when EM testing was employed. In 
2006, however, the numbers of samples of this type submitted to the laboratory 
increased and as a result batch testing was increased to at least three times a week. As 
a result the turn-around-times improved substantially, with 50% of results available 
after day 3 and 90% by day 6. 
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Figure 19: Turn-around-times achieved for outbreak samples (1999-2006). 
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Figure 20: Turn-around-times for samples from sporadic cases of IID (1999-2006). 
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5.5.1.5. Health Board Of Origin 
Figure 21 and Figure 22 show the total number of samples from outbreaks and 
sporadic cases of IID submitted for testing to the WOSSVC during the period 1999-
2006, broken down by health board of origin.  
Figure 21: Total outbreak samples by health board (1999-2006). 
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In total there are fifteen health boards in Scotland. Figure 21 shows that in 
1999 and 2000, when EM was the frontline test for outbreak samples, the WOSSVC 
received outbreak samples from six of these health boards: Aryshire and Arran (AA), 
Argyle and Clyde (AC); Dumfries and Galloway (DG); Forth Valley (FV); Greater 
Glasgow (GG); and Lanarkshire (LN). Lanarkshire and Argyle and Clyde were the 
biggest contributors during this time.  
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Post-2001, when RT-PCR was introduced for norovirus testing in outbreaks, 
two other health boards also submitted substantial numbers of samples: Highlands and 
Islands (HI); and Grampian (GR). Results from the telephone survey (Section 5.5.2) 
show that the laboratories in these two health boards utilised the WOSSVC service as 
either a back up test to EIA or as the frontline test for the investigation of samples 
from outbreaks. Tayside (TY) and the Western Isles (WI) also submitted small 
numbers of samples. Lothian (LO), Fife (FF), the Borders (BR) and Orkney (OR) and 
Shetland (SH) submitted no samples to the WOSSVC during the time period studied. 
This was because these health boards utilised the EM service available in East of 
Scotland Virology Centre in Lothian.  
Figure 22: Total number of sporadic samples by health board (1999-2006). 
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Examination of the samples submitted for sporadic testing shows that from 
1999-2004 samples were received from five health boards: Argyle and Clyde, 
Dumfries and Galloway, Forth Valley, Greater Glasgow and Lanarkshire (Figure 22).  
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From late 2004 when PCR was implemented as the frontline test additional samples 
were also sent from Grampian.  
In 2006 a large increase in sample submissions was observed from Greater 
Glasgow Health Board. Closer examination showed that the majority of these samples 
had been submitted by Bone Marrow Transplant (BMT) wards at the Royal Hospital 
for Sick Children and the Glasgow Royal Infirmary (Figure 23). Both of these wards 
submitted only a few samples between 1999-2005. However, in 2006 both wards sent 
over 300 samples (308 from the GRI unit and 350 from the RHSC). The reasons for 
this are discussed in section 5.6.2. 
Overall, therefore, the number of IID samples submitted for testing to the 
WOSSVC laboratory has increased steadily since the introduction of the first 
molecular tests in 2001, partly as a result of more health boards using the service, and 
partly as a result of those who already do so increasing their usage. 
Figure 23: Number of sporadic samples submitted from the RHSC and GRI bone 
marrow transplant wards (1999-2006). 
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5.5.1.6. Age Of Patients  
Figure 24 and Figure 25 show the total number of samples from outbreaks and 
sporadic cases of IID submitted for testing to the WOSSVC during the period 1999-
2006, broken down by the age of the patient.  
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Figure 24: Total outbreak samples by age group (1999-2006) 
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Examination of the data from outbreak samples shows that, each year, 
although samples were submitted from all age groups the majority were from the 65 
years and over age group (Figure 24). This is in line with the known epidemiology of 
norovirus outbreaks. The data also show that after the norovirus outbreak service was 
introduced in 2001, the large increases in sample submission rates outlined earlier 
have come predominantly from the 65 years and over age group.  
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Figure 25: Total number of sporadic samples by age group (1999-2006). 
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Examining the samples submitted from sporadic cases of gastroenteritis shows 
that the majority of samples in each year were from the under 5 years age group. For 
the period of 1999-October 2004 this is in line with the coding protocol in place at the 
time since the service was only offered on a routine basis for children under 10 years 
of age. After the implementation of the molecular service in November 2004 no 
significant change was observed until 2006 when a large increase in submission was 
observed in the 16-64 year age group. This was largely due to the large increase in 
submissions from the adult BMT patients (outlined in section 5.5.1.5). 
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5.5.2. Survey Of Laboratory Testing Practice 
5.5.2.1. Testing Protocols For Outbreaks Of Viral IID 
In March 2004, three years after the implementation of LightcyclerTM real-
time RT-PCR at the WOSSVC, 20 of the 22 laboratories surveyed (91%) were shown 
to utilise the WOSSVC service for investigating samples from outbreaks of suspected 
viral IID (Table 39). One laboratory (5%) utilised EM and carried out testing for the 
health boards Lothian, Fife, the Borders and Orkney. One other laboratory was found 
to have no protocol for outbreaks of IID (5%).  
Of the laboratories that utilised the WOSSVC outbreak service, 17 (85%) were 
found to use it as their frontline test. These were from the health boards Ayrshire and 
Arran, Argyle and Clyde, Dumfries and Galloway, Highlands and Islands, Forth 
Valley, Greater Glasgow and Lanarkshire.  Three laboratories (15%) used the 
molecular service as a back up to their own testing system. These laboratories carried 
out testing for Grampian and Tayside. In each case norovirus was first tested for using 
an EIA (DAKO Cytomation, Cambridgeshire, UK), which replaced EM during 2003. 
Each stated that samples from all EIA negative outbreaks that tested negative for 
norovirus by EIA were submitted to the WOSSVC for testing by PCR.  
In 2006, laboratories were contacted again by email and asked to outline 
whether their testing policies had changed. Several changes were outlined. In 2005, 
the virus laboratory at Aberdeen Royal Infirmary switched from EIA to real-time RT-
PCR for norovirus as the frontline test for outbreaks of gastroenteritis (the same dual-
labelled probe-based assay as used at the WOSSVC) as the frontline test for outbreaks 
of gastroenteritis.  The laboratories at Ninewells Hospital, Dundee, Perth Royal 
Infirmary, Dumfries Royal Infirmary, Edinburgh Royal Infirmary and Wishaw 
General all stated that they plan to implement this test in their own laboratory as their 
frontline test for outbreaks of gastroenteritis in 2007. 
5.5.2.2. Testing Protocols For Sporadic Viral IID 
The results of the questionnaire (Table 39) showed that in March 2004, 14 
(64%) of the laboratories questioned had their own testing protocol for investigating 
sporadic viral IID. The eight laboratories with no testing protocol (36%) included 
Nuffield Hospital (Greater Glasgow Health Board), Oban (Argyle and Clyde), 
Glasgow Royal Infirmary (Greater Glasgow), Hairmyres Hospital (Lanarkshire), the 
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Western Infirmary (Greater Glasgow), the Southern General Hospital (Greater 
Glasgow), Vale of Leven Hospital (Argyle and Clyde), and Dumfries Royal Infirmary 
(Dumfries and Galloway). No laboratory used the WOSSVC service for sporadic 
cases of IID. 
With regards to the pathogens tested for in the sporadic setting, it was found 
that 10 laboratories tested for rotavirus only (71%). The remaining four laboratories 
tested for rotavirus as well as other non-rotavirus viral pathogens (26%): two of which 
(13%) tested for norovirus, adenovirus and rotavirus and two of which tested for 
adenovirus and rotavirus (13%). No laboratories tested for sapovirus or astrovirus.  
 Of the 14 laboratories with a testing policy, 9 (64%) tested only children (i.e. 
those aged under 5 years) for viral causes of IID whilst two (13%) tested both children 
and elderly patients (65yrs and over).  None of the laboratories tested samples from 
the adult population. Three laboratories (21%) did not state their testing policy with 
regards to the age group tested.  
Overall 13 laboratories used antigen detection methods (93%) for testing 
sporadic samples of IID.  Four laboratories used EIA (26%), three used Latex 
agglutination (20%), and six used ICG (40%).  PAGE was utilised in one laboratory 
(7%). None of the laboratories were using molecular tests for the investigation of 
sporadic IID. 
The laboratories were contacted again in 2006 and asked whether the testing 
service had changed. All laboratories stated that the testing protocol for sporadic cases 
of IID remained the same as in 2004. 
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Table 39: Responses to the questionnaire on laboratory testing practice. 
Outbreak IID Sporadic IID 
Laboratory NHS board What viral pathogens  
tested for? 
Test for viral  
pathogens? 
What viral pathogens  
tested for? 
Age group 
tested? 
Tests 
used? 
Aberdeen Royal Infirmary Grampian Dako EIA for norovirus
a
. If 
negative, norovirus at WOSSVCb Yes Rotavirus, adenovirus Not stated EIA 
Falkirk District Royal Infirmary Forth Valley Norovirus at WOSSVC Yes Rotavirus <5yrs, >65yrs ICG 
Inverclyde Hospital Argyle & Clyde Norovirus at WOSSVC Yes Rotavirus <5yrs, >65 yrs ICG 
Wishaw Hospital Lanarkshire Norovirus at WOSSVCc Yes Rotavirus <5yrs ICG 
Raigmore Infirmary Highl&s & Isl&s Norovirus at WOSSVC Yes Rotavirus <5yrs Latex 
Stirling Royal Infirmary Forth Valley Norovirus at WOSSVC Yes Rotavirus <5yrs ICG 
Ninewells Hospital, Dundee Tayside Dako EIA for norovirus
a
. If 
negative, norovirus at WOSSVCc Yes 
Rotavirus, adenovirus, 
norovirus 
Not stated 
 
EIA 
Perth Royal Infirmary Tayside Dako EIA for norovirus
a
. If 
negative, norovirus at WOSSVCc Yes 
Rotavirus, adenovirus, 
norovirus Not stated EIA 
Monklands District General 
Hospital Lanarkshire Norovirus at WOSSVC Yes Rotavirus <5yrs Latex 
Crosshouse Hospital Ayrshire & Arran Norovirus at WOSSVC Yes Rotavirus <5yrs Latex 
Nuffield Hospital Greater Glasgow None No - - - 
Edinburgh Royal Infirmary Lothian EMc Yes Rotavirus <5yrs PAGE 
Royal Hospital for Sick Children, 
Glasgow Greater Glasgow Norovirus at WOSSVC Yes Rotavirus, adenovirus <5yrs EIA 
Oban Hospital Argyle & Clyde Norovirus at WOSSVC No - - - 
GRI Greater Glasgow Norovirus at WOSSVC No - - - 
Hairmyres Hospital Lanarkshire Norovirus at WOSSVC No - - - 
Western Infirmary Greater Glasgow Norovirus at WOSSVC No - - - 
Southern General Hospital Greater Glasgow Norovirus at WOSSVC No - - - 
Royal Alexandria Hospital Argyle & Clyde Norovirus at WOSSVC Yes Rotavirus <5yrs ICG 
Vale of Leven Hospital Argyle & Clyde Norovirus at WOSSVC No - - - 
Victoria Infirmary Greater Glasgow Norovirus at WOSSVC Yes Rotavirus <5yrs ICG 
Dumfries Royal Infirmary Dumfries & Galloway Norovirus at WOSSVCc No - - - 
a
 EIA implemented in late 2003 in place of EM 
b
 Replaced by dual-labelled probe-based real-time PCR in 2005 (as used at WOSSVC)  
c
 Planned replacement by dual-labelled probe-based real-time PCR in 2007 (as used at WOSSVC) 
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5.6. Discussion 
Since the introduction of molecular tests at WOSSVC for detection of viral 
pathogens in cases of gastroenteritis the number of samples tested by the routine 
diagnostic service has risen steadily, as have the detection rates for each of the main 
viral causes. Furthermore, this has been achieved at the same time as a substantial 
reduction in sample turn-around-times. The reduced turn-around-times were 
maintained despite fluctuations in sample submissions. These improvements in the 
WOSSVC laboratory service have been observed for both outbreaks and sporadic 
cases of gastroenteritis.  
5.6.1. Effects On The Diagnostic Service For Outbreaks Of IID 
The improvements outlined above have been most telling for norovirus 
diagnosis in outbreak samples. Since the implementation of LightcyclerTM real-time 
RT-PCR in 2001, followed by the dual-labelled probe-based real-time RT-PCR in 
2004, there has been a significant increase in the numbers of outbreak samples tested 
at the WOSSVC, with the number continuing to rise each year. The increase in the 
number of samples submitted is due to steadily increasing use by health boards who 
were already using the service pre-2001, together with an increase in the number of 
health boards utilising the service (from 6 to 9), both of which suggest that users find 
the service useful (although the increases in sample submissions will also be a 
reflection of outbreak activity). Laboratories were shown to use the service in two 
ways. The majority of those questioned in 2004 used the WOSSVC norovirus service 
as their frontline test for outbreak samples. A small number at this time (three) utilised 
the service as a back up to their own frontline norovirus test (EIA). From 2007, 
moreover, a number of the laboratories questioned plan to implement the dual-
labelled probe-based real-time RT-PCR for norovirus described in this thesis in their 
own laboratories. This further highlights the usefulness of this test.  
The implementation of the RT-PCR assays for norovirus in samples from 
outbreaks has led to significant improvements in the pathogen detection rate. For 
example, in 1999 and 2000, less than 100 norovirus detections were made using EM.  
After 2001, the number of positive detections increased substantially. Increases in the 
number of outbreaks classified as being caused by norovirus were also seen after 
2001. Although this increase in detection may be a result of a sudden increase in 
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norovirus activity in Scotland in 2001 or improved submission of samples by 
clinicians, it is more likely that this is due to the use of the real-time RT-PCR. The 
ability of the real-time RT-PCR assays to test larger numbers of samples compared to 
EM has no doubt contributed to the increase in the number of detections. However, it 
is the increased sensitivity of the RT-PCR assays that is most important. This can be 
seen when comparing the overall norovirus detection rates for EM and the real-time 
RT-PCR methods. For samples tested by EM, the detection rate was always below 
12%. However, from 2001-2006, when real-time RT-PCR was implemented, the 
detection rate for norovirus in outbreak samples rose to 28-41%. Interestingly, the 
dual-labelled probe-based real-time RT-PCR assay (introduced in 2004) resulted in a 
slightly greater detection rate than the LightcyclerTM real-time RT-PCR assay (28-
41% vs 28-35%). This confirms the increased sensitivity of the dual-labelled probe-
based real-time RT-PCR assay outlined in Chapter 4. The improved sensitivity of the 
PCR assays in comparison to EM can also be seen when examining the annual 
number of outbreaks classified as norovirus negative by the WOSSVC. Using EM, the 
majority of submitted outbreaks tested negative. However, after the implementation of 
RT-PCR the overall number and proportion of negative outbreaks fell. Two phases of 
reduction were observed. The first was seen after the implementation of the 
LightcyclerTM real-time RT-PCR in 2001. A further improvement was observed in 
2004 when the dual-labelled probe-based real-time RT-PCR was implemented, again 
highlighting the improved sensitivity of this assay compared to the LightcyclerTM real-
time RT-PCR. The low and reducing number of negative outbreaks detected in all 
years since 2001 also suggests that the emergence of a new norovirus variant in 2002 
and again in 2006 has had no recognisable effect on either PCR’s sensitivity. 
Despite the increased sensitivity of both the RT-PCR assays, a fairly large 
proportion of the total outbreak samples submitted remained negative for norovirus 
and other viral pathogens. There are several possible explanations for this. Perhaps 
alternative nucleic extraction methods may have increased the detection rate achieved 
in this study. Only one method was used throughout this thesis and it had not been 
compared to other extraction methods (as it was already established for existing PCR 
methodology in the WOSSVC). Some of these may have been due to norovirus types 
that cannot be detected by the RT-PCR assays employed or those that are shed at 
levels below the detection limit of both RT-PCR assays. Vinje et al highlighted that 
the primers utilised by the LightcyclerTM real-time RT-PCR assay failed to detect 
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some G1 and G2 types in the panels tested and, compared to other commonly used 
assays, failed to detect certain norovirus types at a lower limit of detection (Vinje et 
al, 2003). The dual-labelled probe-based real-time assay has also been shown to be 
less sensitive for some G1 and G2 noroviruses (Jolkihumar et al, 2005). Therefore, 
use of other tests may have improved detection further. In addition a number of the 
outbreak samples that tested negative for viral pathogens may have been caused by 
non-viral pathogens and thus were diagnosed accurately. 
Some of the samples may also have been negative due to the presence of PCR 
inhibitors. PCR inhibitors generally exert their effects through direct interaction with 
DNA/RNA or interference with DNA polymerases. The use of an internal control, a 
superior alternative to a positive control, would have provided the capability to detect 
these (Rosenstraus et al, 1998). An internal control is present in each PCR reaction to 
ensure it is working optimally. It is the ideal positive control as it can detect extraction 
failures, PCR inhibition, and technical errors relating to each individual sample (a 
positive control will detect general errors/failures that are assumed to be related to all 
samples at each stage rather than to the individual sample). Several internal control 
systems are described in the literature (Jenson et al, 2004; Neisters et al, 2002; 
Maroufi et al, 2006). Most are separate PCR assays that are multiplexed with the 
diagnostic assay, although some are used as separate assays altogether. (More 
complicated versions also exist where the PCR primers for a particular pathogen also 
contain regions that are weakly complimentary to the internal control. Consequently, 
the primers bind to the internal control in the absence of the pathogen nucleic acid.) 
The internal control target usually takes the form of a non-human virus, an 
oligonucleotide or a plasmid, which is added manually to the sample, extraction or 
PCR mastermix (Tedder et al, 2006; Jenson et al, 2004; Neisters et al, 2002). Some 
systems also target parts of the human genome that should be present in all clinical 
samples (Muller et al, 2007; Whiley et al, 2004). 
Many of the newer automated nucleic acid extraction machines can be adapted 
to add the chosen internal control to all samples during the process of extraction. In 
most cases the internal control is usually added to the lysis buffer, which is then added 
to a “lysis plate” already containing the selected volume of clinical sample. For best 
control, clinical samples should be spiked with an internal control before extraction 
and each diagnostic test should be multiplexed with an internal control assay. 
However, such a system increases the number of pipetting steps involved, prolongs 
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hands-on time and can be difficult to standardise. An internal control was not included 
in this research due to concerns that it would significantly increase testing costs and 
would also increase technician hands-on time in order to spike samples and interpret 
results. However, it is something that is likely to be explored in the near future (see 
Chapter 6).   
A number of samples are also likely to have been sent from an outbreak site 
from patients and HCWs that do not have specific norovirus symptoms but are feeling 
“unwell”. Also, in the hospital and residential home setting, a large number of patients 
are likely to suffer from enteric illness due to non-norovirus causes such as 
incontinence, reaction to medication and changes in diet (Lopman et al, 2002).  
Enteric illness due to these causes is difficult to differentiate from norovirus illness 
and therefore these individuals are likely to have samples submitted for testing. A 
negative test result in such cases is entirely reasonable. A number of the RT-PCR 
negative samples may also be from outbreaks that have tested negative but could not 
be labelled as true negative outbreaks as they did not meet the minimum criteria of six 
submitted samples. 
One of the key objectives in introducing the new tests was the improvement of 
turn-around-times, since EM unlike PCR can be slow as it requires technical expertise 
and has been found unsuited to processing large numbers of samples (Utagawa et al, 
2002). As mentioned previously, a rapid result is more likely to be of use to clinicians 
and public health officials as it will affect patient and outbreak management. The data 
presented here shows that, in fact, this objective has been achieved. Although sample 
numbers have increased significantly since the introduction of RT-PCR for norovirus, 
these have been processed in shorter times than achieved on smaller numbers of 
samples using EM. It should be noted that the turn-around-times calculated included 
weekends, when the laboratory was closed. Also, the endpoint used in the calculation 
was the date the paper report was sent out, which means that the majority of results 
were actually generated the previous day, at least. As a result, the turn-around-times 
for the tests themselves are likely to be shorter than shown.   
For example, when EM was the frontline test for outbreaks, 90% of sample 
results were reported by day 13. In comparison, following implementation of the RT-
PCR assays the same proportion of a larger number of samples was processed in just 
5-8 days (depending on the RT-PCR test used). Furthermore the reductions in turn-
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around-times were maintained despite fluctuations in the sample numbers submitted. 
This shows both real-time PCR methods used for norovirus to be robust. 
Comparing the two RT-PCR assays in routine service, it was shown that the 
dual-labelled probe-based real-time assay resulted in better turn-around-times. Many 
factors contribute to this. Firstly, the dual-labelled probe-based real-time assay utilises 
a one step RT-PCR kit whereas the LightcyclerTM real-time RT-PCR was a two-step 
assay (with separate reverse transcriptase and PCR steps). Fewer technical steps not 
only speeds up the process but also reduces the likelihood of error, which in turn 
results in fewer test repeats and thus reduced turn-around-times. The utilisation of 
such a kit in the LightcyclerTM real-time RT-PCR assay would also have had this 
effect compared to the two-step process. However, during the LightcyclerTM period of 
use an affordable kit of this type was not available. A second reason for the improved 
performance of the dual-labelled probe-based real-time assay is that it can process 96 
samples and controls per run, whereas the LightcyclerTM real-time RT-PCR can 
process only 32 samples and controls. The dual-labelled probe-based real-time assay 
also offers simpler result interpretation in comparison to the LightcyclerTM real-time 
RT-PCR assay (as outlined in Chapter 4). Again, easier interpretation reduces the 
number of repeat tests needed and thus helps reduce turn-around-times.  
A further improvement in turn-around-times was observed after the 
implementation of primer/probe pools, reduced RT-PCR cycling parameters, and 
pooled PCR positive controls in 2005. As outlined in Chapter 4, primer/probe pools 
are aliquots containing pre-optimised primer and probe. These are stored in 24-
reaction aliquots at –20oC. The associated mastermix and enzyme are also stored in 
24-reaction aliquots at –20oC. Depending upon the amount of tests to be carried out, 
the desired number of aliquots are defrosted and then added together with a minimum 
of pipetting, therefore increasing the ease and speed of the setup process and reducing 
the risk of errors. In addition to this, the use of reduced RT-PCR cycling parameters 
was shown in Chapter 4 to halve the time required to carry out each step of the RT-
PCR process compared to the manufacturer’s estimate (with the exception of the Taq 
activation phase which remains as the manufacturers describe). As a result DNA and 
RNA testing times are significantly reduced (by 30-40 minutes) and more test runs 
can be carried out in the laboratory each day. Pooled positive controls allow more 
samples to be processed per run, therefore improving throughput and rapidity. These 
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amendments therefore contributed to the reduction in turn-around-times observed in 
2005 and 2006.  
5.6.2. Effects On The Diagnostic Service For Sporadic Cases Of IID 
Similar improvements to those described above for the norovirus outbreak 
testing service were also observed for the testing of sporadic cases of gastroenteritis 
(although some caution should be applied in interpreting these results, since the time 
period involved since the introduction of these tests has been relatively short). The 
dual-labelled probe-based real-time PCR assays, which test for the five main causes of 
IID, were implemented in November 2004. In 2005 similar numbers of samples were 
tested as when EM was employed. However a large increase in sample submission 
was observed in 2006. Although this may be partly the result of increased disease 
activity in the community it is also likely to be due to increasing awareness of the 
utility of the service, especially in local BMT units (this is discussed further below). 
As with the norovirus outbreak service, the increased submission rates suggest users 
find the service useful. 
When compared to the norovirus outbreak diagnostic service, it was found that 
fewer health boards use the sporadic service on a routine basis. This may be partly 
due to the fact that the service is fairly recent in nature. However, it is more probably 
due to the fact that most laboratories already have their own testing protocol for 
sporadic cases of gastroenteritis. This was indicated by the results of the laboratory 
survey, which highlighted that 64% of the laboratories questioned had an in-house 
testing service in place for sporadic gastroenteritis. In most cases laboratories tested 
for rotavirus only. As a result the other viral causes of sporadic IID are largely 
untested for, despite increasing evidence, confirmed by the results shown here, that 
these are common causes of illness. Examination of the health boards that did use the 
WOSSVC molecular service in each year suggests the service is mainly used by 
laboratories with no testing protocol for sporadic gastroenteritis of their own 
(although this was not explicitly asked in the questionnaire). These included the 
following health boards: Argyle and Clyde, Dumfries and Galloway, Greater Glasgow 
and Lanarkshire.  
In 2006, most health boards submitted the same or slightly fewer sporadic 
samples than observed in 2005. The substantial increase in total sample numbers 
observed in 2006 originated primarily from Greater Glasgow health board. This was 
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the result of a sharp increase in the number of samples being sent from the BMT ward 
at the Royal Hospital for Sick Children and the equivalent adult ward at Glasgow 
Royal Infirmary. Anecdotal evidence from clinicians working at these units suggests 
that they first became aware of the new test’s availability at WOSSVC in 2006 and 
would have made use of the service had they been aware of it in previous years 
(Personal communication, Dr Balfour, RHSC). Also during 2006, there were 
occurrences of both outbreaks and sporadic cases of norovirus in each environment, 
affecting multiple patients and causing long term shedding in a number of those 
affected. Several patients with long term shedding suffered prolonged isolation and 
illness and may also have subsequently infected other patients. Patients, on the other 
hand, who were sent home to recover posed an infectious risk to family members and 
others (e.g. school pupils). Similar problems were also observed with occurrences of 
rotavirus, adenovirus, and astrovirus. One patient died as of a result of a disseminated 
adenovirus group F infection. Molecular methods are particularly useful in this setting 
as virus from immunocompromised patients is often shed at low levels, which other 
methods find difficult to detect. RT-PCR is more likely to detect those infected and 
can do so earlier than either EM or EIA (Cubitt et al, 1997). The increased sensitivity 
also decreases the likelihood of false negative results, which might otherwise lead to 
an infected patient remaining on the ward, causing further infections.  
As a result of these issues, both wards began to screen all patients with 
diarrhoea in order to distinguish viral infection from other causes (e.g. other 
pathogens or issues relating to the management of the transplant) and to isolate those 
with infection from other patients. Increased monitoring of infected patients also 
occurred in order to determine when shedding, and therefore the presumed infection 
or infectiousness, had stopped. Thus, in 2006, although the Royal Hospital for Sick 
Children already has an EIA-based service for investigating cases of gastroenteritis, 
the BMT ward chose largely to bypass this service in favour of the molecular test 
employed at WOSSVC - highlighting its usefulness. The awareness demonstrated by 
clinicians at these units of the problems caused by viral IID in BMT patients, together 
with their recently acquired awareness of the WOSSVC molecular service is likely to 
result in further use of the service in future years.  
Compared to the data obtained when using EM, the detection rates for most 
pathogens in sporadic samples showed significant increases when dual-labelled probe-
based real-time PCR was implemented. These increased detection rates have led to an 
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increase in the overall detection rate. When EM was the frontline test the overall 
detection rate was between 2-23% whereas using the dual-labelled probe-based real-
time PCR the figure was between 48-52%. Again this shows the increased sensitivity 
of the real-time PCR assays when compared to EM and confirms the findings 
described in Chapter 4 and published in the literature. The most significant increases 
were observed for adenovirus and norovirus, which were the most common pathogens 
detected in the sporadic setting. Adenovirus has long been recognised as a common 
cause of sporadic gastroenteritis. However, these data also confirm other more 
recently published accounts that indicate norovirus is also a common cause of 
gastroenteritis in the sporadic setting (Oh, Gaedicke, Schreier, 2003; Kirkwood and 
Bishop, 2001; Simpson et al, 2003; McIver et al, 2001; Subekti et al, 2002; Qiao et 
al, 1999; Phan et al, 2004; Bereciartu, Bok, Gomez, 2002; Sakai et al, 2001; Boga et 
al, 2004; Rodriguez-Baez et al, 2002; Phan et al, 2005; Buesa et al, 2002; de Wit et 
al, 2001; Bonn et al, 1999; Farkas et al, 2000; Pang et al, 2000; Froggatt et al, 2004; 
Chikhi-Brachet et al, 2002; Simpson et al, 2003; Fretz et al, 2005).  
Although the detection rates for astrovirus and sapovirus in sporadic samples 
remained small, increases were observed after the implementation of the dual-labelled 
probe-based real-time PCR assays in comparison to the EM test used previously. At 
the time of writing none of the laboratories questioned use either EM or a molecular 
method to test cases of sporadic gastroenteritis, which means that the WOSSVC is the 
only laboratory currently able to test for these pathogens.  
The benefits of dual-labelled probe-based real-time PCR assays in testing for 
adenovirus, astrovirus, norovirus and sapovirus are therefore clear. However, the 
utility of the assay for rotavirus is questionable based on the evidence shown, as 
detection rates for this pathogen did not significantly improve compared to when EM 
was used (1-15% vs 0-12%). This lack of improvement in detection rate may be due 
to the fact that most of those seeking medical attention for rotavirus infection shed 
virus at levels that are equally detectable by both EM and RT-PCR (Kang et al, 2004). 
The low number of rotavirus detections overall compared to norovirus and adenovirus 
moreover, may be explained by the fact that some of the laboratories that use the 
service already screen sporadic samples for rotavirus before deciding whether or not 
to send them to the WOSSVC. The assay remains useful however, for those health 
boards that do not have a sporadic testing service, and is also likely to prove valuable 
for detecting rotavirus in the BMT setting. 
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Samples from sporadic cases of IID that did not test positive for any viral 
pathogens are likely to result from a number of factors. Some are likely to contain 
PCR inhibitors and may therefore have been falsely classified as negative. Some are 
also likely to be from patients with intestinal illness due to other infectious causes 
(e.g. bacterial or parasitic infections, or other viral pathogens such as rotavirus C and 
enterovirus). Some cases may be due to viral infections that are not detected by the 
assays used (e.g. non-predominant noroviruses). For example, the sapovirus real-time 
RT-PCR assay is likely to miss any non-G1 sapoviruses. Perhaps using an alternative 
extraction protocol may also improve detection rates of all pathogens. Patients with 
non-infectious causes of illness may also contribute to the proportion of sporadic 
samples that tested negative for viral pathogens.  
As with the diagnostic service for IID outbreaks, utilisation of the RT-PCR 
assays for sporadic cases of gastroenteritis has allowed more samples to be tested with 
reduced turn-around-times. When EM was the frontline test 50% of samples were 
reported by day 5-9, whilst 90% were reported by day 11-23. Initially, the results for 
the replacement RT-PCR assays were disappointing, with once-weekly batch testing 
leading to prolonged turn-around-times (with 90% of results not reported until day 23) 
since samples that needed repeat testing had to wait another week before this could 
take place. However, as the sample numbers increased testing was increased in 
frequency to at least three times a week. As a result turn-around-times improved 
significantly, and in 2006 90% of samples were reported by day 6. 
5.7. Summary 
Chapter 5 examined real effects of implementing the developed PCR assays as 
the frontline tests for the investigation of outbreaks and sporadic cases of 
gastroenteritis on the laboratory diagnostic service offered by the WOSSVC. The 
results showed that since the introduction of molecular tests in the laboratory for the 
detection of viral pathogens in cases of gastroenteritis the number of samples tested 
by the routine diagnostic service has risen steadily, as have the detection rates for each 
of the main viral causes. Furthermore, this has been achieved at the same time as a 
substantial reduction in sample turn-around-times. The reduced turn-around-times 
were maintained despite fluctuations in sample submissions. These improvements in 
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the WOSSVC laboratory service have been observed for both outbreaks and sporadic 
cases of gastroenteritis.  
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Chapter 6  
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Discussion 
6.1. Summary Of Research 
The research in this thesis sought to advance knowledge in the field of public 
health by developing and assessing PCR methods for the detection of viral causes of 
IID in a routine diagnostic setting, an approach that distinguishes it from previous 
work in this area. 
As described in Chapter 2, outbreaks and sporadic cases of Infectious 
Intestinal Disease (IID) are a major public health issue, resulting in significant 
morbidity and sometimes mortality every year. Viral pathogens have been shown to 
be responsible for a significant proportion of the IID burden, particularly in sporadic 
cases in children and outbreaks in all age groups.  
Laboratory diagnosis of viral IID is important, as the aetiological causes of IID 
(bacteria, parasites or viruses) cannot be differentiated based on clinical or 
epidemiological data alone. Before this research began, Electron Microscopy or EM 
was the frontline method used at the West of Scotland Specialist Virology Centre 
(WOSSVC) for the diagnosis of viral causes of IID in samples from both outbreaks 
and sporadic cases of IID. However, although rapid on a small number of samples, 
this test has limited sensitivity compared to other emerging techniques and is 
laborious, requiring highly specialised staff and expensive equipment. Alternative 
methods of detection include antigen detection methods. These offer similar 
sensitivity to EM but in comparison have the potential for improved rapidity, ease of 
use and throughput. These methods, however, are not available for all the main viral 
causes of IID.  
In recent years, the molecular method Polymerase Chain Reaction (PCR) has 
been increasingly used in research on the main causes of viral IID. PCR assays are not 
currently offered by commercial companies but have been found to be more sensitive 
than either EM or antigen detection methods. However, conventional gel-based PCR 
methods can be expensive to implement and are technically complex, consisting of 
numerous steps. As a result, in the past these have not been considered suitable for use 
in the routine diagnostic setting, where the ideal test is one that is not only sensitive 
but also rapid, high throughput, and easy to use.  
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Real-time PCR has the potential to overcome many of the pitfalls associated 
with gel-based methods. Using this technique, for example, all or the majority of the 
numerous steps associated with PCR can be carried out in a single step. The relatively 
recent nature of the technology, however, means that the choice of assays of this type 
is limited and, prior to this research, there were no examples of its use in a diagnostic 
setting.   
The overall aim of this research was therefore to examine whether PCR 
methods could be adapted for use in the routine diagnostic setting and, in comparison 
to the EM-based service, bring significant benefits to the laboratory service in terms 
of increased detection rate and throughput, and reduced turn-around-times.  
Based on a review of the literature (see Chapter 2) the decision was taken to 
divide the proposed new service into two parts: a separate service for samples from 
outbreaks of gastroenteritis and one for those from sporadic cases of IID. For the 
outbreak service, a norovirus assay was chosen as the frontline test for sample 
investigation, based on an increasing number of reports showing norovirus to be the 
principle cause of outbreaks of IID. For the sporadic service, the decision was taken to 
employ this same norovirus assay together with PCR tests for adenovirus, astrovirus, 
rotavirus and sapovirus to investigate sporadic cases of gastroenteritis in children 
under 10 years of age and immunocompromised patients (the patient groups already 
tested using the EM-based service) since these viral pathogens have been shown to 
contribute significantly to IID in children and can cause severe and chronic infection 
in immunocompromised individuals of all age groups. In the case of the outbreak 
service, moreover, it was decided that samples that tested negative for norovirus 
should be examined further using the tests for the other non-norovirus pathogens.  
Following this, the PCR and associated methods for use in the proposed 
service were chosen and adapted as described in Chapter 3. In each case a review of 
the available methods was conducted and an appropriate test selected for each 
pathogen based on a combination of clinical and laboratory requirements. In selecting 
an appropriate test evidence of its sensitivity and specificity was key (including the 
ability to detect a wide range of virus subtypes). However, other factors also played a 
important part. Based on the desire to use the test in a routine setting, for example, 
preference was given to single round assays over nested techniques in order to 
minimise test complexity and length (and hence the potential for error). Priority was 
also given to tests that targeted the most conserved regions of the virus, in order to 
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minimise the risk of sensitivity drift over time and/or sudden loss of sensitivity due to 
the emergence of a new virus type or subtype, which is more likely when targeting 
more variable areas of the genome. 
With regards the outbreak service there were two phases of development. In 
2000, when the initial developments took place, there were no real-time PCR methods 
for the detection of norovirus available in the literature. The early work, therefore, 
sought to adapt a published gel-based method (Green et al, 1995) into real-time 
format in order to increase its potential for rapid turn-around-times, and by 
association, high throughput, since speed is particularly important in an outbreak 
setting where rapid results may inform decisions on the infection control procedures 
to be used. The novel real-time assay was developed using SYBR green technology, 
which was the predominant real-time technology available at the time, and was 
implemented on the Lightcycler™ RT-PCR platform, which was one of only two 
PCR platforms available in the laboratory, the other being a conventional PCR block 
(the ABI 9700).  
From 2003, several other real-time PCR platforms were obtained by the 
laboratory, which can be used for other real-time PCR chemistries including dual-
labelled probes. Such chemistries use an additional probe, which specifically binds to 
the PCR product and fluoresces in direct relation to the amount of PCR product being 
produced. The use of a probe increases the specificity of the assay in comparison to 
SYBR green based methods, which bind to all dsDNA. Compared to the 
Lightcycler™ platform, these platforms also offer improved throughput. 
Consequently, from this point on, the research focused on developing a real-time PCR 
assay for norovirus that used dual-labelled probe-based technology. The assay 
described by Kageyama et al was chosen for investigation (Kageyama et al, 2003). 
The original publication used separate RT-PCR assays to detect G1 and G2 norovirus 
types. Here, as a further development the assays were multiplexed in an attempt to 
improve rapidity, throughput and reduce testing costs. 
As with the outbreak service, the research relating to the sporadic service also 
took place in two stages. The first development phase took place between 2000 and 
2002. The aim of the initial studies was to develop a novel gel-based multiplex RT-
PCR assay for adenovirus, astrovirus, rotavirus and sapovirus. The assays chosen to 
be multiplexed were all single round PCR assays selected from the published 
literature (Gentsch et al, 1992; Rasool et al, 2002; Cooper et al, 1999; Vinje et al, 
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2000; Noel et al, 1995). Multiplexing was attempted in order to reduce the number of 
steps involved in the testing process and thus improve rapidity, ease of use and 
throughput (as well as reducing costs). Real-time PCR methods were not considered 
at this time since the decision had been taken to prioritise use of the only available 
real-time platform in the laboratory for use in the norovirus outbreak service.  
In 2003, when the other real-time platforms became available in the laboratory 
the possibility of implementing real-time PCR for all tests in the sporadic service was 
examined. Here the decision was taken to move straight to dual-labelled probed-based 
technology, rather than SYBR green based assays, in line with the ongoing 
developments in tests for the outbreak service. Where possible these assays were 
chosen from the literature (Pang et al, 2004; Le Cann et al, 2004; Heim et al, 2003). 
However, no such assay was available for sapovirus and thus a novel in-house method 
was designed (Gunson, Collins and Carman, 2006(i)). The new method detected 
sapovirus G1 types only. However, although it was known that this test would miss 
non-G1 types, data from the HPA and other studies suggested that this was 
reasonable, given that sapovirus G1 types were the most predominant strains pre-2004 
(Okada et al, 2002; Gallimore et al, 2006). 
Following selection and adaptation of the appropriate tests a series of studies 
was then carried out to assess the sensitivity of each assay in comparison to existing 
and possible alternative methods (see Chapter 4). Results from the first experiment 
relating to the outbreak service showed that the SYBR green based Lightcycler™ RT-
PCR assay developed as described in Chapter 3 was more sensitive than EM for the 
detection of norovirus, in both samples from outbreaks and sporadic cases of IID 
(Miller, Gunson and Carman, 2002). This was the first real-time RT-PCR for 
norovirus to be published at the time and was implemented as the routine test for 
outbreak samples in the WOSSVC laboratory in January 2001. It was subsequently 
compared to two commercial EIA methods for norovirus and was found to be both 
more sensitive and specific than either (Gunson, Miller and Carman, 2003(ii)). This 
study was one of the first to show the relatively poor sensitivity and specificity of the 
EIA methods, findings that have subsequently been confirmed in other studies 
(Wilhelmi et al, 2007; Castriciano et al, 2007; Dimitriadis, Bruggink and Marshall, 
2006; Dimitriadis and Marshall, 2005). The Lightcycler™ method was also compared 
to a recommended gel-based RT-PCR that was held to be the most sensitive of the 
gel-based methods available at that time (Vinje et al, 2003). However, although the 
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Lightcycler™ RT-PCR assay was indeed shown to be less sensitive it did not miss 
any outbreaks and, moreover, involved fewer and shorter steps than the gel-based 
assay (Gunson, Miller and Carman, 2003 (i)). As a result the decision was taken to 
retain it as the frontline test for norovirus in the outbreak service at this stage.  
The final experiment in this series, carried out in 2003 once the relevant 
technology became available, showed that the new multiplexed dual-labelled probe-
based assay for norovirus (based on the test published by Kageyama et al, 2003) was 
also more sensitive than the Lightcycler™ RT-PCR, which in this case missed both 
individual cases and outbreaks of norovirus. The dual-labelled probe-based RT-PCR 
also had the potential to offer better throughput and rapidity than the Lightcycler™ 
test. As a result it was implemented in 2004 and remains the frontline test for 
norovirus in the outbreak service at the time of writing.  
The initial experiment for the sporadic service focused on multiplexing the 
individual assays for adenovirus, astrovirus, rotavirus and sapovirus chosen and 
adapted as described in Chapter 3. The results, however, showed that the rotavirus 
RT-PCR could not be successfully multiplexed as the primers interacted with and 
reduced the sensitivity of the astrovirus and sapovirus RT-PCR assays. Instead, the 
multiplexing process resulted in two RT-PCR assays: a rotavirus RT-PCR and a novel 
multiplex RT-PCR for adenovirus, astrovirus and sapovirus. 
The two assays developed were then compared to antigen detection methods 
for astrovirus and rotavirus, and shown to be more sensitive than either (Gunson et al, 
2003(iii), Gunson et al, 2003(iv)). However, the number of steps involved in carrying 
out the two gel-based assays plus concerns over the appearance of non-specific 
products in the multiplex RT-PCR meant that these were not implemented in the 
sporadic service at this stage. 
In the final experiment in this series, again carried out once the technology 
became available, the two gel-based RT-PCR methods were compared to the dual-
labelled probe-based real-time PCR assays selected (or developed in the case of 
sapovirus) as described in Chapter 3. The results showed that for each pathogen the 
real-time PCR assay detected a lower dilution of pathogen and identified more clinical 
samples as positive than the relevant gel-based assay (Gunson and Carman, 2005). 
The dual-labelled probe-based approach also involved fewer, shorter steps and had the 
potential to offer better throughput and rapidity than the EM test still in use in the 
routine service at this time. As a result these assays were implemented in the service 
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for sporadic cases of IID in November 2004, alongside the dual-labelled probe-based 
norovirus RT-PCR. From this date EM was used solely to investigate outbreaks that 
tested negative for a viral pathogen using all of the PCR methods available. 
Following implementation of the dual-labelled probe-based real-time PCR 
methods in the routine service a number of experiments were carried out that 
attempted to further modify these tests in order to reduce turn-around-times, improve 
throughput and reduce cost (see Chapter 4). In the first experiment it was shown that 
reducing PCR cycling times had no effect on test sensitivity and improved rapidity 
considerably (e.g. reducing turn-around-times from 100 minutes to 60 minutes). The 
second experiment showed that the test for adenovirus, a DNA test, could be carried 
out under the same conditions (i.e. on the same PCR plate) as any of the RNA tests for 
astrovirus, rotavirus or sapovirus without affecting its sensitivity, thus allowing more 
tests to be carried out per PCR run. (The norovirus assay involved a different 
annealing temperature to any of the other tests and as a result was always kept 
separate). Further studies then showed that pooled positive controls, primer/probe 
pools and reduced reagent volumes could all be employed without affecting test 
performance, thereby improving test efficiency (Gunson, Collins and Carman, 
2006(ii)). Use of these measures was therefore implemented in January 2005.  
The effect of implementing the various changes on the WOSSVC laboratory 
diagnostic service for IID was then examined, as described in Chapter 5. Sample 
submission data from the period 1999-2006 showed that since the introduction of 
molecular tests for the detection of viral pathogens in cases of gastroenteritis the 
number of samples tested by the routine diagnostic service has risen steadily. In 1999, 
when EM was the frontline test, a total of 887 IID samples from outbreaks and 668 
from sporadic cases were submitted for testing at the WOSSVC. In the years 
following implementation of the LightcylerTM real-time assay for norovirus in the 
outbreak service the number of outbreak samples tested rose to between 1112-4025 
(the latter figure a peak in activity due the emergence of a new worldwide variant of 
norovirus in 2002). The rise in the number of outbreak samples tested continued 
following implementation of the dual-labelled probe-based assay in 2004, from 2033 
to 3189 in 2006. Similar patterns were observed in the submission rates for samples 
from sporadic cases of IID, although some caution should be applied in interpreting 
the results for this service since the time period involved since the introduction of the 
new tests has been relatively short. In 1999, a total of 668 samples from sporadic 
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cases were tested, rising to 1153 in 2006 following introduction of real-time PCR tests 
to the sporadic service. The increased use of the service reflects greater use of the 
service by existing users (health boards), an increasing number of health boards 
submitting samples to the laboratory for diagnosis, and an increase in sample 
submission from immunocompromised patients and adult patients.  
In addition to increased submission rates, the detection rates in the routine 
service have risen for all viral pathogens following implementation of the PCR 
methods, in both outbreaks and sporadic cases of gastroenteritis. For example, for 
samples submitted from outbreaks of IID the norovirus detection rate achieved by EM 
was always below 12%. However, from 2001-2003, when the Lightcycler™ RT-PCR 
was the frontline test, the detection rate was between 28-35%. A slight further 
improvement in detection rate was observed after the implementation of the dual-
labelled probe-based real-time RT-PCR assay in 2004, with a detection rate of 
between 28-41%. The improved detection rate resulted in an increase in the number of 
outbreaks confirmed to be caused by norovirus, from a total of 15 and 16 in the years 
1999 and 2000 respectively, compared to between 83-223 in the 6 years post-
implementation of the PCR-based service. Similar improvements were observed after 
the implementation of the PCR service for sporadic cases of IID. For example, in the 
years when EM was the frontline test the overall detection rate was between 2-23%, 
whereas following implementation of the real-time PCR assays the figure was 
between 48-52%.  
These improvements, moreover, were achieved at the same time as a 
substantial reduction in sample turn-around-times. For example, when EM was the 
frontline test for outbreaks of gastroenteritis in 1999 and 2000, 50% of results were 
reported between 5 to 7 days after arriving in the laboratory, whilst 90% were 
reported between 11 to 13 days after submission. Following implementation of the 
LightcyclerTM real-time RT-PCR for norovirus in the period 2001-2003 a considerable 
improvement in these turn-around-times was observed, with 50% of results available 
by day 5 and 90% reported by day 8 in each of these years. The implementation of the 
dual-`labelled probe-based real-time RT-PCR in 2004 resulted in further 
improvements, with 50% of outbreak results reported just 3 days after submission and 
90% of sample results reported by day 6 during this year. These reduced turn-around-
times were maintained despite fluctuations in sample submissions. Finally, the 
implementation of the test amendments, e.g. pooled controls, in 2005 saw further 
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reductions in outbreak sample turn-around-times. The final outcome was that at the 
time of writing 50% of outbreak sample results are reported by day 2 with 90% 
reported by day 5 (this was achieved in two consecutive years) compared to best 
results of day 5 and day 11 respectively when EM was the frontline test for outbreaks.  
Similar improvements in turn-around-times were observed for samples from 
sporadic cases IID. For example, between 1999 and 2004, use of EM resulted in 50% 
of samples being processed by days 5 to 9, but 90% was not achieved until days 11 to 
23. At first, use of the new PCR-based service resulted in similar turn-around-times in 
2005 (50% of results were available by day 9 and 90% by day 23). In 2006, however, 
the numbers of samples of this type submitted to the laboratory increased and as a 
result batch testing was increased to at least three times a week. This, together with 
the test amendments outlined above led to a substantial improvement in turn-around-
times, with 50% of results available after day 3 and 90% by day 6. 
6.2. Main Findings 
In conclusion, the implementation of a molecular diagnostic service for viral 
causes of IID at the WOSSVC has enabled more stool samples to be tested in shorter 
periods of time, using more sensitive tests than any previously available.  
Whilst it is possible that some of the increases in sample submission and 
detection rate observed for the PCR-based service were due to increased disease 
activity in the years examined, the size and consistency of the increases over a period 
of several years suggests this was not the determining factor. Moreover, the 
possibility that PCR techniques may be over-sensitive (discussed in Chapter 2) - 
detecting asymptomatic IID or prolonged shedding following resolution of symptoms 
in a minority of cases - is less likely to apply in the routine diagnostic setting, where 
samples are only tested as a result of patients presenting with the symptoms of IID. In 
any case, the detection of prolonged or asymptomatic shedding in patients may still be 
of value in this context, since these patients may pose an infectious risk to others. This 
is particularly important in an outbreak setting where detecting those shedding virus 
in the absence of symptoms may aid infection control procedures (Gallimore et al, 
2004). 
Although previous research has shown the improved sensitivity of PCR in 
comparison to alternative methods such as EM and EIA, to date these studies have 
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focused on use of the tests in a research setting, based on relatively small numbers of 
samples and carried out by highly specialised researchers. The research described in 
this thesis, in contrast, has demonstrated the increased sensitivity of PCR in 
comparison to EM based on high volumes of samples in a routine diagnostic setting 
where the tests are often carried out by less specialised staff. 
Moreover, the research has also shown that such sensitivity can be achieved at 
the same time as reduced turn-around-times in comparison to EM. Studies showing 
the positive effect of real-time PCR methods on rapidity and throughput (and, by 
implication, ease of use) are largely absent from the published literature despite the 
fact that these factors can be very important, since they determine whether a test is 
suitable for a routine diagnostic setting and how clinically useful it will be (discussed 
in more detail in the following section).  
Diagnostic laboratories have in the past been reluctant to implement PCR 
assays as a result of many factors, most of them associated with negative perceptions 
or experiences of conventional gel-based PCR (see Chapter 2 for full details). The 
results shown here, however, have demonstrated that real-time PCR can overcome 
many of these difficulties. The real-time PCR methods introduced at WOSSVC have 
proven to be both robust and capable of high throughput, indicating relative ease of 
use. (In particular, the use of a specific labelled probe in the dual-labelled probe-based 
assays was found to aid ease of interpretation in comparison to a SYBR green based 
approach.) Moreover, several techniques for improving the efficiency of the real-time 
tests without affecting their sensitivity have been successfully demonstrated (Gunson, 
Collins and Carman, 2006(ii)). Such techniques are largely ignored in the scientific 
literature but are of high practical value in a diagnostic setting. 
One drawback of PCR remains, however, which is that the implementation of 
such methods still requires technical expertise in quality control (see Chapter 5). All 
PCR assays, and in particular real-time PCR assays, should be monitored carefully to 
detect any contamination, or sudden or long-term loss in sensitivity. Either could 
result in false negative or positive results. However, to ease this problem there are 
now a number of useful guides available that describe monitoring systems such as 
those used here (described in Chapter 5), and which are relatively easy to implement 
and maintain (Gunson, Collins and Carman, 2005; Niesters, 2002; Gray et al, 1995; 
Gray, 1999). 
 210 
In addition to the benefits seen within the laboratory itself, the wider 
usefulness of the new molecular service for norovirus in outbreaks of IID is indicated 
by the fact that a number of other Scottish Specialist Virology Centres or SVCs 
(Aberdeen, Dundee and Edinburgh) have begun to use the WOSSVC service for 
norovirus outbreaks or plan to do so in the near future, despite having their own 
testing capability. Moreover, since publications relating to the research carried out 
here, which were among the first to show the practical advantages of both the 
Lightcycler™ and dual-labelled probe-based real-time RT-PCR methods, and the 
reduced sensitivity and specificity of commercial EIA methods for norovirus (Miller, 
Gunson and Carman, 2002; Gunson, Miller and Carman, 2003) a number of virology 
laboratories have replaced or are about to replace EM or commercial EIA methods for 
the detection of viral pathogens in outbreak samples with the real-time PCR test for 
norovirus described here.  
In the sporadic setting the real-time PCR tests implemented have proven 
useful for laboratories with limited or no testing protocol of their own. They have also 
proven useful in the BMT setting for the detection of viral IID in 
immunocompromised patients, where the sensitivity of EM and EIA may not be good 
enough (Cubitt et al, 1999). At the time of writing no other laboratory in Scotland 
offers real-time PCR testing for viral causes of sporadic IID. The WOSSVC, in fact, 
provides the only service in Scotland that tests for all five main causes of viral IID.  
It is not only virology laboratories that can benefit from use of the PCR tests 
described here. The WOSSVC is currently involved in a pilot study to outsource real-
time PCR tests to microbiology laboratories affiliated to District General Hospitals 
(DGHs). The first phase of the study will examine the effect of implementing the 
WOSSVC real-time RT-PCR for norovirus in two DGH sites. Each site will be 
provided with a “kit” for the test containing the standard operating procedures, pre-
optimised primer/probe pools, and PCR controls and reagents. The WOSSVC will 
also offer full training to laboratory staff and a troubleshooting service. To facilitate 
the implementation of the test the laboratories involved have obtained automated 
extraction equipment and PCR platforms similar to those in use at the WOSSVC. 
Having a norovirus service on-site at the DGH will negate the need to send samples to 
the WOSSVC and therefore has the potential to improve the rapidity of sample results 
significantly. For clinicians, access to a sensitive and rapid service for norovirus will 
aid patient management and infection control decisions (see below for a detailed 
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discussion). In the laboratory, supported implementation of the test will provide useful 
experience of real-time PCR methodology, which in future could be used in other 
areas of their service. The plan is that, if successful, the project may be widened to 
include other sites and tests. 
Finally, awareness of the benefits of implementing real-time PCR, 
demonstrated in this research, has been used to improve other diagnostic services in 
the WOSSVC laboratory. Based on the successful experience of implementing real-
time PCR in the norovirus outbreak service, for example, in 2004 conventional RT-
PCR assays for the detection of viral and bacterial respiratory infections were 
replaced in the laboratory with a number of real-time PCR methods (Gunson et al, 
2005). Since their implementation significant improvements have been observed in 
throughput, rapidity and overall detection rates. This service also benefited from the 
test amendments described in Chapter 4, which once implemented led to further 
improvements in rapidity, ease of use and cost. Similar real-time PCR systems have 
also been developed in the laboratory to test for viral pathogens in other sample types 
and/or patient groups (e.g. CSF samples and plasma from BMT patients). Plans for 
further use of this technology in the laboratory include extending its use to other areas 
of microbiology such as rapid MRSA screening (Gilpin et al, 2007), bacterial 
gastroenteritis (Wang and Mestaphai, 2007; Shannon et al, 2007) and bacterial sepsis 
(Stratidis, Bia and Edberg, 2007). 
6.3. Implications For Patient Management 
The changes in the WOSSVC diagnostic service for viral causes of IID 
introduced in this research are likely to aid patient management on a number of fronts. 
More sensitive testing, for example, increases the likelihood of obtaining an accurate 
diagnosis, which enables clinicians to confirm the initial clinical diagnosis and to 
exclude other, more serious causes of IID or non infectious causes of intestinal illness 
(Fine et al, 1998). A more rapid, accurate result also enables the clinician to correctly 
advise the patient on the likely duration of illness, its infectiousness and how they can 
reduce the likelihood of further spread to other members of the public (Guerrant et al, 
2001). Patients, for example, can be advised on the sources of IID (e.g. soiled 
nappies) and informed that simple procedures such as frequent hand washing can 
reduce the risk of infection.  
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Accurate management based on a laboratory diagnosis is particularly 
important if the patient poses a public health hazard, since such patients may also 
require follow up testing before returning to their place of work. This applies to 
patients working in the food industry or the National Health Service (Bresee et al, 
2002), children attending nursery school or elderly residents in a care home. The 
ability to swiftly advise a patient in such matters based on an accurate laboratory 
result will help prevent further infections, which in turn saves on further health care 
expenditure related to, for example, GP/hospital visits by newly infected patients. 
Furthermore, the ability to provide a result rapidly can help reduce the number of 
unnecessary tests that are carried out in the meantime, and in those with more serious 
illness may help prevent unnecessary hospitalisation or, if already hospitalised, may 
mean a reduction in the length of stay. All of these factors contribute to reducing 
unnecessary health care costs as well as improved care for the patient. 
Access to a more rapid and sensitive service also has benefits in reducing the 
prescription of unnecessary treatments. Although not generally recommended for 
treating IID, particularly in children and for patients managed in the primary care 
setting, a recent study in Ireland found that approximately 7.5% of patients who 
consulted a GP for symptoms of IID received empirical therapy, which represented 
15% of all treatments prescribed (Acute Gastroenteritis in Ireland, North and South - 
A Telephone Study, 2003). This is despite the increasing evidence that shows viruses 
to cause much of the illness in all age groups (Phan et al, 2005; Bon et al, 1999; 
Bereciartu, Bok and Gomez, 2002; Qiao et al, 1999; Oh, Gaedicke and Schreier, 
2003; de Wit et al, 2001 (i); de Wit et al, 2001 (ii)) and the fact that antibiotics may, 
in some bacterial infections, result in more severe or prolonged symptoms (Armon et 
al, 2001). Those with travel associated IID, immunocompromised patients with IID 
and patients hospitalised due to IID are also likely to receive empirical anti-microbial 
treatment (Guerrant et al, 2001), despite data showing that viral pathogens can cause 
many of these cases (Keswick et al, 1982; Vollet et al, 1979; Bolivar et al, 1979; 
Steffen et al, 1999; Chapin et al, 2005). Consequently, access to a more rapid and 
sensitive viral diagnosis service can help encourage more judicious use of antibiotics, 
potentially reducing the number of patients receiving unnecessary treatment and/or 
reducing the duration of treatment (Armon et al, 2001). This will both reduce costs 
and help prevent the emergence of antimicrobial resistance (Holmberg et al, 1984; 
Cohen and Tauxe, 1986).  
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For all of this to be effective, however, it is important that clinicians receive 
laboratory results as early as possible after the onset of symptoms, and while the 
illness is still occurring. The sensitivity of the testing is key in providing an accurate 
diagnosis, but unless clinicians and public health managers receive test results within 
a clinically useful timeframe these are of little practical value either to them or to the 
patient.  
Previously, using the EM-based service the best turn-around-times achieved 
for samples from cases of IID were 50% of results reported by day 5 and 90% 
reported by day 11 (the figures were the same for both outbreak and sporadic samples, 
although turn-around-times for the latter varied considerably more and could be as 
high as day 9 for 50% of results and day 23 for 90%). Based on these figures, it is 
likely that in a large proportion of cases the laboratory diagnosis was not received by 
clinicians until after resolution of the illness - too late to take steps to prevent the 
spread of the infection and/or unnecessary treatment/testing/hospitalisation. Following 
implementation of the new PCR-based service, on the other hand, turn-around-times 
for outbreak samples were reduced to days 2 and 5 respectively (50% and 90% of 
results reported), and days 3 and 6 for sporadic samples. Consequently, results from 
the new service are far more likely to be of value to clinicians in providing 
appropriate patient care. This increased utility is likely to have been a factor in the 
increased uptake of the service i.e. the increase in sample submission rates observed 
following introduction of the new tests.  
One of the main advantages of a rapid diagnostic result in any context is that it 
allows the appropriate treatment, (where available) to be started when the illness is 
occurring, the pathogen is present and when treatment is likely to be most useful. 
However, historically rapid and sensitive tests for the majority of viral pathogens have 
not been available and as a result anti-viral therapies have been mainly restricted to 
the treatment of those viral pathogens known to cause chronic infections such as 
HBV, HCV and HIV (Waugh et al, 2002; O’Shea, 2007; Sandrock and Kelly, 2007). 
In recent years, improvements in the rapidity and sensitivity of routine diagnostic tests 
for some viral pathogens have led to the emergence of new therapies. For example, 
the availability of rapid and sensitive tests for influenza such as DIF, bedside tests and 
real-time PCR have led to the development of new anti-influenza therapies. Examples 
include oseltamivir, a neuraminidase inhibitor that has been shown to be most 
effective when given within 48 hours of disease onset (Waugh et al, 2002; Mitamura, 
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2007). Similarly, the availability of rapid and sensitive tests has made the use of pre-
emptive therapies feasible for CMV, adenovirus and EBV-related disease in BMT 
patients (Cochrane, 2006; Baillie, 2006; Okano and Gross, 2007; Neofytos et al, 
2007).  
The improvement in rapidity offered by the real-time PCR service 
implemented in this research can thus help create demand for the development of new 
anti-viral agents aimed at reducing the clinical severity of IID, the duration of 
infection or at preventing infection altogether (Estes et al, 2006) – particularly since 
data from the telephone survey suggest that other testing centres also intend to utilise 
or replicate the service. Such drugs could be used, for instance, to treat those with 
severe disease (to reduce severity or duration of symptoms) or could be used 
prophalatically in the outbreak setting to reduce the number of cases and further 
spread. Recent studies using nitrazoxanide, a thiolzolide anti-infective agent, have 
shown it to reduce the duration of symptoms due to norovirus and rotavirus in 
paediatric patients (Rossignol and Gohary, 2006; Rossignol et al, 2006). 
6.4. Implications For Infection Control 
The new molecular service for IID is also likely to be beneficial in the 
outbreak setting as the increased rapidity and sensitivity of the service allows timely, 
focused implementation of control measures that are recommended by published 
guidelines and the previous experience of infection control teams (MMWR weekly, 
2005). Previously, the turn-around-times of the EM-based service (where the best 
performance achieved for outbreak samples was 50% of results reported by day 5 and 
90% reported by day 11) were such that it was of limited use in this context, since 
results would often be obtained too late to inform decisions on possible control 
measures. As discussed in Chapter 2, the quicker infection control procedures can be 
implemented following the start of a norovirus outbreak the more likely it is that these 
will be effective. One estimate, for example, is that control procedures must be 
implemented within 3 days if they are to be successful (Lopman et al, 2003). The 
improved turn-around-times of the PCR-based service (50% of results reported by day 
2 and 90% by day 5), therefore, mean that the test results are now much more likely to 
be of value in this setting. 
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Even where results were reported ‘in time’ to be of use, moreover, the poor 
detection rate of the EM-based service for outbreaks (a total of 15-16 outbreaks 
confirmed in the years 1999-2000 compared to between 83-223 in the 6 years post-
implementation of the PCR-based service) meant that false negative results were more 
likely and thus may have led to under-implementation of infection control procedures. 
Based on the new real-time PCR service, swift and confident knowledge of the 
actual cause of an outbreak can help persuade ward managers to implement expensive 
control procedures such as short-term ward closure. It can also help exclude other, 
potentially more serious, causes of outbreaks that may require different infection 
control measures. Once an outbreak of norovirus has been confirmed, moreover, the 
improved rapidity and sensitivity of the PCR tests described here can also aid ward 
management in other ways. Screening, for example, can be used to aid decisions on 
staff deployment and patient cohorting or isolation measures, by identifying those 
with symptomatic and asymptomatic infection (Gallimore et al, 2004).  
The rapid and sensitive testing provided by the PCR-based service may also 
allow new forms of infection control to be employed in future. A holding ward, for 
example, could be used to temporarily house all newly admitted patients with 
symptoms of gastroenteritis. A rapid test could then be carried out to exclude 
norovirus or other viral infection before allowing the patient to be transferred to 
another ward. Norovirus-positive cases could remain in the holding ward until the risk 
of infection was past, thereby preventing spread to others within the hospital.  
In future, screening could also be considered for Health Care Workers 
(HCWs) before allowing them to return to work after a period of illness due to viral 
IID. Most current guidelines for norovirus infections suggest a worker should not 
return to work until 48-72 hours after clinical symptoms have abated (Joint Working 
Group from NHS Boards, Local Authorities and SCIEH, 2003). A further 
development of this would be to screen the returning HCWs to identify those with 
prolonged shedding, preventing these individuals from returning to work until the risk 
of infection had abated.  
The new PCR-based service could also be used in future to test environmental 
surfaces for viral contamination, thus measuring the effectiveness of infection control 
procedures such as cleaning. Several studies have established that contaminated 
fomites can be responsible for prolonging or reseeding outbreaks in closed settings 
(Kussi, 2002; Evans, 2002), although the relationship between the presence of virus 
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on an inanimate surface and infectivity has yet to be fully proven. Areas at risk 
include much-handled items such as door handles, lockers, taps, soft furnishings, 
floors, walls, soiled linen and commodes (Green, 1997; Gallimore et al, 2006). Whilst 
in theory most of these areas can be cleaned using already established procedures, in 
practice the cleaning is often poorly executed and/or external pressures to re-open a 
ward can prevent the proper procedures from being carried out (Christie, 2002; 
Cowden, 2002). The rapidity of the new PCR service, however, means that in future 
the effectiveness of the cleaning process could be tested using environmental swabs 
before a ward is re-opened, thereby encouraging strict adherence to procedure and 
reducing the risk of outbreaks recurring.  
6.5. Implications For Disease Surveillance 
At present the surveillance of viral and other causes of IID in Scotland is 
carried out by Health Protection Scotland (HPS), formerly known as the Scottish 
Centre of Infection and Environmental Health (SCIEH). HPS collect data on cases of 
IID from three surveillance systems: the national surveillance scheme for laboratory 
confirmed infections, the national surveillance scheme for general outbreaks of IID, 
and the notifications of food poisoning system (Wall et al, 1996). Two of these 
systems utilise laboratory data (the national surveillance scheme for laboratory 
confirmed infections and the national surveillance scheme for general outbreaks of 
IID) and are therefore likely to have been affected by the changes in the WOSSVC 
service described in this thesis.  
The first of these schemes, the national surveillance system for laboratory 
confirmed infections, is a voluntary system operated by HPS that aims to detect 
unusual outbreaks or new trends associated with a particular pathogen. It relies on 
clinical microbiology laboratories in Scotland reporting all laboratory-confirmed 
infections to the HPS. In each case laboratories are asked to submit the following 
data: patient details (surname and forename or, if these are not available, the 
laboratory number can be submitted instead), organism and type, the age of the 
patient, NHS board of origin, and clinical details. The HPS provide a standard form 
requesting these data, although some laboratories send their own form to the HPS. 
The report is sent on a weekly basis to the HPS by post, email or fax. The data 
collected from these reports are then examined by health board and for the nation as a 
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whole, and are compared to historical data in order to identify any outbreaks or new 
trends associated with a particular pathogen.  
The data collected by the system are skewed by a number of factors. For 
example, not all cases of viral IID occurring in the community are likely to seek 
medical attention (Wheeler et al, 1999; Wall et al, 1996; WHO 7th report). Of those 
that do, most are likely to be suffering from severe infections and to be from 
particular at-risk patient groups (e.g. infants and the elderly). The GP/hospital sample 
submission rate is also important, as not all patients who present to GPs/hospitals 
have a sample submitted for laboratory investigation. Where a sample is submitted the 
testing protocol of the laboratory is very important. The absence of a test for a 
particular pathogen or the routine use of an insensitive diagnostic assay increases the 
chance of underestimating the presence of some pathogens in the community.  
Figure 26: Number of norovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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Comparing the number of norovirus detections made by the WOSSVC service 
to that collected by the national surveillance scheme for laboratory confirmed 
infections (Figure 26) suggests that the WOSSVC service is a major contributor to 
this surveillance system. In 2001 and 2002, in fact, when real-time PCR was first 
introduced in the laboratory, almost all reported cases were likely to have originated 
from the WOSSVC. In subsequent years, once other laboratories began to replace EM 
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with more sensitive tests e.g. EIA (or introduce a norovirus testing protocol), the 
proportion of cases contributed by the WOSSVC initially fell but has since risen and 
continues to represent more than 50% of all reported cases. Thus the improvements 
observed in this research in terms of rapidity, detection rate and uptake of the service 
since the transition to real-time PCR are likely to substantially improve the quality of 
the HPS surveillance data. The increase in service sensitivity, together with the rise in 
the number of individuals tested from a greater range of health boards, allows a more 
accurate picture of the role of norovirus-related illness to be drawn, in different age 
groups, health board regions and in Scotland as a whole. The increased rapidity of the 
service, moreover, will help improve the timeliness of the surveillance data, creating a 
more accurate picture of when cases are occurring. Taken together, these 
improvements can aid the identification of unusual trends such as the large increases 
in disease activity observed as a result of the emergence of a new worldwide 
norovirus variant in 2002 and again in 2006 (Lopman et al, 2004; Gallimore et al, 
2007).  
The improved timeliness of the surveillance data will also increase public 
health officials’ ability to investigate unusual outbreaks of norovirus whilst these are 
still occurring (and thus implement suitable control measures). Possible examples 
include outbreaks of norovirus where the source is a pre-packaged food that is widely 
distributed e.g. through a supermarket chain, and which causes illness over a wide 
geographic area that can only be linked via a national surveillance scheme.  
For non-norovirus causes of IID the new PCR-based service in the laboratory 
is likely to have less impact on the data collected by the national surveillance of 
laboratory confirmed infections, for a number of reasons. Between 2004 and 2006, for 
example, when real-time PCR for non-norovirus pathogens was first introduced in the 
laboratory, the rotavirus and adenovirus detections reported by the WOSSVC 
contributed only a tiny proportion of the total number of cases reported to the HPS 
surveillance scheme (Figure 27). In the case of rotavirus, this can largely be attributed 
to the fact that many laboratories already screen for rotavirus (as shown in the results 
of the telephone survey described in Chapter 5) and report their cases to the HPS 
directly. Samples that are submitted to the WOSSVC tend to come from a small 
number of laboratories with no rotavirus protocol of their own, or have already been 
screened for rotavirus pre-submission. In the case of adenovirus, meanwhile, cases 
reported to the HPS include detections from all types of adenovirus-related diseases 
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(e.g. eye infections and respiratory infections) since the HPS system does not require 
respondents to distinguish between the different types. No attempt is made in the 
system to distinguish between trends in adenovirus related to IID and those related to 
other diseases. Thus, although the WOSSVC is one of the few laboratories to test for 
adenovirus in samples from cases of IID (as shown in the results of the telephone 
survey described in Chapter 5) the contribution made by these detections to the 
overall figures is tiny, and is too small to have a significant impact on the analysis of 
trends in adenovirus.  
Comparing the number of astrovirus and sapovirus detections reported by the 
WOSSVC since the introduction of real-time PCR for their detection in late 2004 with 
thenumber collected by the HPS surveillance system in the same period (Figure 28 
and Figure 29) confirms that the WOSSVC is the only laboratory currently able to test 
for these pathogens, as suggested by the telephone survey described in Chapter 5. (In 
fact, in some cases the number detected by the WOSSVC exceeded the number 
published by the HPS, either due to faulty reporting by the WOSSVC or failure to 
include all reported cases by the HPS.) Prior to this (between 1999-2003), EM was 
used to test for astrovirus and sapovirus in a number of laboratories including the 
WOSSVC, but was gradually phased out in other laboratories in favour of focusing on 
alternative tests (mostly EIA) for the detection of rotavirus. However, despite the fact 
that the WOSSVC is currently the only laboratory to test for these pathogens in 
sporadic cases of IID, the number of samples submitted to this service and hence the 
rate of detections has been, to date, too low for the HPS to determine any useful 
epidemiological patterns - although the situation may improve as more samples from 
sporadic cases of IID are submitted to the WOSSVC service, of which there were 
some early indications in 2006.  
 220 
Figure 27: Number of rotavirus and adenovirus detections made at the WOSSVC vs 
total reported by the HPS surveillance system (1999-2006). 
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 Figure 28: Number of astrovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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Figure 29: Number of sapovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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The national surveillance scheme for general outbreaks of IID is another 
voluntary system operated by the HPS that employs laboratory data. It aims 
specifically to provide information useful for formulating infection control and 
prevention policies. Under this scheme, all preliminary reports of suspected ‘general 
outbreaks’ of IID from laboratories, Consultants in Public Health Medicine (CPHMs), 
Environmental Health Officers (EHOs) and other sources (for example, news reports, 
members of the public, hospitals etc.) are investigated. A general outbreak of IID is 
defined in this context as “affecting members of more than one private residence, or 
residents of an institution” and is considered distinct from family outbreaks. 
Following the report of a suspected outbreak the HPS sends out a standardised 
questionnaire to the appropriate lead investigator. The data requested in the 
questionnaire include the causal pathogen (laboratory-confirmed, suspected or 
unknown), the vehicle of transmission and source, number of persons involved in the 
outbreak, number of cases confirmed using laboratory methods, and the NHS board of 
origin. Once complete, the form can be submitted by mail, fax or email.  
Unlike the national surveillance scheme for laboratory confirmed infections, in 
this system the recording and reporting of IID outbreak activity is not dependent on 
laboratory results. Outbreaks of gastroenteritis can be included in the final collected 
data regardless of whether or not any patient samples have been submitted to a 
laboratory for testing. As a result, the new molecular services implemented at the 
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WOSSVC as part of this research are likely to have less impact on the outbreak data 
collected by this surveillance system than on the previous scheme described. 
However, laboratory confirmation (or otherwise) of the viral cause of the outbreak 
remains a component in the system and this is dependent on the quality of the 
laboratory tests employed. As a result, the increased sensitivity of the PCR-based 
service for the detection of norovirus (the principle cause of outbreaks of IID) is likely 
to help increase the number of outbreaks proven to be caused by norovirus, thereby 
improving the quality of the collected data. This will help contribute to a more 
accurate measure of the role, epidemiology and public health effect of norovirus 
outbreaks in Scotland, which in turn will provide more accurate information on which 
to base infection control and prevention policies.  
The availability of a rapid, sensitive diagnostic service for norovirus such as 
that developed in this research could also be used as the basis for new surveillance 
systems for viral IID. One possible system would be to recruit a small number of GPs 
throughout Scotland to act as sentinel sites (Clothier et al, 2005). Each GP would be 
paid to submit all or a defined number of IID samples each week to their nearest 
Specialist Virology Centre (or a central facility) for testing. Results would then be 
returned both to the GPs and the HPS. Thus, instead of relying on individual 
clinicians’ awareness of the tests available for IID to ensure that samples are 
submitted for testing, surveillance of community acquired viral IID in Scotland would 
be based on regular, systematic collection of data from a representative set of 
geographic locations. While it is possible that such a system could be implemented 
based on tests other than PCR, the use of molecular methods means that the data are 
more likely to accurately represent the level of infection in the community and the 
times at which it occurs, thus increasing the likelihood of the necessary investment in 
the system. A similar PCR-based system is already in place for the surveillance of 
viral respiratory infections in Scotland3. Other possible sentinel sites could include 
microbiological laboratories, schools or accident and emergency departments 
(Takahashi et al, 2001).  
                                                 
3
 http://www.hps.scot.nhs.uk/resp/influenzaseason.aspx#background 
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6.6. Future Work 
There are a number of areas in which the molecular service for IID developed 
as described in this thesis would benefit from further research.  
Some of this research is already underway. For example, as mentioned in 
Chapter 5, the current WOSSVC molecular service for IID does not include an 
internal control, largely because of concerns relating to the increased cost and 
complexity of using such a system at the time. Research is now underway, however, 
to investigate the use of an internal control system, based on the recent advent of 
specialised commercial kits for multiplex real-time PCR (see below). 
Research is currently underway at the WOSSVC on a laboratory-wide internal 
control system that uses murine cytomegalovirus (mCMV) for DNA tests and the 
plant virus brome mosaic virus (BMV) for RNA tests. The aim is to add these viruses 
to the sample lysis buffer, which will then be automatically added to each sample 
during the process of nucleic acid extraction. This method is intended to detect the 
presence of PCR inhibitors in the sample and will also aid the detection of post-
extraction technical errors. It will not, however, detect cases where the original 
sample was not added to the bio-robot lysis plate. The main breakthrough that has 
favoured this development is the advent of new commercial kits specially designed 
for multiplex real-time PCR (in this case the Qiagen Quantitect multiplex kit). These 
kits contain synthetic factors that increase the concentration of primers at the target 
site and stabilise the bound primers. As a result, the process of multiplexing an 
internal control PCR assay to the existing assays is made easier since these kits reduce 
the need for complex optimisation procedures, and reduce test competition and primer 
interaction.  
The availability of such kits also favours the implementation of multiplex real-
time PCR tests. This has led to the development of a novel dual-labelled probe-based 
multiplex RT-PCR for adenovirus, astrovirus, rotavirus and sapovirus (no such assay 
is currently available in the published literature) partly based on the results of the 
research described in this thesis. The multiplex test includes a new in-house astrovirus 
RT-PCR that targets the 3’ NCR region and can theoretically detect all serotypes of 
astrovirus, and a sapovirus real-time RT-PCR that can detect all 5 genotypes (Oka et 
al, 2006). The assays for adenovirus and rotavirus, however, are those outlined in this 
thesis. To date, the new multiplex assay has been shown to be as sensitive as the 
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equivalent singleton assays using dilution series of typed samples. The inclusion of an 
RT step, moreover, has been shown to have no effect on the sensitivity of the 
adenovirus PCR. However, the sensitivity of the multiplex assay is still to be 
compared with that of the current service on clinical samples. If found to have 
comparable or improved sensitivity the test is planned for implementation in late 
2007, with the aim of further improving the efficiency of platform use within the 
laboratory, and further reducing turn-around-times and test costs.  
Another extension of the research carried out here that is currently being 
pursued is the development of nucleotide sequencing protocols for viral causes of IID. 
Nucleotide sequencing is a powerful technique, allowing the determination of the 
precise order of the nucleotides in a DNA sequence (or RNA molecule following 
reverse transcription). The sequence can then be compared with a library of known 
sequences for epidemiological and clinical purposes. If implemented successfully, a 
sequencing service for the 5 main viral causes of IID will compliment the current 
molecular diagnostic service as it can be used to provide data on the circulating types, 
subtypes and variants of each pathogen, to investigate outbreak transmission routes 
and sources, and to link cases previously thought unrelated. A system of this type has 
already been published that sequences the RdRp and ORF2 regions  of norovirus 
(Gallimore et al, 2007). This method was used to show the emergence of a new 
variant of norovirus (G2 v4.4) in Scotland in January 2006. The new variant became 
the predominant strain by April of that year and, like the variant that emerged in 2002, 
was associated with a significant increase in norovirus detections, outbreaks and 
sample submissions. The new variant was also found in England and Wales, where it 
also resulted in an increase in disease activity (Gallimore et al, 2007). Following the 
early success of this system the possibility of offering a typing service for every 
norovirus outbreak in Scotland is now being considered. The aim would be to use this 
facility to monitor the emergence of new variants and to investigate large outbreaks 
(potentially identifying their sources and transmission routes, and any previously 
unrecognised links between outbreaks). A similar service for rotavirus is also possible 
if the new vaccination program is implemented in Scotland (see chapter 2). This could 
be used to monitor the types of rotavirus circulating in the community before and after 
introduction of the vaccine in order to help determine its effectiveness (Mazick et al, 
2007). A rotavirus typing service would also be useful in the laboratory for 
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monitoring the PCR target sites used in the current tests, to ensure that variations do 
not occur which may result in reduced test sensitivity. 
Other research under consideration includes a comparison of alternative 
sample preparation methods to those employed here. All of the samples tested in the 
research described in this thesis were processed using the Qiagen Blood kit on the 
Biorobot 9604. However, in recent years several other kits and extraction platforms 
have been made available, including some specifically designed for the extraction of 
viral pathogens from stool (e.g. the Qiagen DNA stool mini kit) or for viruses in 
general (e.g. the Qiagen Virus kit), together with some kits that concentrate the eluted 
nucleic acid further than is achievable with the current system (e.g. the Nuclisens™ 
EasyMag kit). These kits and platforms have the potential to offer improved nucleic 
acid extraction compared to the method employed in this research, which in turn 
could lead to improved pathogen detection rates. In future, therefore, a comparison of 
these methods would be useful.   
 Similarly, the number of real-time PCR methods published for norovirus has 
increased significantly in recent years (Houde et al, 2006; Jolkihumar et al, 2005; 
Pang et al, 2004; Schmid et al, 2004; Hoehne et al, 2006; Simpson et al, 2004; 
Richards et al, 2004), although detailed sensitivity comparisons between these 
methods remain rare. The dual-labelled probe-based RT-PCR assay investigated in the 
research described in Chapter 4 and subsequently implemented (Kageyama et al, 
2003) was one of the first of its type to be published. It is possible that one or more of 
the assays published subsequently may offer increased sensitivity in comparison. A 
comparative evaluation of the sensitivity of a number of these published real-time 
PCR assays, similar to the study carried out by Vinje et al for conventional PCR 
methods (Vinje et al, 2003), would therefore be of considerable interest. For the 
sporadic service a comparison of the latest published methods for the detection of 
non-norovirus causes of IID would also be useful, although here the choice of real-
time assays remains limited to a small number of SYBR green and dual-labelled 
probe-based RT-PCR tests for astrovirus and sapovirus.  
6.7. Thesis Conclusion. 
The thesis expounded in this research is that the implementation of the 
molecular method Polymerase Chain Reaction (PCR) for the diagnosis of the viral 
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causes of outbreaks and sporadic cases of gastroenteritis can bring significant benefits 
to a routine laboratory service. The data presented here confirm that this is in fact the 
case. Since the introduction of the adapted molecular tests at the WOSSVC for the 
detection of viral pathogens in outbreaks and sporadic cases of gastroenteritis the 
number of samples tested by the routine diagnostic service has risen steadily. 
Moreover, the rate of positive detections has improved and this has been achieved at 
the same time as a substantial reduction in sample turn-around-times. This is a 
significant improvement over the previous EM-based service. 
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